Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23428.Concentration of VLDL Particles,AGRP,Agouti-related protein,40516,0.229275813561429,0.00450066740116744,0.220454505455141,0.238097121667718,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN1,CCN family member 1,40280,0.337427013817645,0.00655934109691615,0.324570705267689,0.350283322367601,0
NMR metabolomics,X23428.Concentration of VLDL Particles,F7,Coagulation factor VII,40376,0.103903197014728,0.00258956313472547,0.0988276532706658,0.10897874075879,0
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.128368738603001,0.00269138860267252,0.123093616941763,0.133643860264239,0
NMR metabolomics,X23428.Concentration of VLDL Particles,LDLR,Low-density lipoprotein receptor,40356,0.376536145317579,0.00370047098505797,0.369283222186866,0.383789068448293,0
NMR metabolomics,X23428.Concentration of VLDL Particles,MFGE8,Lactadherin,40332,0.171772866972668,0.00358143500837133,0.164753254356261,0.178792479589076,0
NMR metabolomics,X23428.Concentration of VLDL Particles,NPY,Pro-neuropeptide Y,40489,0.297570994160609,0.005580460241276,0.286633292087708,0.30850869623351,0
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.181896793598403,0.00246094042761562,0.177073350360277,0.18672023683653,0
NMR metabolomics,X23428.Concentration of VLDL Particles,PROC,Vitamin K-dependent protein C,40372,0.0898223038246744,0.00217736839543926,0.0855546617696134,0.0940899458797353,0
NMR metabolomics,X23428.Concentration of VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.144118108898565,0.00364591757610406,0.136972110449402,0.151264107347729,0
NMR metabolomics,X23428.Concentration of VLDL Particles,TFPI,Tissue factor pathway inhibitor,40309,0.122937423556427,0.00265299605286395,0.117737551292814,0.12813729582004,0
NMR metabolomics,X23428.Concentration of VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.251973064786977,0.00649975495516682,0.23923354507485,0.264712584499104,1.11296127010018e-308
NMR metabolomics,X23428.Concentration of VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0742835552386546,0.00191912389994855,0.0705220723947555,0.0780450380825538,1.11553865986406e-308
NMR metabolomics,X23428.Concentration of VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.10806217855558,0.00287173090523609,0.102433585981317,0.113690771129843,4.91046585278721e-297
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL27,C-C motif chemokine 27,40359,0.191436378528536,0.00518355529716444,0.181276610146094,0.201596146910978,1.55953359521641e-286
NMR metabolomics,X23428.Concentration of VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,40424,0.143361489681482,0.00402685968521472,0.135468844698461,0.151254134664503,3.29211206982741e-267
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.182450507151207,0.00524783231498429,-0.192736258488576,-0.172164755813838,2.97046613256975e-255
NMR metabolomics,X23428.Concentration of VLDL Particles,FURIN,Furin,40411,0.101800367157015,0.00294990827964898,0.0960185469289029,0.107582187385127,9.31399779731526e-252
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL23,C-C motif chemokine 23,40422,0.123434730951053,0.00358978971177119,0.116398743115981,0.130470718786125,5.02815469595018e-250
NMR metabolomics,X23428.Concentration of VLDL Particles,CES1,Liver carboxylesterase 1,40352,0.227797746444905,0.0066717826192398,0.214721052511195,0.240874440378615,1.22673990375407e-246
NMR metabolomics,X23428.Concentration of VLDL Particles,APCS,Serum amyloid P-component,37882,0.1047403424269,0.00314004465827217,0.0985858548966861,0.110894829957113,1.88700775035391e-234
NMR metabolomics,X23428.Concentration of VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.0994995330131892,0.00305291297784673,0.0935158235766096,0.105483242449769,1.15428387657574e-225
NMR metabolomics,X23428.Concentration of VLDL Particles,LPL,Lipoprotein lipase,40359,-0.129512667312041,0.0040368297080486,-0.137424853539817,-0.121600481084266,6.79521865761087e-219
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.053478035890705,0.00166825800245907,0.0502082502058852,0.0567478215755247,1.58489720378966e-218
NMR metabolomics,X23428.Concentration of VLDL Particles,PTH,Parathyroid hormone,37572,0.220873489480091,0.00691739283418041,0.207315399525097,0.234431579435085,1.60324850229214e-215
NMR metabolomics,X23428.Concentration of VLDL Particles,GHR,Growth hormone receptor,37671,0.0798720731250171,0.00253128659520868,0.0749107513984081,0.0848333948516261,9.34088339018425e-211
NMR metabolomics,X23428.Concentration of VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.186283810065624,0.00595472584302518,0.174612547413295,0.197955072717954,1.62098339057321e-208
NMR metabolomics,X23428.Concentration of VLDL Particles,PAMR1,Inactive serine protease PAMR1,40332,0.0769579258516444,0.00246254506176419,0.0721313375305866,0.0817845141727022,4.06387598698888e-208
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.22042974546032,0.00708658931604883,0.206540030400864,0.234319460519776,4.07654631860518e-206
NMR metabolomics,X23428.Concentration of VLDL Particles,CFP,Properdin,38013,0.0593733009538426,0.00192273988378174,0.0556047307816303,0.0631418711260548,2.10065946183319e-202
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.236378474739761,0.00775449006773154,0.221179674207007,0.251577275272515,2.23073776071353e-198
NMR metabolomics,X23428.Concentration of VLDL Particles,P4HB,Protein disulfide-isomerase,40266,0.103372182911517,0.00341168333491084,0.0966852835750921,0.110059082247943,4.47249127737521e-196
NMR metabolomics,X23428.Concentration of VLDL Particles,NRP1,Neuropilin-1,40424,-0.0748708971817181,0.00248684199853035,-0.0797451074988376,-0.0699966868645986,9.78132466335491e-194
NMR metabolomics,X23428.Concentration of VLDL Particles,TTR,Transthyretin,37871,0.0673588764084797,0.00225048781957832,0.0629479202821062,0.0717698325348532,1.33582346379675e-190
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.274409286697925,0.00927408725192196,0.256232075684158,0.292586497711692,2.47698909966192e-187
NMR metabolomics,X23428.Concentration of VLDL Particles,CD4,T-cell surface glycoprotein CD4,40309,0.0797968513352596,0.00269918317010702,0.0745064523218499,0.0850872503486694,5.04990890211909e-187
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0961069726632772,0.00324374194175598,0.0897492384574355,0.102464706869119,5.857478949738e-187
NMR metabolomics,X23428.Concentration of VLDL Particles,GCG,Pro-glucagon,39980,0.325208810526113,0.0110212257675804,0.303607208021655,0.34681041303057,3.05817520913831e-186
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL6,C-X-C motif chemokine 6,40516,0.199774365200453,0.0068782963602022,0.186292904334456,0.213255826066449,8.30918150244681e-181
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0468274566661077,0.00163732934396729,0.0436182911519318,0.0500366221802836,2.4325366291897e-175
NMR metabolomics,X23428.Concentration of VLDL Particles,SYAP1,Synapse-associated protein 1,37671,0.142941277330681,0.00499048424708912,0.133159928206387,0.152722626454976,4.14710834101654e-175
NMR metabolomics,X23428.Concentration of VLDL Particles,SNCA,Alpha-synuclein,37671,0.286948634761398,0.0100585121715253,0.267233950905209,0.306663318617588,9.16026198572967e-174
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.372909490484359,0.0131267514174099,0.347181057706235,0.398637923262482,3.73128779479488e-173
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.198799094869943,0.00701315919930667,0.185053302839302,0.212544886900584,1.79303730913474e-172
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS15,Enteropeptidase,40305,0.231214032995836,0.00816196960560803,0.215216572568844,0.247211493422827,2.94440243636556e-172
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA5,Plasma serine protease inhibitor,37835,0.0824089164599643,0.00290852602050735,0.0767082054597699,0.0881096274601587,1.46642508821694e-171
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC39A5,Zinc transporter ZIP5,40341,0.131966948644748,0.00474964545704365,0.122657643548942,0.141276253740553,6.00982609201383e-166
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR37,Prosaposin receptor GPR37,40042,0.164829158500642,0.00595548690419677,0.153156404168416,0.176501912832868,1.2313626665792e-164
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG2,Desmoglein-2,40332,-0.0657308242385944,0.0023912234234554,-0.070417622148567,-0.0610440263286218,1.50552669028713e-162
NMR metabolomics,X23428.Concentration of VLDL Particles,CHMP6,Charged multivesicular body protein 6,37990,0.135239368773359,0.00493670963759757,0.125563417883667,0.14491531966305,7.41802032632565e-161
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPIND1,Heparin cofactor 2,37981,0.0663170000146042,0.00242243263589222,0.0615690320482555,0.071064967980953,1.2053970975321e-160
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN3,Contactin-3,40332,0.0846822462319178,0.00310402324144066,0.0785983606786941,0.0907661317851415,3.39424284098482e-160
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA4,Kallistatin,37781,0.0572620626561273,0.00212262029797423,0.0531017268720978,0.0614223984401568,4.10922924123223e-156
NMR metabolomics,X23428.Concentration of VLDL Particles,CPM,Carboxypeptidase M,40415,0.0816656081029709,0.00304342104948189,0.0757005028459864,0.0876307133599555,3.56518174944978e-155
NMR metabolomics,X23428.Concentration of VLDL Particles,CFI,Complement factor I,38013,0.0477147776962509,0.00178149058943419,0.0442230561409599,0.051206499251542,4.91690305580067e-154
NMR metabolomics,X23428.Concentration of VLDL Particles,AGR3,Anterior gradient protein 3,39963,0.141043543885717,0.00528817367801281,0.130678723476812,0.151408364294622,2.82278514331062e-153
NMR metabolomics,X23428.Concentration of VLDL Particles,INHBC,Inhibin beta C chain,40332,0.100691013769878,0.00378500349940868,0.0932724069110366,0.108109620628719,1.37002152476113e-152
NMR metabolomics,X23428.Concentration of VLDL Particles,CFH,Complement factor H,37301,0.0543710898210871,0.00204705973650426,0.0503588527375388,0.0583833269046355,2.27290861807779e-151
NMR metabolomics,X23428.Concentration of VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.196519233748463,0.00747737168105544,0.181863585253595,0.211174882243332,5.33833061658663e-149
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF9,Protein turtle homolog A,37990,0.185768983683142,0.00706260648774627,0.17192627496716,0.199611692399125,9.33585594961952e-149
NMR metabolomics,X23428.Concentration of VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,39980,0.253235368903983,0.00966496634529258,0.234292034867209,0.272178702940756,4.16464621751964e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.121466680766209,0.00464079015509214,0.112370732062229,0.13056262947019,6.69927891595642e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.060283708071679,0.00230464060769298,0.0557666124806007,0.0648008036627572,9.86585282356572e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0483997953038287,0.00186536010086082,0.0447436895061415,0.0520559011015159,1.95770779847462e-145
NMR metabolomics,X23428.Concentration of VLDL Particles,KLKB1,Plasma kallikrein,37721,0.0577036993435408,0.0022394491492223,0.0533143790110651,0.0620930196760165,6.61187983980195e-143
NMR metabolomics,X23428.Concentration of VLDL Particles,NCS1,Neuronal calcium sensor 1,40489,0.0653788656710621,0.00254377169633306,0.0603930731462493,0.0703646581958749,8.60473030733196e-143
NMR metabolomics,X23428.Concentration of VLDL Particles,ADIPOQ,Adiponectin,38013,-0.151927901678955,0.00590325638915536,-0.163498284201699,-0.14035751915621,1.18676415543255e-142
NMR metabolomics,X23428.Concentration of VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.235358432864683,0.00917301817301094,0.217379317245582,0.253337548483785,2.71135705904593e-142
NMR metabolomics,X23428.Concentration of VLDL Particles,CRIP2,Cysteine-rich protein 2,40228,0.0825632751260822,0.00321961897761234,0.076252821929962,0.0888737283222024,3.98190697858769e-142
NMR metabolomics,X23428.Concentration of VLDL Particles,F10,Coagulation factor X,37987,0.0591758916647978,0.00230621722901019,0.0546557058959378,0.0636960774336577,7.96742563911275e-142
NMR metabolomics,X23428.Concentration of VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,40411,0.0576015640796292,0.00224906268103953,0.0531934012247917,0.0620097269344667,8.22167808790362e-142
NMR metabolomics,X23428.Concentration of VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.318007961162699,0.0123937127893577,0.293716284095557,0.34229963822984,8.45856747921291e-142
NMR metabolomics,X23428.Concentration of VLDL Particles,GUSB,Beta-glucuronidase,40419,0.132929324548748,0.00519958462225104,0.122738138689136,0.14312051040836,2.5425537670242e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.167999123254635,0.00659281340586211,0.155077208979145,0.180921037530125,2.1178097581903e-140
NMR metabolomics,X23428.Concentration of VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,37598,0.191336993443581,0.00749782947018525,0.176641247682018,0.206032739205144,3.05914441352543e-140
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINF2,Alpha-2-antiplasmin,37755,0.0307869659666752,0.00120697125111265,0.0284213023144944,0.033152629618856,3.68916152999208e-140
NMR metabolomics,X23428.Concentration of VLDL Particles,KYNU,Kynureninase,40516,0.100657550076699,0.00397068985957223,0.0928749979519374,0.108440102201461,4.78043889613236e-139
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,40359,0.0674239003722788,0.00266048329323626,0.0622093531175358,0.0726384476270219,6.08504170799823e-139
NMR metabolomics,X23428.Concentration of VLDL Particles,CREG1,Protein CREG1,40145,0.0811840662671199,0.00321098991345675,0.0748905260367446,0.0874776064974951,2.82222828653474e-138
NMR metabolomics,X23428.Concentration of VLDL Particles,SOST,Sclerostin,40330,0.0867420322085847,0.00344192744765706,0.0799958544111769,0.0934882100059925,1.90839584004162e-137
NMR metabolomics,X23428.Concentration of VLDL Particles,PRAP1,Proline-rich acidic protein 1,37998,0.0949895414077765,0.00376392235885175,0.087612253584427,0.102366829231126,2.29750791048715e-137
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL22,C-C motif chemokine 22,40204,0.114631798624123,0.00458521876284118,0.105644769848954,0.123618827399291,2.60005437583773e-135
NMR metabolomics,X23428.Concentration of VLDL Particles,ATRN,"Attractin, Isoform 2",38013,0.0362502444757503,0.00145556193246907,0.0333973430881109,0.0391031458633897,6.61071843573131e-134
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.150388644086044,0.00603938233645436,0.138551454706593,0.162225833465494,7.56800955598532e-134
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL17,C-X-C motif chemokine 17,40516,0.0913847647097092,0.00369012756298106,0.0841521146862663,0.0986174147331521,6.62005055579611e-133
NMR metabolomics,X23428.Concentration of VLDL Particles,PROS1,Vitamin K-dependent protein S,38013,0.0552690980923844,0.00223410180925953,0.0508902585462357,0.0596479376385331,3.40873624344098e-132
NMR metabolomics,X23428.Concentration of VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.085882053113494,0.00348522710346068,0.0790510079907111,0.0927130982362769,1.23170212967472e-131
NMR metabolomics,X23428.Concentration of VLDL Particles,STAB2,Stabilin-2,37998,0.0613904589082997,0.00248772837016874,0.0565145113027689,0.0662664065138304,1.47412609122221e-131
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,40377,0.0875230386563945,0.00355359138777631,0.080557999536353,0.0944880777764361,1.74169876132418e-131
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTA1,Glutathione S-transferase A1,40333,0.181140240124342,0.00737053182136159,0.166693997754474,0.195586482494211,6.25017612467412e-131
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAPIN,SNARE-associated protein Snapin,37959,0.125388339467774,0.00510284108819624,0.115386770934909,0.135389908000639,1.79331719984609e-130
NMR metabolomics,X23428.Concentration of VLDL Particles,SORT1,Sortilin,40330,0.0792192227620328,0.00323752864067403,0.0728736666263117,0.0855647788977539,7.91708073463306e-130
NMR metabolomics,X23428.Concentration of VLDL Particles,NUMB,Protein numb homolog,37598,0.181969010551141,0.00743138795614076,0.167403490157105,0.196534530945177,1.60093203625606e-129
NMR metabolomics,X23428.Concentration of VLDL Particles,BCHE,Cholinesterase,37748,0.0616404890668071,0.00251826271989762,0.0567046941358077,0.0665762839978064,1.8451153523866e-129
NMR metabolomics,X23428.Concentration of VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0669058110089787,0.00274813884888244,0.0615194588651691,0.0722921631527882,1.38972513306546e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,F9,Coagulation factor IX,40372,0.0388662153704122,0.00160160489153182,0.0357270697830099,0.0420053609578146,9.05118764867263e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.126024045766522,0.00522816920116613,0.115776834132237,0.136271257400808,4.55730912737494e-126
NMR metabolomics,X23428.Concentration of VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0550489341347128,0.00228662462496789,0.0505671498697758,0.0595307183996499,8.39859883112687e-126
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAT,Tissue-type plasminogen activator,40490,0.10523254297103,0.00437172519919839,0.0966639615806008,0.113801124361459,8.45628254555245e-126
NMR metabolomics,X23428.Concentration of VLDL Particles,NAA80,N-alpha-acetyltransferase 80,37572,0.255265827603203,0.0105944165940819,0.234500771078803,0.276030884127604,1.49852030507674e-125
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTA3,Glutathione S-transferase A3,39980,0.16191288600359,0.00675250924791037,0.148677967877685,0.175147804129494,8.62277037877971e-125
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0581502782041123,0.00242606965743925,0.0533951816755313,0.0629053747326932,9.33691210703327e-125
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.14346503653925,0.00601263088879201,0.131680279997217,0.155249793081282,1.30506989287111e-123
NMR metabolomics,X23428.Concentration of VLDL Particles,LAT2,Linker for activation of T-cells family member 2,40305,0.259981307512903,0.0109185667320706,0.238580916718045,0.281381698307762,3.7020802763403e-123
NMR metabolomics,X23428.Concentration of VLDL Particles,GRP,Gastrin-releasing peptide,37628,0.115511888038246,0.00484808735911396,0.106009636814383,0.12501413926211,6.95545551181736e-123
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO3,Beta-enolase,37628,0.119698158686542,0.00505809685334961,0.109784288853977,0.129612028519107,2.77608388296303e-121
NMR metabolomics,X23428.Concentration of VLDL Particles,CPB2,Carboxypeptidase B2,37981,0.0469995557892421,0.00199281809486511,0.0430936323233065,0.0509054792551778,1.48246164693994e-120
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP5,Retinol-binding protein 5,40305,0.11618874099136,0.00494344557746487,0.106499587659528,0.125877894323191,4.20630305641113e-120
NMR metabolomics,X23428.Concentration of VLDL Particles,UPB1,Beta-ureidopropionase,37990,0.190626123135705,0.00814715704925368,0.174657695319168,0.206594550952242,1.00426555234624e-118
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR5,Cadherin-related family member 5,40359,0.0810514176370255,0.00347709119212377,0.0742363189004629,0.0878665163735881,3.32518396146762e-118
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,40411,0.0444856843509288,0.00191005309034658,0.0407419802938495,0.0482293884080081,5.12832005246895e-118
NMR metabolomics,X23428.Concentration of VLDL Particles,EEF1D,Elongation factor 1-delta,37990,0.190414605332652,0.00817349636583268,0.17439455245562,0.206434658209684,9.79103449269873e-118
NMR metabolomics,X23428.Concentration of VLDL Particles,APOM,Apolipoprotein M,40372,0.05542022747209,0.00238864571574598,0.0507384818692278,0.0601019730749521,3.82777311568321e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.165068996836863,0.00711043514320822,0.151132543956175,0.179005449717552,6.29811022882971e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,DTYMK,Thymidylate kinase,37990,0.142830525437604,0.00618047824579057,0.130716788075854,0.154944262799353,6.35420618312181e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,IL16,Pro-interleukin-16,40516,0.0831602538559347,0.00360638169387951,0.0760917457359308,0.0902287619759385,8.95809543422815e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,ACY1,Aminoacylase-1,40359,0.12249414182042,0.00531320875756318,0.112080252655596,0.132908030985244,1.0339415634239e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP29,Synaptosomal-associated protein 29,40411,0.187685132469198,0.0081454980355821,0.171719956319457,0.203650308618939,1.36544735963016e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL13,C-X-C motif chemokine 13,40471,0.130270207210752,0.0056659644779041,0.11916491683406,0.141375497587444,4.09087661831572e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0532754416987766,0.00231563041089671,0.048736806093419,0.0578140773041341,7.19179815842991e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,GLA,Alpha-galactosidase A,37642,0.0741213531931897,0.00323088613226893,0.0677888163739426,0.0804538900124368,3.04108007430494e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,40228,0.0600344982052786,0.00262412183621055,0.0548912194063059,0.0651777770042512,5.47733579563023e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0434376743873574,0.00189664139327854,0.0397202572565315,0.0471550915181834,7.13001723544157e-114
NMR metabolomics,X23428.Concentration of VLDL Particles,FCN2,Ficolin-2,40291,0.0835125027314937,0.00366712176720243,0.0763249440677769,0.0907000613952104,5.46302435282976e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,AFM,Afamin,38013,0.0378990448434487,0.00166468989967332,0.0346362526400889,0.0411618370468084,1.25856771190602e-112
NMR metabolomics,X23428.Concentration of VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,40305,0.137567700660396,0.00607816741599975,0.125654492525036,0.149480908795755,1.19533615342311e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,40359,-0.0800821841388014,0.00354288175583214,-0.0870262323802324,-0.0731381358973704,2.24901814240681e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,NOMO1,Nodal modulator 1,40332,0.0477199333998496,0.00211673375332007,0.0435711352433422,0.0518687315563569,8.34964801048325e-111
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,40341,0.0865367772206103,0.00384002892947829,0.0790103205188328,0.0940632339223877,1.0075451288971e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",39961,0.110331650602948,0.00489727081484311,0.100732999805856,0.119930301400041,1.27067235236606e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,AMBP,Protein AMBP,40470,0.0402578957904818,0.00178998238072043,0.0367495303242698,0.0437662612566938,2.59934076969287e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.0831740981204506,0.0037151520338896,0.075892400134027,0.0904557961068742,2.54516729918641e-109
NMR metabolomics,X23428.Concentration of VLDL Particles,MLN,Promotilin,40341,0.177623325668905,0.00793881527211723,0.162063247735555,0.193183403602255,3.40388842737562e-109
NMR metabolomics,X23428.Concentration of VLDL Particles,YES1,Tyrosine-protein kinase Yes,40305,0.226351773873719,0.010156943345119,0.206444164917285,0.246259382830152,2.34698470206464e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.177173975440787,0.00795731717511005,0.161577633777571,0.192770317104002,3.69727270173792e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,DPY30,Protein dpy-30 homolog,40414,0.118260858228896,0.00531669976907733,0.107840126681505,0.128681589776288,5.6934155126171e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR2,Cadherin-related family member 2,40305,0.152946830763433,0.00687925094219914,0.139463498916723,0.166430162610144,7.2828959160697e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL17,C-C motif chemokine 17,40333,0.179917999667976,0.00809537988846514,0.164051055086584,0.195784944249368,8.65417405423414e-108
NMR metabolomics,X23428.Concentration of VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.164987747226761,0.00743402504057316,0.150417058147237,0.179558436306284,3.27291503761228e-107
NMR metabolomics,X23428.Concentration of VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0592760949963771,0.00267514809086965,0.0540328047382726,0.0645193852544816,7.05349388251364e-107
NMR metabolomics,X23428.Concentration of VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.0565751171019585,0.00255805068724095,0.0515613377549662,0.0615888964489508,8.52395895032682e-107
NMR metabolomics,X23428.Concentration of VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0401509446471668,0.00181891310234106,0.0365858749665784,0.0437160143277553,2.22709165134652e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.0909355469965408,0.00412093994014924,0.0828585047138482,0.0990125892792333,2.70532894120111e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,YTHDF3,YTH domain-containing family protein 3,40044,0.166871305438884,0.00758128525772698,0.152011986333739,0.181730624544029,9.17278960887799e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0790537638514786,0.00359142144303529,0.0720145778231294,0.0860929498798278,1.58163743986819e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.10682235736274,0.00487310164283222,0.0972710781427889,0.116373636582691,6.28769201397456e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,EHBP1,EH domain-binding protein 1,37990,0.146245006492103,0.00667409213773458,0.133163785902143,0.159326227082063,1.29075542217352e-104
NMR metabolomics,X23428.Concentration of VLDL Particles,FN1,Fibronectin,38013,0.0513309895458403,0.00234415288586593,0.046736449889543,0.0559255292021375,1.75751838514504e-104
NMR metabolomics,X23428.Concentration of VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,37671,0.144606411733857,0.00660749411743246,0.131655723263689,0.157557100204025,2.52996537672518e-104
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH9,Myosin-9,37998,0.219583166506314,0.0100397112849103,0.19990533238789,0.239261000624739,3.06185792114106e-104
NMR metabolomics,X23428.Concentration of VLDL Particles,FYB1,FYN-binding protein 1,40311,0.178374362358055,0.00817932078829289,0.162342893613001,0.194405831103109,6.52437215570772e-104
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK1,Dickkopf-related protein 1,40471,0.116203255107692,0.00533906310859363,0.105738691414848,0.126667818800535,1.57683375116627e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.0402942041250214,0.00185563126481275,0.0366571668459884,0.0439312414040544,4.92654888145535e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,APOC1,Apolipoprotein C-I,37981,0.0702777895793079,0.00324193406025249,0.063923598821213,0.0766319803374028,1.82756794900509e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,TJAP1,Tight junction-associated protein 1,40411,0.159582351080893,0.00738730855508279,0.145103226312931,0.174061475848856,4.9305074727124e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0561201825505057,0.00259784181191107,0.05102841259916,0.0612119525018514,8.80171464482225e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,CES2,Cocaine esterase,40305,0.103433722144726,0.00479695715581563,0.0940316861193272,0.112835758170124,1.16488596141331e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,HEG1,Protein HEG homolog 1,37671,0.0508168238545335,0.00236384951747774,0.0461836788002772,0.0554499689087899,8.66107476600092e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.0465108989980144,0.00217192633484865,0.0422539233817111,0.0507678746143178,2.51184115697325e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.0395899883620167,0.00185215728041136,0.0359597600924104,0.043220216631623,5.84630722208401e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINF1,Pigment epithelium-derived factor,37790,0.0495996995606492,0.00231917927470179,0.0450541081822337,0.0541452909390647,8.34803975519476e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,SARG,Specifically androgen-regulated gene protein,37931,0.207271633089352,0.00971917408349568,0.1882220518857,0.226321214293004,2.81941897870986e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18R1,Interleukin-18 receptor 1,40516,0.0620711360310835,0.00291588731487042,0.0563559968939375,0.0677862751682295,3.48220536235211e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,40355,0.06880123395406,0.00324988859843011,0.062431452301137,0.075171015606983,4.0335618528676e-98
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFB1,BPI fold-containing family B member 1,40261,-0.116327706212084,0.00551919673841866,-0.127145331819385,-0.105510080604784,2.81087412181725e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL16,C-C motif chemokine 16,40536,0.0998128105043885,0.00473635446071471,0.0905295557613877,0.109096065247389,2.84870069599673e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.138545636902068,0.00657815540248962,0.125652452313189,0.151438821490948,3.91234054116584e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,DAB2,Disabled homolog 2,40489,0.207870472762868,0.00987555541316495,0.188514384153064,0.227226561372671,4.77980399146673e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.178826604429543,0.00853574061869736,0.162096552816896,0.195556656042189,3.70546198118087e-96
NMR metabolomics,X23428.Concentration of VLDL Particles,ELN,Elastin,37990,0.0659911231123126,0.0031486561803003,0.059819756998924,0.0721624892257012,5.21696548783152e-96
NMR metabolomics,X23428.Concentration of VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0518267953951069,0.0024796213602546,0.0469667375290079,0.0566868532612059,1.0123258169427e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.135872993129323,0.00650410318513034,0.123124950886467,0.148621035372178,2.08313641518995e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,F11R,Junctional adhesion molecule A,40332,0.105606199368549,0.0050642108449601,0.0956803461124271,0.115532052624671,2.67636264138949e-95
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.134717651823823,0.0064741216644445,0.122028373361512,0.147406930286134,1.19400354512331e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.156965859493538,0.00755494266929861,0.142158171861713,0.171773547125364,2.28008682001315e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,BTD,Biotinidase,38013,0.0384388629220569,0.00185059091464449,0.0348117047293537,0.0420660211147601,2.31064204245927e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.0502493253141386,0.00242249120258994,0.0455012425570623,0.0549974080712149,2.55219360186848e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.155659725162023,0.0075030649123335,0.140953717933849,0.170365732390196,3.90961530270946e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,SORD,Sorbitol dehydrogenase,40417,0.123971494433698,0.00599216064368601,0.112226859572073,0.135716129295322,7.3958875548799e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,LEFTY2,Left-right determination factor 2,40453,0.0963262835932496,0.00465641075944384,0.0871997185047396,0.105452848681759,7.67392604478629e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,SCLY,Selenocysteine lyase,40434,0.0883518386858135,0.0042727214311567,0.0799773046807464,0.0967263726908806,9.17619437521124e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.126123640840368,0.00610606140688164,0.11415576048288,0.138091521197856,2.64722594261509e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0497295688799488,0.00241519949926458,0.0449957778613903,0.0544633598985074,8.99130460900657e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,39961,0.145467812075926,0.007078772355926,0.131593418258311,0.159342205893541,1.31697574369934e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,GHRL,Appetite-regulating hormone,40359,0.145256399619588,0.00707083651439224,0.131397560051379,0.159115239187797,1.40877165465921e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,OTUD7B,OTU domain-containing protein 7B,37959,0.116327737158081,0.00566010041398487,0.10523394034667,0.127421533969491,1.89622070730029e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.116809742782607,0.00569205682036749,-0.127966174150527,-0.105653311414687,2.11783789707673e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL5,C-X-C motif chemokine 5,40309,0.210682135264772,0.0102873090019082,0.190519009621032,0.230845260908513,5.04028472819938e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.150566964979443,0.00735909354659014,0.136143141628126,0.164990788330759,7.29066980176248e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5E,5'-nucleotidase,40411,0.10591626004539,0.00519010138156718,0.0957436613375182,0.116088858753262,2.10534775774369e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,TPD52L2,Tumor protein D54,37671,0.197457528565354,0.00967270369093537,0.178499029331121,0.216416027799588,3.189100494573e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.175110991286735,0.00858018397079069,0.158293830703985,0.191928151869485,3.29986490370051e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,NUCB2,Nucleobindin-2,40447,0.0678777075514747,0.00333129371368856,0.0613483718726451,0.0744070432303043,3.92618507512058e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,CD63,CD63 antigen,40203,0.0952209557124842,0.00468026266998844,0.0860476408793069,0.104394270545662,7.50804509661494e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.195378005768488,0.00961184636456619,0.176538786893938,0.214217224643037,1.6802623277924e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,TXLNA,Alpha-taxilin,40228,0.162310348995397,0.00800093173245498,0.146628522799786,0.177992175191009,2.40087929989876e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.202993184732054,0.00999962940474107,0.183393911098761,0.222592458365346,3.00155185884372e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.0987649766026342,0.00487320728387658,0.0892134903262361,0.108316462879032,3.53260023325775e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM20A,Pseudokinase FAM20A,37990,0.0514112425787955,0.00253564582876252,0.0464413767544209,0.05638110840317,4.5859371147458e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.152708801735426,0.00753399271591942,0.137942176012224,0.167475427458628,5.20785789930093e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP20,Centrosomal protein 20,39980,0.133599283730025,0.00660324310704812,0.120656927240211,0.146541640219839,7.29354580410509e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.0927547464466841,0.00458175077066342,0.0837745149361838,0.101734977957184,8.62247194834177e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,MTSS1,Protein MTSS 1,37901,0.20084555485324,0.00992240626349229,0.181397638576795,0.220293471129685,9.10411010784909e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,MINK1,Misshapen-like kinase 1,37942,0.167834820236077,0.0082976941011155,0.15157133979789,0.184098300674263,1.21046698271013e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,AXIN1,Axin-1,40341,0.170184196477431,0.00843015028106948,0.153661101926535,0.186707291028327,1.66521512690481e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFC,Vascular endothelial growth factor C,40411,0.101067839093063,0.00500889039582325,0.0912504139172498,0.110885264268877,2.00091671386534e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0624455413085795,0.00309732515997863,0.0563747839950214,0.0685162986221376,2.77410030547448e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0624985207742934,0.00310161106801016,-0.0685776784675933,-0.0564193630809935,3.3641761753708e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,CD99L2,CD99 antigen-like protein 2,40332,0.0428712612499046,0.00213341294323597,0.0386897718811621,0.0470527506186471,1.02855790205948e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.175181270029959,0.00872404794444689,0.158082136058843,0.192280404001075,1.38349755621803e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.149563626844732,0.00744752016721906,0.134966487316982,0.164160766372481,2.17960281216493e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,KAZN,Kazrin,37901,0.186821781052759,0.00930525194470688,0.168583487241133,0.205060074864384,2.29833157073045e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,ATG16L1,Autophagy-related protein 16-1,37901,0.151743236765772,0.00758814566991413,0.13687047125274,0.166616002278804,1.08602904142396e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,40422,0.223812305928064,0.0112058933284969,0.20184875500421,0.245775856851918,1.11616927302342e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.191640650396929,0.00960150484452684,0.172821700901656,0.210459599892201,2.2306435616054e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,TCTN3,Tectonic-3,37990,0.0522616037377492,0.00261845421598347,0.0471294334744216,0.0573937740010768,2.25183056976554e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,CD6,T-cell differentiation antigen CD6,40502,0.0948470925731637,0.00476763726235403,0.0855025235389498,0.104191661607378,5.12586791349922e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.086304636111683,0.00434606786007858,0.077786343105929,0.094822929117437,1.06010600344931e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,KHK,Ketohexokinase,37628,0.114727047339,0.00577589883245503,0.103406285627388,0.126047809050611,1.56063003621325e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,37959,0.202818748728267,0.0102213814146293,0.182784841155593,0.22285265630094,2.16176499257963e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,40471,0.170772601545886,0.0086415664927861,0.153835131220025,0.187710071871747,6.69105146721699e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.097558910708998,0.00494354025474892,0.0878695718096902,0.107248249608306,1.15684647822819e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300LG,CMRF35-like molecule 9,40332,-0.0666792264583312,0.00338304115411224,-0.0733099871203912,-0.0600484657962713,1.86097784967834e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,SELP,P-selectin,40403,0.101778530298617,0.00516928663768648,0.0916467284887519,0.111910332108483,2.74865441467449e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.187077678838576,0.00951458447983683,0.168429093258096,0.205726264419056,4.65421877456978e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.127637057965803,0.00649657726836069,0.114903766519816,0.14037034941179,6.17478276956425e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.0801521227153251,0.00408329695935536,0.0721488606749886,0.0881553847556616,8.81332577105525e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.118003925935533,0.00601119988287683,0.106221974165095,0.129785877705972,8.99663282184895e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,37942,0.0820371021559539,0.00417994599324054,0.0738444080092025,0.0902297963027054,1.38753165619188e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,ARF6,ADP-ribosylation factor 6,37901,0.184981539607501,0.00942526132055049,0.166508027419222,0.20345505179578,1.40447304605463e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0402747205634924,0.00205866215337279,0.0362397427428818,0.0443096983841031,3.09762316426246e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.122810039075277,0.00628260675629158,0.110496129832946,0.135123948317609,4.4197247507444e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,PLTP,Phospholipid transfer protein,40461,-0.0599714043168155,0.00306909227172996,-0.0659868251694063,-0.0539559834642248,4.73447001348371e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNA4,Plexin-A4,40341,0.144698407091794,0.00741090468716205,0.130173033904956,0.159223780278631,6.45962107301438e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.189922793447049,0.00971779253559601,0.170875920077281,0.208969666816818,6.81659352164661e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,BECN1,Beclin-1,37628,0.10685192769454,0.00546792524183928,0.0961347942205349,0.117569061168545,7.45053567260852e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,37901,0.166960541963713,0.00854991466156717,0.150202709227041,0.183718374700384,9.18464552545102e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF21,Fibroblast growth factor 21,40453,0.205017683088707,0.0105123590093382,0.184413459430404,0.225621906747009,9.78153227906192e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,PLIN1,Perilipin-1,39961,0.0621102582099832,0.00318637835687191,0.0558649566305143,0.0683555597894522,1.27201226358997e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,MTSS2,Protein MTSS 2,37900,0.172079290095681,0.00882306384049352,0.154786084968314,0.189372495223048,1.461294584818e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,CTBS,Di-N-acetylchitobiase,37819,0.0473909117914138,0.00243166404467093,0.0426248502638587,0.0521569733189688,1.94678226327486e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,THPO,Thrombopoietin,40042,0.066689395213339,0.00342787525605602,0.0599707597114692,0.0734080307152088,2.56469438243654e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,AAMDC,Mth938 domain-containing protein,37628,0.0937273919998612,0.0048133847692301,0.0842931578521702,0.103161626147552,2.78388516278735e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,AGRN,Agrin,40422,0.0575359343410924,0.00297848642913958,0.0516981009399788,0.063373767742206,3.33305817363467e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.178347559385959,0.00922233737303871,0.160271778134803,0.196423340637115,3.48435956473225e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.179728864261861,0.00930861069700915,0.161483987295723,0.197973741227999,4.02246071614435e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,EZR,Ezrin,40471,0.0409589490235411,0.0021252111175984,0.0367935352330482,0.0451243628140339,7.65020850824594e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0556599796261416,0.00289297654850861,0.0499897455910647,0.0613302136612184,1.46709212069826e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,40332,-0.0701139039879997,0.00365098084128109,-0.0772698264369107,-0.0629579815390888,2.84807759659639e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.106272319979691,0.00553532766286878,0.0954230777604683,0.117121562198914,3.29328161397351e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,RTBDN,Retbindin,40305,0.0504349997825329,0.00263159612448369,0.0452770713785449,0.0555929281865209,5.9448413310937e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,DOK2,Docking protein 2,40359,0.207583038276706,0.0108331057441834,0.186350151018107,0.228815925535305,6.27597163601045e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0865534701182618,0.00451772262317709,0.0776987337768347,0.0954082064596889,6.67429127291379e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,C1S,Complement C1s subcomponent,38013,0.0356642338028444,0.00186322377444948,0.0320123152049234,0.0393161524007654,1.32191684439779e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,USO1,General vesicular transport factor p115,40305,0.155317422984677,0.00814570917632749,0.139351832999075,0.171283012970279,3.71379144418781e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL10,C-X-C motif chemokine 10,40422,0.115337254802685,0.00606122924904319,0.10345724547456,0.12721726413081,7.53777074459529e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R9B,Neurabin-2,40516,0.160118733007484,0.00842817638200241,0.143599507298759,0.176637958716208,1.31962465493311e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.127672839888012,0.0067159410217644,0.114509595485354,0.14083608429067,1.61599361592125e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA3F,Semaphorin-3F,40359,0.044086329144166,0.00232275658049849,0.039533726246389,0.0486389320419431,1.87624435823648e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.155026208154073,0.00816375216254943,0.139025253915476,0.171027162392669,2.2655061405151e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,NCK2,Cytoplasmic protein NCK2,40422,0.177859972564052,0.00937853613861636,0.159478041732364,0.19624190339574,2.48841245340414e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,CMIP,C-Maf-inducing protein,37900,0.139819134362991,0.00737434737318142,0.125365413511556,0.154272855214427,3.90515163898949e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,37942,0.150576326652417,0.00795473510898528,0.134985045838806,0.166167607466028,6.88815966045488e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINH1,Serpin H1,37714,0.218765126327207,0.0115586709286141,0.196110131307124,0.241420121347291,7.52681426028241e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK10,Kallikrein-10,40354,0.0667250827699141,0.00353124216450353,0.0598038481274872,0.073646317412341,9.02371520070379e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBIN,Erbin,40305,0.173821235299676,0.00920817562992502,0.155773211065023,0.191869259534329,1.28607047320013e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN1,Dynactin subunit 1,40489,0.11138546475051,0.00590669446369682,0.0998083436016643,0.122962585899356,1.79887178645692e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,NPPC,C-type natriuretic peptide,40341,0.0730284971687653,0.00387448444412816,0.0654345076582741,0.0806224866792565,2.16001469040745e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN2,CCN family member 2,40358,0.097355313213346,0.0051706711232954,0.087220797811687,0.107489828615005,3.13093233922431e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.11669355448558,0.00619869447437971,0.104544113315796,0.128842995655365,3.43173481089275e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.0769776195329282,0.00408554185377543,0.0689699574995284,0.0849852815663281,3.64257641648336e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.0967413508246319,0.00513520751086432,0.0866763441033378,0.106806357545926,3.84685376142231e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.0520302130163953,0.00276604811081952,0.046608758719189,0.0574516673136015,4.39839815660391e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,C9,Complement component C9,37987,-0.0823398867536076,0.00437571492411975,-0.0909162880048823,-0.0737634855023329,5.35950739392862e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,DCXR,L-xylulose reductase,40411,0.0882630864944126,0.00469593018257434,0.0790590633365669,0.0974671096522583,5.68996160583401e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.0669199312763438,0.00355826002862844,0.059945741620232,0.0738941209324555,6.60014689679002e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0472647099106064,0.00252017386374641,0.0423251691376634,0.0522042506835493,1.22125895804973e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,CES3,Carboxylesterase 3,40305,0.115537563842678,0.00617064954667737,0.10344309073119,0.127632036954165,2.16549793576403e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,ASAH2,Neutral ceramidase,40228,0.088459923175709,0.00472731327757315,0.0791943891516656,0.0977254571997523,2.68529243730594e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0488536706576961,0.00261509517045685,0.0437280841236007,0.0539792571917916,4.59298405989692e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.167544557756424,0.00898192618730336,0.149939982429309,0.185149133083538,7.65659713466137e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL5,C-C motif chemokine 5,40403,0.167512936985179,0.00899376808614,0.149885151536345,0.185140722434014,1.29650232353108e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.109208551405832,0.00586398075049612,0.0977151491348593,0.120701953676804,1.86012641517524e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.063119963188053,0.0033930362837752,0.0564696120718536,0.0697703143042524,1.97514462422331e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNB3,Plexin-B3,40310,0.0779520924017599,0.00419198098578917,0.0697358096696132,0.0861683751339067,2.26359480558691e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,THOP1,Thimet oligopeptidase,40288,0.0500058234530441,0.00269108567037944,0.0447312955391004,0.0552803513669879,2.90320993176828e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,SLA2,Src-like-adapter 2,37959,0.172201470913823,0.00926060793340031,0.154050679364359,0.190352262463288,3.14391397642029e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,BCR,Breakpoint cluster region protein,40341,0.151977054111846,0.00818190823642824,0.135940513968447,0.168013594255246,3.29372123933011e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.0828163055873686,0.00445806850073531,0.0740784913259274,0.0915541198488098,3.31660909985754e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.137421688490235,0.00740231676299489,0.122913147634765,0.151930229345705,4.12990660602971e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,HJV,Hemojuvelin,37959,0.0769230352664304,0.00414034644258076,0.0688079562389721,0.0850381142938887,4.21739656564002e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA5,Integrin alpha-5,40332,0.0414723709684918,0.00223793699092423,0.0370860144662803,0.0458587274707032,7.24801098363086e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.098755824680284,0.00532946204770988,0.0883100790667726,0.109201570293795,7.51773196406882e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,HMOX2,Heme oxygenase 2,39961,0.075969132575821,0.00410493506282021,0.0679234598526934,0.0840148052989487,1.18656035249579e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,F13B,Coagulation factor XIII B chain,37934,0.0429306866930761,0.00232102853434669,0.0383814707657565,0.0474799026203956,1.88880889638776e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,FETUB,Fetuin-B,40372,0.0560579401062268,0.00303486395757037,0.0501096067493888,0.0620062734630647,2.15347625451636e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,BID,BH3-interacting domain death agonist,40341,0.111179630017002,0.00602097726042659,0.0993785145865655,0.122980745447438,2.4067335807222e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,FUOM,Fucose mutarotase,37671,0.1036499313472,0.00560724106636137,0.0926597388571321,0.114640123837269,2.42024845545334e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,PCBP2,Poly(rC)-binding protein 2,37959,0.119118853400289,0.00644769687980029,0.10648136751588,0.131756339284698,2.78900053375207e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.15809398626452,0.00856634386925309,0.141303952280784,0.174884020248256,2.86941785000077e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,PAXX,Protein PAXX,37671,0.075147692224925,0.00407313111469372,0.0671643552401253,0.0831310292097247,4.5862136824375e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,STC1,Stanniocalcin-1,40471,0.0685079375346316,0.0037218376938821,0.0612131356546227,0.0758027394146405,6.8238454244851e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.0526464154426552,0.00286151382779004,0.0470378483401867,0.0582549825451237,8.06344675461824e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP85,Centrosomal protein of 85 kDa,39980,0.10392196135649,0.00566274480261552,0.0928229815433632,0.115020941169616,1.95065144247759e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.17916350461821,0.0097828684180259,0.159989082518879,0.198337926717541,5.06722708093879e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,NPL,N-acetylneuraminate lyase,37990,0.070987352614103,0.00387722831065525,0.0633879851252187,0.0785867201029873,5.4898858128304e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,37990,0.148121153477529,0.00809319667838144,0.132258487987901,0.163983818967157,6.20718413501677e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.1837200899047,0.0100477498542674,0.164026500190336,0.203413679619064,6.27246144424018e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A4,Protein S100-A4,40411,0.0948066004928168,0.00518998397570741,0.0846342319004302,0.104978969085203,8.5197677594523e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,40305,0.226214638767208,0.0123878863071283,0.201934381605237,0.25049489592918,9.64336408570216e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.138753619089179,0.00759617361374459,0.12386511880624,0.153642119372119,1.25587363877573e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,PLSCR3,Phospholipid scramblase 3,37919,0.0977796497832939,0.00537973439739674,0.0872353703643963,0.108323929202192,5.9891042532894e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,40042,0.0561247432790688,0.00309117443793875,0.0500660413807088,0.0621834451774287,6.43371114344086e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.0618093599667129,0.00340701465382861,0.0551316112452088,0.068487108688217,7.95677163336636e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,MME,Neprilysin,40305,0.132772765173502,0.00731872236459738,0.118428069338891,0.147117461008113,8.16130998652101e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,F2,Prothrombin,38013,0.0240328865136522,0.00132364031122815,0.021438551503645,0.0266272215236593,8.2675982027841e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.169932298804491,0.00937824266278359,0.151550943185435,0.188313654423547,1.20439549286569e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,40192,0.0387735819656141,0.00214181714036131,0.0345756203705059,0.0429715435607223,1.63644131424585e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,NFX1,Transcriptional repressor NF-X1,37562,0.110778991269667,0.00611548461563062,0.098792641423031,0.122765341116303,1.86801708138479e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,SRPK2,SRSF protein kinase 2,40341,0.134482754683201,0.00743636529603038,0.119907478702981,0.14905803066342,2.24456097996299e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,NHLRC3,NHL repeat-containing protein 3,37370,0.0519702053236597,0.00287100425236053,0.0463430369890331,0.0575973736582864,2.41217730668508e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.0908869870205268,0.00502867955716799,0.0810307750884776,0.100743198952576,2.66855273857723e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.0788990443513022,0.00436641703494329,0.0703408669628133,0.087457221739791,4.07599231769942e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.081579148631025,0.00452371398897576,0.0727126692126325,0.0904456280494175,5.75605733513602e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL3,C-X-C motif chemokine 3,40350,0.150754529242288,0.0083676630603963,0.134353909643912,0.167155148840665,7.51336128235952e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP5,Fatty acid-binding protein 5,40432,0.111973236478605,0.00621614845461643,0.099789585507557,0.124156887449653,7.8634651304525e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,IKBKG,NF-kappa-B essential modulator,40341,0.148817187198634,0.00826988128947634,0.132608219871261,0.165026154526008,1.09527553203123e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.120130383520931,0.00668006359179028,0.107037458881022,0.13322330816084,1.89264438240563e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXO1,Forkhead box protein O1,40341,0.136655055614438,0.00760930777243848,0.121740812380458,0.151569298848417,2.07473715125279e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,DAG1,Dystroglycan,40422,0.0763811275025608,0.00425428645386498,0.0680427260529854,0.0847195289521362,2.24833027519165e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0858532963741553,0.00477771928444852,0.0764889665766362,0.0952176261716744,2.30211540857374e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.171314953954505,0.00955183788513248,0.152593351699645,0.190036556209364,4.31545851518196e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS1,Galectin-1,40359,0.0541754967403908,0.00302611690461583,0.0482443076073438,0.0601066858734378,5.58668841362623e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,40536,0.0348026152203629,0.00194582683196635,0.0309887946297088,0.0386164358110169,7.38853272442893e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,RGCC,Regulator of cell cycle RGCC,37959,0.120322597839886,0.00673235576413562,0.10712718054218,0.133518015137592,1.2590087995841e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,40396,0.083052114165214,0.00465432608669032,0.073929635035301,0.092174593295127,1.55848598084661e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0740809621527428,0.00415226449913867,0.065942523734431,0.0822194005710546,2.27513199776746e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.182905390384241,0.0102736652088307,0.162769006574932,0.203041774193549,4.23711404226018e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,RILPL2,RILP-like protein 2,37990,0.155804205665119,0.00875330957095033,0.138647718906056,0.172960692424181,4.47786815946313e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.103365344238145,0.00580776373757975,0.0919821273124889,0.114748561163801,4.61066329354122e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBPL,FK506-binding protein-like,37901,0.0943510614436491,0.0053025389784944,0.0839580850458001,0.104744037841498,5.02292142445175e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP23,Synaptosomal-associated protein 23,40359,0.138929214502171,0.0078167192113623,0.123608444847901,0.154249984156441,5.39869396440093e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,37959,0.121146531338214,0.00681423750574827,0.107790625826948,0.134502436849481,6.48703307343817e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0976884355431835,0.00550185943162824,0.0869047910571922,0.108472080029175,7.2917838092093e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,SDC4,Syndecan-4,40359,0.0722162424562975,0.00406944881990765,0.0642401227692785,0.0801923621433165,8.71130917505499e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.0876949223441932,0.00494235382780268,0.0780079088416999,0.0973819358466864,9.51873544253951e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,37598,0.141783993868418,0.00798602337795397,0.126131388047628,0.157436599689207,1.0427495494454e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF19,Fibroblast growth factor 19,40422,0.122210079556506,0.00689109934419359,0.108703524841887,0.135716634271125,1.05778433045581e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,37671,0.131313276990433,0.00740114833098419,0.116807026261704,0.145819527719162,1.26581338414984e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.150530829809109,0.00852535142248956,0.133821141021029,0.167240518597188,4.16277372130832e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS9,Galectin-9,40350,0.0508781798895689,0.00289254613385489,0.0452087894672133,0.0565475703119244,1.32501283832188e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,GPC5,Glypican-5,40228,0.0887614677541009,0.00504643734017371,0.0788704505673604,0.0986524849408413,1.35124681204436e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,CD2AP,CD2-associated protein,40359,0.101127867574779,0.0057504745874407,0.0898569373833948,0.112398797766162,1.4043029967102e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0494983538610759,0.00281376483530417,0.0439833747838797,0.0550133329382721,1.73249354150195e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.112682436839683,0.00640944771542344,0.100119919317453,0.125244954361913,2.07594353694224e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,NIT2,Omega-amidase NIT2,37936,0.119156335161705,0.00679907285114364,0.105830152373463,0.132482517949947,5.19542276731285e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,PLG,Plasminogen,37705,0.0353353977653479,0.00201715769675481,0.0313817686797084,0.0392890268509873,6.13682075831736e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,IST1,IST1 homolog,37812,0.157435216863918,0.00900861383032896,0.139778333756473,0.175092099971363,1.23035930667164e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,SEC31A,Protein transport protein Sec31A,37628,0.120181062631756,0.00688134266274855,0.106693631012769,0.133668494250743,1.52926848053646e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.161197064288453,0.00923146330823637,0.14310339620431,0.179290732372597,1.55634233583304e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL13,C-C motif chemokine 13,40483,0.109343955207683,0.00627164375634732,0.0970515334452426,0.121636376970124,1.88584533971493e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,40422,0.134213699970136,0.00770664966987352,0.119108666617184,0.149318733323088,2.64235423336223e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,37987,0.0424516121277948,0.00243651874987768,0.0376760353780346,0.0472271888775551,2.98309340425183e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.181740174174364,0.0104409480313273,0.161275916032962,0.202204432315765,3.10629528860966e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.036241905011506,0.00208263609079428,0.0321599382735492,0.0403238717494628,3.33216077312661e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,OGFR,Opioid growth factor receptor,40305,0.051629971941703,0.00297584483681758,0.0457973160615405,0.0574626278218654,8.20858629838265e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,AP3B1,AP-3 complex subunit beta-1,37901,0.11895509746163,0.0068711238720377,0.105487694672436,0.132422500250824,1.99034219320578e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.174033847202535,0.0100617272616593,0.154312861769683,0.193754832635387,2.04983207552476e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.139172852452849,0.00804475583158502,0.123405131022942,0.154940573882755,2.46101858772278e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,IDUA,Alpha-L-iduronidase,40489,0.0702939701962047,0.00407016104644763,0.0623164545451673,0.078271485847242,3.11262152344045e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.132673215686672,0.00768270074330683,0.117615122229791,0.147731309143554,3.24265797947826e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCC,Tubulin-specific chaperone C,40228,0.126407886049942,0.00732118237529695,0.11205836859436,0.140757403505524,3.43756680973818e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.106984344783614,0.00620321309446842,0.0948260471184554,0.119142642448772,6.03777406496376e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.119219896245868,0.00691975402577276,0.105657178355353,0.132782614136382,8.12727397257412e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0472831495316319,0.00274537273348805,-0.0526640800892685,-0.0419022189739953,9.32359916495513e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,STK11,Serine/threonine-protein kinase STK11,40042,0.112746391246446,0.00656451787832144,0.0998799362049364,0.125612846287956,1.63297300430494e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,MYDGF,Myeloid-derived growth factor,37990,0.155346654035554,0.00903956004963619,0.137629116338267,0.173064191732841,1.69495446704854e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,CNPY4,Protein canopy homolog 4,40305,0.115598217452854,0.00673627388972251,0.102395120628998,0.12880131427671,2.04205137413352e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,BACH1,Transcription regulator protein BACH1,40341,0.112139414760478,0.00653632187781328,0.0993282238799643,0.124950605640992,2.18598053779385e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.0677593895924515,0.00394988432718123,0.0600176163111763,0.0755011628737267,2.2515970281388e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.107571855531763,0.00627234088370075,0.0952780673997095,0.119865643663816,2.48817588996574e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,MITD1,MIT domain-containing protein 1,40228,0.149258253692627,0.00870774079757029,0.132191081729389,0.166325425655865,2.86654992382902e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.15982913363968,0.00933589363844818,0.141530782108322,0.178127485171038,4.02087821306418e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD5,Programmed cell death protein 5,40471,0.0898473967446833,0.00525027355176175,0.0795568605832302,0.100137932906136,4.50311739560292e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,APPL2,DCC-interacting protein 13-beta,37671,0.171489317782479,0.010050776170853,0.151789796487607,0.191188839077351,1.38953939191407e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,GOLM2,Protein GOLM2,40471,0.0344295743304067,0.00202046842655897,0.0304694562143511,0.0383896924464622,1.52554116748578e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.118221441869022,0.0069382831155328,0.104622406962578,0.131820476775466,1.97807232992437e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.154061212210658,0.00905065089851601,0.136321936449566,0.171800487971749,2.09529894888808e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,HEXIM1,Protein HEXIM1,40341,0.125131931588483,0.00735551246581373,0.110715127155488,0.139548736021478,2.48286545990786e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,SIAE,Sialate O-acetylesterase,40374,0.0717235242555317,0.0042165743821886,0.063459038466442,0.0799880100446213,2.56450602390569e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,LEP,Leptin,40359,0.0977636790423682,0.0057490659136973,0.0864955098515215,0.109031848233215,2.78098554394812e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,37598,0.149907062927766,0.00881025616360084,0.132638960847108,0.167175165008424,3.08876183419124e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL7,C-C motif chemokine 7,40341,0.0930551456401566,0.00547881115952806,0.0823166757674816,0.103793615512832,3.931969981002e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.080672657145069,0.00474559635978859,0.0713712882798834,0.0899740260102547,3.95284280785393e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.111253361993054,0.00655128043169153,0.0984128523469385,0.124093871639169,4.08541130333636e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0693049983018078,0.00407830483485428,-0.0772984757781222,-0.0613115208254935,4.24170339353732e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,MVK,Mevalonate kinase,40044,0.117127872808495,0.00689895543085721,0.103605920164015,0.130649825452975,4.52462286092092e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH2,Cadherin-2,40359,0.0538459884386556,0.00317317785330327,0.0476265598461812,0.06006541703113,5.08411854026367e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D23,TBC1 domain family member 23,40305,0.137028043080563,0.00807632293978312,0.121198450118588,0.152857636042537,5.32147958226377e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0495305088957457,0.0029199049404197,0.0438074952125231,0.0552535225789683,5.64993736044413e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP43,Centrosomal protein 43,39934,0.105348984093147,0.00621044577702823,0.0931765103701715,0.117521457816122,5.81308315983532e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0572734013453896,0.00337830993884254,-0.063894888825521,-0.0506519138652582,6.60163818329983e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.13892634401622,0.00819081782411582,0.122872341080953,0.154980346951487,7.28959960307828e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,DNMBP,Dynamin-binding protein,40228,0.0941138192934526,0.00555343476780844,0.083229087148548,0.104998551438357,7.44021478118484e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.147095895860737,0.00868554612016691,0.13007222546521,0.164119566256264,9.11531921096358e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.0978523142412872,0.00577784289843681,0.086527742160351,0.109176886322223,9.1510229986978e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA1,GDNF family receptor alpha-1,40453,0.0424143614982471,0.00250745577235198,0.0374997481844372,0.047328974812057,1.23943293632826e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,CD36,Platelet glycoprotein 4,37598,0.0677187536093109,0.00400010163634111,0.0598785544020824,0.0755589528165395,1.29067129989438e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP2,Methionine aminopeptidase 2,40453,0.089474081355748,0.00529971475468179,0.0790866404365717,0.0998615222749243,2.12953909742755e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSD,Cathepsin D,39243,0.0606980101169407,0.0035969171030495,0.0536480525949637,0.0677479676389177,2.68473907493719e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,DTNB,Dystrobrevin beta,37878,0.0634595393471188,0.0037608648956,0.0560882441517428,0.0708308345424948,3.14767054228877e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.158384792765733,0.00939532392606323,0.139969957870649,0.176799627660817,3.23424086253176e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.0586140227154827,0.00347728128597456,0.0517985513949725,0.0654294940359928,3.34940946728166e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.0996739805625392,0.0059102348639752,0.0880899202291478,0.111258040895931,3.62289650357745e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.148823610376345,0.00883678045483155,-0.166143700067815,-0.131503520684875,4.27147775207661e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.092682688067472,0.00551408851711249,0.0818750745739316,0.103490301561013,7.62726535834289e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.0668248430062352,0.00398568734522752,0.0590128958095892,0.0746367902028811,1.49061495127201e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,GLB1,Beta-galactosidase,40228,0.0616581856204887,0.00367920248255862,0.0544469487546738,0.0688694224863036,1.70108208624373e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0480779959911005,0.00286746536988133,0.0424577638661331,0.0536982281160679,1.83113677810795e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.138914482121187,0.00829607664558545,0.12265417189584,0.155174792346535,2.1742699494414e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.101907163630486,0.00609117636417469,0.0899684579567041,0.113845869304269,2.7710165638669e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,GDF2,Growth/differentiation factor 2,40359,0.0538261136467481,0.00321855826133335,0.0475177394545348,0.0601344878389615,2.99619232140125e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.114683459142784,0.00685964149893485,0.101238561804872,0.128128356480696,3.27215133696018e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,37671,0.11891587298176,0.00711044536964488,0.104979400057256,0.132852345906264,3.80211497569584e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM13A,Protein FAM13A,37901,0.101431493755038,0.00606587189822746,0.0895423848345124,0.113320602675564,3.86101247995695e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA4D,Semaphorin-4D,40471,0.0448771210952445,0.00268784922090277,0.0396089366222751,0.050145305568214,4.66521479283243e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,37959,0.17806234891097,0.010656421698182,0.157175762382533,0.198948935439406,4.69514958744809e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFC,Platelet-derived growth factor C,39980,0.044640768834982,0.00267576835716069,0.039396262854947,0.0498852748150169,5.99496016556617e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,VNN1,Pantetheinase,37987,0.108681244399872,0.00652380128437579,0.0958945938824959,0.121467894917249,1.06682523310288e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.161489457388158,0.00969969400579352,0.142478057136803,0.180500857639513,1.26582609209198e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0415257410052663,0.0024967400743377,0.0366321304595644,0.0464193515509682,1.35938935239605e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,LAT,Linker for activation of T-cells family member 1,40516,0.113007559043749,0.00680183401725194,0.0996759643699355,0.126339153717563,1.78930861741279e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.0948065513652864,0.00571096524508005,0.0836130594849295,0.106000043245643,2.32320754675906e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,SYTL4,Synaptotagmin-like protein 4,37990,0.109578411694138,0.00659784157414736,0.0966466422088089,0.122510181179467,2.45512858700697e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,COMMD1,COMM domain-containing protein 1,37628,0.0919572273633738,0.00554300220068489,0.0810929430500314,0.102821511676716,3.44461138492329e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA11,Annexin A11,40312,0.100539032787018,0.00606887337221577,0.0886440409774751,0.112434024596561,3.98032664785508e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.179665938169762,0.0108498693607763,0.158400194222641,0.200931682116884,4.63197628753642e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,ACE2,Angiotensin-converting enzyme 2,40042,0.0728955570479464,0.00440377047504407,0.06426416691686,0.0815269471790327,5.05166670402136e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.107851334855052,0.00651393766190643,0.0950840170377154,0.120618652672389,5.7121203367452e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,AZI2,5-azacytidine-induced protein 2,37959,0.0820942562454773,0.00496113337831305,0.0723704348239837,0.0918180776669708,6.6311604081236e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA1,Ephrin type-A receptor 1,40400,0.0508016068047693,0.00307312532162298,0.0447782811743883,0.0568249324351503,7.05121214504326e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CRKL,Crk-like protein,40374,0.158253792061876,0.00958559924359646,0.139466017544427,0.177041566579325,1.00117780465532e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,EREG,Proepiregulin,40192,0.119394868484762,0.00723933244812899,0.105205776886429,0.133583960083094,1.33828701240596e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,STAT2,Signal transducer and activator of transcription 2,37598,0.114320710440044,0.0069288088596521,0.100740245075126,0.127901175804963,1.50499700155255e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.0727580262554151,0.00441705462006202,0.0641005992000935,0.0814154533107366,1.82104907629624e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.124491223377108,0.00756041741586508,0.109672805242013,0.139309641512204,2.02910236047515e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,CD22,B-cell receptor CD22,40516,0.0605961654500815,0.00369233420732834,0.0533591904037179,0.067833140496445,4.88572881336854e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,CKB,Creatine kinase B-type,37998,-0.0895494424618978,0.00545696034747282,-0.100245084742945,-0.0788538001808511,6.12409765796172e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.064176147668041,0.00391215911620748,0.0565083158002744,0.0718439795358077,6.82065975611157e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,STAMBP,STAM-binding protein,40192,0.0955585323426702,0.00583341425040629,0.0841250404118739,0.106992024273467,8.13662289430354e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.0920314641406322,0.00561411810886449,0.0810277926472577,0.103035135634007,8.13707001216371e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,OPHN1,Oligophrenin-1,37942,0.157676094275376,0.00962462182138488,0.138811835505462,0.176540353045291,9.60538543831652e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,ARSB,Arylsulfatase B,40305,0.0810347088588897,0.00495221421489699,0.0713283689976915,0.0907410487200878,1.0780209196332e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0410570385654628,0.00251085871944214,0.0361357554753561,0.0459783216555694,1.29385987963296e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX15,Sorting nexin-15,37671,0.0797222597236572,0.00488541221824991,0.0701468517758874,0.089297667671427,2.76881234544745e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,40422,0.193579998507866,0.0118795251370808,0.170296129239187,0.216863867776544,3.20345410153176e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,DLK1,Protein delta homolog 1,40536,0.0777594832251052,0.0047727641345724,0.0684048655213433,0.0871141009288671,3.33211142347014e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,RTN4R,Reticulon-4 receptor,40489,0.0496991010772842,0.00305132826106107,0.0437184976856045,0.0556797044689639,3.6018821770244e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.116232197884456,0.00713763768109261,0.102242428029515,0.130221967739398,4.64743779426782e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,DBNL,Drebrin-like protein,40422,0.135065071390626,0.00831117574620684,0.11877516692806,0.151354975853191,6.52180986539556e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSO,Cathepsin O,40516,0.0440096117483262,0.00271009182146491,0.038697831778255,0.0493213917183975,7.83901713559753e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.125163315199521,0.00770759850158588,0.110056422136413,0.14027020826263,9.9184810597308e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0486200364830192,0.00299720656958243,0.0427455116066376,0.0544945613594008,1.04291872159069e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD1,Sushi domain-containing protein 1,40042,0.0719876660757928,0.00443788624717677,0.0632894090313263,0.0806859231202593,1.08036989094993e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,37562,0.0931711223731678,0.00574065678975186,0.0819194350652541,0.104422809681081,1.15253668547368e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,SNCG,Gamma-synuclein,40228,0.0979021033841237,0.00603875040873875,0.0860661525829958,0.109738054185252,1.22885963115636e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.1168428994827,0.00722183504331152,0.102688102797809,0.13099769616759,2.07367976399997e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,FST,Follistatin,40396,0.0757341894792816,0.00468157958708841,0.0665582934885884,0.0849100854699749,2.13508288135202e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,TWF2,Twinfilin-2,37998,0.120817234236969,0.00746811040725309,0.106179737838753,0.135454730635185,2.54608987055181e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,QDPR,Dihydropteridine reductase,40290,0.0637694539343053,0.00394570030598719,0.0560358813345704,0.0715030265340402,2.74533942609875e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.129091673565477,0.0079876838189884,0.11343581328026,0.144747533850695,2.84822060423149e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,SH2B3,SH2B adapter protein 3,39980,0.142148060673989,0.0088023367527972,0.124895480638507,0.159400640709472,3.44236692974719e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,WASHC3,WASH complex subunit 3,37942,0.109132807737052,0.00675448237935642,0.0958940222735136,0.122371593200591,3.55581684663303e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,40042,0.108734012210087,0.00673437239043278,0.0955346423248392,0.121933382095336,3.58274990272356e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP2B,DNA topoisomerase 2-beta,37598,0.115192094030614,0.00713158990132344,0.10121417782402,0.129170010237208,3.95950040844529e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.214335805524237,0.0132862466080326,0.188294762172493,0.240376848875981,5.30595364345237e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.170228343374114,0.0105604753930061,-0.190926875144406,-0.149529811603823,5.32073267333837e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC27,Cell division cycle protein 27 homolog,39980,0.0883949535663717,0.00548694943555672,0.0776405326726805,0.0991493744600628,6.39197815289251e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,40228,0.115465799171652,0.00716823207033296,0.1014160643138,0.129515534029505,6.49357861543101e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,LBR,Delta(14)-sterol reductase LBR,40471,0.0951513303947999,0.00590898178716337,0.0835697260919597,0.10673293469764,6.93733397366054e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,HS1BP3,HCLS1-binding protein 3,37628,0.129839903167854,0.00805666193028225,0.114048845784501,0.145630960551207,7.05238641259727e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0327776242093265,0.00203561803528024,0.0287878128601772,0.0367674355584758,7.06695321981282e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,DDHD2,Phospholipase DDHD2,37959,0.0960277198502471,0.00596280345394836,0.0843406250805084,0.107714814619986,8.19241973779306e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,GAS6,Growth arrest-specific protein 6,40429,-0.0372670602811209,0.00231607417303857,-0.0418065656602765,-0.0327275549019653,8.44732182079807e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2,Microtubule-associated protein 2,37942,0.0665198470056537,0.00413106870010825,0.0584229523534415,0.0746167416578659,8.48624755307172e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0916617887059372,0.00569902979258474,0.0804916903124711,0.102831887099403,1.16806097780358e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,CASC3,Protein CASC3,37572,0.0594668209412969,0.00369991936075349,0.0522149789942201,0.0667186628883738,1.40974193127745e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,PPY,Pancreatic prohormone,40337,0.145920871151139,0.00909351847610858,0.128097574937966,0.163744167364312,1.70654322888833e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0678015016628015,0.00422341946226093,0.0595235995167701,0.0760794038088329,1.83997876890178e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,BRAP,BRCA1-associated protein,37778,0.15829126714269,0.00986300710714369,0.138959773212688,0.177622761072692,2.00457669878928e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,SPART,Spartin,37671,0.111424246634894,0.00695816913482252,0.0977862351306419,0.125062258139146,3.54812776533524e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,40489,0.053265777118079,0.00333682712407677,0.0467255959548886,0.0598059582812695,6.34824352049526e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,LYN,Tyrosine-protein kinase Lyn,40305,0.120788753606495,0.00756865417151898,0.105954191430318,0.135623315782672,6.83204408648945e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,37671,0.180265158213807,0.0112892043538917,0.158138317680179,0.202391998747434,7.26639828065584e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.118627434735276,0.00743422838623939,0.104056347098246,0.133198522372305,8.46248636375471e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.0963211688881702,0.00604135072430847,0.0844801214685256,0.108162216307815,8.62283725394875e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,GTPBP2,GTP-binding protein 2,37572,0.115020276436076,0.00721095226039552,0.100886810005701,0.129153742866451,9.60130258019711e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP10,Stromelysin-2,40341,-0.085986334869033,0.00540034109336851,-0.0965710034120353,-0.0754016663260308,1.21489437581514e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.158511707794669,0.00995628677594316,0.13899738571382,0.178026029875518,1.24004495476983e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,37608,0.0812400833159957,0.00510159144970338,0.0712409640745771,0.0912392025574144,1.44639635307246e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP7,Matrilysin,40015,0.0692130539688795,0.00435220910104377,0.0606827241308337,0.0777433838069253,1.68338744587962e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.129043061995055,0.00810891720807992,0.113149584267218,0.144936539722892,1.71312445889069e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM17,Splicing factor 45,37959,0.109388839361594,0.00687806610009209,0.0959078298054134,0.122869848917774,1.93196222023443e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,EGLN1,Egl nine homolog 1,40341,0.0760355401342623,0.00478453574296982,0.0666578500780414,0.0854132301904831,1.96079338181702e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,ISM1,Isthmin-1,40341,0.0558078906805514,0.00351718558394176,0.0489142069360255,0.0627015744250772,2.89078843638224e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,KIFBP,KIF-binding protein,40305,0.117760930385977,0.00743131976031867,0.103195543655753,0.132326317116202,4.00309536351101e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,40359,0.113191996110954,0.00714371237008396,0.0991903198655895,0.127193672356319,4.0902421094194e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,HGF,Hepatocyte growth factor,40516,0.04884904159705,0.00308647802471438,0.0427995446686098,0.0548985385254902,5.38609358416502e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,CNST,Consortin,40359,0.153726771710443,0.00971545524757298,0.1346844794252,0.172769063995686,5.77788709838273e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,DOK1,Docking protein 1,37942,0.194387361963056,0.0122844188638647,0.170309900989881,0.21846482293623,6.77062270997151e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,CRADD,Death domain-containing protein CRADD,40192,0.109083782458611,0.00691245818107067,0.095535364423712,0.122632200493509,1.12767254191409e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0633002737431909,0.00401281877927094,0.0554351489358199,0.071165398550562,1.2594063064944e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,40536,0.0957885930916763,0.00608141522052672,0.0838690192594439,0.107708166923909,1.75513176287395e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,HAO1,Hydroxyacid oxidase 1,40489,0.185137637381649,0.0117546837327594,0.16209845726544,0.208176817497857,1.78539762390915e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,37598,0.0691646495740091,0.00439203830755323,0.0605562544912048,0.0777730446568134,2.2807712846951e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,TAX1BP1,Tax1-binding protein 1,37942,0.0909614655378111,0.00578003798805904,0.0796325910812153,0.102290339994407,2.60925277925875e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,MAX,Protein max,39961,0.148264714859442,0.00942740658496566,0.129786997952909,0.166742431765974,2.6421645861337e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM5,Tripartite motif-containing protein 5,40341,0.120705375903873,0.00767696167702495,0.105658531016904,0.135752220790842,2.74365693333474e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,OGA,Protein O-GlcNAcase,37901,0.099539342341944,0.00633047952273402,0.0871316024773853,0.111947082206503,3.22045281944443e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,40305,0.04894477495552,0.00311621263072603,0.042836998199297,0.055052551711743,3.55697536792162e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,MTDH,Protein LYRIC,37598,0.12963455558148,0.00825958999477667,0.113445759191718,0.145823351971243,5.16023021759751e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFA,Vascular endothelial growth factor A,40456,0.0829418557651387,0.00529538010468102,0.0725629107599639,0.0933208007703135,6.9144447498723e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",40305,0.108773403232778,0.00694754877475002,0.0951562076342675,0.122390598831288,7.73706362969453e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,40341,0.0773203497179074,0.00494321513118951,0.067631648060776,0.0870090513750389,9.68648335506407e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE4,Ribonuclease 4,37575,0.0385796768275432,0.00246605122359358,0.0337462164292998,0.0434131372257867,1.13172308018686e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.11921518674311,0.00762758803872996,0.104265114187199,0.134165259299021,1.19593709466888e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0279687873375434,0.00178941455229647,0.0244615348150423,0.0314760398600444,1.36508788895251e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,C2,Complement C2,40372,0.0337232645477339,0.00216069025791082,0.0294883116422287,0.0379582174532391,1.63701609371744e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.10107694348431,0.00650092011418949,0.0883351400604983,0.113818746908121,4.10378166817449e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,MPI,Mannose-6-phosphate isomerase,40305,0.120307777047071,0.00774800951769155,0.105121678392396,0.135493875701747,5.63730747372471e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.0691359263721334,0.00445283387959719,0.0604083719681229,0.0778634807761439,5.73595203024732e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,A1BG,Alpha-1B-glycoprotein,38013,0.0245242499957813,0.00158044431297536,0.0214265791423496,0.027621920849213,7.68573943371915e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,SHBG,Sex hormone-binding globulin,37987,-0.0754579935108373,0.00486626428592179,-0.084995871511244,-0.0659201155104306,9.10827899283448e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,ICA1,Islet cell autoantigen 1,40044,0.110665557690629,0.00714916149472268,0.0966532011609727,0.124677914220286,1.19571652267637e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.0867609571781623,0.00560574370112285,0.0757736995239615,0.0977482148323631,1.47207984155063e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS8,Galectin-8,40471,0.0841562217928836,0.00544742293121066,0.0734792728477107,0.0948331707380565,1.86680946691856e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.0371027681305955,0.00240314658310533,0.0323926008277091,0.041812935433482,2.17171189097418e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,40044,0.0564139421994468,0.00365396094395507,0.0492521787492949,0.0635757056495987,2.2174489575004e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINC1,Antithrombin-III,37981,0.0205236515626045,0.00132872422423082,0.0179193520831121,0.0231279510420969,2.28544457013714e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.0850693652527187,0.00551554904055718,0.0742588891332266,0.0958798413722108,2.76661447689019e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.108584949540027,0.00704069563985068,0.0947851860859199,0.122384712994135,2.82906358442626e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,COCH,Cochlin,37990,0.0649294910350206,0.00420807656663143,0.056681660964423,0.0731773211056182,2.93215927836397e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.0814743588743516,0.00528571079165509,0.0711143657227076,0.0918343520259956,3.81424965948266e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.0973808392157511,0.00631783201787359,0.0849978884607188,0.109763789970783,3.85246430181952e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.12086760892074,0.00786415838781106,0.10545385848063,0.136281359360849,6.28852221341962e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,LSP1,Lymphocyte-specific protein 1,40341,0.0552976283566174,0.00360435578720917,0.0482330910136874,0.0623621656995474,9.5844952184678e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,C3,Complement C3,37360,0.0651798509203096,0.00424581516792362,0.0568580531911793,0.0735016486494399,1.01000708725987e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.123827948696091,0.00807584853668207,0.107999285564194,0.139656611827988,1.0970505992869e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,37987,0.0999108960379946,0.00651228987784919,0.0871468078774102,0.112674984198579,1.11302754386689e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.0937817315247846,0.0061168092826248,0.08179278533084,0.105770677718729,1.33975176483782e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.105718791914077,0.00690587914938614,0.0921832687812798,0.119254315046873,1.6217307206267e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF2,TNF receptor-associated factor 2,40341,0.098273725582125,0.00642295987899843,0.0856847242192881,0.110862726944962,1.79845214708139e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.0680633261794121,0.00445009887606527,0.0593411323823242,0.0767855199765,2.31621190698184e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,RWDD1,RWD domain-containing protein 1,40471,0.088672003934804,0.00580974808865412,0.0772848976810419,0.100059110188566,3.16162297199907e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,PGF,Placenta growth factor,40516,0.0361098205927505,0.00236840564820539,0.0314677455222679,0.0407518956632331,4.02577510372809e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.093935143128056,0.00616106781951432,0.081859450201808,0.106010836054304,4.7041283353458e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,UBXN1,UBX domain-containing protein 1,37671,0.0950952165749828,0.00623659970665846,0.0828714811499323,0.107318952000033,4.70901760349079e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,CST3,Cystatin-C,40372,0.038521843620405,0.00252977714981697,0.0335634804067637,0.0434802068340462,5.41044833050824e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,40341,0.0452352480202063,0.00297182156505393,0.0394104777527006,0.051060018287712,5.93021227644951e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3GLB2,Endophilin-B2,37942,0.0919885070884279,0.00603948083854685,0.0801511246448761,0.10382588953198,5.9357074135054e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.132722561771991,0.00871700780272413,0.115637226478651,0.14980789706533,6.4466986377876e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0575863405887289,0.00378565800040964,0.0501664509079261,0.0650062302695318,6.82065992836738e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,ATOX1,Copper transport protein ATOX1,40411,0.0983834669458201,0.00646965332492526,0.0857029464289666,0.111063987462674,7.34755752200601e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.0770404381084435,0.00506754588128182,0.0671080481811311,0.0869728280357558,7.87089635727967e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDC,Nuclear migration protein nudC,40516,0.0866731153005892,0.00570320162006486,0.0754948401252621,0.0978513904759163,8.44907955738007e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0698373659251489,0.00459621113720137,0.0608287920962342,0.0788459397540636,1.03227369503226e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.109744205246586,0.00722411193181304,0.095584945860232,0.123903464632939,1.07809339281357e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,DGKA,Diacylglycerol kinase alpha,37598,0.0745524375629048,0.00490720976104802,0.0649343064312507,0.0841705686945589,1.08991158695758e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53,Cellular tumor antigen p53,39980,0.0590075553105162,0.00388797827363051,0.0513871178942004,0.066627992726832,1.18014901524128e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,39980,0.126832905980624,0.008369371974632,0.110428936910345,0.143236875050903,1.65457459674447e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0773233800185639,0.00510930374783314,0.0673091446728109,0.0873376153643168,2.20991438548462e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.120076108483753,0.00793482752789368,0.104523846529081,0.135628370438425,2.23665220622072e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,CETN3,Centrin-3,37901,0.104824058178995,0.00692676659540181,0.0912475956520075,0.118400520705983,2.58720380535775e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.091851835729548,0.00607097869611445,0.0799527174851637,0.103750953973932,2.77324929794152e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,FIS1,Mitochondrial fission 1 protein,40354,0.105112738308371,0.00696285416772778,0.0914655441396242,0.118759932477117,3.87796548141886e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,40332,0.0710151669474925,0.00470668799967142,0.0617900584681365,0.0802402754268485,4.3801794430442e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,CD244,Natural killer cell receptor 2B4,40516,0.0361816352801616,0.00240252303762008,0.0314726901264262,0.040890580433897,6.62052371383797e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,ST13,Hsc70-interacting protein,37671,0.0773164595391608,0.00514404179640042,0.067234137618216,0.0873987814601056,1.21766435989578e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNLR1,Interferon lambda receptor 1,40341,0.0507240839832327,0.00337737025852984,0.0441044382765142,0.0573437296899511,1.23062337561758e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,YJU2,Splicing factor YJU2,37900,0.0434131832463679,0.00289000374977523,0.0377487758968085,0.0490775905959274,1.35818732900682e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,DLG4,Disks large homolog 4,37942,0.0949292829563207,0.006323794520211,0.0825346456967072,0.107323920215934,1.58015351924151e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,40341,0.0838068249819435,0.00559518908365861,0.0728402543779726,0.0947733955859143,2.24387793938858e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,37901,0.0795876867578679,0.00531332564575372,0.0691735684921906,0.0900018050235452,2.56684694450073e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.113585011619992,0.00758406840144227,0.0987202375531653,0.128449785686819,2.69040655357339e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.036140568108013,0.00241528770174406,0.0314066042125946,0.0408745320034313,2.86189026348856e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.141158532399861,0.00943598756161751,0.122663996779091,0.159653068020632,2.96426999755388e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFB2,BPI fold-containing family B member 2,37951,0.0917544023463525,0.0061327776026972,0.079734158245066,0.103774646447639,3.31728941520171e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,GRAP2,GRB2-related adapter protein 2,40359,0.171043080007737,0.0114396983861343,0.148621271170914,0.19346488884456,3.32838298403842e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0850856797577727,0.00569198502429421,0.0739293891101561,0.0962419704053894,3.47727595203561e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB27B,Ras-related protein Rab-27B,37990,0.110738767073704,0.00740442620351491,0.0962260917148144,0.125251442432593,3.59191859440098e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0833328646550566,0.00557479474361077,0.0724062669575795,0.0942594623525337,4.12068258343456e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0472651800419015,0.0031627760807563,0.0410661389236191,0.0534642211601838,4.44294486172308e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,NUB1,NEDD8 ultimate buster 1,40341,0.112414744023692,0.00753511138736162,0.0976459257044628,0.12718356234292,5.42175603949502e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",40314,0.14713098023489,0.00987652196582199,0.127772997181879,0.166488963287901,7.4847668263966e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,F11,Coagulation factor XI,37810,0.0407645108398661,0.00273463944893342,0.0354046175199566,0.0461244041597756,7.49504263514301e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.103955816143772,0.00698715840778902,0.0902609856645056,0.117650646623039,9.88500175053022e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,37900,0.0738709770359396,0.00496247666218538,0.0641445227780563,0.083597431293823,1.0119907504147e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.0823415877060642,0.00553970976218453,0.0714837565721825,0.0931994188399458,1.2147175424216e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.123022287406302,0.00827918222511776,0.106795090245071,0.139249484567533,1.32429046503985e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,40471,0.0599613618892845,0.00403597381834281,0.0520508532053326,0.0678718705732364,1.34582848572972e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0661549724837379,0.00445292996084153,0.0574272297604885,0.0748827152069873,1.59526415669766e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED8,Protein TMED8,37901,0.137592461051626,0.00926708876912781,0.119428967064136,0.155755955039117,1.78099088491978e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,CLUL1,Clusterin-like protein 1,40338,-0.0608618314752623,0.00410509011408161,-0.0689078080988622,-0.0528158548516623,2.12968899740496e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,MGLL,Monoglyceride lipase,40396,0.115324280192263,0.00777901684437361,0.100077407177291,0.130571153207235,2.15203649092767e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PKD2,Polycystin-2,37562,0.0799612498343516,0.00539070944364172,0.0693954593248138,0.0905270403438894,2.24671492699201e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,C4BPB,C4b-binding protein beta chain,40411,0.0550777081750519,0.00372466550467364,0.0477773637858916,0.0623780525642123,3.74210115465865e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRY2,Protein sprouty homolog 2,40044,0.122801152594148,0.00830931512915965,0.106514894940995,0.139087410247301,4.31640247304247e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",40042,0.123979943055721,0.00839734475094837,0.107521147343863,0.14043873876758,5.34109474325542e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.076792339114986,0.00520070263651859,0.0665989619474095,0.0869857162825624,6.00444372416465e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,CACYBP,Calcyclin-binding protein,37642,0.136569582027759,0.00925635068973651,0.118427134675875,0.154712029379642,7.09158612380267e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,GMPR2,GMP reductase 2,37671,0.0902676361926608,0.00612348140524003,0.0782656126383903,0.102269659746931,8.54455154283827e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.104167393264009,0.00707222145048423,0.0903058392210602,0.118028947306958,8.94528476084797e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,GMPR,GMP reductase 1,40516,0.067777855109083,0.00460515869867114,0.0587517440596875,0.0768039661584784,1.02850195209522e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0607292111447665,0.00413041943724729,0.0526335890477618,0.0688248332417711,1.28870896887182e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,STXBP1,Syntaxin-binding protein 1,37959,0.102685523087666,0.00698179800319018,0.0890011990014129,0.116369847173918,1.36806188495499e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM2,Paralemmin-2,37942,0.0490346293278105,0.00333586656151441,0.0424963308672423,0.0555729277883788,1.54712071375444e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,MAMDC4,Apical endosomal glycoprotein,37900,0.0724660802738806,0.00493025710030721,0.0628027763572784,0.0821293841904827,1.57356022705878e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,NSFL1C,NSFL1 cofactor p47,40471,0.0883216030041323,0.00601665541739804,0.0765289583860321,0.100114247622232,1.80046528654046e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,TDRKH,Tudor and KH domain-containing protein,39961,0.112763494484487,0.0076831751671935,0.0977044711567873,0.127822517812186,1.92122061031958e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,PF4,Platelet factor 4,37934,0.12897523780525,0.00878507596621787,0.111756488911463,0.146193986699037,2.01169508411756e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.12432527033089,0.00848683158119738,0.107691080431744,0.140959460230037,2.81448708911546e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,PMVK,Phosphomevalonate kinase,39951,0.146514082036005,0.0100076564143546,0.12689907546387,0.166129088608141,3.2651174006857e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.1317638667733,0.00900128789359866,0.114121342501846,0.149406391044753,3.83917671881106e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL16,C-X-C motif chemokine 16,40517,0.0313281171999345,0.00214314228894502,0.0271275583136022,0.0355286760862667,4.40023772922426e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,TALDO1,Transaldolase,37966,0.058924105993631,0.0040293150921717,0.0510266484129744,0.0668215635742875,4.60698678782471e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG6,Large proline-rich protein BAG6,40042,0.0473644495130307,0.00324165761613093,0.041010800585414,0.0537180984406473,4.95104043526164e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.112614978828209,0.00771335740365124,0.0974967983170529,0.127733159339366,6.50627754862157e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.112774312126888,0.0077308194488518,0.0976219060071383,0.127926718246637,6.98173210986998e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCB,Tubulin-folding cofactor B,40228,0.1329213292353,0.00913713517892454,0.115012544284608,0.150830114185992,1.23447523894222e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,CD69,Early activation antigen CD69,40288,0.115358160652128,0.00793293055558649,0.0998096167631789,0.130906704541078,1.33650121765985e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC13,Mucin-13,39961,0.0659039640404458,0.00453664841185679,0.0570121331532065,0.0747957949276851,1.67549643577437e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.120428527513077,0.00829682488229538,0.104166750743778,0.136690304282376,1.95794040751508e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,GP5,Platelet glycoprotein V,37671,0.0470258214115163,0.00324359536584027,0.0406683744944694,0.0533832683285633,2.87164536286949e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.098935472622336,0.00683763407854603,0.0855337098283858,0.112337235416286,3.78901027143507e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH9,Protocadherin-9,37901,0.0442218888232665,0.00305497508446707,0.0382341376577111,0.050209639988822,3.91917912967642e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,GH1,Somatotropin,40330,-0.228498086653594,0.0157990067076762,-0.259464139800639,-0.197532033506548,4.14686338579232e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,37671,0.1547675083972,0.0107004664556692,0.133794594144088,0.175740422650311,4.70213319939427e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,LPP,Lipoma-preferred partner,37562,0.0878559079928307,0.00607544286517436,0.0759480399770889,0.0997637760085724,4.92759327341406e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,IL7,Interleukin-7,40341,0.0840586426522511,0.00581826266460382,0.0726548478296276,0.0954624374748746,5.17138908722423e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,RRAS,Ras-related protein R-Ras,37572,0.170517903981092,0.0117945722883721,0.147400542295882,0.193635265666301,5.17751978077785e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL11,Eotaxin,40516,0.0490154211543134,0.00339690953732852,0.0423574784611495,0.0556733638474773,6.63907746651027e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,MESD,LRP chaperone MESD,40332,0.157546644444627,0.0109207391305964,0.136141995748658,0.178951293140596,6.98866192898957e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,37880,0.113898572207377,0.00790667233535644,0.0984014944300785,0.129395649984676,1.06670165905752e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA4,Protein disulfide-isomerase A4,37998,0.0784585378359977,0.00546063049180235,0.0677557020720651,0.0891613735999303,1.80268020484008e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,GOLGA3,Golgin subfamily A member 3,37959,0.101627403942593,0.00707390310154944,0.0877625538635563,0.11549225402163,1.84599111534224e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,CDCP1,CUB domain-containing protein 1,40228,0.0630094264113006,0.0043894682958662,0.0544060685514029,0.0716127842711984,1.95288456343136e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0568555128321326,0.0039607058749751,0.0490925293171815,0.0646184963470838,1.96243305686216e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0699757446794343,0.00488871486694757,0.0603938635402171,0.0795576258186516,3.47949718275593e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.0883247448023214,0.00616727260218371,0.0762368905020413,0.100412599102601,3.57727723975323e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,EGF,Pro-epidermal growth factor,40324,0.132445967465002,0.0092701087773626,0.114276554261371,0.150615380668633,5.05716020678502e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.0745686545713385,0.00521693790607737,0.0643434562754269,0.0847938528672502,5.21272724184808e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.079770900985993,0.00558297727051749,0.0688282655357787,0.0907135364362073,5.59273675193144e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.0615377650545836,0.00430886858555928,0.0530923826268875,0.0699831474822798,6.16977476089379e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0493450929822575,0.00345746406001885,0.0425684634246206,0.0561217225398945,6.26291474338107e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,NEXN,Nexilin,37987,0.0881339594398504,0.0061727252144908,0.0760354180194485,0.100232500860252,6.46796757265612e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,SUGT1,Protein SGT1 homolog,39980,0.104638212419867,0.0073527304406865,0.0902268607561215,0.119049564083613,1.13630446669265e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.126902162609944,0.00892496411004801,0.10940923295425,0.144395092265638,1.35392329824432e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,EHD3,EH domain-containing protein 3,37628,0.150348963709747,0.0105761960824423,0.12961961938816,0.171078308031334,1.58665498511886e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPB1,Heat shock protein beta-1,40116,0.0869148647935404,0.00612108725122853,0.0749175337811325,0.0989121958059483,1.77306176940388e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0779022439837875,0.00549016049808464,0.0671415294075417,0.0886629585600334,2.01769041452493e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,YWHAQ,14-3-3 protein theta,37671,0.0946329084415422,0.00666628409600842,0.0815669916133657,0.107698825269719,2.09776945940927e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.128785547952682,0.00908585338872221,0.110977275310787,0.146593820594578,2.49671115730382e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,AMN,Protein amnionless,40044,0.0609511601616003,0.00430140234549166,0.0525204115644366,0.0693819087587639,2.68158095772298e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,SPARC,SPARC,40411,0.0905111136122338,0.00639147928338564,0.0779838142167979,0.10303841300767,2.99244688311576e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,LACTB2,Endoribonuclease LACTB2,40359,0.0843548707598979,0.00595931177237691,0.0726746196860391,0.0960351218337566,3.26595140273717e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,CTF1,Cardiotrophin-1,40042,0.108068883897299,0.00763449390978445,0.0931052758341214,0.123032491960476,3.29822032364637e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.123098748686031,0.00870211006558745,0.106042612957479,0.140154884414582,3.72350674110868e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.0909952731856338,0.00643293539522985,0.0783867198109833,0.103603826560284,3.74803772154215e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.143543424877883,0.0101515511587191,0.123646384606794,0.163440465148973,4.10174255607183e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP7,Caspase-7,37942,0.106926267887673,0.00756028231476428,0.0921081145507349,0.121744421224611,4.32107799602381e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,CD207,C-type lectin domain family 4 member K,40029,0.0491166998712224,0.00347558319631916,0.0423045568064368,0.0559288429360079,4.58359020835814e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.0607832968791329,0.00430168465169211,0.0523519949618164,0.0692145987964495,5.18196349264779e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,F2R,Proteinase-activated receptor 1,40396,0.0730955975218755,0.0051848226319456,0.0629333451632621,0.0832578498804889,7.26669154021995e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN2L,Ataxin-2-like protein,37959,0.0614368444723624,0.00435926947334825,0.0528926763045999,0.069981012640125,8.6587483475614e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,SULT2A1,Bile salt sulfotransferase,40341,0.0677319928100736,0.0048110391920336,0.0583023559936878,0.0771616296264594,9.57041081929772e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0478591797423705,0.00340013935403579,0.0411949066084604,0.0545234528762806,1.12633843063938e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.0342826914147974,0.00243915349104993,0.0295019505723396,0.0390634322572553,1.47100496328971e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB6,Serpin B6,40433,0.0757597749148477,0.0053949875653129,0.0651855992868344,0.086333950542861,1.57254461681113e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.0929015058194378,0.00661759571344623,0.0799310182210832,0.105871993417792,1.88313456832032e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,GPI,Glucose-6-phosphate isomerase,37987,0.0593814729308949,0.00423263620950068,0.0510855059602735,0.0676774399015162,2.10690074581264e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.119640091901803,0.00853930117229895,0.102903061604097,0.136377122199509,2.47073676085482e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.1366715894752,0.00975436298367446,0.117553038027198,0.155790140923201,2.82550387574582e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0520441633271236,0.00371657158413024,0.0447596830222283,0.0593286436320188,3.04342287887505e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.0910751929151807,0.00650829954513314,0.0783189258067197,0.103831460023642,3.53733572250236e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0690582766288011,0.00493816838860152,0.0593794665871422,0.0787370866704601,3.5783748178053e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP25,Synaptosomal-associated protein 25,37541,0.0592006507485771,0.00423151814050437,0.0509068751931885,0.0674944263039656,3.70895870064347e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.109245427713869,0.00783343573201668,0.0938918936791159,0.124598961748621,6.72139100424742e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0615076246555958,0.00441875562631832,0.0528468636280119,0.0701683856831797,8.82240397374592e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1R2,Interleukin-1 receptor type 2,40330,0.0245324863637746,0.00176271216164833,0.0210775705269439,0.0279874022006053,8.96917197687778e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP3R1,Calcineurin subunit B type 1,40228,0.0519662560704028,0.00373659745649407,0.0446425250556744,0.0592899870851311,1.03502265137084e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,CERT,Ceramide transfer protein,39961,0.0773492218984907,0.00556263787056832,0.0664464516721768,0.0882519921248046,1.07841291946571e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,STK24,Serine/threonine-protein kinase 24,39961,0.077634506820309,0.00558457545437949,0.0666887389297252,0.0885802747108928,1.1323876945127e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,40307,0.0821964827033405,0.00591331219573576,0.0706063907996984,0.0937865746069826,1.13873646702408e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.0975256547910509,0.00703275146088223,0.0837414619277218,0.11130984765438,1.81438813961162e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,F12,Coagulation factor XII,38013,0.0523738256574246,0.00377560661255885,0.0449736366968093,0.05977401461804,1.86363495900418e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,SELE,E-selectin,40536,0.0625207236350074,0.00450987588230414,0.0536813669056913,0.0713600803643235,1.88539538987514e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,40516,0.0849064157240587,0.00613064787363375,0.0728903458917365,0.0969224855563808,2.27411956063296e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0371514879783328,0.00268442808034349,0.0318900089408596,0.0424129670158061,2.61756502729884e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,37959,0.0765165281038334,0.00553204468026753,0.065673720530509,0.0873593356771577,3.24150817270892e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.071521313909616,0.00517504165896691,0.0613782322580409,0.0816643955611912,3.39622631553791e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,STX8,Syntaxin-8,40341,0.0609818451404399,0.00441395235442077,0.0523304985257752,0.0696331917551046,3.64093016875703e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.14811356652806,0.0107214029233308,0.127099616798332,0.169127516257788,3.67778842165286e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,PENK,Proenkephalin-A,37671,0.0385348732224976,0.00278890189774368,0.03306862550292,0.0440011209420752,4.00040961207941e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.123567186751453,0.00894592304219297,0.106033177588755,0.141101195914151,4.19535522406793e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.108788459401592,0.00789291777666833,0.0933183405593225,0.124258578243862,6.38347518524069e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.111824346027051,0.00811797359883864,0.0959131177733271,0.127735574280775,7.02116661811196e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,PXN,Paxillin,39961,0.0643764068122702,0.0046785454862257,0.0552064576592679,0.0735463559652726,7.92447704197818e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,CD226,CD226 antigen,37598,0.0522031677853861,0.00379207877878336,0.0447706933789707,0.0596356421918015,8.04522473378822e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0630205111051176,0.00458384230504686,0.0540361801872258,0.0720048420230095,1.01241271702285e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL8,C-C motif chemokine 8,40470,0.0749094684523118,0.00545271233621841,0.0642221522733237,0.0855967846312999,1.04943182552743e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,NIT1,Deaminated glutathione amidase,37628,0.0615418717214543,0.00448153563109455,0.052758061884509,0.0703256815583996,1.27758273487162e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,ESM1,Endothelial cell-specific molecule 1,40357,-0.0419703505151738,0.00305877979681613,-0.0479655589169334,-0.0359751421134142,1.3239389396534e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,PPBP,Platelet basic protein,37934,0.104110456745849,0.00758586617099984,0.0892421590506896,0.118978754441009,1.4040288637015e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,THTPA,Thiamine-triphosphatase,37884,0.109849679414388,0.00800423224117805,0.0941613842216787,0.125537974607097,1.41354627121977e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.079604356494183,0.00580868260821615,0.0682193385820793,0.0909893744062866,1.8430685543052e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0298548461892377,0.00218072490398023,0.0255806253774365,0.0341290670010389,2.01941234523264e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.128536547565443,0.00938698675042369,0.110138053534613,0.146935041596273,2.17363988723545e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,BIN2,Bridging integrator 2,40332,0.112120456035945,0.00819419918574912,0.0960598256318765,0.128181086440013,2.2339695713143e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,CD274,Programmed cell death 1 ligand 1,40228,0.0429895450030302,0.00314380419801755,0.0368276887749158,0.0491514012311446,2.51780214194774e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,AP2B1,AP-2 complex subunit beta,37572,0.0605314666723528,0.00442872485111046,0.0518511659641763,0.0692117673805293,3.07159188269224e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,37901,0.108296988971538,0.00792453496529961,0.0927649004395506,0.123829077503525,3.10062089407185e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.135567934854463,0.00993654375361706,0.116092309097373,0.155043560611552,3.8126151259016e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0741575316982078,0.00543525413208256,0.063504433599326,0.0848106297970896,3.83698129805098e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.114400995531316,0.00838698307190991,0.0979625087103725,0.130839482352259,4.38083790519852e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,STX4,Syntaxin-4,40305,0.0735914856893458,0.00540060529807435,0.0630062993051201,0.0841766720735715,4.80502318375474e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0713254979576397,0.00523477435341337,0.0610653402249495,0.0815856556903299,4.93941016318128e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0582901782671055,0.00427918040589836,0.0499029846715447,0.0666773718626663,5.62513027985972e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L1,Bcl-2-like protein 1,37942,0.122730790571853,0.00901381072173408,0.105063721557254,0.140397859586452,6.1005498734643e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,DNM3,Dynamin-3,37959,0.0674654511848293,0.00495564245731043,0.0577523919685009,0.0771785104011578,6.26211753848127e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,CIAPIN1,Anamorsin,40411,0.0783475823142425,0.00576433398709242,0.0670494876995414,0.0896456769289437,7.65946951365291e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.0366741632322266,0.00269907726222055,0.0313839717982743,0.0419643546661789,8.1603249147115e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,SDHB,Succinate dehydrogenase,37901,0.0873455297319953,0.00643389751114898,0.0747350906101433,0.0999559688538474,1.04854266631173e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,RP2,Protein XRP2,40305,0.0506806334708934,0.00373620426091265,0.0433576731195046,0.0580035938222822,1.10724347681951e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,VSNL1,Visinin-like protein 1,37942,0.0459002766617426,0.00338543081113741,0.0392648322719133,0.0525357210515719,1.32721048828865e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB9,Serpin B9,40228,0.0410695722630225,0.00303620349079231,0.0351186134210696,0.0470205311049755,1.85450293729548e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,LAP3,Cytosol aminopeptidase,40044,0.0600089009375607,0.00443991541928106,0.0513066667157698,0.0687111351593516,2.15883257396811e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.0907540449055262,0.00671982201370558,0.0775831937586633,0.103924896052389,2.68860810124242e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA2,Integrin alpha-2,37671,0.041349551262561,0.00306246223340121,0.0353471252850946,0.0473519772400273,2.8541764401628e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTD,Deoxycytidylate deaminase,37671,0.115211359161566,0.00854126730621066,0.0984704752413933,0.131952243081739,3.40895848089506e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.115050395795138,0.0085327314145926,0.0983262422225361,0.131774549367739,3.62433110788005e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,SFRP1,Secreted frizzled-related protein 1,40178,0.0531135017400538,0.00394418358740285,0.0453829019087442,0.0608441015713634,4.17307363489928e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,ESYT2,Extended synaptotagmin-2,37942,0.0992771057385698,0.00736966144383526,0.0848325693086527,0.113721642168487,4.26782689076279e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,GASK1A,Golgi-associated kinase 1A,37562,0.0528525355366404,0.00392821055995185,0.0451532428391347,0.060551828234146,5.40995450389552e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.0550257441267284,0.0040904643948691,0.047008433912785,0.0630430543406719,5.56933460552904e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,40328,0.044132983320337,0.00328273960488819,0.0376988136947561,0.0505671529459178,5.5985632580861e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN9,Septin-9,40305,0.0342245699406715,0.00254686498168093,0.0292327145765769,0.0392164253047661,6.07268813366968e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK13,Kallikrein-13,40032,0.0527305574066822,0.00392423483272524,0.0450390571345407,0.0604220576788236,6.19029704420314e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0570221401429307,0.00425035994013835,0.0486914346602595,0.0653528456256019,8.89489166352487e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.064027014803154,0.00477501250395737,0.0546679902953976,0.0733860393109104,9.05699505314441e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.12417572366707,0.00925721519175819,0.106031581891224,0.142319865442916,9.27261007397805e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0602725555068694,0.00449759252100689,0.0514572741656959,0.0690878368480429,1.00346458434509e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINE2,Glia-derived nexin,37990,0.0778200481357984,0.00580710975467272,0.0664381130166399,0.089201983254957,1.08618981723535e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.118126617962253,0.00882035167180718,0.100838728685511,0.135414507238995,1.23299323424775e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,MICALL2,MICAL-like protein 2,37572,0.0829925021618678,0.00619812426260134,0.0708441786071692,0.0951408257165664,1.27908689642641e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.0888407758787046,0.00663577425592794,0.0758346583370859,0.101846893420323,1.30636135379523e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.0803945327216372,0.00600910062219316,0.0686166955021386,0.0921723699411358,1.47342410190522e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,MARCO,Macrophage receptor MARCO,40359,0.0320534978118093,0.0024010563993413,0.0273474272691004,0.0367595683545183,1.96151666460442e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSZ,Cathepsin Z,40345,0.0374524934075293,0.00280590457917523,0.0319529204323458,0.0429520663827127,2.01530228518856e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.090991144346034,0.00681672906537681,0.0776303553778954,0.104351933314173,2.02761908866341e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,SPON2,Spondin-2,40267,-0.0416442747841526,0.00312052699457653,-0.0477605076935226,-0.0355280418747826,2.08766286766846e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0465358008397323,0.00349068057335359,0.0396940669159593,0.0533775347635054,2.73713865810808e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.0934201486790555,0.00700729402493163,0.0796858523901895,0.107154444967922,2.75557273979503e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.106733766700377,0.00801017387490481,0.0910338259055633,0.12243370749519,2.97786934104749e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.0974737514302498,0.00732112559792915,0.0831243452583086,0.111823157602191,3.150947443181e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.0700510251755185,0.00526220911794333,0.0597370953043496,0.0803649550466874,3.22584536362926e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,40536,0.0863511237887874,0.00648856889991886,0.0736335287449465,0.0990687188326284,3.3842584133755e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,40287,0.106855680827975,0.00803640541399788,0.0911043262165391,0.122607035439411,3.98319488030497e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.109793329195098,0.00825540849415617,0.0936127285465519,0.125973929843644,4.22687584126581e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,APOL1,Apolipoprotein L1,37987,0.078264346033726,0.00588895138428762,0.0667220013205223,0.0898066907469297,4.71274465322376e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP2,Caspase-2,40341,0.0811395878404502,0.00610940318859043,0.069165157590813,0.0931140180900874,4.87113889762482e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D5,TBC1 domain family member 5,40341,0.0940609780527122,0.00708341110940089,0.0801774922782864,0.107944463827138,5.00468643556023e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL3,C-C motif chemokine 3,40341,0.0738242194736182,0.00556278155957965,0.062921167616842,0.0847272713303943,5.55878687046045e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP3,Caspase-3,40536,0.105462793513709,0.00794782598513323,0.0898850545828477,0.12104053244457,5.65219569055041e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,SPOCK1,Testican-1,40228,0.0302225597156606,0.00227787028061762,0.0257579339656501,0.0346871854656712,5.81848917177917e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM106A,Transmembrane protein 106A,37900,0.084113005339316,0.00633695552185971,0.071692572516471,0.096533438162161,5.88908425956951e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,ELOA,Elongin-A,40305,0.0611960216677281,0.00461299745771028,0.0521545466506159,0.0702374966848402,5.9522441540997e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.0423042158134231,0.00319067177808073,0.0360504991283849,0.0485579324984614,6.541536130709e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,GP6,Platelet glycoprotein VI,40311,0.105212788765062,0.00795000917633711,0.0896307707794414,0.120794806750683,9.03744446577862e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,TMSB10,Thymosin beta-10,40332,0.090690231060472,0.00685838049957694,0.0772478052813012,0.104132656839643,1.04418469289242e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.0435702849285022,0.00329577148042827,0.0371105728268628,0.0500299970301416,1.19946394256097e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.0651171647099122,0.00492958379384065,0.0554551804739846,0.0747791489458399,1.25303052031442e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,RFC4,Replication factor C subunit 4,37900,0.0245450175912751,0.00185783300712909,0.0209036648973021,0.0281863702852481,1.32650199762762e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,GMFG,Glia maturation factor gamma,37990,0.0857060048683544,0.0064875092604497,0.072990486717873,0.0984215230188358,1.33394917201698e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.0810046461549084,0.00613494352446031,0.0689801568469662,0.0930291354628506,1.34742506460514e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.113329786838726,0.00858611642148234,0.0965009986526209,0.130158575024832,1.43741486843196e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,FAP,Prolyl endopeptidase FAP,40536,0.0322245649332907,0.00244357371380993,0.0274351604542233,0.0370139694123582,1.66106267915116e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXJ3,Forkhead box protein J3,37598,0.0521907902405456,0.00395527851476305,0.04443844435161,0.0599431361294812,1.66623373844412e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.145916860427129,0.0110787649021182,0.124202481218977,0.16763123963528,2.07723052350208e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,SMTN,Smoothelin,37905,0.11467182390942,0.00870643229591877,0.0976072166094187,0.13173643120942,2.26022540107945e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL24,C-C motif chemokine 24,40396,0.0985192453142013,0.00748820157620566,0.0838423702248382,0.113196120403564,2.49979829159252e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYBB1,Beta-crystallin B1,37990,0.0771518737475228,0.00586333561842373,0.0656597359354123,0.0886440115596333,2.65469331527638e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.116546057745428,0.00885782105135048,0.099184728484781,0.133907387006075,2.68751254147285e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.128353295830519,0.00976440798677221,0.109215056176445,0.147491535484592,3.17167632535418e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH7,Protocadherin-7,37901,0.0414560982011838,0.00315564858535935,0.0352710269738794,0.0476411694284881,3.51625390687379e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,MYO9B,Unconventional myosin-IXb,40044,0.0787137667965441,0.00599450425034113,0.0669645384658755,0.0904629951272127,3.53100737296258e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP4,Dipeptidyl peptidase 4,40068,0.0354582934319575,0.00270286622597543,0.0301606756290456,0.0407559112348693,4.13843448663753e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.0726399472571419,0.00554136805956788,0.0617788658603888,0.0835010286538949,5.1640434926069e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,FADD,FAS-associated death domain protein,40359,0.090322133836834,0.00689847862883177,0.0768011157243237,0.103843151949344,5.73804326441849e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.11039852462449,0.00843043435681287,0.0938748732851366,0.126922175963843,6.13526283367544e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMA,Granzyme A,40516,0.0415880826681735,0.00318087521919249,0.0353535672385562,0.0478225980977907,7.28100802806093e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PSME1,Proteasome activator complex subunit 1,40216,0.0445702784117459,0.0034104339780537,0.0378858278147607,0.0512547290087312,7.90057467204871e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.109307988256081,0.00836652686046054,0.0929095956095788,0.125706380902584,9.10698837776933e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0680944860575711,0.00521253496819147,0.0578779175199158,0.0783110545952264,9.14980759687108e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0484119289366476,0.00370961322672255,0.0411410870122715,0.0556827708610238,1.00447639039455e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CD5,T-cell surface glycoprotein CD5,40470,0.0394088748399775,0.0030201056625442,0.0334894677413909,0.0453282819385642,1.01657158722601e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0675770094037789,0.00518015082816501,0.0574239137805755,0.0777301050269823,1.08128703014928e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,40305,0.0699260848149984,0.00536654645254001,0.05940765376802,0.0804445158619768,1.30426126171288e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS2,Trypsin-2,40403,0.0590213838944326,0.00453181181041246,0.0501390327460242,0.067903735042841,1.40955213450149e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0719387493537892,0.005527660114919,0.0611045355285479,0.0827729631790304,1.74817842749385e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,DBI,Acyl-CoA-binding protein,40270,0.0926247336283627,0.0071287626167804,0.0786523588994731,0.106597108357252,2.10518482689186e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.067966707082138,0.00523081920813328,0.0577143014341968,0.0782191127300792,2.11426416372919e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.067638627805748,0.00520725378682426,0.0574324103835725,0.0778448452279236,2.21362100416144e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0813527760227867,0.00626714114696321,0.0690691793747389,0.0936363726708346,2.44974649238666e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.147377126603791,0.0113541538632786,0.125122985031765,0.169631268175817,2.69119269234506e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0754830785628751,0.00581533811664723,0.0640850158542465,0.0868811412715037,2.72097379591424e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARF1,Scavenger receptor class F member 1,40536,0.049606564161213,0.00382454409808933,0.0421104577289579,0.057102670593468,2.79538884239087e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,40422,0.101924287085557,0.00786453630534088,0.0865097959270887,0.117338778244025,3.21506314431228e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.0630619650119549,0.00486948717781877,0.0535177701434301,0.0726061598804797,3.64844975344732e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,BLMH,Bleomycin hydrolase,40536,0.0377812047315879,0.00291799040297782,0.0320619435417514,0.0435004659214244,3.75629422324453e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,UROD,Uroporphyrinogen decarboxylase,37671,0.0824030365003416,0.00636591029099207,0.0699258523299971,0.094880220670686,4.30448822497866e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0824596007255149,0.00637368313726768,0.0699671817764702,0.0949520196745595,4.66613594769023e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.103705191416015,0.00803341625792382,0.0879596955504843,0.119450687281546,6.19938725121487e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.0931888042414243,0.00721826097949092,0.0790410127216221,0.107336595761226,6.70414332229103e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.065006895077848,0.00503658500740315,0.0551351884633378,0.0748786016923581,6.94486862625241e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP170,Centrosomal protein of 170 kDa,37628,0.0901714120748006,0.00698949930903047,0.0764719934291009,0.1038708307205,7.53079453611747e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,37572,0.0946025972616771,0.00734125963533773,0.0802137283764151,0.108991466146939,9.09462499861667e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.0890487850100895,0.00691993881319734,0.0754857049362227,0.102611865083956,1.04392776085847e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0618250724680043,0.00480461025311698,0.052408036371895,0.0712421085641135,1.13686680892155e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPING1,Plasma protease C1 inhibitor,37981,0.0216696589154173,0.00168408566372,0.0183688510145261,0.0249704668163085,1.14322690292949e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,COMT,Catechol O-methyltransferase,39877,0.0988187900483641,0.00768556638584521,0.0837550799321075,0.113882500164621,1.21498263142432e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0788960082187888,0.00613836939861929,0.066864804197495,0.0909272122400826,1.28791303276651e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,FUS,RNA-binding protein FUS,39960,0.0457615950686127,0.00356630659915765,0.0387716341342637,0.0527515560029617,1.69143558738562e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB33A,Ras-related protein Rab-33A,37562,0.077606070366289,0.00604680219134499,0.0657543380712528,0.0894578026613252,1.77235104952629e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,MIF,Macrophage migration inhibitory factor,40307,0.0798875487944599,0.00622972856707709,0.0676772808029888,0.092097816785931,1.85675806654767e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,PTX3,Pentraxin-related protein PTX3,40341,-0.0569754134079755,0.00444627785196346,-0.0656901179978239,-0.0482607088181271,2.09203203498233e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL18,C-C motif chemokine 18,40172,0.0813486569936701,0.00635008008054792,0.0689025000357961,0.093794813951544,2.19841469680023e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL26,C-C motif chemokine 26,40341,0.102916809015641,0.00803730522571974,0.0871636907732307,0.118669927258052,2.35526848357841e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,DXO,Decapping and exoribonuclease protein,37942,0.0530259710923075,0.00414298334312558,0.0449057237397814,0.0611462184448336,2.73694488522435e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPACT,Protein IMPACT,37942,0.0658114348042154,0.00514385042538212,0.0557294879704665,0.0758933816379644,2.90871815756595e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,37901,0.113218343775644,0.00885010947331677,0.0958721292079432,0.130564558343345,2.96248776173229e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,BGLAP,Osteocalcin,37998,0.10560822723549,0.00825823635497427,0.0894220839797408,0.12179437049124,3.13156562496239e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,JAM3,Junctional adhesion molecule C,37671,0.0586010915581721,0.00458219264565814,0.0496199939726822,0.0675821891436621,3.14398734919508e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0370030517729952,0.00289548655002083,0.0313278981349544,0.042678205411036,3.23939766523422e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL11,C-X-C motif chemokine 11,40471,0.0917250864909733,0.00718667808431183,0.0776391974457221,0.105810975536225,3.99029214943366e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6AP2,Renin receptor,39980,0.0481257956363355,0.0037721646462815,0.0407323529296237,0.0555192383430472,4.31196057520944e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0684304750828219,0.00536954824755822,0.0579061605176078,0.0789547896480361,5.14810205683917e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0486864286639553,0.00381994490524881,0.0411993366496676,0.0561735206782429,5.45434036603788e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CETN2,Centrin-2,39961,0.0774543825239343,0.00608049198603669,0.0655366182313024,0.0893721468165662,5.55816885878512e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,PYY,Peptide YY,37562,0.109741175502625,0.00861203004488685,0.0928615966146471,0.126620754390604,5.66591717688962e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,NRGN,Neurogranin,37987,0.104346806914119,0.00819841780989131,0.0882779080067321,0.120415705821506,6.75262463675912e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18,Interleukin-18,40292,0.0544153885428957,0.00428074288308669,0.0460251324920458,0.0628056445937456,7.70864338519427e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0459970709334302,0.00362649948484185,0.0388891319431401,0.0531050099237202,1.1782554852345e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.0637004621481043,0.00503515211723335,0.053831563998327,0.0735693602978817,1.6663111301854e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,OCLN,Occludin,37959,0.0499116880164368,0.00394428202687289,0.0421808952437659,0.0576424807891077,1.70853761660128e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,37987,0.0296242587445529,0.00234126177880412,0.0250353856580968,0.034213131831009,1.73003823036535e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSL,Cathepsin L1,40359,0.0277053290843432,0.00219146563023453,0.0234100564490835,0.0320006017196029,1.84602946671051e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS3,Galectin-3,40374,0.0336790255118108,0.00267443514621661,0.0284371326252262,0.0389209183983953,3.43476618178259e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,REEP4,Receptor expression-enhancing protein 4,37959,0.070794632948724,0.00562106688862863,0.0597773418470119,0.0818119240504361,3.61378894748889e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP10,Caspase-10,39961,0.081743463746471,0.00649603844762697,0.0690112283891221,0.0944756991038198,3.90338605620743e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,C1R,Complement C1r subcomponent,38013,0.0226675288549135,0.00180260307427602,0.0191344268293325,0.0262006308804945,4.61193538653702e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,40332,0.0599860185816057,0.00477464090638892,0.0506277224050834,0.0693443147581279,4.97548520453533e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0367374804036598,0.00292475162888412,0.0310049672110469,0.0424699935962727,5.14174598712042e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.125397493769905,0.00999505076990821,0.105807194260885,0.144987793278925,6.23840036495203e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CA13,Carbonic anhydrase 13,40173,0.117463489161892,0.00936601732838905,0.0991060951982493,0.135820883125534,6.57775635722539e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFR,Epidermal growth factor receptor,40536,0.0185462693036832,0.00147967852014464,0.0156460994041997,0.0214464392031667,7.15742276285227e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,37978,0.0548742338923396,0.00437721127855105,0.0462948997863796,0.0634535679982997,7.47198202070951e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,TADA3,Transcriptional adapter 3,37900,0.0440994570355616,0.00352265840431853,0.0371950465630972,0.0510038675080259,9.32253000512753e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,AFP,Alpha-fetoprotein,40182,0.078734020179228,0.00629853945961043,0.0663888828383916,0.0910791575200645,1.09806429015501e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PARK7,Parkinson disease protein 7,40332,0.0604496702868206,0.00483934854491938,0.0509645471387786,0.0699347934348626,1.22499762445269e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0532834402542683,0.00426685513189531,0.0449204041957535,0.0616464763127831,1.27574071059095e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0403625830484669,0.003234624495301,0.0340227190376769,0.0467024470592569,1.55994042923422e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARB2,Lysosome membrane protein 2,40011,0.0348328766196182,0.00279521014326347,0.0293542647388218,0.0403114885004146,1.78506032707889e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.0516037735408531,0.0041509502725332,0.043467911006688,0.0597396360750182,2.7407849449411e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,DBN1,Drebrin,37598,0.0582737216326076,0.00468967207812354,0.0490819643594855,0.0674654789057298,2.97978936865455e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,37419,0.0603046975577659,0.00485491597315188,0.0507890622503882,0.0698203328651436,3.1738633040367e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0692418909903158,0.00558164543292321,0.0583018659417863,0.0801819160388453,3.80124389520102e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB2B,Ras-related protein Rab-2B,37900,0.0688284730600169,0.00555857467077615,0.0579336667052956,0.0797232794147382,5.05057920779638e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0504351843673674,0.00407664190934145,0.0424449662250582,0.0584254025096767,5.40029043264158e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.0530026483973962,0.00428369097616438,0.0446066140841141,0.0613986827106784,5.7125051545375e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,HPSE,Heparanase,37848,0.1037688165898,0.00840139978585704,0.0873020730095204,0.12023556017008,7.41111198915175e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,40411,0.0933679467653077,0.0075678181110763,0.0785350232675982,0.108200870263017,8.19912111614222e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPT1,Angiopoietin-1,40263,0.0944679352802912,0.00766849396839252,0.0794376871022418,0.109498183458341,1.03311780975843e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,37628,0.0623188282973429,0.0050606585920384,0.0523999374569477,0.0722377191377382,1.17548617966494e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.082511590308137,0.00670327665007017,0.0693731680739995,0.0956500125422745,1.23875693289626e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.065056965245451,0.00528866308209535,0.0546911856045441,0.0754227448863579,1.28264881527663e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN3,Ataxin-3,37942,0.0693843682241529,0.00563857056685699,0.0583327699131132,0.0804359665351927,1.30023692563144e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0479079250088293,0.00390186765391954,0.040260264407147,0.0555555856105116,1.70197134255135e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0735295136385755,0.00599146958097209,0.0617862332598702,0.0852727940172808,1.83840009874688e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRN1,Secernin-1,40341,0.0624473308073466,0.00508906653674214,0.052472760395332,0.0724219012193612,1.8594385896653e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,MIA,Melanoma-derived growth regulatory protein,40411,0.0410493361284775,0.00334644013547527,0.034490313462946,0.047608358794009,1.95711818746969e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA3,Annexin A3,40442,0.0776027192705594,0.00632864063460402,0.0651985836267355,0.0900068549143833,2.06444227761078e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0786693153909919,0.00641502268312239,0.066095870932072,0.0912427598499117,2.17023913251112e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX6,Peroxiredoxin-6,40489,-0.066303898691901,0.00541128546909882,-0.0769100182113346,-0.0556977791724673,2.30929471410755e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,40203,0.0440215501245274,0.0035929501761464,0.0369793677792805,0.0510637324697744,2.34378092373106e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,TSC22D1,TSC22 domain family protein 1,37959,0.0746281451283333,0.00608932395863616,0.0626930701694064,0.0865632200872602,2.38703695369448e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0772581585789058,0.00631115073216017,0.0648883031438718,0.0896280140139397,2.86853708803905e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCA,Tubulin-specific chaperone A,37671,0.096556865957358,0.00788878999632883,0.0810948375645535,0.112018894350163,2.92098956785662e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,37901,0.0920560011844993,0.0075338396934185,0.077289675385399,0.1068223269836,3.73352457796728e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.0639272542064041,0.00523425759378734,0.0536681093225809,0.0741863990902273,3.7888129985415e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,40411,0.0264353024007741,0.00216620338046444,0.0221895437750638,0.0306810610264844,4.22391446272387e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,39980,0.0582343978261327,0.00477228838707134,0.0488807125874729,0.0675880830647925,4.31200505966432e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0426813046381283,0.00350077867219041,0.0358197784406351,0.0495428308356215,5.18039294967825e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,APP,Amyloid-beta precursor protein,40309,0.0737112288353196,0.00605655073758637,0.0618403893896503,0.0855820682809889,6.32399542108353e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.0263304193315803,0.00216797434474227,0.0220811896158855,0.0305796490472752,8.59801577499458e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0455339629591047,0.00374804503114624,0.0381877946980581,0.0528801312201514,8.81921183164542e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA6,Integrin alpha-6,40341,0.0583847244470797,0.00481014958472657,0.0489568312610157,0.0678126176331438,9.39137203353894e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSS,Cathepsin S,37057,0.0271593497126133,0.00224018875525345,0.0227685797523165,0.0315501196729101,1.21740183478319e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ABHD14B,Protein ABHD14B,40171,0.0642074016182829,0.00529999679711405,0.0538194078959394,0.0745953953406265,1.24805390160493e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,MEP1A,Meprin A subunit alpha,37901,0.0750750706478098,0.00619563908766223,0.0629316180359918,0.0872185232596277,1.27851692309159e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0339477758712315,0.00280393167955581,0.0284520697793021,0.0394434819631608,1.35935108019773e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.0881371608061009,0.0072805824460138,0.0738672192119139,0.102407102400288,1.48401400116377e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.130499612632409,0.0107946118529901,0.109342173400548,0.15165705186427,1.68730439115792e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,C1RL,Complement C1r subcomponent-like protein,37993,0.0212445176448116,0.0017566044214586,0.0178015729787528,0.0246874623108705,1.68908518135069e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,TST,Thiosulfate sulfurtransferase,39923,0.0830557752722294,0.00687037542199064,0.0695898394451278,0.0965217110993311,1.71005895168543e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,BDNF,Brain-derived neurotrophic factor,37998,0.0902167711679118,0.0074872940552853,0.0755416748195526,0.104891867516271,2.89304789652459e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,AGXT,Serine--pyruvate aminotransferase,40359,0.0836490649074074,0.0069495364901956,0.070027973386624,0.0972701564281908,3.17990648368596e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0325917408743624,0.00270665542011892,0.0272866962509293,0.0378967854977955,3.18456825346198e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0428199789142237,0.00355699185647442,0.0358482748755338,0.0497916829529136,3.30724625471002e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF6,SLAM family member 6,39980,0.0413462049081133,0.00344101626504217,0.0346018130286306,0.0480905967875959,4.12128119223552e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.0920511980576268,0.00766673760513881,-0.107078003763699,-0.0770243923515547,4.5576309299922e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARA5,Scavenger receptor class A member 5,40471,0.0317998900929236,0.00265200472011422,0.0266019608414997,0.0369978193443474,5.49044930703702e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,TREML2,Trem-like transcript 2 protein,40332,0.0362783247280886,0.00303322783167956,0.0303331981779967,0.0422234512781806,7.935302833861e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB6A,Ras-related protein Rab-6A,40341,0.0516883306375777,0.00432469508287481,0.0432119282751431,0.0601647330000123,8.77037487704519e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.0378992364605996,0.0031815704904345,0.031663358299348,0.0441351146218512,1.49201773715546e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,37990,0.0292353589996869,0.00245529603138007,0.0244229787781819,0.0340477392211918,1.58033335235351e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.0941018998796237,0.0079047328832464,0.0786086234284608,0.109595176330787,1.63306908609491e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CD72,B-cell differentiation antigen CD72,37671,0.0455789873137411,0.00383767216233771,0.0380571498755592,0.0531008247519231,2.28412048691304e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0585453628081196,0.0049367761808145,0.0488692814937232,0.068221444122516,2.81592174153974e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,BLNK,B-cell linker protein,37598,0.0412250889782102,0.00347702586839518,0.0344101182761557,0.0480400596802648,2.90994831847018e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,AIF1,Allograft inflammatory factor 1,39980,0.0565688514458768,0.00477572615773432,0.0472084281767176,0.0659292747150361,3.14117571713018e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,RGS10,Regulator of G-protein signaling 10,37959,0.0642697017374375,0.00542507083876032,0.0536365628934673,0.0749028405814077,3.22784510449018e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,ARFIP1,Arfaptin-1,37959,0.0736347462404921,0.0062198130043655,0.0614439127519357,0.0858255797290485,3.54981752011517e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,BTC,Probetacellulin,39980,0.0806730354660709,0.0068226021532096,0.06730073524578,0.0940453356863617,4.01118569999556e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,RILP,Rab-interacting lysosomal protein,40434,0.0644034334094734,0.00544895507851235,0.0537234814555892,0.0750833853633576,4.21552526613706e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS8,Prostasin,40293,0.043147285033451,0.00365074883465244,0.0359918173175322,0.0503027527493698,4.26010020231484e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,FRMD4B,FERM domain-containing protein 4B,37562,0.0755847481928214,0.00639446947703774,0.0630515880178274,0.0881179083678154,4.45883252325704e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRG1,Scrapie-responsive protein 1,37990,0.0293720416462031,0.0024875383835116,0.0244964664145204,0.0342476168778858,5.11496937667236e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL1,Growth-regulated alpha protein,40329,0.103817202920867,0.00879748159739257,0.0865741389899773,0.121060266851756,5.26124065333419e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,37572,0.0461293300229531,0.00391270306693361,0.0384604320117632,0.053798228034143,6.3963965311796e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",37942,0.112504464063067,0.00954985212935931,0.0937867538895224,0.131222174236611,7.02817353872391e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0717006734467714,0.00608781277350005,0.0597685604107113,0.0836327864828315,7.35713317758798e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,NID1,Nidogen-1,40355,0.0420968793229476,0.00357708324871825,0.0350857961554598,0.0491079624904354,7.68921002618852e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,ACRBP,Acrosin-binding protein,37900,0.0403711950404861,0.00343008162083544,0.0336482350636487,0.0470941550173236,8.00640033679056e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA1,Carboxypeptidase A1,40536,0.0607879773749526,0.00517202513085094,0.0506508081184847,0.0709251466314204,9.1679445615392e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,HNMT,Histamine N-methyltransferase,40147,0.0492832223106232,0.00420335983005962,0.0410446370437063,0.05752180757754,1.28990779933234e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM1,Intercellular adhesion molecule 1,40291,0.0302468287142591,0.00258060665452657,0.0251888396713871,0.0353048177571312,1.34646094896074e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,TTF2,Transcription termination factor 2,37572,0.051742614610606,0.00441415504795715,0.04309087071661,0.060394358504602,1.41317622559635e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,PON3,Serum paraoxonase/lactonase 3,40422,-0.0289999908888817,0.00247706470858444,-0.0338550377177072,-0.0241449440600562,1.57146455517244e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ADD1,Alpha-adducin,37671,0.074441173836451,0.00635809796158762,0.0619793018317393,0.0869030458411628,1.65749565035106e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL4,C-C motif chemokine 4,40376,0.0715358122968014,0.00611988360876166,0.0595408404236286,0.0835307841699743,1.9481631638139e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.0557271472529148,0.00477844588339411,0.0463613933214624,0.0650929011843673,2.83239283067449e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CD40LG,CD40 ligand,40516,0.080655829913508,0.00692459568187942,0.0670836223770244,0.0942280374499917,3.14625433853346e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCA,Calcitonin,40192,0.0580367528242425,0.00498547131049367,0.0482652290556749,0.0678082765928101,3.41559159368209e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CD164,Sialomucin core protein 24,40332,0.027950863299973,0.00240170889660563,0.023243513862626,0.03265821273732,3.5388052236256e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0428967678729697,0.00368717085015926,0.0356699130066575,0.0501236227392818,3.89641894899626e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0395742969434762,0.00340460661698387,0.0329012679741878,0.0462473259127646,4.19868667661883e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,LARP1,La-related protein 1,37900,0.0667836170822827,0.00575056032302148,0.0555125188491606,0.0780547153154048,4.95373036114092e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,PKN3,Serine/threonine-protein kinase N3,37714,0.0811290692629051,0.00699280073100346,0.0674231798301383,0.0948349586956719,5.69329745251328e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0406077675398715,0.00350091529846946,0.0337459735548714,0.0474695615248717,5.88636299199591e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRB1,Chymotrypsinogen B,40332,0.0557738243822992,0.00481732132510745,0.0463318745850886,0.0652157741795098,7.10689721229774e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0704884082249004,0.00608859336460561,0.0585547652302734,0.0824220512195274,7.57198924862077e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,MATN2,Matrilin-2,40379,0.0310390007412146,0.00268431651419473,0.0257777403733929,0.0363002611090363,8.41352998374522e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAL,Integrin alpha-L,37598,0.0456847117075068,0.00395666335046017,0.0379296515406048,0.0534397718744087,1.08392691780374e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CD83,CD83 antigen,40341,0.0351117298696347,0.00304495011864814,0.0291436276370844,0.0410798321021851,1.21724056259121e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP5,Microfibrillar-associated protein 5,40536,0.0427462625304185,0.00370849268359807,0.0354776168705663,0.0500149081902708,1.27837420315532e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CD84,SLAM family member 5,40341,0.0320715683491918,0.00278878903596807,0.0266055418386943,0.0375375948596892,1.73803846403401e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CEMIP2,Cell surface hyaluronidase,37598,0.0352286560959453,0.0030650170685385,0.0292212226416098,0.0412360895502807,1.98101951612026e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,GSR,"Glutathione reductase, mitochondrial",37944,0.0230593366234099,0.00200722811270381,0.0191251695225104,0.0269935037243093,2.09536142762254e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPB6,Heat shock protein beta-6,40489,0.0378925015041724,0.00330226147281654,0.031420069017452,0.0443649339908928,2.32218770330254e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM,Paralemmin-1,37824,0.0304674872809986,0.00265543172574763,0.0252628410985333,0.035672133463464,2.48117572593436e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0674344146250523,0.00588716650099402,0.055895568283104,0.0789732609670006,3.08374966742143e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,C19orf12,Protein C19orf12,39961,0.0644577351035291,0.00563045957163205,0.0534220343431303,0.075493435863928,3.18082564764633e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PARD3,Partitioning defective 3 homolog,37714,0.0770379980778105,0.0067277738330368,0.0638515613650583,0.0902244347905626,3.2328125138597e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0682677458143848,0.00596783581757895,0.0565707876119301,0.0799647040168396,3.48506745712388e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0588175137665359,0.00514072929294182,0.0487416843523699,0.0688933431807018,3.6040244401582e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRD1,Natural killer cells antigen CD94,40516,0.0471626390940272,0.00412740858608086,0.0390729182653087,0.0552523599227457,4.02102007138414e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.0796502617035367,0.00697131718612542,0.0659864800187309,0.0933140433883426,4.29639780729833e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",37628,0.0895534240253621,0.00785101908388347,0.0741654266209505,0.104941421429774,5.35901141675528e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0422267895624075,0.00370553707289373,0.0349639368995358,0.0494896422252792,6.08359062275593e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CALB2,Calretinin,39961,0.0325059432242973,0.00285496600442676,0.0269102098556208,0.0381016765929737,6.47315480513315e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXO3,Forkhead box protein O3,39980,0.0999381650327879,0.00877983464483012,0.0827296891289209,0.117146640936655,6.70034507938868e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,GGH,Gamma-glutamyl hydrolase,40077,0.0352487637518098,0.00309973465837862,0.0291732838213877,0.0413242436822319,7.59321880599264e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CPB1,Carboxypeptidase B,40536,0.057825997084744,0.00509402094437686,0.0478417160337654,0.0678102781357227,9.43563685652022e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,DNM1,Dynamin-1,37901,0.11670106210604,0.0102794235372,0.0965533919731285,0.136848732238952,9.79943107826732e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0699966269990366,0.0061687326990289,0.05790591090894,0.0820873430891332,1.05580831556392e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.122832374635864,0.0108344566198088,0.101596839661038,0.144067909610689,1.11545691098558e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,39980,0.0466450359057423,0.0041163496923023,0.0385769905088298,0.0547130813026548,1.19589003069193e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS3BP,Galectin-3-binding protein,38013,0.0303348191296972,0.00268376970280542,0.0250746305121986,0.0355950077471959,1.71687125763885e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.0613944465357074,0.00543400753329477,0.0507437917704497,0.0720451013009652,1.73652920876054e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0693317251058766,0.00613706961666516,0.0573030686572128,0.0813603815545403,1.85329961456705e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.0624031147645116,0.00553819789617653,0.0515482468880056,0.0732579826410176,2.4460699007335e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CORO1A,Coronin-1A,39990,0.0918053371583955,0.00814845326783375,0.0758343687534413,0.10777630556335,2.49278905435045e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR5,Complement factor H-related protein 5,37785,0.0426422322087301,0.00378937728035341,0.0352150527392374,0.0500694116782228,3.02883932875451e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,MDK,Midkine,40352,0.0516136132721883,0.00458941238144723,0.0426183650045518,0.0606088615398249,3.11621368896556e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0506265176861486,0.00451474397637861,0.0417776194924465,0.0594754158798507,4.6950066659485e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,RASSF2,Ras association domain-containing protein 2,39980,0.0557905267209775,0.00497973135561493,0.0460302532639722,0.0655508001779828,5.06317902571821e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CFB,Complement factor B,37770,0.0332893239804091,0.00297150385941158,0.0274651764159624,0.0391134715448558,5.32134903958931e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,37598,0.0890336428035174,0.00794784788423459,0.0734558609504176,0.104611424656617,5.37928080892841e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.092034677221313,0.00822671477227008,0.0759103162676637,0.108159038174962,6.30614751609481e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.0648068584633798,0.00579992333212162,0.0534390087324214,0.0761747081943381,7.06679209886857e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLN4,Cerebellin-4,40489,0.0318516801267295,0.00285250291217162,0.0262607744188731,0.0374425858345858,7.62262994221477e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.066271105796868,0.00594015509338643,0.0546284018138306,0.0779138097799054,8.56808424394373e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0773697954524692,0.00695542150446116,0.0637371693037253,0.091002421601213,1.23460956392986e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,TPP1,Tripeptidyl-peptidase 1,40255,0.0449520296474871,0.00404565188792892,0.0370225519471464,0.0528815073478278,1.41215233242577e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPA1,Inositol monophosphatase 1,40228,0.0613493041456921,0.00552331101189825,0.0505236145623715,0.0721749937290126,1.47454311610145e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ASAH1,Acid ceramidase,37882,0.0464512821025558,0.00418215159356534,0.0382542649791677,0.0546482992259439,1.54364693789817e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,FMNL1,Formin-like protein 1,39961,0.0602822687084968,0.00543075898899777,0.0496379810900612,0.0709265563269324,1.603717454284e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.0367464441326448,0.00330970904200389,0.0302594144103172,0.0432334738549724,1.62837587212057e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CPXM1,Probable carboxypeptidase X1,40411,0.069046586703502,0.00622287396213593,0.0568497537377156,0.0812434196692885,1.67503694352273e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF2,Fibroblast growth factor 2,40341,0.066512404986964,0.00599639836568811,0.0547594641902154,0.0782653457837127,1.74420313804757e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0497293729864752,0.00448299045943351,0.0409427116859855,0.0585160342869649,1.80249119064395e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,KITLG,Kit ligand,40359,-0.0365345615817368,0.00329510150163112,-0.0429929605249338,-0.0300761626385398,1.83342047681495e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0493448032484328,0.00445374830889745,0.0406154565629938,0.0580741499338718,2.09605731577112e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ALCAM,CD166 antigen,40536,0.019433936966567,0.00175523625649613,0.0159936739038346,0.0228742000292994,2.1728015302033e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,GET3,ATPase GET3,37990,0.0563575231750569,0.00509282741770585,0.0463755814363535,0.0663394649137604,2.42451686920623e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,EPCAM,Epithelial cell adhesion molecule,40358,-0.0998179559178516,0.00903253780175609,-0.117521730009294,-0.0821141818264096,2.74981105587501e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC3B,Tetranectin,37681,0.0211022729586396,0.00190979754908994,0.0173590697624233,0.0248454761548559,2.93059786938323e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,DPT,Dermatopontin,40536,0.0263806059795617,0.00239631774359141,0.0216838232021225,0.0310773887570008,4.36562659039928e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.066320587052029,0.00602754353679119,0.0545066017199183,0.0781345723841397,4.69785187809336e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,RBKS,Ribokinase,39991,0.0495700365039671,0.0045063492125798,0.0407375920473107,0.0584024809606235,4.84680223317823e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.0474720318949628,0.00431636901014297,0.0390119486350825,0.055932115154843,4.95018860772677e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA4,Annexin A4,40279,0.0713717160409421,0.00649271850511176,0.0586459877709231,0.0840974443109612,5.23902510652399e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0885546670150086,0.00806217602051435,0.0727528020148005,0.104356532015217,6.02803214161164e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO2,Roundabout homolog 2,40471,0.0231467828905245,0.00210928514096379,0.0190125840142355,0.0272809817668135,6.42500259448767e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.0242156600725394,0.00220738317735674,0.0198891890449202,0.0285421311001586,6.68749116745002e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,40359,0.0348988456142949,0.00318151307505432,0.0286630799871884,0.0411346112414013,6.76096631686303e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,MENT,Protein MENT,37671,-0.0215347396961326,0.0019657734961449,-0.0253876557485766,-0.0176818236436886,8.29448544930022e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR4,Complement factor H-related protein 4,37973,0.0728860611160934,0.006657895985563,0.0598365849843899,0.0859355372477969,8.95221778558654e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0762861345925495,0.00697741848049873,0.062610394370772,0.089961874814327,1.04503292513227e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.086919713797838,0.00795387188505988,0.0713301249031207,0.102509302692555,1.06767907783889e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB10,Ras-related protein Rab-10,37990,0.0531479982031204,0.00486504982740748,0.0436125005414017,0.062683495864839,1.14892936665797e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.053634386059323,0.00491097958485496,0.0440088660730073,0.0632599060456387,1.14928082182211e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,40044,0.0674241174779958,0.00618081565861611,0.0553097187871082,0.0795385161688834,1.31916780113559e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0813417092118372,0.00746026692179206,0.0667195860451247,0.0959638323785496,1.39157721115376e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,SWAP70,Switch-associated protein 70,37901,0.0347635226281482,0.00318829935766759,0.0285144558871198,0.0410125893691767,1.44692689567772e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,IMMT,MICOS complex subunit MIC60,37900,0.0438371383072819,0.00402923977909065,0.0359398283402643,0.0517344482742996,1.87314114246363e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS27,Serine protease 27,40314,0.0398513241471437,0.00366457342573905,0.0326687602326952,0.0470338880615923,1.90066856039819e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0482074699669527,0.00443402979786939,0.0395167715631287,0.0568981683707767,2.04663317285716e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PSAP,Prosaposin,37901,0.0279853947167529,0.0025772218190804,0.0229340399513553,0.0330367494821505,2.35336618153006e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX9,Sorting nexin-9,40359,0.0673964288044571,0.00621646387210391,0.0552121596151335,0.0795806979937808,2.72330726570971e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.031857162822296,0.00294011964621803,0.0260945283157086,0.0376197973288833,2.90996433875102e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0215531772445566,0.00199163401677144,0.0176495745716845,0.0254567799174286,3.37596996005212e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PDZD2,PDZ domain-containing protein 2,37562,0.0603954892024205,0.00558164971289293,0.0494554557651504,0.0713355226396907,3.5906677368821e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNRD2,Protein ZNRD2,37901,0.0666547843971265,0.006167350774289,0.05456677687952,0.0787427919147329,4.09105069184885e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,VWC2,Brorin,40167,0.0380188761013122,0.00352596812113995,0.0311079785838779,0.0449297736187465,5.17464540310844e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.051948739231386,0.00482042338702948,0.0425007093928082,0.0613967690699638,5.74228927797997e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP1,Guanylate-binding protein 1,37931,0.0628090987441619,0.0058341231569284,0.0513742173565822,0.0742439801317415,6.42232002508819e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,DDT,D-dopachrome decarboxylase,37998,0.0398736122590599,0.0037086689767711,0.0326046210645886,0.0471426034535313,7.48551634290198e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.044354783810165,0.0041281697749674,0.0362635710512289,0.0524459965691011,8.0885709384658e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0280144692279707,0.00260842663633008,0.0229019530207637,0.0331269854351776,8.51966460382016e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0337852241494157,0.0031478858761655,0.0276153678321313,0.0399550804667,8.81766359687661e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,39980,0.0391856742278753,0.00365715300836611,0.0320176543314777,0.0463536941242729,1.07530027881321e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.0365242114813223,0.003408957058884,0.0298426556459097,0.0432057673167349,1.11789763832888e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0275959198986745,0.0025774061670526,0.0225442038112514,0.0326476359860976,1.16405025678768e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.040633447646658,0.00379502835156753,0.0331951920775857,0.0480717032157304,1.16786502862822e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G15,Phospholipase A2 group XV,40411,0.0248924916696593,0.00233017014342083,0.0203253581885544,0.0294596251507641,1.50809746661087e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN4,CCN family member 4,40489,0.0394306519248539,0.00370720680342553,0.0321645265901398,0.0466967772595679,2.47449689994368e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL2,C-C motif chemokine 2,40203,0.0509633994152275,0.00479660105248277,0.0415620613523613,0.0603647374780937,2.80157254760394e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ANG,Angiogenin,40309,0.0330845983945622,0.00311972168393681,0.026969943894046,0.0391992528950783,3.45751188777187e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0647191362495424,0.00611285958606174,0.0527379314608614,0.0767003410382234,4.3373793647938e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,POMC,Pro-opiomelanocortin,37628,0.0653756719554214,0.00618301187831665,0.0532569686739208,0.0774943752369221,5.03083477514934e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,FXN,"Frataxin, mitochondrial",40489,0.0706126461546733,0.00669804830111182,0.0574844714844941,0.0837408208248525,6.70319518513857e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1F,Protein phosphatase 1F,37990,0.0499896887512531,0.00474463584234431,0.0406902025002582,0.0592891750022479,7.4193401430077e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,FGL1,Fibrinogen-like protein 1,37987,-0.0599970821596377,0.00569614232668012,-0.0711615211199307,-0.0488326431993446,7.66706542478789e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0431028557131906,0.00409817971666064,-0.0511352879578454,-0.0350704234685357,8.70159065458395e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,THBD,Thrombomodulin,40359,0.0264092283260988,0.00251355096206698,0.0214826684404475,0.03133578821175,9.76522210190905e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ENAH,Protein enabled homolog,40044,0.044964543216673,0.00428745433693645,0.0365611327162776,0.0533679537170685,1.20059478544082e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0359227984623192,0.00342559685175913,0.0292086286328713,0.0426369682917671,1.21187681118728e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CD46,Membrane cofactor protein,40250,0.0271980944786359,0.00259643636725877,0.0221090791988087,0.0322871097584631,1.36274277682781e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,ARSA,Arylsulfatase A,40332,0.0422712065594354,0.00403577229092138,0.0343610928692295,0.0501813202496413,1.37622292219695e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,ATG4A,Cysteine protease ATG4A,39980,0.0564628732492369,0.00539371384061762,0.0458911941216264,0.0670345523768474,1.46979138196745e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.0264434619863807,0.00253028116307686,0.02148411090675,0.0314028130660113,1.75551115579345e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,ASPN,Asporin,37990,0.0258674112327827,0.00247611827385075,0.0210142194160352,0.0307206030495301,1.89450966199585e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO2,Gamma-enolase,40471,0.0621299570498566,0.00595660528804454,0.0504550106852893,0.0738049034144239,2.17154082275386e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,BAP18,Chromatin complexes subunit BAP18,37942,0.0612259675629391,0.00587205606173974,0.0497167376819292,0.072735197443949,2.33882973067541e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,ACYP1,Acylphosphatase-1,37622,0.0625436835552565,0.00599898842044579,0.0507856662511828,0.0743017008593303,2.37510077368569e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMA4,Laminin subunit alpha-4,40422,0.030920732941121,0.0029698425724784,0.0250998414990633,0.0367416243831787,2.64576358747482e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.04665292346804,0.00447956040728466,0.037872985069762,0.0554328618663179,2.67943221983092e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL1,Fc receptor-like protein 1,40359,0.0423762173838879,0.00407859389551287,0.0343821733486826,0.0503702614190931,3.31856552999977e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,GRK5,G protein-coupled receptor kinase 5,40042,0.0494809428292339,0.00476899078182471,0.0401337208968574,0.0588281647616103,3.86749983252657e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,37959,0.0331071599372816,0.00319378593622296,0.0268473395022846,0.0393669803722786,4.39091607790585e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,MCAM,Cell surface glycoprotein MUC18,40403,-0.031892998124063,0.00307785038396423,-0.0379255848766329,-0.0258604113714931,4.42924048003353e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,WDR46,WD repeat-containing protein 46,37900,0.0334517274888652,0.00322764304302549,0.0271255471245352,0.0397779078531951,4.48642640382063e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,TREML1,Trem-like transcript 1 protein,37987,0.0494303815090257,0.00478546573305912,0.0400508686722298,0.0588098943458216,6.42903542116872e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0356905244776257,0.0034614905472613,0.0289060030049936,0.0424750459502579,7.54562520973806e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0267819036164261,0.00259832281973307,0.0216891908897493,0.0318746163431029,8.10803891013644e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.0961785219368786,0.00935054299957682,0.0778514576577081,0.114505586216049,1.00753949338702e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,BMPER,BMP-binding endothelial regulator protein,37671,0.0209652247540225,0.00203859296587898,0.0169695825408997,0.0249608669671453,1.02920362160363e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0407820313591328,0.00396988537059857,0.0330010560327596,0.048563006685506,1.12035179247218e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,TNF,Tumor necrosis factor,40014,0.0370538842637562,0.00360757935735647,0.0299830287233375,0.0441247398041749,1.14001000465045e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0513381317509657,0.00500223144124054,0.0415337581261342,0.0611425053757971,1.23178252064259e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,OPLAH,5-oxoprolinase,37628,0.0632369681304117,0.00617255890107769,0.0511387526842994,0.075335183576524,1.54265398618457e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0260483052044954,0.00254534960527706,0.0210594199781524,0.0310371904308384,1.7316794784385e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0645374998414035,0.00631269469147883,0.052164618246105,0.076910381436702,1.85442437096243e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,DMD,Dystrophin,37628,0.0480703568060989,0.00471605747875434,0.0388268841477404,0.0573138294644574,2.6249974548199e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0550543217264033,0.00540894717261594,0.044452785268076,0.0656558581847305,3.02777815925209e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,KLF4,Krueppel-like factor 4,37541,0.0361057746958311,0.00354887352399893,0.0291499825887931,0.043061566802869,3.19205923784779e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.057247700599006,0.00563018374378775,0.046212540461182,0.06828286073683,3.36530804923022e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,HPCAL1,Hippocalcin-like protein 1,40516,0.0674676576768838,0.0066413726733604,0.0544505672370974,0.0804847481166702,3.58648055271271e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,40167,0.0258711748213015,0.002547829270908,0.0208774294503218,0.0308649201922812,3.76827574760646e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0608819090825815,0.00599636691123292,0.049129029936565,0.072634788228598,3.79794412544108e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.050488780641215,0.00498286007890834,0.0407223748865547,0.0602551863958754,4.6966734005338e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,ASS1,Argininosuccinate synthase,37562,0.0740015368328928,0.00730216044564794,0.0596893023594228,0.0883137713063627,4.77704534516112e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0278424778838474,0.00275182413910907,0.0224489025711936,0.0332360531965011,5.43823727834832e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0399574695327704,0.00394860475932962,0.0322182042044843,0.0476967348610564,5.52326365135553e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3C,Protein FAM3C,40330,0.0271788361836249,0.00268801569529927,0.0219103254208383,0.0324473469464115,5.8287084762106e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CGA,Glycoprotein hormones alpha chain,40332,0.0821073156608962,0.00812163169420115,0.066188917540262,0.0980257137815305,5.91243328693249e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.0698852384948694,0.00691615228493932,0.0563295800163883,0.0834408969733504,6.40954357510629e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0678541890218479,0.00672395032485777,0.0546752463851267,0.0810331316585692,7.12668222700548e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0273594243816376,0.00271187234265115,0.0220441545900414,0.0326746941732339,7.31037630837073e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CR1,Complement receptor type 1,37959,0.0331722704922381,0.00328898764087951,0.0267258547161142,0.0396186862683619,7.74875421304729e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,FCN1,Ficolin-1,37967,0.0515043905310531,0.00511876300504398,0.0414716150411669,0.0615371660209393,9.86989256787245e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,37901,0.0240771846032645,0.00239718086322943,0.0193787101113349,0.0287756590951942,1.18343747410772e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,BRK1,Protein BRICK1,39961,0.040265485471967,0.00401011242300775,0.0324056651228718,0.0481253058210622,1.18883490098542e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,40273,0.0305956743153859,0.00304986433666633,0.0246179402155198,0.0365734084152519,1.29961403502589e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0627848052364081,0.00625920191960307,0.050516769473986,0.0750528409988301,1.35737492039834e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ACAN,Aggrecan core protein,40224,0.0257581136314268,0.00257167278634885,0.020717634970183,0.0307985922926705,1.52302248339207e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK4,Dickkopf-related protein 4,40203,0.0413993108913872,0.00413659122576979,0.0332915920888784,0.049507029693896,1.65114930991755e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,AMOTL2,Angiomotin-like protein 2,37855,0.0436586166376739,0.00436670212890529,0.0350998804650195,0.0522173528103283,1.87744446699799e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,GNAS,Neuroendocrine secretory protein 55,37959,0.081750248367053,0.00818412482709573,0.0657093637059454,0.0977911330281607,2.05559871899105e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3B,Protein FAM3B,40305,0.0326932622793929,0.00327457427984792,0.026275096690891,0.0391114278678948,2.10052389215781e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,NPPB,Natriuretic peptides B,40042,-0.116206053148053,0.0116409551231369,-0.139022325189401,-0.0933897811067041,2.1370604330593e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,LGMN,Legumain,40422,0.0320761030369077,0.0032146019572408,0.0257754832007157,0.0383767228730996,2.22187676845162e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP12,Macrophage metalloelastase,40346,0.0467601851810225,0.00469262408314319,0.0375626419780619,0.0559577283839832,2.54866407667175e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0282176533196883,0.00283377648392348,0.0226634514111983,0.0337718552281784,2.7283380698811e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0322358391884779,0.00323637490143349,0.0258925443816682,0.0385791339952875,2.73140256770953e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PTN,Pleiotrophin,40042,0.0451860818436671,0.00455134443926279,0.036265446742712,0.0541067169446222,3.68163179373604e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.0281639003190476,0.00283839957597833,0.0226006371501301,0.0337271634879652,3.99403072464876e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,40136,0.0265687604579078,0.00267868948176706,0.0213185290736443,0.0318189918421712,4.04343307528708e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,NBN,Nibrin,40044,0.0454297538885097,0.00461601983818162,0.0363823550056737,0.0544771527713457,8.66890524625213e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR3,Toll-like receptor 3,40516,0.0542315064975631,0.00551791632271643,0.0434163905050389,0.0650466224900874,9.86101560275654e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,STXBP3,Syntaxin-binding protein 3,39980,0.0392906533692757,0.00400733519072603,0.0314362763954527,0.0471450303430987,1.2503340645362e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN6,Dynactin subunit 6,39961,0.0628652799115314,0.00642071015922499,0.0502806879994504,0.0754498718236124,1.43051790545798e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,FGA,Fibrinogen alpha chain,37698,0.02733832645677,0.00279227145282599,0.021865474409231,0.0328111785043089,1.47201290106505e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,TSHB,Thyrotropin subunit beta,40359,0.0743495591633337,0.00760008992607804,0.0594533829082208,0.0892457354184467,1.54621762769749e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFA2,BPI fold-containing family A member 2,37150,-0.0986062399030019,0.0100764226882842,-0.118356028372039,-0.0788564514339649,1.55586936960924e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,TSNAX,Translin-associated protein X,37562,0.0351183053773812,0.00358907921874734,0.0280837101086364,0.042152900646126,1.56331012892882e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PZP,Pregnancy zone protein,38013,0.0578083686558709,0.00591656895187949,0.0462118935101871,0.0694048438015547,1.78602303216717e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PMM2,Phosphomannomutase 2,37562,0.0537208337797599,0.00550016793234032,0.0429405046323729,0.064501162927147,1.85850690711907e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,ING1,Inhibitor of growth protein 1,39925,0.0395452338402726,0.00405039234503989,0.0316064648439944,0.0474840028365508,1.87832389157332e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,LY75,Lymphocyte antigen 75,40341,0.0342980620383941,0.0035290103303395,0.0273812017909287,0.0412149222858595,2.88942526197155e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.0830780233641121,0.00855064934753979,0.0663187506429341,0.0998372960852901,2.97574598364592e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,STK4,Serine/threonine-protein kinase 4,40359,0.0756526934515092,0.00778680316079805,0.060390559256345,0.0909148276466734,2.98610818117153e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,EPPK1,Epiplakin,37628,0.064760738605553,0.00667201592171748,0.0516835873989868,0.0778378898121193,3.36277804879072e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.063304694145584,0.00652772469951355,0.0505103537345375,0.0760990345566306,3.55804071655493e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0271806100354915,0.00281222107706373,0.0216686567244466,0.0326925633465364,5.00420349097673e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGES2,Prostaglandin E synthase 2,37484,0.0479398602332904,0.00496695780973077,0.0382046229262181,0.0576750975403627,5.72317533440954e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12A_IL12B,Interleukin-12,40305,0.0685979255402309,0.00711019165354691,0.054661949899279,0.0825339011811829,5.76941206943774e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF22,Kinesin-like protein KIF22,37562,0.107304108302021,0.0111229612633832,0.0855031042257899,0.129105112378252,5.98212999977282e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0355085345066617,0.00369099797777728,0.0282741784702182,0.0427428905431051,7.74574814874133e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNA4,Ephrin-A4,40203,0.025699877448337,0.00267257096308489,0.0204616383606906,0.0309381165359834,7.84524384856126e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0391648596504367,0.00407669926090125,0.0311745290990703,0.0471551902018032,8.80662923446723e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3BP1,SH3 domain-binding protein 1,37901,0.0406914494465045,0.0042405478077519,0.0323799757433108,0.0490029231496983,9.77443298641924e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,AMOT,Angiomotin,37671,0.0363289567717252,0.00378674964347351,0.0289069274705171,0.0437509860729332,1.00014280513093e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CCS,Copper chaperone for superoxide dismutase,40228,0.0420017962329156,0.00438190298350313,0.0334132663852494,0.0505903260805817,1.05648433122384e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,BOLA1,BolA-like protein 1,37541,0.0477173148286806,0.00497753023858277,0.0379613555610583,0.0574732740963028,1.07322200596387e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0415881985040594,0.00434203654605577,0.0330778068737901,0.0500985901343288,1.13527906761792e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.0509246305350557,0.00531904907167089,0.0404992943545808,0.0613499667155307,1.17761553308701e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP8,Caspase-8,40434,0.0536805116411431,0.00560718563342119,0.0426904277996376,0.0646705954826486,1.18111055464987e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0178103330253643,0.0018670029448221,-0.0214696587972156,-0.014151007253513,1.63721742499501e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,C5,Complement C5,38013,0.0132459521196708,0.00138822178938168,0.0105250374124827,0.0159668668268589,1.64192113469647e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0366580165219564,0.00384690839200048,0.0291180760736355,0.0441979569702774,1.8127883570787e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0279656754571488,0.00293823733338152,0.0222067302837211,0.0337246206305766,2.06291382113207e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,UNC79,Protein unc-79 homolog,37482,0.0489077508748349,0.00514099090731357,0.0388314086965003,0.0589840930531695,2.16744415623182e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0464964363387405,0.00489101802192984,0.0369100410157581,0.056082831661723,2.3102551371483e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,NGRN,Neugrin,37942,0.0189805762214492,0.00199812868209576,0.0150642440045415,0.0228969084383569,2.46666541683047e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0360317100217296,0.00379960350951563,0.0285844871430789,0.0434789329003802,2.81022250659924e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,MSTN,Growth/differentiation factor 8,40042,0.0437702623020109,0.00463742558825524,0.0346809081490307,0.0528596164549912,4.3055656330381e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,SF3B4,Splicing factor 3B subunit 4,40305,0.0627641724236099,0.00665561009398387,0.0497191766394015,0.0758091682078183,4.64459537375735e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0329502638679615,0.00349632661059153,0.0260974637112021,0.0398030640247209,4.92741149688747e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA9,Serpin A9,40228,0.0616270372345895,0.00654316582812441,0.0488024322114656,0.0744516422577133,5.19381750217662e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB6,Integrin beta-6,40044,0.0257546133359613,0.00273770711212421,0.0203887073961978,0.0311205192757248,5.78145544608183e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,FSHB,Follitropin subunit beta,37628,0.0596687688306972,0.00634182233473183,0.0472387970546228,0.0720987406067716,5.83988940009993e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,40357,0.0339570225935335,0.0036114260758168,0.0268786274849326,0.0410354177021345,6.02924765283538e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL25,C-C motif chemokine 25,40516,0.0416367418488437,0.00442856187097103,0.0329567605817405,0.0503167231159469,6.06740469282825e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMB1,Laminin subunit beta-1,37628,0.0251698548860619,0.00267777455281867,0.0199214167625373,0.0304182930095865,6.37190288307018e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,PQBP1,Polyglutamine-binding protein 1,39980,0.0470189721011055,0.00500372431685897,0.0372116724400619,0.0568262717621491,6.39235224360516e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,NID2,Nidogen-2,40332,0.0627283835356624,0.00668754208271921,0.0496208010535327,0.075835966017792,7.47751858986898e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,37628,0.0476170802074888,0.00508482585467884,0.0376508215323183,0.0575833388826593,8.86127032844694e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0431648338168826,0.00461117426608594,0.0341269322553542,0.0522027353784111,8.92907585196874e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.0962165620097164,0.0102810946461188,0.0760656165033234,0.116367507516109,9.3434981523003e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,NAA10,N-alpha-acetyltransferase 10,37562,0.0436227116906474,0.00467093714518922,0.0344676748860765,0.0527777484952183,1.12540723765927e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,OXT,Oxytocin-neurophysin 1,40471,0.111853583831629,0.0119807954812638,0.0883712246883521,0.135335942974906,1.12813873322675e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,BRDT,Bromodomain testis-specific protein,37562,0.0316323768043926,0.00338821436398567,0.0249914766509807,0.0382732769578045,1.15943198327438e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.0520861398135464,0.005585838255589,0.041137896832592,0.0630343827945008,1.26023502395583e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.0772788240647253,0.00828615352341005,0.0610379631588416,0.093519684970609,1.26936387690218e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CLU,Clusterin,38013,0.0280191323393535,0.00300518173366608,0.0221289761413679,0.033909288537339,1.29595343058645e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0333525346019823,0.00358473127618913,0.0263264613006516,0.040378607903313,1.55733104402807e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,37714,0.0293550594092482,0.00315571656190912,0.0231698549479063,0.0355402638705901,1.5886233666665e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.0375683894098255,0.00404579172004061,0.0296386376385459,0.0454981411811051,1.85309926919009e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0247990321194441,0.00267852795028757,0.0195491173368804,0.0300489469020077,2.33543416015308e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17D,Interleukin-17D,40044,0.0287834934641479,0.00310893358724063,0.0226899836331563,0.0348770032951395,2.3418169538504e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA3,Protein disulfide-isomerase A3,37671,0.0214396515336984,0.00232025831617602,0.0168919452339934,0.0259873578334034,2.83145000478045e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN3,Calsyntenin-3,37942,0.025621760423688,0.00277419379616992,0.0201843405831949,0.031059180264181,2.94261758103754e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,BST2,Bone marrow stromal antigen 2,40471,0.0447678809168393,0.00485456505247674,0.0352529334139849,0.0542828284196937,3.2776019873302e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0729875870355258,0.00792022622975562,0.0574639436252048,0.0885112304458468,3.56399728195403e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,RGMB,RGM domain family member B,40471,0.0216581533397721,0.00235397738954233,0.0170443576562692,0.0262719490232751,3.98729881116997e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0309705530419768,0.00336834838038768,0.024368590216417,0.0375725158675367,4.32555105880972e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CSTB,Cystatin-B,40097,0.0348397836173451,0.00379542870361542,0.0274007433582589,0.0422788238764313,4.86652351961175e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CPQ,Carboxypeptidase Q,37986,0.0304147577902888,0.00331652335606899,0.0239143720123936,0.036915143568184,5.37037823004129e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0298652609586869,0.00326246593314695,0.0234708277297189,0.0362596941876549,6.14572078153493e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.0128594647438741,0.00140642703338297,0.0101028677584434,0.0156160617293047,6.76394830107974e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.0288127372394857,0.00315552463409038,0.0226279089566685,0.0349975655223028,7.60219114147739e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,STX16,Syntaxin-16,39980,0.0488877987146684,0.00536025477685991,0.038381699352023,0.0593938980773138,8.38381520186693e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,MAGED1,Melanoma-associated antigen D1,39980,0.0401209157173793,0.00441013915278205,0.0314770429779265,0.0487647884568322,1.03515096726744e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.095743289347147,0.0105652501198617,0.075035399112218,0.116451179582076,1.45427163341919e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0393226953589909,0.00434262455753588,0.0308111512262206,0.0478342394917612,1.55002117029419e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0295569546118796,0.00326652866660147,0.0231545584253407,0.0359593507984185,1.61536476023553e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.0479015233632838,0.00530355692176624,0.037506551796622,0.0582964949299457,1.91201342161882e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA2,Apolipoprotein A-II,37987,-0.039009789909779,0.00432011950593057,-0.0474772241414029,-0.0305423556781551,1.94953141544877e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,GIP,Gastric inhibitory polypeptide,37628,0.0422436570163723,0.00469011103457081,0.0330510393886135,0.0514362746441311,2.40628085418411e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,STX6,Syntaxin-6,39980,0.05624517515574,0.00624814485591766,0.0439988112381414,0.0684915390733386,2.47131243797202e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.0182955610780383,0.00203237743730848,0.0143121013009137,0.0222790208551629,2.50711391749849e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,40403,0.037257660177027,0.00414043699455371,0.0291424036677018,0.0453729166863523,2.54173139429792e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0268500161817006,0.0029866905612808,0.0209961026815903,0.032703929681811,2.74550885351952e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0521477149352924,0.00580205644795333,0.0407756842973039,0.0635197455732809,2.80080614134552e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ERI1,3'-5' exoribonuclease 1,37714,0.0273763743345231,0.00305269994031498,0.0213930824515057,0.0333596662175404,3.42202666853059e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0555485605671766,0.00620074313076284,0.0433951040308814,0.0677020171034718,3.72144993140194e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,HRG,Histidine-rich glycoprotein,37934,0.0255987671002046,0.00286202232608788,0.0199892033410723,0.0312083308593368,4.22550493369236e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,MEP1B,Meprin A subunit beta,40359,0.0958748872257715,0.0107321666007417,0.0748398406883177,0.116909933763225,4.57531433833212e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SCG2,Secretogranin-2,40392,0.0260402738156088,0.00292482538333402,0.0203076160642741,0.0317729315669435,6.00127325555262e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,XCL1,Lymphotactin,40489,0.0454811584880882,0.00511169784098461,0.0354622307197584,0.055500086256418,6.31341067641706e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL20,C-C motif chemokine 20,40516,0.0714625883934832,0.00804049276461435,0.055703222574839,0.0872219542121273,6.88104468416089e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,INSR,Insulin receptor,37598,0.013657916019392,0.0015365720336989,0.0106462348333422,0.0166695972054419,6.98820052570241e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP6,Gastrotropin,40017,0.0448982348256115,0.00506854865456536,0.0349638794626634,0.0548325901885596,8.99617793594179e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,DENR,Density-regulated protein,37598,0.0463836443978465,0.00523586960012561,0.0361213399816004,0.0566459488140927,9.11384902488566e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS7_LGALS7B,Galectin-7,40270,0.0323067747370043,0.0036477927856749,0.0251571008770815,0.0394564485969271,9.11707329316293e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.027720326150355,0.00313231858332845,0.0215809817270313,0.0338596705736788,9.68139734992268e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,TPMT,Thiopurine S-methyltransferase,39980,0.0593503690077778,0.00671439907608685,0.0461901468186476,0.0725105911969081,1.06529430829987e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0608053992446474,0.00688865395380755,0.0473036374951846,0.0743071609941102,1.20971837992414e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0346647113177025,0.00393107868830051,0.0269597970886335,0.0423696255467715,1.30909486873039e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PER3,Period circadian protein homolog 3,37598,0.0946687025693437,0.010735746311907,0.073626639798006,0.115710765340681,1.30948798099061e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,LTA,Lymphotoxin-alpha,40341,0.0321933556077995,0.00365277276077736,0.0250339209966759,0.0393527902189232,1.33776795363969e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,COLEC12,Collectin-12,40357,0.0204100736165958,0.00231603661095615,0.0158706418591217,0.0249495053740698,1.34839302856515e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,39925,0.0528530938505788,0.00600175148966662,0.0410896609308323,0.0646165267703254,1.42880100985723e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,C7orf50,Uncharacterized protein C7orf50,37942,0.0175473721683677,0.00199228615709375,0.013642491300464,0.0214522530362715,1.43212799229063e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,39980,0.0366481175967442,0.00416189192207983,0.0284908094294678,0.0448054257640207,1.4364251837397e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,SPAG1,Sperm-associated antigen 1,37959,0.0460210119801782,0.00522669068421214,0.0357766982391224,0.056265325721234,1.46604895726155e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.044272290943907,0.00503115763351852,0.0344112219822107,0.0541333599056033,1.5408132857855e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,FRZB,Secreted frizzled-related protein 3,40176,0.0212825273041484,0.00241997319217647,0.0165393798474825,0.0260256747608143,1.58317515760487e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,VGF,Neurosecretory protein VGF,37959,0.0243509545023734,0.00276851738335513,0.0189246604309974,0.0297772485737494,1.59245011716664e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,XRCC4,DNA repair protein XRCC4,39961,0.029731399546649,0.00338286191106846,0.0231009902009548,0.0363618088923432,1.66740365371101e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK7,Kallikrein-7,37352,0.0309352029527938,0.0035211496228758,0.0240337496919572,0.0378366562136303,1.75097950819074e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0303257031231163,0.00345479737892109,0.023554300260431,0.0370971059858016,1.86882183121573e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CD302,CD302 antigen,40305,0.0239536590940949,0.00273105077389649,0.0186007995772578,0.029306518610932,1.95063964759029e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0389581094433081,0.0044450164324603,0.0302458772356859,0.0476703416509303,2.06846683014557e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PAEP,Glycodelin,40228,-0.104557095731539,0.0119463659644585,-0.127971973021877,-0.0811422184412,2.30087426876979e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSE,Cathepsin E,37671,0.0409894325812231,0.0046823745364565,0.0318119784897683,0.0501668866726778,2.30705227598213e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.0308215590308879,0.00352646581303679,0.0239096860373358,0.03773343202444,2.55956161167307e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0216621427531948,0.0024789826931047,0.0168033366747096,0.02652094883168,2.59892594008847e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,LIPF,Gastric triacylglycerol lipase,37628,0.0473438874970304,0.00542454745437808,0.0367117744864493,0.0579760005076114,2.90830911603811e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0533150129927722,0.00611147483532956,0.0413365223155262,0.0652935036700181,3.01288490378602e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ECE1,Endothelin-converting enzyme 1,39961,0.0279235609245481,0.0032038510303173,0.0216440129051262,0.03420310894397,3.18023608551843e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.0193159555869573,0.00222530701593121,0.0149543538357321,0.0236775573381825,4.33199244916476e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,37714,0.0550204268862667,0.00634851640122754,0.0425773347398607,0.0674635190326727,4.96110064264239e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.0240173225110265,0.00277255269149691,-0.0294515257863604,-0.0185831192356925,5.05068386559982e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINI1,Neuroserpin,37642,0.0251182361354142,0.00289998338786648,0.0194342686951959,0.0308022035756325,5.19216664797642e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,37998,0.0203859374686488,0.00235439615946516,0.0157713209960971,0.0250005539412005,5.30729277179504e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,GRN,Progranulin,40262,0.019046784242748,0.00220078150765229,0.0147332524877495,0.0233603159977465,5.41864292809394e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFA,Protransforming growth factor alpha,40341,0.037602581593635,0.00434708788089439,0.029082289347082,0.046122873840188,5.63268666956244e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,VCAM1,Vascular cell adhesion protein 1,40372,-0.0211478965002067,0.00245040296749532,-0.0259506863164975,-0.0163451066839159,6.68544009558716e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0236195289313935,0.00273638502985753,0.0182562142728728,0.0289828435899143,6.71815259204129e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.056649793923373,0.00656527439800991,0.0437818561032736,0.0695177317434724,6.78399297640985e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PRG2,Bone marrow proteoglycan,37998,-0.0409004988829246,0.0047418613679592,-0.0501945471641247,-0.0316064506017246,7.08984105389977e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0332581770886728,0.00385987363718951,0.0256928247597814,0.0408235294175643,7.54865833718216e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.0745357126667074,0.00865077802917085,0.0575801877295325,0.0914912376038822,7.5786061435968e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CHCHD6,MICOS complex subunit MIC25,37900,0.0226972885959597,0.00263452161819823,0.0175336262242912,0.0278609509676283,7.7440180357226e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.029166487137063,0.00339676864329117,0.0225088205962123,0.0358241536779136,9.78305422839914e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP6,Bone morphogenetic protein 6,40024,0.0329352332892319,0.00383968328861742,0.0254094540435417,0.040461012534922,1.05895904888341e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,TXN,Thioredoxin,37819,0.0346221844343511,0.00404749162774471,0.0266891008439715,0.0425552680247308,1.31742415469462e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CLTA,Clathrin light chain A,40042,0.0367612631045968,0.00430002826288006,0.0283332077093518,0.0451893184998417,1.35454432318263e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,STAM,Signal transducing adapter molecule 1,37900,0.0291541028503743,0.00341087840938078,0.0224687811679879,0.0358394245327606,1.39363345821669e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0441935336916593,0.00517326160889419,0.0340539409382267,0.0543331264450919,1.45429925227917e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PVALB,Parvalbumin alpha,40417,0.0873106673704676,0.0102459369125643,0.0672286310218415,0.107392703719094,1.71412675640529e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0227769687741049,0.00267471376600771,0.0175345297927298,0.02801940775548,1.80394929877247e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,C8B,Complement component C8 beta chain,38013,0.0236231722880165,0.00277507843924431,0.0181840185470976,0.0290623260289353,1.87772735074075e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,C7,Complement component C7,37678,-0.0243716368872505,0.00286461886924361,-0.029986289870968,-0.018756983903533,1.96160193835338e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRDL1,Chordin-like protein 1,40396,0.0235138904774167,0.00276633536727561,0.0180918731575565,0.0289359077972769,2.06147925804196e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,APRT,Adenine phosphoribosyltransferase,40216,0.0374065419748226,0.00440142327086414,0.0287797523639289,0.0460333315857163,2.08616099165402e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PIGR,Polymeric immunoglobulin receptor,40154,0.0271102396212416,0.00319127842619431,0.0208553339059007,0.0333651453365824,2.15289749334243e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0316051535496132,0.0037262959190859,0.0243016135482049,0.0389086935510216,2.44982177719073e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,SLIT2,Slit homolog 2 protein,39961,0.0404017392614893,0.00476448308151355,0.0310633524217227,0.0497401261012559,2.45745037595632e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,STX7,Syntaxin-7,37598,0.0388002150946801,0.00457764027694559,0.0298280401518667,0.0477723900374934,2.57645791201995e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.0254216089292527,0.00300002839089807,0.0195415532830925,0.031301664575413,2.58073809166642e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL2,Fc receptor-like protein 2,40442,0.0373369464551329,0.00441424706504683,0.0286850222076412,0.0459888707026247,2.9453457787958e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0369905097168007,0.00438499144502278,0.0283959264845561,0.0455850929490454,3.56976938551878e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,IDS,Iduronate 2-sulfatase,40516,0.00659047012493969,0.000784467800694454,0.00505291323557856,0.00812802701430082,4.7850109123526e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP3,Stromelysin-1,40332,-0.0368091008389469,0.00438463267819115,-0.0454029808882016,-0.0282152207896923,5.04672771732972e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.0419487686987575,0.00499672041761472,0.0321551966802326,0.0517423407172823,5.10993934378559e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,HDGF,Hepatoma-derived growth factor,40471,0.0725582622075811,0.00866312887865616,0.055578529605415,0.0895379948097471,5.94819935065088e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO1,Roundabout homolog 1,40379,0.0182622855984082,0.00218260472394949,0.0139843803394672,0.0225401908573492,6.38479509465377e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.0469955890074402,0.00561779129676471,0.0359847180657814,0.0580064599490991,6.58721437373373e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0432084675187491,0.0051860162950429,0.033043875580465,0.0533730594570332,8.61302496173847e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.0318725525927445,0.00382519232798831,0.0243751756298874,0.0393699295556016,8.69328384168229e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0231179945663681,0.00277478803819077,0.0176794100115142,0.028556579121222,8.74882704713241e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0368658747046404,0.0044270528906296,0.0281888510390064,0.0455428983702744,8.92920873077912e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD1,Programmed cell death protein 1,40455,0.0330634881136001,0.00397151686359734,0.0252793150609493,0.0408476611662509,9.0958106808218e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,AMIGO2,Amphoterin-induced protein 2,40305,0.0170324356940103,0.00204779593992622,0.0130187556517549,0.0210461157362657,9.71121681221102e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.0150253611288086,0.00180652979939731,-0.0185661595356274,-0.0114845627219899,9.72730327105503e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PKD1,Polycystin-1,37990,0.0195374437737091,0.00235177833221059,0.0149279582425764,0.0241469293048419,1.06946381827061e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0215461041030698,0.00259727125956733,0.0164554524343178,0.0266367557718218,1.1844939478916e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0171934024379928,0.00207474024761743,0.0131269115526626,0.0212598933233229,1.25197752406261e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0766359241144357,0.00925905341796425,0.0584881794152257,0.0947836688136456,1.38297595864125e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0527845233709733,0.00637719266322534,0.0402852257510516,0.0652838209908949,1.38334021174413e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0181875769208943,0.00219862559577131,0.0138782707531826,0.0224968830886061,1.41873454678648e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0471506761716833,0.00571528801833684,0.0359487116557431,0.0583526406876235,1.7353007974786e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PPL,Periplakin,37598,0.0247596485110898,0.00300275429507467,0.0188742500927434,0.0306450469294361,1.79771445181673e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0451587763423076,0.00548237506776312,0.0344133212094919,0.0559042314751233,1.92544841720207e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0499034012852582,0.00606052001215923,0.0380247820614261,0.0617820205090903,1.9728537932701e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PVR,Poliovirus receptor,40471,0.0274328145580177,0.00333327765052212,0.0208995903629943,0.0339660387530411,2.01520944323931e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,AHCY,Adenosylhomocysteinase,40359,0.0505262637529191,0.00614696240540702,0.0384782174383214,0.0625743100675169,2.19581674689315e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRIB,Protein scribble homolog,37628,0.0694304091369,0.00844891263945075,0.0528705403635765,0.0859902779102235,2.26749548920621e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.0408540776928867,0.00497293167709435,0.0311071316057818,0.0506010237799916,2.30862862932429e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ELOB,Elongin-B,37562,0.0299752986712234,0.00365595460794863,0.0228096276396441,0.0371409697028027,2.64728011812429e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SMS,Spermine synthase,37541,0.0476006531875887,0.00581010672940288,0.0362128439979591,0.0589884623772184,2.78933136770672e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0354626030012467,0.00433354320628091,0.0269688583169361,0.0439563476855573,2.97549579153048e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CA4,Carbonic anhydrase 4,40536,-0.0173174168262806,0.00211759291438952,-0.0214678989384841,-0.0131669347140772,3.10262752420041e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0480829374081208,0.00588701691842595,0.0365443842480059,0.0596214905682357,3.42997232522233e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0385549958299866,0.0047251942834395,0.0292936150344451,0.047816376625528,3.61441432503488e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN2,Dynactin subunit 2,40305,0.0695935873786247,0.00853708079744433,0.0528609090156338,0.0863262657416156,3.84753890659659e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0400867296207541,0.00491900701429542,0.0304454758727351,0.0497279833687731,3.97780298897708e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.047023237014796,0.00577177004430501,-0.0583359063016339,-0.0357105677279582,4.06124951579879e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.0279772598052434,0.00343700034460122,0.021240739129825,0.0347137804806618,4.24282012328883e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP9,Caspase-9,37598,0.0461932554775024,0.00568223058787379,0.0350560835252697,0.057330427429735,4.69733755599987e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0253439696172239,0.00312178947609805,-0.031462676990376,-0.0192252622440717,5.06684211611719e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.0185423196221029,0.00228477944804059,0.0140641519039433,0.0230204873402625,5.24902947012173e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12B,Interleukin-12 subunit beta,40516,0.0399111912331383,0.0049210363522604,0.0302659599827079,0.0495564224835686,5.41019186033802e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP1,Interstitial collagenase,39757,0.0683715148901467,0.00843263576530513,0.0518435487901486,0.0848994809901447,5.53461541749808e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYGD,Gamma-crystallin D,37942,0.0704959152229431,0.00871219452461684,0.0534200139546941,0.0875718164911921,6.38728718998346e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,37628,0.0172516678501728,0.00213447370122342,0.0130680993957749,0.0214352363045707,6.90117355320597e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL19,C-C motif chemokine 19,40471,0.0958849356285846,0.0118837078984038,0.0725928681477132,0.119177003109456,7.6108300609173e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PODXL,Podocalyxin,40305,0.0111354172797665,0.00138086624682645,0.00842891943598669,0.0138419151235464,7.90235752778807e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,TREH,Trehalase,37998,0.0545113347786994,0.00676012012068081,0.041261499342165,0.0677611702152338,8.02207089424356e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QA,Complement C1q subcomponent subunit A,40442,-0.016614304351911,0.00206191221127899,-0.0206556522860178,-0.0125729564178042,8.31810159720636e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.0855230098857383,0.0106140114753828,-0.106326472377489,-0.0647195473939879,8.33651334118135e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.028685303439646,0.00356396250547749,0.0216999369289102,0.0356706699503819,9.08198323539251e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.034674810770113,0.00430926500495569,0.0262286513603999,0.0431209701798262,9.22111307337287e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,REN,Renin,40359,-0.0518163137170188,0.00647049940039735,-0.0644984925417977,-0.03913413489224,1.24513831874466e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN5,CCN family member 5,40332,0.028481158255448,0.00356080546131624,0.0215019795512682,0.0354603369596279,1.34554582382739e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CSNK1D,Casein kinase I isoform delta,37598,0.0463140626772499,0.00579754349856154,0.0349508774200693,0.0576772479344305,1.47828288404163e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1,Integrin beta-1,40333,0.0158418406886729,0.00198598125838408,0.0119493174222401,0.0197343639551057,1.60307198591804e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,40042,0.0405417137522611,0.00508483842522689,0.0305754304388164,0.0505079970657058,1.65463240673114e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_E,,40341,0.0208158818848955,0.00261583505655574,0.0156888451740463,0.0259429185957448,1.87104779248083e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CST5,Cystatin-D,40070,0.039810228387132,0.0050117052840969,0.0299872860303021,0.049633170743962,2.0995828632758e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CBS,Cystathionine beta-synthase,37628,0.0365895954988857,0.00461191921771542,0.0275502338321635,0.0456289571656079,2.298016019147e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,TCOF1,Treacle protein,37990,0.0217871659792932,0.00274748041707581,0.0164021043618246,0.0271722275967618,2.36481767528229e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0285822723717221,0.00360542228571442,0.0215156446917219,0.0356489000517224,2.40906127091198e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,39980,0.0258334782895104,0.00326750143211291,0.0194291754825691,0.0322377810964517,2.83139436022363e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,NPHS1,Nephrin,37598,0.0249732770798625,0.00315847420453131,0.0187826676389812,0.0311638865207439,2.85176124670088e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGR1,Prostaglandin reductase 1,37990,0.0570587955566747,0.00721849000719193,0.0429105551425785,0.0712070359707709,2.89640958280245e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.0360145844350506,0.0045606326913781,0.0270757443599495,0.0449534245101516,3.08621006314177e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300LF,CMRF35-like molecule 1,40489,0.0434716716163028,0.00551146942961619,0.0326691915342551,0.0542741516983506,3.28073947990472e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CYTL1,Cytokine-like protein 1,37998,0.0164423704922246,0.00208988441884695,0.0123461970312846,0.0205385439531646,3.88799930127936e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ADA,Adenosine deaminase,40516,0.0242491516190098,0.00308443758919364,0.0182036539441903,0.0302946492938294,4.02635428635837e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,EDF1,Endothelial differentiation-related factor 1,37959,0.0496938358721108,0.00632136159008606,0.0373039671555421,0.0620837045886794,4.08997559170887e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0400650117368511,0.00509746138442102,0.0300739874233859,0.0500560360503163,4.14144692110057e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPG,Macrophage-capping protein,40185,0.0413794342508787,0.00526726426432014,0.0310555962928112,0.0517032722089462,4.22216766177671e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SCT,Secretin,37572,0.0328595489494426,0.00418459586907613,0.0246577410460534,0.0410613568528318,4.39382528935082e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,GLO1,Lactoylglutathione lyase,40042,0.0420594869347386,0.00537369829283256,0.0315270382807868,0.0525919355886904,5.31945692737681e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ERMAP,Erythroid membrane-associated protein,37598,0.03184813979412,0.00408396910885236,0.0238435603407694,0.0398527192474707,6.7442347949251e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.0386418405852394,0.00496553845667968,0.0289093852101472,0.0483742959603315,7.67103110181767e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.042900996470014,0.00552035904856789,0.0320810927348209,0.0537209002052071,8.33614324825098e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.0402588801356303,0.00519404381068415,0.0300785542666893,0.0504392060045712,9.68200304641038e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0365226158604972,0.00472372701896244,0.0272641109033308,0.0457811208176636,1.13569775750882e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,S100P,Protein S100-P,40042,0.0376058851408173,0.0048653582035639,0.0280697830618321,0.0471419872198026,1.14696939873078e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL8,Interleukin-8,40209,0.0475541196116132,0.00615420518704854,0.035491877444998,0.0596163617782283,1.16634843380582e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.018071510304318,0.00233887348688677,0.0134873182700199,0.0226557023386161,1.17033487647961e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAV,Integrin alpha-V,40489,0.011464965487136,0.00148610372541444,0.00855220218532365,0.0143777287889483,1.28288442921357e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN2,Nectin-2,40330,0.0202196516409321,0.0026217605155491,0.0150810010304559,0.0253583022514083,1.30932570047817e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB8,Serpin B8,40516,0.0381355615791545,0.00494657663452521,0.028440271375485,0.0478308517828239,1.33692177768538e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0281255679584855,0.00365706594812461,0.0209577187001613,0.0352934172168098,1.56343390629044e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,NADK,NAD kinase,40359,0.0372969988452641,0.00485600748344101,0.0277792241777197,0.0468147735128085,1.67545716577307e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,GLRX,Glutaredoxin-1,40260,0.0394368973642736,0.00513648823129511,0.0293693804309352,0.049504414297612,1.71288109845435e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0259414336500684,0.003385368956492,0.0193061104953441,0.0325767568047927,1.92261086576481e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA2,Annexin A2,37441,0.0497465360286636,0.00649810636315348,0.0370102475568828,0.0624828245004444,2.06071508441913e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA12,Serpin A12,39903,0.0793821648043392,0.0103733406217576,0.0590504171856943,0.0997139124229842,2.08690293893249e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,APLP1,Amyloid-like protein 1,40359,-0.0361066688616834,0.00471918423462508,-0.0453562699615486,-0.0268570677618183,2.10746988217853e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,KLB,Beta-klotho,39961,-0.0511102204690636,0.00668505758407483,-0.0642129333338503,-0.038007507604277,2.20399597073828e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,AK1,Adenylate kinase isoenzyme 1,40359,0.0442700232461791,0.00579902234834149,0.0329039394434297,0.0556361070489284,2.40370540444094e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.0336505706878131,0.00441063386796104,0.0250057283066095,0.0422954130690167,2.49154927502345e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINI2,Serpin I2,37901,0.0387964187498857,0.00508534183295126,0.0288291487573012,0.0487636887424702,2.52319930036423e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.0263510597486903,0.00345997978457449,0.0195694993709243,0.0331326201264563,2.7627186798992e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ADM,Pro-adrenomedullin,40489,0.0186028134105716,0.00244362865075955,0.0138133012550829,0.0233923255660603,2.83147687110312e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300E,CMRF35-like molecule 2,40436,0.027591159368513,0.00362502154654346,0.0204861171372879,0.0346962015997382,2.86434328122711e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,HGFAC,Hepatocyte growth factor activator,37849,0.0200093096004035,0.00263273278293108,0.0148491533458585,0.0251694658549484,3.15271671112467e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0286551817481252,0.00377118093804031,0.0212636671095662,0.0360466963866842,3.19867271402189e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSF,Cathepsin F,40411,0.0275035595927888,0.0036311691847764,0.0203864679906271,0.0346206511949506,3.80808515568007e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF23,Fibroblast growth factor 23,40469,0.0423562045653784,0.00559587959463573,0.0313882805598923,0.0533241285708644,3.95992631149322e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,40330,0.0499712773390689,0.00662400174645117,0.0369882339160246,0.0629543207621132,4.8051745709189e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,40305,0.0244316302950397,0.00326010470982696,0.0180418250637789,0.0308214355263006,7.02611008354482e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.0303682775120647,0.00407033615434084,0.0223904186495567,0.0383461363745728,9.13413606819223e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,COL2A1,Collagen alpha-1(II) chain,37628,0.0556782797867241,0.0074752775291901,0.0410267358295115,0.0703298237439367,1.0041190188524e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TPR,Nucleoprotein TPR,37562,0.0317735899182526,0.00427743672893339,0.0233898139295431,0.040157365906962,1.1690390854405e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,BSG,Basigin,40502,0.0135952961768364,0.00183242450606284,0.0100037441449533,0.0171868482087196,1.23633280806025e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0363419253700789,0.00490104765022484,0.0267358719756382,0.0459479787645196,1.27567956745159e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX2,Sorting nexin-2,37900,0.0525863021400954,0.0070908657878887,0.0386882051958336,0.0664843990843573,1.27871761050299e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,DAPK2,Death-associated protein kinase 2,37598,0.0353193586764756,0.00476642934732458,0.0259771571557195,0.0446615601972318,1.33983140910085e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,HMOX1,Heme oxygenase 1,40184,-0.0314508731417133,0.00425797751625392,-0.039796509073571,-0.0231052372098556,1.5848976383608e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYM,Ketimine reductase mu-crystallin,37541,0.0517744267483072,0.00700886295085712,0.0380370553646273,0.0655117981319872,1.5927798458512e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR15L,Protein GPR15L,37901,0.0404505184293232,0.00548127188592856,0.0297072255329032,0.0511938113257432,1.67863927580753e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0229154183368685,0.00310640628135564,0.0168268620254114,0.0290039746483255,1.71801220800896e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0253569401536826,0.00343980561433337,0.0186149211495892,0.032098959157776,1.76785876112701e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,GRSF1,G-rich sequence factor 1,37402,0.05288336469095,0.00718560186411728,0.0387995850372802,0.0669671443446199,1.95541950180825e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,FEN1,Flap endonuclease 1,39980,0.0414056151174197,0.00562714703677564,0.0303764069253395,0.0524348233095,1.95746640739414e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,BGN,Biglycan,39956,-0.0811765550941891,0.0110365141675768,-0.10280812286264,-0.0595449873257385,2.00071306301314e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA2,Carboxypeptidase A2,40398,0.0427044649235297,0.00581714908063748,0.0313028527254803,0.0541060771215792,2.22008595662058e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PRL,Prolactin,40471,-0.0509447013233859,0.0069636881213629,-0.0645935300412572,-0.0372958726055146,2.68037021654746e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,MANSC1,MANSC domain-containing protein 1,40411,-0.0181527448824996,0.00248901948263506,-0.0230312230684643,-0.0132742666965349,3.1704838745012e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.0172625430541786,0.00236666303576939,0.0126238835040706,0.0219012026042866,3.17615967880695e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,LACRT,Extracellular glycoprotein lacritin,37863,0.0352916076404809,0.00484170102863441,0.0258018736243575,0.0447813416566044,3.29509767470722e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A13,Protein S100-A13,37598,0.0231261623094284,0.003173221800349,0.0169066475807444,0.0293456770381124,3.32761083953728e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0253522281929201,0.00348106057207396,0.0185293494716551,0.032175106914185,3.42412281690853e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,COPB2,Coatomer subunit beta',37562,0.0286734009008901,0.00393792753444133,0.020955062933385,0.0363917388683951,3.49361216283986e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300A,CMRF35-like molecule 8,37671,0.0195795408117776,0.00269001604947198,0.0143071093548125,0.0248519722687426,3.56355515258409e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,XG,Glycoprotein Xg,40458,0.0196813118107324,0.00271623139893837,0.0143574982688132,0.0250051253526516,4.49442108642647e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CD14,Monocyte differentiation antigen CD14,40048,0.0272898677867116,0.00377274318364641,0.0198952911467646,0.0346844444266586,4.92847596528054e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.0366573497140762,0.00506769903667002,0.026724659602203,0.0465900398259494,4.96733996689587e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA6,Corticosteroid-binding globulin,38013,0.0117488880754973,0.00162483219040508,0.00856421698230335,0.0149335591686913,5.05756561653499e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMG3,Proteasome assembly chaperone 3,40341,0.0336205707361645,0.0046518727453536,0.0245029001552714,0.0427382413170575,5.15017580962469e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.0270740438631732,0.0037496995621021,0.0197246327214531,0.0344234550048934,5.42036412787952e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,NFIC,Nuclear factor 1 C-type,37959,0.0286157566319802,0.00396667473738495,0.0208410741467057,0.0363904391172548,5.72089997791505e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0357539579386005,0.00495625805901067,0.0260396921429396,0.0454682237342614,5.73364239938611e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,C2orf69,UPF0565 protein C2orf69,37572,0.0395795925549291,0.00549155922028924,0.0288161364831622,0.050343048626696,6.01707589309811e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,APOB,Apolipoprotein B-100,37987,0.0146381634031339,0.00203164615996213,0.0106561369296081,0.0186201898766597,6.10806847709845e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK6,Kallikrein-6,40387,0.0199040676317972,0.00276425658497836,0.0144861247252397,0.0253220105383548,6.26651739176529e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0478570584650254,0.00665405918710757,0.0348151024582946,0.0608990144717563,6.66887122943574e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CIT,Citron Rho-interacting kinase,37572,0.0295184604183904,0.00410380772539394,0.0214749972766183,0.0375619235601625,6.68484343424641e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0241487709195464,0.00335992074382438,0.0175633262616506,0.0307342155774422,6.96175239132529e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,YAP1,Transcriptional coactivator YAP1,37942,0.0173827376445335,0.00242041614138654,0.0126387220074159,0.0221267532816511,7.24494016265274e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CSDE1,Cold shock domain-containing protein E1,37562,0.0765145101462392,0.0106660863007842,0.0556089809967022,0.0974200392957761,7.69594780383398e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL14,C-C motif chemokine 14,40309,0.0253591659681031,0.00353778869608573,0.0184251001237751,0.0322932318124311,7.94072889884489e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.0222269197362248,0.00310104690975886,-0.0283049716793522,-0.0161488677930974,7.97731573602283e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0544917344084204,0.00761316133067062,0.039569938200306,0.0694135306165348,8.58007580607527e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.0521430179311804,0.007286252402808,0.0378619632216767,0.0664240726406841,8.65562743459173e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,37628,0.0343738194260657,0.00482706602300259,0.0249127700209806,0.0438348688311508,1.12656716601387e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,FGR,Tyrosine-protein kinase Fgr,39961,0.0357597625666247,0.00502274756388367,0.0259151773414127,0.0456043477918367,1.13021410262538e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.0304122026158224,0.00428052559703783,0.0220223724456282,0.0388020327860165,1.25768902882131e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.0555273914264322,0.00783306470512254,0.040174584604392,0.0708801982484724,1.41958819441565e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP7,Dipeptidyl peptidase 2,40251,0.0372028837947989,0.00526148257565837,0.0268903779465085,0.0475153896430893,1.60497459801412e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,UMOD,Uromodulin,40502,-0.0346535364065266,0.00491474620845223,-0.044286438975093,-0.0250206338379603,1.84968957106816e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,THBS4,Thrombospondin-4,40355,0.0288522184561092,0.00409247498690946,0.0208309674817667,0.0368734694304518,1.86187565426512e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL3,Fc receptor-like protein 3,40044,0.0350328290076625,0.00497280115449353,0.0252861387448551,0.0447795192704698,1.93375709584279e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0266107588593245,0.00378722300671432,0.0191878017661644,0.0340337159524845,2.22059043224339e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0402049194763187,0.00572641663795442,0.028981142865928,0.0514286960867094,2.29294373313264e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0410365392871815,0.0058615240075795,0.0295479522323257,0.0525251263420374,2.64565552141429e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.0231192663766653,0.0033019446768819,-0.0295910779433538,-0.0166474548099768,2.65107986243987e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTG,Protogenin,40489,0.0159518030898703,0.00228599966257024,0.0114712437512326,0.020432362428508,3.11035034113297e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CABP2,Calcium-binding protein 2,37572,0.0415815428698162,0.00595857422530921,0.0299027373882102,0.0532603483514223,3.12815737912194e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.0209397088468484,0.00300239350326345,0.0150550175804521,0.0268244001132448,3.21575355115031e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,NFASC,Neurofascin,40516,0.0172088195304319,0.00247054411070654,0.0123665530734471,0.0220510859874167,3.39694594934257e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.0210881519293549,0.00303744434468218,0.0151347610137778,0.027041542844932,4.02124737275795e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG4,Desmoglein-4,40250,0.032081036102315,0.00462706097794433,0.0230119965855441,0.0411500756190859,4.2690608076113e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTX1,Neuronal pentraxin-1,40332,0.0248320250425705,0.00358251650151799,0.0178102926995953,0.0318537573855458,4.32587625863012e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.033177274009921,0.00478945850376189,0.0237899353425477,0.0425646126772943,4.46304957997406e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX5,Sorting nexin-5,37628,0.0188143369822356,0.00272474647524525,0.013473833890755,0.0241548400737163,5.25097522805978e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0488810627718682,0.00708158028696337,0.03500116540942,0.0627609601343164,5.3409894009402e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,GC,Vitamin D-binding protein,38013,0.0162968516818431,0.00236312092036286,0.0116651346779319,0.0209285686857543,5.57281941723309e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA7,Thyroxine-binding globulin,38013,0.0117141944549196,0.00170048438257392,0.00838124506507469,0.0150471438447644,5.87707801242723e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CLGN,Calmegin,37572,0.0278786110876002,0.00404827075013022,0.019944000417345,0.0358132217578555,5.97660732637526e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CLPS,Colipase,40311,0.042776190626807,0.00622745346801733,0.030570381829493,0.054981999424121,6.70708382706606e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CHAD,Chondroadherin,37671,0.0335956243325649,0.0048921180666082,0.0240070729220129,0.043184175743117,6.83545567716907e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CD80,T-lymphocyte activation antigen CD80,37990,0.0212568426294006,0.00309551282951064,0.0151896374835597,0.0273240477752414,6.84325442246349e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,LCP1,Plastin-2,37998,0.0293739393957892,0.00428196506833597,0.0209812878618507,0.0377665909297277,7.18898221864759e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,40311,0.0251711833486711,0.00367790551636867,0.0179624885365885,0.0323798781607537,7.98940110206422e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SFRP4,Secreted frizzled-related protein 4,37671,0.0260279385482706,0.00380378408604435,0.0185725217396237,0.0334833553569176,8.11702166903886e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0255826909952515,0.00375227750419429,0.0182282270870306,0.0329371549034723,9.6426902358661e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0158081853328731,0.00232496716976255,-0.0203651209856077,-0.0112512496801385,1.09516524036077e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DGKZ,Diacylglycerol kinase zeta,40044,0.0216182028886644,0.00318392531516946,0.0153777092709322,0.0278586965063965,1.16347147591266e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0231146859493598,0.00340750175029868,0.0164359825187744,0.0297933893799452,1.21493930095378e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,40536,0.0210670541039041,0.00311150945880369,0.0149684955646489,0.0271656126431593,1.32607485909989e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CD276,CD276 antigen,40357,-0.0220708207470788,0.00326548477162577,-0.0284711708994653,-0.0156704705946923,1.43955349762375e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,GFAP,Glial fibrillary acidic protein,39959,0.0287689591239249,0.00425757989427945,0.0204241025311372,0.0371138157167127,1.45779961559709e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,LBP,Lipopolysaccharide-binding protein,40403,-0.0356456582982603,0.0052823746600374,-0.0459991126319336,-0.025292203964587,1.5501835985298e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,POSTN,Periostin,37998,-0.0232345054472967,0.00344315873371481,-0.0299830965653778,-0.0164859143292157,1.55968172004372e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,BAX,Apoptosis regulator BAX,39934,0.0547454783560945,0.00811715808751385,0.0388358485045674,0.0706551082076217,1.59086186252556e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.0136727242614796,0.00202952509560112,0.00969485507410138,0.0176505934488578,1.67353657071274e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0217979225180922,0.00323769510504708,0.0154520401121999,0.0281438049239845,1.73646084554912e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.033674276420324,0.00500879306734578,-0.0434915108323218,-0.0238570420083263,1.84043004732087e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.0185184068021034,0.00275407349549406,-0.0239163908532717,-0.013120422750935,1.84165839024427e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH5,Cadherin-5,40536,-0.0184688227369865,0.00275546377877893,-0.0238695317433932,-0.0130681137305798,2.11520923177953e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0231861618855886,0.00345990315947489,0.0164047516930178,0.0299675720781594,2.13763764895301e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRR3,Small proline-rich protein 3,37942,0.0433332470758776,0.00647028650280364,0.0306514855303824,0.0560150086213727,2.20762138511041e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.0180099519451205,0.00269021292435886,0.0127371346133771,0.0232827692768639,2.23467467109198e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,RPL14,60S ribosomal protein L14,37628,0.0251612784665745,0.00375832192623889,0.0177949674911463,0.0325275894420027,2.24689335101922e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.024667359213298,0.0036902077353365,0.0174345520520385,0.0319001663745576,2.410311229995e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,APOE,Apolipoprotein E,38013,0.0455391006589815,0.00681769465783154,0.0321764191296317,0.0589017821883313,2.49028665057394e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSH,Pro-cathepsin H,40013,0.043854576054479,0.00657327326100236,0.0309709604629144,0.0567381916460436,2.61478379905127e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,APOD,Apolipoprotein D,37345,-0.0269851278260386,0.00405098162986263,-0.0349250518205693,-0.0190452038315078,2.82281041876151e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0286744362739339,0.00431881948686111,0.0202095500796861,0.0371393224681816,3.25375606032686e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR2,Folate receptor beta,40471,-0.0177381836324122,0.00267464206819812,-0.0229804820860805,-0.0124958851787439,3.41801133740597e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSC,Dipeptidyl peptidase 1,40349,0.0256214148220528,0.0038633882548809,0.0180491738424863,0.0331936558016194,3.42191486237015e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.0176437366919935,0.00267130821769892,0.0124079725853036,0.0228795007986834,4.10294973626536e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0411696882181349,0.00623431648796865,0.0289504279017163,0.0533889485345534,4.16343229680121e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0343874895147812,0.00520852374033057,0.0241787829837333,0.0445961960458291,4.18309308416785e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DHPS,Deoxyhypusine synthase,37900,0.0247096313447534,0.00374562939798967,0.0173681977246936,0.0320510649648131,4.35482817432093e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.0151581509545396,0.00229876338302527,0.0106525747238101,0.0196637271852691,4.4136975232185e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,40359,0.0104167993535918,0.00158658055478178,0.00730710146621949,0.013526497240964,5.34404526014781e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.0180810863646844,0.00275440714869999,0.0126824483532324,0.0234797243761364,5.41922327547916e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A11,Protein S100-A11,40207,0.026732021004483,0.00408140032236319,0.0187324763726511,0.0347315656363148,5.94308534875482e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ANPEP,Aminopeptidase N,40370,0.0167789259579167,0.00256680058307163,0.0117479968150963,0.0218098551007371,6.47155353164917e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,REG4,Regenerating islet-derived protein 4,40379,0.0288380601636928,0.00441322651519086,0.0201881361939187,0.0374879841334669,6.57758039735971e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0208168533418363,0.00318636381725796,0.0145715802600107,0.0270621264236619,6.64234198038105e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,GM2A,Ganglioside GM2 activator,37714,0.0228073332398878,0.00349671368718564,0.0159537744130039,0.0296608920667716,7.16507098888642e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR2,Complement factor H-related protein 2,37911,0.0338171873905264,0.00519998387550936,0.0236252189945281,0.0440091557865248,8.13383185972524e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,40457,0.015412547922768,0.00237452069819324,0.0107584873543093,0.0200666084912268,8.78899654349357e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,MSLN,Mesothelin,40271,0.031960081157648,0.00492450736008255,0.0223080467318861,0.0416121155834098,8.83855797817564e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.034155012001776,0.00526627964473468,0.023833103898096,0.044476920105456,9.10358749359079e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,MDM1,Nuclear protein MDM1,37572,0.0184703578530613,0.00285059567040891,0.0128831903390598,0.0240575253670628,9.53312578591248e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.0239498728045226,0.0037294879989026,0.0166400763266735,0.0312596692823717,1.39237423564174e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.0146087431161052,0.00227630011335536,-0.0190702913382817,-0.0101471948939287,1.43015337539158e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0168908516607983,0.0026323412742015,0.0117314627633634,0.0220502405582332,1.43246900394133e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ICOSLG,ICOS ligand,40305,0.0111506544116709,0.00173808982067061,0.00774399836315652,0.0145573104601853,1.44373201697961e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CD101,Immunoglobulin superfamily member 2,37901,0.0248024693690353,0.00386793913178994,0.017221308670727,0.0323836300673435,1.48110037305707e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.0431923454119153,0.00674515900604174,0.0299718337600735,0.0564128570637571,1.57017139232358e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNGR2,Interferon gamma receptor 2,40228,0.029974860207969,0.00469164244302534,0.0207792410196393,0.0391704793962987,1.716635392889e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0343237068369377,0.0053834934005666,0.0237720597718271,0.0448753539020482,1.87175524008006e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,RSPO3,R-spondin-3,40489,0.0165370470230457,0.00259565221980386,0.0114495686722302,0.0216245253738613,1.92847301886068e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ENSA,Alpha-endosulfine,37900,0.030591191841963,0.00480289003735842,0.0211775273687405,0.0400048563151855,1.96034126468251e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPH3,Neurexophilin-3,37598,0.0176031556933906,0.00276370469843337,0.0121862944844612,0.02302001690232,1.96082028714715e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.021080101462904,0.00331383654264094,0.0145849818393278,0.0275752210864803,2.0554719788118e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0511652193707359,0.00804688337441218,0.0353933279568881,0.0669371107845838,2.09425868314733e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN1,Tetraspanin-1,40042,0.0175774503417596,0.00277352898682986,0.0121413335275731,0.0230135671559462,2.39819729565239e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,37942,0.0205972627853613,0.00326458529595572,0.0141986756052881,0.0269958499654345,2.89049861509836e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,37942,0.136929918135987,0.0217035896516328,0.094390882418787,0.179468953853187,2.89448050653407e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE3,Eosinophil cationic protein,40288,0.0621388025281791,0.00986320792373016,0.042806914997668,0.0814706900586902,3.05387940800411e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0399903716937553,0.0063569338560029,0.0275307813359896,0.052449962051521,3.24102194584813e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.0416045449724012,0.0066143340621939,0.0286404502105012,0.0545686397343013,3.27423631224895e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,COMP,Cartilage oligomeric matrix protein,40198,0.0192865732569428,0.00307316248851238,0.0132631747794585,0.025309971734427,3.56925698410747e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.0210829848225052,0.00336158595542379,0.0144942763498745,0.0276716932951358,3.67970491905379e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17RB,Interleukin-17 receptor B,40126,-0.030310874086522,0.00485445433613436,-0.0398256045853454,-0.0207961435876987,4.37701767525748e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.0146128045229748,0.00234549785845165,0.0100156287204095,0.01920998032554,4.77663272618854e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHB4,Ephrin type-B receptor 4,40536,-0.0139140874777945,0.00223496816764956,-0.0182946250863876,-0.00953354986920137,4.91518382887022e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.0332176749051798,0.0053364697379065,0.022758194218883,0.0436771555914765,4.94968980514083e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0178287909954105,0.00286592047786955,-0.0234459951320348,-0.0122115868587862,5.06326641985406e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GNLY,Granulysin,40332,0.028659476148225,0.00461125944218529,0.0196214076415418,0.0376975446549082,5.25695025226075e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CD86,T-lymphocyte activation antigen CD86,37901,0.0164845027350015,0.00266007910201522,0.0112707476950517,0.0216982577749513,5.92304460054064e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,MRC1,Macrophage mannose receptor 1,37987,0.0159211753434082,0.00257195491517665,0.010880143709662,0.0209622069771545,6.17835520776661e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0246352763906888,0.00398359404348188,0.0168274320654643,0.0324431207159133,6.39931097306486e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1A,Protein phosphatase 1A,39980,0.0174451441079523,0.00282196495931858,0.0119140927876879,0.0229761954282167,6.49122103603028e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM5,Intercellular adhesion molecule 5,40359,0.0247372294475797,0.00400627211360838,0.0168849361049073,0.0325895227902521,6.7930988247039e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS22,Brain-specific serine protease 4,37598,0.0198899569011287,0.00322124630760537,0.0135763141382221,0.0262035996640352,6.82778253469279e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ULBP2,UL16-binding protein 2,40228,0.0208637053340154,0.00338983631711219,0.0142196261524755,0.0275077845155552,7.69982730901156e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,37998,0.0172957988263174,0.00280997756940594,0.0117882427902818,0.0228033548623531,7.71285816194125e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CDA,Cytidine deaminase,37970,0.0256382271601454,0.00417015045731086,0.0174647322638161,0.0338117220564746,8.06569633247014e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.0194636243471918,0.00316712024834322,0.0132560686604391,0.0256711800339445,8.16069014250211e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB1A1,Uteroglobin,40384,0.0316281322518371,0.00515002955969773,0.0215340743148296,0.0417221901888447,8.37651600350647e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LTB,Lymphotoxin-beta,37900,0.0198125841164806,0.00322631563883524,0.0134890054643635,0.0261361627685976,8.43492284908941e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0332884399584903,0.00542091700506569,0.0226634426285616,0.0439134372884191,8.4510474699354e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0173881396324309,0.00283276875639391,0.0118359128698988,0.0229403663949629,8.54181864798988e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0254998413407979,0.00416494197595002,0.0173365550679359,0.0336631276136599,9.47512137100988e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ECM1,Extracellular matrix protein 1,37655,0.0206049943275705,0.00337055894254561,0.0139986988001811,0.0272112898549599,1.003875789109e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,AFAP1,Actin filament-associated protein 1,37671,0.0470887448371633,0.00770740943552539,0.0319822223435335,0.0621952673307931,1.02723035991311e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00818785817215076,0.001340768612877,0.00555995169091185,0.0108157646533897,1.04411122049209e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.0144737547955955,0.00237175429045454,-0.0191223932048864,-0.00982511638630465,1.07315671568575e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,37942,0.0255267866644507,0.00419273681512765,0.0173090225068005,0.0337445508221009,1.17186817902097e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300C,CMRF35-like molecule 6,40471,0.0188401416345203,0.00309672328046711,0.0127705640048048,0.0249097192642359,1.19964711881671e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0369404407310262,0.00607121508124161,0.0250408591717927,0.0488400222902598,1.20115151265929e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MST1,Hepatocyte growth factor-like protein,37787,0.0340766862712638,0.00560173303081201,0.0230972895308723,0.0450560830116554,1.21000753944378e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM3,Myomesin-3,37671,-0.0497787844773333,0.00820204285875146,-0.0658547884804862,-0.0337027804741805,1.3217102525042e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0185891192481262,0.00306764828729015,0.0125765286050375,0.0246017098912149,1.39410615698331e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MTPN,Myotrophin,40042,0.0182192131286412,0.0030111577178985,0.0123173440015601,0.0241210822557222,1.47638254677765e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1B,Interleukin-1 beta,39946,0.0309552711185398,0.00512160994493894,0.0209169156264595,0.0409936266106201,1.5373698902409e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0208839439115489,0.00345691884173351,0.0141083829817512,0.0276595048413466,1.56448216700523e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LYZL2,Lysozyme-like protein 2,37482,0.019750965591983,0.0032699742826049,0.0133418159980774,0.0261601151858887,1.58215437750941e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.0132680733177104,0.0022039869461347,0.00894825890328637,0.0175878877321344,1.78201809163175e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2,Apoptosis regulator Bcl-2,37901,0.0295267554030552,0.00491878114173612,0.0198859443652524,0.039167566440858,1.98862292956034e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CD59,CD59 glycoprotein,39665,0.0122870488051943,0.00204862374783246,0.00827174625944268,0.0163023513509459,2.04653991916068e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0278402264441634,0.0046496659195125,0.0187268812419189,0.0369535716464079,2.17686387530411e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,TF,Serotransferrin,38013,0.0118361827324358,0.0019836659189319,0.00794819753132926,0.0157241679335423,2.4794882163172e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,HEPH,Hephaestin,37990,0.0136047630149266,0.00228029366942788,0.009135387422848,0.0180741386070053,2.48854300505948e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP2,Retinol-binding protein 2,40305,-0.0412726836022584,0.00692016992587837,-0.05483621665698,-0.0277091505475368,2.51192408155438e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0182574420032606,0.00307096320248596,0.0122383541263881,0.0242765298801331,2.81875254520889e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH17,Cadherin-17,40359,-0.0365415652684735,0.00615004773544094,-0.0485956588299378,-0.0244874717070093,2.88017688484475e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS53,Serine protease 53,37942,0.0197717219440124,0.00334078514294332,0.0132237830638435,0.0263196608241813,3.33208598570436e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GBA,Lysosomal acid glucosylceramidase,37572,0.0284333356351097,0.0048171663342759,0.0189916896199289,0.0378749816502905,3.66871743732278e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.0152775247032698,0.00259874622029097,0.0101839821114995,0.0203710672950401,4.23239264136668e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,40341,0.0283107286662888,0.00482176376063679,0.0188600716954407,0.0377613856371369,4.406225924848e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PPME1,Protein phosphatase methylesterase 1,40305,0.0326936166162568,0.00557125188191406,0.0217739629277052,0.0436132703048083,4.49144673287443e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,39934,0.0286160254397422,0.00487648128248128,0.0190581221260789,0.0381739287534055,4.49628086697726e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1R1,Interleukin-1 receptor type 1,40303,-0.0118811514169111,0.00202822522975055,-0.0158564728672221,-0.00790582996659999,4.7802607293324e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE6,Ribonuclease K6,37917,0.0157147026348715,0.00268283049206244,0.0104563548704291,0.0209730503993139,4.80831682919366e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.0112421703879171,0.00192263652727347,0.00747380279446115,0.0150105379813731,5.09539294232078e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNB2,Plexin-B2,40472,0.012348044845452,0.00211624359541551,0.00820020739843758,0.0164958822924664,5.48652650225104e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CILP,Cartilage intermediate layer protein 1,37998,0.0285726336605559,0.00489730226458462,0.0189739212219701,0.0381713460991417,5.52304215521472e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFLAM,Pikachurin,37901,0.0163350100736078,0.00280040210507619,0.0108462219476585,0.0218237981995572,5.56597382691201e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CD93,Complement component C1q receptor,39725,-0.0166927984653903,0.00286442980273719,-0.0223070808787552,-0.0110785160520254,5.7357443065086e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GIMAP8,GTPase IMAP family member 8,37482,0.0274807261640587,0.00471767281194825,0.0182340874526402,0.0367273648754773,5.84401667709677e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,40272,0.0122449152525408,0.00210593470664858,0.00811728322750961,0.016372547277572,6.19949985776751e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,TEK,Angiopoietin-1 receptor,40411,0.011356123286248,0.00195509374173522,0.00752413955244693,0.015188107020049,6.4242076295988e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0293141558522399,0.00506291929829038,0.0193908340275907,0.039237477676889,7.17303944696565e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LEPR,Leptin receptor,40359,-0.0160946848874552,0.0027838015984728,-0.0215509360204619,-0.0106384337544486,7.54034964785807e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPH1,Neurexophilin-1,39961,0.019800631265801,0.00343139727543382,0.0130750926059508,0.0265261699256513,8.05795598364554e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNA1,Ephrin-A1,40303,0.0142379655935949,0.00247982079838574,0.00937751682875889,0.019098414358431,9.55425908802877e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0306072929152334,0.00533842951621833,0.0201439710634455,0.0410706147670213,1.00569268684861e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0147079678772422,0.00256612062493402,-0.0197375643021128,-0.00967837145237149,1.01297544646487e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GAS2,Growth arrest-specific protein 2,37714,0.0279097894452408,0.00486994226140199,0.0183647026128929,0.0374548762775887,1.01993951249057e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0345417020842771,0.00603127265562873,0.0227204076792447,0.0463629964893094,1.04007284224113e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.0234903857742085,0.00410308009056833,0.0154483487966946,0.0315324227517224,1.0526348813041e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.030530804224514,0.00533520265634195,0.0200738070180838,0.0409878014309442,1.06891834932099e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0172721550164526,0.00302395316498749,0.0113452068130772,0.0231991032198281,1.14167661994615e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NME3,Nucleoside diphosphate kinase 3,40379,0.0124098368080951,0.0021749043206919,0.00814702433953892,0.0166726492766512,1.17771677628737e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.021103378662133,0.00370224162852802,0.0138469850702181,0.0283597722540479,1.21859279459e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,LMNB2,Lamin-B2,37942,0.0141689961781671,0.00248696454128748,0.00929454567724366,0.0190434466790906,1.24259321881901e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN2,Ataxin-2,37541,0.0595489313496006,0.0104903552013829,0.0389878351548902,0.0801100275443111,1.40364436290468e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.033908402983166,0.00597869657823255,0.0221901576898302,0.0456266482765018,1.44435798028491e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.0150943032828083,0.00266473635610222,0.00987142002484796,0.0203171865407687,1.50008212565219e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,40182,0.0147698185754603,0.00260810475171346,0.00965793326210192,0.0198817038888187,1.51308317160001e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,VIT,Vitrin,37990,0.0190034819492234,0.00335542541309416,0.0124268481395588,0.0255801157588879,1.51325228559529e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG3,Desmoglein-3,40419,0.0171584818387125,0.00304241338875541,0.0111953515967519,0.0231216120806731,1.73172463373124e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NEFL,Neurofilament light polypeptide,39903,0.0219024047683604,0.00388642797244822,0.0142850059423619,0.0295198035943589,1.7748274953353e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0357093833154738,0.00633794943588346,0.0232870024211422,0.0481317642098054,1.7885971462399e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0214851474905817,0.00381788175921623,0.0140020992425179,0.0289681957386455,1.85918492894818e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PRELP,Prolargin,40357,0.0118393078785446,0.00210685315792865,0.00770987568900448,0.0159687400680848,1.94804877797986e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0307011448244258,0.00546657677529905,0.0199866543448397,0.041415635304012,1.98600144220165e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR2,TGF-beta receptor type-2,40411,0.0160433808557193,0.00286693407362119,0.0104241900714217,0.0216625716400168,2.22952637766624e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.0172013071817201,0.00307410531179137,0.011176060770609,0.0232265535928312,2.23551646451187e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QL2,Complement C1q-like protein 2,37598,0.0219102940228828,0.00391789364009435,0.0142312224882978,0.0295893655574677,2.28462979767014e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.0153573780374027,0.00275742584137368,0.0099528233883103,0.0207619326864951,2.59772137014513e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,MILR1,Allergin-1,40044,-0.0252716769427099,0.00453974080252653,-0.0341695689156619,-0.0163737849697579,2.63789543444089e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,AGT,Angiotensinogen,37987,0.0122465897965987,0.00220491482974886,0.00792495673029091,0.0165682228629064,2.8410498749005e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,LUZP2,Leucine zipper protein 2,37900,0.022584701471269,0.00406784676791111,0.0146117218061633,0.0305576811363748,2.87763182398598e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL15,C-C motif chemokine 15,40536,0.0223857831865051,0.00403691491881835,0.0144734299456212,0.0302981364273891,2.98121767674987e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP4,Guanylate-binding protein 4,39961,0.0248097894922017,0.00448652297622921,0.0160162044587925,0.033603374525611,3.25686375366362e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA5,Protein disulfide-isomerase A5,37482,0.0309575799120543,0.00559894922942174,0.0199836394223877,0.0419315204017209,3.27928487592559e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0347783694793582,0.00629452040556315,-0.047115629474262,-0.0224411094844545,3.34328296146316e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0426128474212261,0.00771388666119913,0.0274936295652758,0.0577320652771764,3.37349313397688e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,HSBP1,Heat shock factor-binding protein 1,37628,0.0479929076024576,0.00868948366819131,0.0309615196128027,0.0650242955921126,3.39376244242356e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.0113829833530187,0.00206137226149867,0.00734269372048135,0.0154232729855561,3.40374829932503e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.0132368318332048,0.00239786586827068,0.00853701473139429,0.0179366489350153,3.43781156611631e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,LXN,Latexin,40183,-0.0332187737273095,0.00603451740298516,-0.0450464278371604,-0.0213911196174586,3.75383176255793e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRC,Chymotrypsin-C,40360,0.031294317816476,0.0056943543106921,0.0201333833675194,0.0424552522654325,3.9520220256749e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0274404705354812,0.00499433503972868,0.0176515738576129,0.0372293672133494,3.98264392366383e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBP1,Z-DNA-binding protein 1,37598,0.0201629541459585,0.00366957293729631,0.0129705911888577,0.0273553171030592,3.98811755136178e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.0196946372803282,0.00358641443553277,0.0126652649866839,0.0267240095739724,4.0582124246661e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.0517593314280221,0.00946988944274658,0.0331983481202388,0.0703203147358054,4.69573945650702e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.0158784563797994,0.00290947250521879,0.0101758902695706,0.0215810224900282,4.90159063939038e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA2,GDNF family receptor alpha-2,40305,0.0105160509953075,0.00193136341968849,0.00673057869271803,0.0143015232978969,5.26100642634465e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A12,Protein S100-A12,40139,0.0378341615546424,0.00695500487336326,0.0242023520028504,0.0514659711064344,5.41251542791922e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,39961,0.0419911917604086,0.00771934159953474,0.0268612822253205,0.0571211012954967,5.41675695648075e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.023995283282788,0.00441544948520744,-0.0326495642737946,-0.0153410022917814,5.57940386534856e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.0177900347358971,0.00328514889189599,0.0113511429077809,0.0242289265640132,6.20953981205005e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.0162149816343307,0.00299603013932404,-0.0220872007074059,-0.0103427625612556,6.33380887425515e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18BP,Interleukin-18-binding protein,40403,0.0148978119010613,0.00276782425896244,0.00947287635349487,0.0203227474486277,7.44968899134555e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.0203156521534249,0.00377668215259769,0.0129133551343334,0.0277179491725164,7.58875761971144e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NCF2,Neutrophil cytosol factor 2,40324,0.0406098317850213,0.00755228753350666,0.0258073482193482,0.0554123153506943,7.67420728774782e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASET2,Ribonuclease T2,40465,0.0128627156455746,0.00239559544888209,0.00816734856576566,0.0175580827253834,8.01366708539296e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,39957,0.0137862489825485,0.00256792857068792,0.00875310898400019,0.0188193889810969,8.04807902981043e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PEPD,Xaa-Pro dipeptidase,37987,0.0126179568833068,0.00235039819009336,0.00801117643072383,0.0172247373358898,8.07341522636547e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDHB15,Protocadherin beta-15,37900,-0.0196552392027754,0.00367033273658217,-0.0268490913664764,-0.0124613870390743,8.68843989956582e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF1C,Kinesin-like protein KIF1C,37562,0.0183327986942293,0.003431186325135,0.0116076734969647,0.0250579238914939,9.29546460368718e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAC1,Cartilage acidic protein 1,40536,0.0141870402671444,0.00265829890599904,0.00897677441138628,0.0193973061229025,9.58380623228066e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0187374738264097,0.00351253640082658,0.0118529024807896,0.0256220451720298,9.73814644447762e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0244250005850638,0.00458028411590492,0.0154476437178902,0.0334023574522374,9.83947847224582e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,37990,-0.015862527771524,0.00297585311503635,-0.0216951998769953,-0.0100298556660527,9.95619869024571e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.0146843389948933,0.0027566760555442,-0.02008742406376,-0.00928125392602669,1.01330757957762e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0210690455372024,0.0039696137375403,0.0132886026116235,0.0288494884627814,1.12610792627791e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0185899363911632,0.00351354673779113,0.0117033847850926,0.0254764879972338,1.23648916661085e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,FSTL1,Follistatin-related protein 1,37628,-0.0108171667434923,0.00204676116844539,-0.0148288186336453,-0.00680551485333934,1.27698402932316e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0299115816637369,0.00566753087512323,0.0188032211484954,0.0410199421789785,1.32835403867972e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ALPP,"Alkaline phosphatase, placental type",40305,0.049375182185373,0.00937103164122539,0.0310079601685712,0.0677424042021747,1.39027425804051e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CA7,Carbonic anhydrase 7,37714,-0.0167800988163661,0.00320352904280529,-0.0230590157402645,-0.0105011818924678,1.64806743989347e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL28,C-C motif chemokine 28,40278,0.0283796283969334,0.00541957593731317,0.0177572595597996,0.0390019972340672,1.65741597806952e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.0192008553953992,0.00367430653213223,0.01199921459242,0.0264024961983783,1.76083921935094e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MPO,Myeloperoxidase,40332,0.0221700625652643,0.00424775131851612,0.0138444699809727,0.0304956551495559,1.81914433490178e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0164230214157496,0.00315119695545831,0.0102466753830513,0.0225993674484479,1.89488211120166e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN2,Prefoldin subunit 2,39961,0.0265337629455579,0.00511146474048119,0.0165152920542148,0.0365522338369011,2.11775323343069e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SPON1,Spondin-1,40379,0.0154878561417339,0.00298697130483949,0.00963339238424845,0.0213423198992193,2.18497695263469e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.0134051596913404,0.00258652427140472,-0.0184747472632937,-0.00833557211938716,2.21380756419434e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,RCOR1,REST corepressor 1,40042,0.021070245295617,0.00407125944903331,0.0130905767755117,0.0290499138157223,2.30292025091068e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0225826473710867,0.00436713956984702,0.0140230538141865,0.0311422409279868,2.361381058339e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF16,Fibroblast growth factor 16,37598,0.0231738567184245,0.00448361110270519,0.0143859789571223,0.0319617344797267,2.39350431561201e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK3,Dickkopf-related protein 3,40536,-0.0137593362349294,0.00267308027819771,-0.0189985735801969,-0.00852009888966193,2.67274083378807e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL9,C-X-C motif chemokine 9,40422,0.0315674418916842,0.00614912026938594,0.0195151661636878,0.0436197176196806,2.87510422675797e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.0452052079466698,0.00880610379012166,0.0279452445180313,0.0624651713753082,2.87921429458461e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0360083034945498,0.00702055804554435,-0.0497685972638167,-0.0222480097252829,2.94737955918226e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.0127546731955909,0.00248837923502241,0.00787744989494694,0.0176318964962348,2.99901883670301e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,DGCR6,Protein DGCR6,37541,0.0211420856537521,0.00413963002020101,0.0130284108141581,0.0292557604933461,3.31492818533922e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.0129278596774011,0.002531830380186,0.00796547213223658,0.0178902472225657,3.325967790926e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PRUNE2,Protein prune homolog 2,37714,0.0137417967067077,0.00269221117545659,0.00846506280281275,0.0190185306106026,3.3665424220725e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.0123036119917462,0.00241149812679819,0.00757707566322176,0.0170301483202707,3.4052053428905e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.0471311541329957,0.00924479768554771,0.0290113506693222,0.0652509575966692,3.4781114815254e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH1,Protocadherin-1,40475,0.0100490235605937,0.00197872752755911,0.00617071760657781,0.0139273295146095,3.84638673602482e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GPC1,Glypican-1,40489,0.0135282233121225,0.00266768558066868,0.00829955957401188,0.0187568870502331,3.99835906597417e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX1,Peroxiredoxin-1,39953,-0.0411423297659617,0.00811318555218749,-0.0570441734482492,-0.0252404860836742,4.00201085490118e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCB,Calcitonin gene-related peptide 2,37942,0.0183647201447081,0.00363160918813089,0.0112467661359716,0.0254826741534447,4.31695954417273e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.0164916550111425,0.00326132695317967,0.0100994541829104,0.0228838558393747,4.32261741600166e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.012312884625248,0.00244085209274685,0.00752881452346414,0.0170969547270318,4.59710761931128e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ITM2A,Integral membrane protein 2A,40341,-0.0271057603680301,0.00537588303695371,-0.0376424911204594,-0.0165690296156009,4.65508990055704e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,37562,0.0217973918864237,0.00433109741216365,0.0133084409585829,0.0302863428142645,4.89866360216479e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN2,Contactin-2,40489,0.0204850820084792,0.00407508756677531,0.0124979103775996,0.0284722536393588,5.03828564658354e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,40489,0.0264542010727937,0.00526518143627455,0.0161344454576955,0.0367739566878918,5.10529944660802e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,VWF,von Willebrand factor,40536,-0.0325482546274679,0.00649076226495648,-0.0452701486667826,-0.0198263605881532,5.37233989590604e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL3,Myosin light chain 3,37628,-0.0311383281367263,0.00622268196443616,-0.0433347847870212,-0.0189418714864314,5.68757704732693e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.0104636753204566,0.00209304737222611,0.00636130247089343,0.0145660481700198,5.81603884008252e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0525282359497292,0.0105606111578972,0.0318294380802507,0.0732270338192077,6.62862627181622e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0161220569773451,0.00324637225562524,0.00975916735631967,0.0224849465983706,6.91237905859418e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0157305305424062,0.00316900989114817,0.00951927115575582,0.0219417899290567,6.9812768349666e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,37875,-0.0122141552431384,0.00246177280176154,-0.017039229934591,-0.00738908055168577,7.07974130025102e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.014189614298952,0.00286174418399153,0.00858059569832864,0.0197986328995754,7.19704906473013e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.00969040096476954,0.00195534411095911,0.00585792650728968,0.0135228754222494,7.28895685003001e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0173773797387044,0.00350813349901843,0.0105014380806283,0.0242533213967805,7.38161285551666e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP2,Guanylate-binding protein 2,40044,0.0267752769265637,0.00541125204763961,0.0161692229131901,0.0373813309399374,7.57328919973371e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF7,SLAM family member 7,40341,-0.0259005265879042,0.00524643598468817,-0.036183541117893,-0.0156175120579153,8.02264195864169e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.012633724429887,0.00256535581008813,0.00760562704211432,0.0176618218176598,8.5317903237404e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LHB,Lutropin subunit beta,39980,0.0379818407802037,0.00772091945075308,0.0228488386567277,0.0531148429036798,8.77247632563397e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,DLL4,Delta-like protein 4,37628,0.0377361141556667,0.0076777968251188,0.0226876323784339,0.0527845959328996,8.9866083070008e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTX2,Neuronal pentraxin-2,37998,-0.0145749207569691,0.00297332905518995,-0.0204026457051414,-0.00874719580879685,9.60201808481258e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.0266062458304317,0.00542792257195972,0.0159675175893906,0.0372449740714727,9.61370866469309e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PGA4,Pepsin A-4,37987,0.030339250527263,0.00619332965362732,0.0182003244061535,0.0424781766483726,9.75893373413382e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.0118011487457567,0.0024101661239694,-0.0165250743487368,-0.00707722314277669,9.8776324551563e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,JAM2,Junctional adhesion molecule B,40471,0.0116126322605928,0.00237206392174983,0.00696338697396309,0.0162618775472224,9.89699765666272e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC16,Mucin-16,40305,0.0834271130607755,0.0170458010597732,0.0500173429836201,0.116836883137931,9.96306070502172e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PREB,Prolactin regulatory element-binding protein,40044,0.0131877050374955,0.00269609490887177,0.00790335901610688,0.0184720510588842,1.01114764152425e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CFC1,Cryptic protein,39980,0.0205134258996757,0.00419700289935841,0.0122873002169332,0.0287395515824182,1.03072545718891e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPT2,Angiopoietin-2,40489,-0.0171816178984227,0.0035194802075214,-0.0240797991051646,-0.0102834366916807,1.06099824406435e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD1,Bromodomain-containing protein 1,37714,-0.0137912020527443,0.00282558066650983,-0.0193293401591036,-0.00825306394638505,1.06865047597172e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL5,Fc receptor-like protein 5,40332,-0.0246620733575258,0.00508636323317655,-0.0346313452945519,-0.0146928014204998,1.25471342415484e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CA12,Carbonic anhydrase 12,40305,-0.0141484522070509,0.0029382114859659,-0.019907346719544,-0.00838955769455772,1.48314971750661e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAN,Neurocan core protein,40471,0.0162855745522364,0.00338728831980527,0.00964648944541806,0.0229246596590547,1.53947537694836e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,40422,0.0117873772117388,0.00245785976458939,0.00696997207314357,0.016604782350334,1.63497428938388e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0162234787473641,0.00338317942495319,0.00959244707445589,0.0228545104202724,1.63878602196465e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,DSC2,Desmocollin-2,40177,-0.0146880219085333,0.00306417594602094,-0.0206938067627344,-0.00868223705433229,1.65423743028877e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,37671,0.0116455320620471,0.00243302480858025,0.00687680343722978,0.0164142606868644,1.71601687255411e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SYT1,Synaptotagmin-1,37942,0.0170245749993318,0.00356174515922305,0.0100435544872546,0.0240055955114089,1.77284887755939e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0249406269189472,0.00522577324188001,0.0146981113648624,0.035183142473032,1.83758534947577e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHB6,Ephrin type-B receptor 6,40192,0.0135470948718211,0.00284081318467756,0.00797910102985304,0.0191150887137891,1.87043518050125e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTXR,Neuronal pentraxin receptor,40359,0.0146652246367845,0.0030847511395057,0.00861911240335335,0.0207113368702157,2.01074984184894e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,APOBR,Apolipoprotein B receptor,37628,-0.0182642560338764,0.00385806216879271,-0.0258260578847101,-0.0107024541830427,2.22375160123259e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0195881292865567,0.00414202734642305,-0.0277065028855459,-0.0114697556875676,2.27429650849742e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.0312512491771457,0.00661074319378833,0.0182941925173205,0.0442083058369708,2.29773953328623e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF3,Granulocyte colony-stimulating factor,40044,0.0209591203804554,0.00444077650491067,0.0122551984308305,0.0296630423300803,2.3824806547851e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0114000730617455,0.00241560902463434,0.00666547937346218,0.0161346667500288,2.38629080169344e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,EFHD1,EF-hand domain-containing protein D1,37959,0.0148729721117218,0.0031597555356045,0.00867985126193695,0.0210660929615066,2.53884276562122e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PI3,Elafin,40074,0.0228496152790435,0.00486142383130306,0.0133212245696895,0.0323780059883974,2.621378025375e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0184383379244789,0.00392841385983669,0.010738646759199,0.0261380290897588,2.71170044743796e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC4A1,Band 3 anion transport protein,37998,-0.0197348589728365,0.0042067346079106,-0.0279800588043413,-0.0114896591413317,2.74190362148467e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0155644584524939,0.00332687626442553,0.00904378097421989,0.022085135930768,2.91997136011617e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.0159418428351164,0.00341045565066556,0.00925734975981193,0.0226263359104209,2.97660773951914e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TPM3,Tropomyosin alpha-3 chain,37562,-0.0181119211295916,0.0038781336507021,-0.0257130630849677,-0.0105107791742154,3.03794418203848e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SDC1,Syndecan-1,40359,0.0169464260702847,0.0036353267192636,0.00982118570052803,0.0240716664400413,3.16313349577956e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0182550383515836,0.00391870580567641,0.0105743749724579,0.0259357017307094,3.21718103786903e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0146721943988167,0.00315593131933774,-0.0208578197847187,-0.00848656901291473,3.36080293580758e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP3,"Fatty acid-binding protein, heart",37990,0.0200640038375526,0.00432739698325289,0.011582305750377,0.0285457019247283,3.57659753189064e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.0113169934328941,0.00244162303892596,0.00653141227659922,0.016102574589189,3.59719465743793e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM171B,Protein FAM171B,37900,0.0116885628358909,0.00252349522391034,0.00674251219702659,0.0166346134747551,3.65732273066511e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAU,Urokinase-type plasminogen activator,40332,0.0122707045887493,0.00266919910642047,0.00703907434016523,0.0175023348373335,4.31614014271971e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSAB1,Tryptase alpha/beta-1,40498,0.0220125928351577,0.00478868870290086,0.012626762977472,0.0313984226928434,4.32323160266212e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NINJ1,Ninjurin-1,39980,0.0235383760181633,0.00512563951738949,0.0134921225640799,0.0335846294722467,4.41870242322581e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FOSB,Protein fosB,39961,0.0163344637756917,0.00356034088454164,0.0093561956419901,0.0233127319093933,4.51248453767551e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.0242635967016825,0.00529456736048995,0.0138862446751222,0.0346409487282428,4.6242375008407e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6,Interleukin-6,40305,0.0304105979927907,0.00663744806907535,0.017401199777403,0.0434199962081784,4.64792861318008e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK11,Kallikrein-11,40260,0.0123174392147003,0.00270122563263167,0.00702303697474223,0.0176118414546584,5.1551154206251e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,40341,0.01406975698758,0.00309583177699686,0.00800192670466617,0.0201375872704939,5.5408034341508e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0163664955617827,0.00360729636791577,0.00929619468066779,0.0234367964428976,5.74737962694704e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.0110927694149742,0.00244781693564263,0.00629504822111461,0.0158904906088337,5.90132852939232e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.022164794859247,0.00489317181587906,0.012574178100124,0.03175541161837,5.94962764914343e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,HEPACAM2,HEPACAM family member 2,37942,-0.0167739644163193,0.00370439463007113,-0.0240345778912587,-0.00951335094137985,6.00189377202903e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN3,CCN family member 3,40522,0.0138673904079544,0.0030659310818971,0.00785816548743604,0.0198766153284727,6.13881127449067e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB37,Ras-related protein Rab-37,40044,0.034233109116689,0.00757931077872351,0.0193776599903909,0.0490885582429871,6.32859144181029e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.0186098909086042,0.00412550044290238,0.0105239100405155,0.0266958717766928,6.50870778756828e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.0126757324244476,0.00281804798352667,0.00715235837673536,0.0181991064721599,6.90652460186825e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,RPS10,40S ribosomal protein S10,37562,-0.0173360306847481,0.00386356396398032,-0.0249086160541496,-0.00976344531534669,7.28285298412785e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.0150805777149379,0.00336933453939688,0.00847668201772005,0.0216844734121558,7.66435227436606e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IL34,Interleukin-34,39934,0.0146148363832219,0.00326745314271948,0.00821062822349172,0.0210190445429521,7.7732294759079e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0252836435129875,0.0056987491004151,0.0141140952761739,0.0364531917498011,9.19740558339818e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.0319761950250654,0.00722050982177442,0.0178239957743875,0.0461283942757432,9.56290562272616e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CALB1,Calbindin,40305,0.0170685368355303,0.00385843521027974,0.00950600382338198,0.0246310698476786,9.76737925400913e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LMOD1,Leiomodin-1,37959,-0.0145911877378225,0.0032996018964661,-0.021058407454896,-0.0081239680207489,9.85072389317641e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0147125160061972,0.00335770569227859,0.0081314128493312,0.0212936191630633,1.18658112604943e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LIF,Leukemia inhibitory factor,39961,0.0209735351046634,0.004793143911968,0.0115789730372061,0.0303680971721206,1.21813583419411e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,40422,0.0112279389184107,0.00256622041701588,0.00619814690105954,0.0162577309357618,1.22044293566561e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ACRV1,Acrosomal protein SP-10,37598,0.0140656953547694,0.00321763469577856,0.00775913135104341,0.0203722593584954,1.24378025253858e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CRH,Corticoliberin,39947,0.0345325696996689,0.00790322767332346,0.0190422434599549,0.0500228959393829,1.25383376950707e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK8,Kallikrein-8,39801,0.0140727031505048,0.00323110616748262,0.00773973506223891,0.0204056712387708,1.33695971330044e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0245441242746712,0.00564309509819041,0.013483657882218,0.0356045906671245,1.37538184656745e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CST1,Cystatin-SN,36179,0.0413366345754695,0.00952365129100026,0.022670278045109,0.06000299110583,1.43403297874541e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0270828134644093,0.0062500449676481,0.014832725327819,0.0393329016009996,1.48026509121988e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CRLF1,Cytokine receptor-like factor 1,40422,0.0103445374119296,0.00238743829678647,0.00566515835022808,0.015023916473631,1.48055170898384e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0200730517323949,0.00463307573700932,-0.0291538801769332,-0.0109922232878566,1.48290365729702e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SEL1L,Protein sel-1 homolog 1,37628,0.012782560394525,0.00295457799565736,0.0069915875230366,0.0185735332660134,1.52711817341937e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.0192996817356848,0.00446254022705001,0.0105531028906667,0.0280462605807028,1.53785086416698e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.0114515177855437,0.00264859899405163,-0.0166427718138849,-0.00626026375720254,1.54614616768765e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,HYAL1,Hyaluronidase-1,40214,0.00900935515057778,0.00208711758909064,0.00491860467596014,0.0131001056251954,1.59381866695264e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CA2,Carbonic anhydrase 2,40291,0.0277123992507626,0.00642141052438283,0.0151264346229722,0.0402983638785529,1.6011739194085e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNGR1,Interferon gamma receptor 1,40422,0.0079911788114922,0.00186057601750178,0.00434444981718871,0.0116379078057957,1.75723155420753e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,FSTL3,Follistatin-related protein 3,40293,0.0121851235309937,0.00283723383653758,0.00662414521138002,0.0177461018506073,1.75955679131683e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.0135247142172941,0.00316215818295685,0.00732688417869872,0.0197225442558896,1.90477859596089e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.0151147124740186,0.00354296163195205,0.00817050767539256,0.0220589172726446,2.0029287868605e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.0158731961544883,0.00372118221148867,0.00857967901997047,0.0231667132890061,2.00497694710956e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA7A,Semaphorin-7A,40490,0.0103697779464001,0.00244336140426337,0.0055807895940439,0.0151587662987563,2.2074298655985e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM1,Myomesin-1,37541,0.0181125734008128,0.00427087924707626,0.00974165007654331,0.0264834967250822,2.24107571665343e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0548889413360727,0.0129623135733211,0.0294828067323633,0.0802950759397822,2.30378709530932e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0145178243663262,0.00344465242281068,-0.0212693431150351,-0.00776630561761725,2.51850283058497e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.016091915629625,0.00382344896903028,0.00859795565032566,0.0235858756089243,2.58232728608154e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN10,Ataxin-10,39961,0.0277294520814261,0.00659286524076693,0.0148074362095229,0.0406514679533292,2.61414251346946e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CA6,Carbonic anhydrase 6,40295,-0.0243517040715705,0.00579439415127173,-0.0357087166080631,-0.0129946915350779,2.65275584419409e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CLASP1,CLIP-associating protein 1,37482,0.0273808761968546,0.00651982607412231,0.0146020170915749,0.0401597353021343,2.69125392989897e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.0118603046926066,0.00282430847683763,0.0063246600780049,0.0173959493072084,2.69381699015261e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP9,Fatty acid-binding protein 9,40341,0.0213299637995993,0.00508136646651194,0.0113704855252359,0.0312894420739627,2.71127057524186e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFB,Vascular endothelial growth factor B,37598,0.0109173643119779,0.00260175877345379,0.0058179171160085,0.0160168115079473,2.73276410544151e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.0133258599631869,0.00318299293404353,0.00708719381246161,0.0195645261139123,2.84741349313404e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0681471282644326,0.0163315678426394,0.0361372552928593,0.100157001236006,3.02585251133922e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0149697955328455,0.00358839795299572,0.00793653554497388,0.0220030555207171,3.04205619644565e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GAST,Gastrin,37942,0.0493903765579213,0.0118400449000973,0.0261838885537306,0.072596864562112,3.0453665515955e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PROCR,Endothelial protein C receptor,37562,-0.0140657063412547,0.00337650692297736,-0.0206836599102904,-0.0074477527722191,3.12309596453646e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CNPY2,Protein canopy homolog 2,40042,0.0230828758204346,0.00555840910684955,0.0121883939710094,0.0339773576698597,3.30201825250125e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAP,Cartilage-associated protein,37572,0.0183336281709274,0.00442090224605155,0.00966865976866636,0.0269985965731884,3.38930765788123e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TCN1,Transcobalamin-1,37766,0.0124595884081119,0.00301150437270343,0.00655703983761314,0.0183621369786106,3.53529509321734e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.0121259752457142,0.00293562581719011,0.00637214864402154,0.0178798018474068,3.63646634304677e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.00956845794689872,0.00232017651431123,0.00502091197884871,0.0141160039149487,3.74220904859176e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6L,Seizure 6-like protein,40411,0.0102635589925272,0.00249548936124082,0.00537239984449522,0.0151547181405592,3.92772423887525e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,40305,0.00984211077087223,0.00239375640462409,0.00515034821780901,0.0145338733239354,3.94947873597121e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM2,Myomesin-2,37562,-0.0175998381402495,0.00429268347565248,-0.0260134977525283,-0.0091861785279706,4.15710005814057e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,AHNAK2,Protein AHNAK2,37628,0.0106533907328804,0.00260646202176012,0.00554472517023061,0.0157620562955303,4.39011402513972e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NTF3,Neurotrophin-3,40341,0.0129657693738147,0.00317792549186584,0.00673703540975764,0.0191945033378717,4.52657573451641e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.0122405440742524,0.00300322323088335,-0.0181268616067837,-0.006354226541721,4.61176087205491e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP1,Caspase-1,39961,0.0249408435953057,0.00612295833528321,0.0129398452581506,0.0369418419324608,4.65756057248152e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.0132515703180363,0.00325407101563125,0.00687359112739908,0.0196295495086736,4.68148603466067e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.0102111509522188,0.00251337780842583,0.00528493044770415,0.0151373714567334,4.87428649317092e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,37628,0.0143900039104297,0.00356055714544871,0.00741131190535028,0.0213686959155092,5.34113106005709e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.0137474065017016,0.00343676708783258,-0.0204834699938535,-0.00701134300954978,6.36635324337523e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.00984800174000698,0.00247008095064547,0.00500664307674186,0.0146893604032721,6.72342045195247e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMH,Granzyme H,40042,0.0270121029735494,0.00678370925079373,0.0137160328419937,0.0403081731051051,6.86745251911283e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,EP300,Histone acetyltransferase p300,37598,0.0108364194121938,0.002722717570106,0.00549989297478603,0.0161729458496016,6.92851047655064e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CHGA,Chromogranin-A,37998,-0.0326170753903983,0.0082218144716377,-0.0487318317548082,-0.0165023190259884,7.31153502234256e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAM2,Neural cell adhesion molecule 2,40332,-0.00971891268597654,0.00245413660133574,-0.0145290204245946,-0.0049088049473585,7.52084594855056e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL5,Insulin-like peptide INSL5,37901,0.033804348345679,0.00855001033638733,0.0170463280863598,0.0505623686049981,7.73393920342208e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,40332,-0.011303270451358,0.00285931370619501,-0.0169075253155003,-0.00569901558721582,7.74661454059218e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ARTN,Artemin,40044,0.0160170691940167,0.00405230171156638,0.00807455783934659,0.0239595805486868,7.76522824485035e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00916337014272032,0.00232719103386191,0.00460207571635097,0.0137246645690897,8.26793781472196e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,EXTL1,Exostosin-like 1,37562,0.0171541062518139,0.00436202296921699,0.00860454123214857,0.0257036712714792,8.44633868863044e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0232928195250988,0.00592536413761591,0.0116791058153716,0.034906533234826,8.49529092349883e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SAA4,Serum amyloid A-4 protein,38013,0.0116822376987067,0.0029734552887424,0.00585426533277157,0.0175102100646418,8.57789049364583e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.0144921359801042,0.00369532288400204,0.00724930312746022,0.0217349688327482,8.82858079588639e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,40437,0.0288933878247198,0.00737011432186847,0.0144479637538576,0.043338811895582,8.87912429935903e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0111532531080612,0.00285680671754082,-0.0167525942744412,-0.00555391194168122,9.50472125607761e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CYB5A,Cytochrome b5,37482,0.0260818696116759,0.00670593204049276,0.0129382428123101,0.0392254964110417,0.000101002850916448
NMR metabolomics,X23428.Concentration of VLDL Particles,INHBB,Inhibin beta B chain,37671,0.0182324688507114,0.00469411822600429,0.00903199712774299,0.0274329405736798,0.000103205927727501
NMR metabolomics,X23428.Concentration of VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,37900,0.0214379012317131,0.0055219443925215,0.010614890222371,0.0322609122410553,0.000103963288915781
NMR metabolomics,X23428.Concentration of VLDL Particles,UROS,Uroporphyrinogen-III synthase,37572,0.0248272537667837,0.00640466956679221,0.012274101415871,0.0373804061176965,0.000106516604946202
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,40359,0.0111622092708715,0.00288240104687231,0.00551270321900178,0.0168117153227412,0.000108138596199797
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN1,Nectin-1,37598,0.0112821473226577,0.00291462741070799,0.00556947759767001,0.0169948170476453,0.0001089714542753
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO1,Alpha-enolase,40299,0.0278526514492641,0.00720283178122028,0.0137351011580723,0.0419702017404558,0.000110666567381859
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN4B,Sodium channel subunit beta-4,37628,0.0147298846336848,0.00381669134175689,0.00724916960384128,0.0222105996635283,0.000114239055218455
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0186165395174952,0.00482505619823145,0.00915942936896152,0.0280736496660288,0.000114709074003097
NMR metabolomics,X23428.Concentration of VLDL Particles,CD48,CD48 antigen,40396,0.0102721015041843,0.00266453740653564,0.0050496081873744,0.0154945948209941,0.000116128622884146
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA11,Serpin A11,40536,0.014057723920132,0.00364807450953266,0.006907497881448,0.021207949958816,0.000116910718350817
NMR metabolomics,X23428.Concentration of VLDL Particles,NEO1,Neogenin,37959,0.00747912944150981,0.00194271841658507,0.00367140134500307,0.0112868575380165,0.000118746273339447
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.0153384035791112,0.00401374654954367,0.00747146034200559,0.0232053468162168,0.000133257014350669
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF8,SLAM family member 8,39980,0.0185868478559091,0.00486903021340329,0.00904354863763867,0.0281301470741796,0.000135410293266903
NMR metabolomics,X23428.Concentration of VLDL Particles,RPA2,Replication protein A 32 kDa subunit,37598,0.0113607366481342,0.00297833056286923,0.00552320874491048,0.0171982645513579,0.000137102796371464
NMR metabolomics,X23428.Concentration of VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.0155779823878572,0.00409239986782146,0.00755687864692713,0.0235990861287873,0.000141441014278462
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRLB,Fc receptor-like B,39980,0.0209841929357634,0.00555223416406036,0.0101018139742051,0.0318665718973217,0.000157785544524061
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPS,Calcyphosin,37942,0.0325327826147001,0.0086418451819555,0.0155947660580673,0.0494707991713328,0.000167547375669999
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.00832046447994438,0.00221286661285256,-0.0126576830411354,-0.00398324591875337,0.000170493208766842
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA1,Annexin A1,37608,0.0141838597803337,0.00377606690135404,0.00678276865367979,0.0215849509069876,0.000173220846113776
NMR metabolomics,X23428.Concentration of VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.0138350669263151,0.00368573366483834,-0.0210591049093982,-0.00661102894323196,0.000175009252743932
NMR metabolomics,X23428.Concentration of VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.00902869719260764,0.00240954813158383,0.00430598285470334,0.0137514115305119,0.000179556714616847
NMR metabolomics,X23428.Concentration of VLDL Particles,CX3CL1,Fractalkine,40228,-0.0116438555114884,0.00311095664679422,-0.0177413305392051,-0.00554638048377175,0.000182587769139621
NMR metabolomics,X23428.Concentration of VLDL Particles,AREG,Amphiregulin,40305,-0.0168184342389455,0.00450497207573781,-0.0256481795073916,-0.00798868897049934,0.000189644526526504
NMR metabolomics,X23428.Concentration of VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00663336817004146,0.00178227468378971,-0.0101266265502693,-0.00314010978981363,0.00019856387443146
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0237107039548203,0.00637252976191719,0.0112205456214626,0.036200862288178,0.000199293964066354
NMR metabolomics,X23428.Concentration of VLDL Particles,NUP50,Nuclear pore complex protein Nup50,37562,-0.0120722555784549,0.00324837695926099,-0.0184390744186064,-0.00570543673830332,0.000202925000404282
NMR metabolomics,X23428.Concentration of VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,37714,0.0156947058993238,0.00422871744286085,0.00740641971131658,0.0239829920873311,0.000206911959779962
NMR metabolomics,X23428.Concentration of VLDL Particles,DNPEP,Aspartyl aminopeptidase,37942,0.0200702530418838,0.00541008917396584,0.00946647826091071,0.0306740278228568,0.000208270216053026
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.0127836828188205,0.00344864096466224,0.00602434652808248,0.0195430191095585,0.000210537705059119
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB7,Integrin beta-7,40489,0.0153293756602397,0.00413854095172714,0.00721783539485446,0.0234409159256248,0.000212893911888921
NMR metabolomics,X23428.Concentration of VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.0101787172914027,0.00274857406647217,0.00479151212111729,0.0155659224616882,0.000213573694354052
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP10,Bone morphogenetic protein 10,37671,0.00967319497711915,0.00261500305720407,0.00454778898499917,0.0147986009692391,0.000217229973478094
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB39B,Ras-related protein Rab-39B,37562,0.0300726784798839,0.00814103894804591,0.0141162421417139,0.0460291148180539,0.000221685328130226
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNG,Interferon gamma,40044,0.038020677372874,0.0103368546842641,0.0177604421917163,0.0582809125540317,0.000235706054355757
NMR metabolomics,X23428.Concentration of VLDL Particles,SDK2,Protein sidekick-2,37671,0.01278687271804,0.0034768581321082,0.00597223077910791,0.0196015146569721,0.000236271254756423
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAN,Brevican core protein,40228,0.011189976618939,0.00305142768077386,0.00520917836462227,0.0171707748732558,0.000246095778069664
NMR metabolomics,X23428.Concentration of VLDL Particles,MELTF,Melanotransferrin,37990,0.00975300321950542,0.00266053744290471,0.00453834983141218,0.0149676566075987,0.00024750773168646
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,37598,0.035975422957072,0.00983179984383571,0.016705095263154,0.05524575065099,0.000254104310130149
NMR metabolomics,X23428.Concentration of VLDL Particles,ERC2,ERC protein 2,37572,0.025678701920844,0.00702457356866532,0.0119105377262599,0.039446866115428,0.000257630245083532
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0119065178976279,0.00325953752279978,0.0055178243529403,0.0182952114423155,0.000260382551425168
NMR metabolomics,X23428.Concentration of VLDL Particles,RALY,RNA-binding protein Raly,37900,0.0160526424342671,0.00439620744024432,0.00743607585138826,0.024669209017146,0.000261727512290675
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARF2,Scavenger receptor class F member 2,40471,-0.00984711148443951,0.00270187074289903,-0.0151427781405216,-0.00455144482835741,0.000268703706403496
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.0120050145277077,0.00330213789946838,0.00553282424474972,0.0184772048106658,0.000278471102609232
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,37562,0.0150408467111905,0.00415138459021751,0.00690413291436417,0.0231775605080168,0.00029220290517421
NMR metabolomics,X23428.Concentration of VLDL Particles,IL32,Interleukin-32,40341,-0.0140515434147152,0.00388182665881319,-0.021659923665989,-0.00644316316344133,0.000295715369141593
NMR metabolomics,X23428.Concentration of VLDL Particles,CD55,Complement decay-accelerating factor,39802,0.00864210880126157,0.00238925387002751,0.00395917121600766,0.0133250463865155,0.00029890743632408
NMR metabolomics,X23428.Concentration of VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,39980,0.0172913408138277,0.00478274714894818,0.00791715640188924,0.0266655252257661,0.000300882696446687
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM4,Intercellular adhesion molecule 4,40341,-0.0172311446307359,0.00479873529796964,-0.0266366658147564,-0.00782562344671542,0.000330699184985585
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSV,Cathepsin L2,40444,0.0138321015628167,0.00385992410921148,0.00626665030876225,0.0213975528168712,0.000340007200969923
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB2,Integrin beta-2,40221,0.00933985802939243,0.00260681102719711,0.0042305084160861,0.0144492076426988,0.000340867170220781
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC13A1,Solute carrier family 13 member 1,37900,0.0202551009422913,0.0056607253227634,0.009160079309675,0.0313501225749075,0.000347210150594731
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.010906520433714,0.00305445304253312,0.00491979247034909,0.0168932483970789,0.000357086300501386
NMR metabolomics,X23428.Concentration of VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0160399594870371,0.00450942238300787,0.0072014916163417,0.0248784273577326,0.000376250308474572
NMR metabolomics,X23428.Concentration of VLDL Particles,CD5L,CD5 antigen-like,37934,0.0151026628837663,0.00424599000384727,0.00678052247622563,0.0234248032913069,0.000376509960078049
NMR metabolomics,X23428.Concentration of VLDL Particles,TSC1,Hamartin,37598,0.0247569044396744,0.00696446773230729,0.0111065476843521,0.0384072611949967,0.000379674222006844
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC1,Sialoadhesin,40422,0.013966576386917,0.00393458524379195,0.00625478930908474,0.0216783634647492,0.000386786276039751
NMR metabolomics,X23428.Concentration of VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.0232773267327408,0.00656305180460215,0.0104137451957206,0.036140908269761,0.000391168262282986
NMR metabolomics,X23428.Concentration of VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.0231358007643764,0.0065393726331306,0.0103186304034404,0.0359529711253124,0.000404665088565431
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN2,Calsyntenin-2,40516,-0.0125374837305313,0.00354787851767243,-0.0194913256251692,-0.0055836418358933,0.000410785610662132
NMR metabolomics,X23428.Concentration of VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.00942017678674094,0.00266662073121375,0.004193600153562,0.0146467534199199,0.000412875655387948
NMR metabolomics,X23428.Concentration of VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.018948039422993,0.00536506373364321,0.00843251450505236,0.0294635643409337,0.000414198894839723
NMR metabolomics,X23428.Concentration of VLDL Particles,STX5,Syntaxin-5,37598,0.0134358318876029,0.00382375017954685,0.00594128153569105,0.0209303822395147,0.000443256770981112
NMR metabolomics,X23428.Concentration of VLDL Particles,GSAP,Gamma-secretase-activating protein,39980,0.0285698647501351,0.00813502163487916,0.012625222345772,0.0445145071544983,0.00044607913113675
NMR metabolomics,X23428.Concentration of VLDL Particles,NRCAM,Neuronal cell adhesion molecule,40359,0.00892580694280465,0.00254260212654765,0.00394230677477125,0.0139093071108381,0.000448501099566178
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.017663868073741,0.00504247387100768,0.00778061928656592,0.027547116860916,0.00046130997804638
NMR metabolomics,X23428.Concentration of VLDL Particles,CAT,Catalase,37786,0.0173000170229659,0.00496156551323475,0.00757534861702581,0.027024685428906,0.000490399337641293
NMR metabolomics,X23428.Concentration of VLDL Particles,PMS1,PMS1 protein homolog 1,37572,0.0165355111190492,0.00474812692016979,0.00722918235551637,0.0258418398825819,0.000498310824354583
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00864668431780308,0.0024849235902733,0.00377623408086742,0.0135171345547387,0.00050338911582609
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.0202266120964169,0.00581311297811849,0.00883291065930469,0.0316203135335292,0.00050372881896162
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM19,Probable RNA-binding protein 19,37562,-0.0151979528298762,0.00437655380661347,-0.0237759982908387,-0.00661990736891384,0.000517135135973551
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC16A1,Monocarboxylate transporter 1,39961,0.0189762820823847,0.00547033933689604,0.00825441698206847,0.029698147182701,0.000523933666722151
NMR metabolomics,X23428.Concentration of VLDL Particles,CR2,Complement receptor type 2,40403,0.0146430086984877,0.00422275349936047,0.00636641183974115,0.0229196055572342,0.000526425071001567
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMB,Granzyme B,40341,0.0198149921839136,0.00572301783288198,0.00859787723146496,0.0310321071363623,0.000536923682935467
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX18,Sorting nexin-18,37901,0.0143013458167295,0.00414209296705686,0.00618284360129809,0.022419848032161,0.000556742788015659
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00837727614966789,0.00242953371309617,-0.0131391622273364,-0.00361539007199939,0.000566308507886597
NMR metabolomics,X23428.Concentration of VLDL Particles,ELAVL4,ELAV-like protein 4,37541,0.0273132697201291,0.00794787874376294,0.0117354273823537,0.0428911120579045,0.000591007698159745
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO4,Roundabout homolog 4,37628,-0.00558908101484543,0.00162816044156091,-0.00878027548030482,-0.00239788654938604,0.000599311308896219
NMR metabolomics,X23428.Concentration of VLDL Particles,MANSC4,MANSC domain-containing protein 4,37562,0.0205860236865565,0.00600776096897513,0.00881081218736524,0.0323612351857477,0.000613128049044129
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAM,Basal cell adhesion molecule,40332,-0.00737883284867692,0.00215360935826359,-0.0115999071908735,-0.00315775850648029,0.000613496191577504
NMR metabolomics,X23428.Concentration of VLDL Particles,CA9,Carbonic anhydrase 9,40489,-0.0139896803082606,0.00409221376409093,-0.0220104192858788,-0.00596894133064234,0.000630985194248561
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF3,Trefoil factor 3,40309,0.0165344002601809,0.00485222949155832,0.00702403045672661,0.0260447700636352,0.000657025527524389
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.0167357834900388,0.00493520055129773,0.00706279040949528,0.0264087765705824,0.000698111174187126
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.00968690529203323,0.00286423838385904,0.00407299805966952,0.0153008125243969,0.000721290911446729
NMR metabolomics,X23428.Concentration of VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,37482,-0.0134772314247858,0.00398547165997151,-0.02128875587833,-0.00566570697124165,0.000722794301940938
NMR metabolomics,X23428.Concentration of VLDL Particles,NME1,Nucleoside diphosphate kinase A,37598,-0.00675463026531194,0.00200550471329447,-0.0106854195033691,-0.00282384102725478,0.000759205055727226
NMR metabolomics,X23428.Concentration of VLDL Particles,NEDD9,Enhancer of filamentation 1,37598,0.0101542801573272,0.00301593780794872,0.00424304205374774,0.0160655182609067,0.000762435681498537
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTN2,Alpha-actinin-2,37562,-0.0168193548835839,0.00499571645289765,-0.0266109591312633,-0.0070277506359045,0.000762767363877297
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR1,Folate receptor alpha,40299,0.00867257669719456,0.00258024790099862,0.00361529081123727,0.0137298625831519,0.000778046114897236
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,40341,0.0186691712955605,0.00556470333703969,0.00776235275496275,0.0295759898361583,0.000795718234061784
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.0157826866381637,0.00471421241016705,0.00654283031423626,0.0250225429620911,0.000816513809632688
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17C,Interleukin-17C,40044,-0.0213589310656328,0.00638640615033892,-0.0338762871202971,-0.00884157501096855,0.000826442008848109
NMR metabolomics,X23428.Concentration of VLDL Particles,IL11,Interleukin-11,40044,0.0194279292303771,0.00581277905253154,0.00803488228741524,0.0308209761733389,0.00083288906121688
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA3G,Semaphorin-3G,37671,0.0131635398452766,0.00393955165699697,0.0054420185975625,0.0208850610929906,0.000835940172900366
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0182505088339803,0.00548026336698897,0.0075091926346819,0.0289918250332787,0.00086977251312172
NMR metabolomics,X23428.Concentration of VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.0111041295162393,0.00333679400089119,0.00456401327449255,0.017644245757986,0.000877804951512586
NMR metabolomics,X23428.Concentration of VLDL Particles,SBSN,Suprabasin,37977,-0.010127981510201,0.0030591639754175,-0.0161239429020193,-0.00413202011838273,0.000933057178349113
NMR metabolomics,X23428.Concentration of VLDL Particles,CD7,T-cell antigen CD7,37567,0.0129074589722412,0.00391555632019384,0.00523296858466128,0.0205819493598211,0.000981730840460294
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD2,Sushi domain-containing protein 2,40332,-0.00856450292185638,0.00260333183285923,-0.0136670333142605,-0.00346197252945229,0.00100468443718011
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC2,Mucin-2,37998,0.0271643931494756,0.00826077597276217,0.0109732722428617,0.0433555140560895,0.00101030260509234
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.00862593634645833,0.00262882964088465,0.00347343025032442,0.0137784424425923,0.00103558535697814
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0231730609714598,0.00706343121859487,0.00932873578301383,0.0370173861599057,0.00103818606033941
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.0145719719036067,0.0044523703765814,0.00584532596550717,0.0232986178417063,0.00106750008680491
NMR metabolomics,X23428.Concentration of VLDL Particles,OLFM4,Olfactomedin-4,37177,0.0366968232119468,0.0112293984367173,0.0146872022759809,0.0587064441479127,0.00108626620497289
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL12,Stromal cell-derived factor 1,40044,0.0120464425331446,0.00369576454726124,0.00480274402051254,0.0192901410457766,0.00111837514227766
NMR metabolomics,X23428.Concentration of VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.0122861931789287,0.00377218241341649,0.00489271564863242,0.0196796707092251,0.00112809143023841
NMR metabolomics,X23428.Concentration of VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,39961,0.0118492533653702,0.00365656580948139,0.0046823843787867,0.0190161223519537,0.00119554448380252
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.011600039799328,0.00358263683659418,-0.0186220079990526,-0.00457807159960338,0.00120733511583824
NMR metabolomics,X23428.Concentration of VLDL Particles,B2M,Beta-2-microglobulin,38013,0.00934134250747964,0.00288867370140322,0.00367954205272932,0.01500314296223,0.00122454794356707
NMR metabolomics,X23428.Concentration of VLDL Particles,CRNN,Cornulin,39857,0.0195447620127615,0.00604484836674681,0.00769685921393777,0.0313926648115852,0.00122629891303605
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD3,Bromodomain-containing protein 3,37562,0.0142961938401795,0.00442554156345387,0.0056221323758099,0.022970255304549,0.00123929375783424
NMR metabolomics,X23428.Concentration of VLDL Particles,PSPN,Persephin,40341,0.0290838431820502,0.0090400208366583,0.0113654023421999,0.0468022840219005,0.00129693325167442
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKCQ,Protein kinase C theta type,40044,0.012973328960994,0.00403863305112143,0.005057608180796,0.020889049741192,0.00131940997713027
NMR metabolomics,X23428.Concentration of VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0166118947345438,0.00518143357661074,0.00645628492438678,0.0267675045447009,0.00134846678154542
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,37598,0.00940910174644584,0.00294229737386951,0.0036421988936616,0.0151760045992301,0.00138771845349499
NMR metabolomics,X23428.Concentration of VLDL Particles,LMNB1,Lamin-B1,37874,0.0165754650965801,0.0051885908669604,0.00640582699733774,0.0267451031958225,0.00140349122708047
NMR metabolomics,X23428.Concentration of VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.011193747380063,0.00350481992916559,-0.0180631944412276,-0.00432430031889847,0.00140738453750241
NMR metabolomics,X23428.Concentration of VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0212187470914384,0.00668454115581146,-0.0343204477568288,-0.00811704642604791,0.00150482512405365
NMR metabolomics,X23428.Concentration of VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,39961,0.011130786789448,0.00351321852021864,0.00424487848981946,0.0180166950890765,0.00153652287125178
NMR metabolomics,X23428.Concentration of VLDL Particles,QSOX1,Sulfhydryl oxidase 1,37761,0.0129437449030615,0.00408759673884897,0.0049320552949175,0.0209554345112055,0.0015458543487873
NMR metabolomics,X23428.Concentration of VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.00960418351644167,0.00303356685173795,-0.0155499745458481,-0.00365839248703527,0.00154920837199985
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.00906753667996057,0.00286688858786501,0.00344843504774514,0.014686638312176,0.001565885675509
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,37714,0.0203756240068527,0.00646353788124454,0.0077070897596134,0.033044158254092,0.00162297826189202
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00727642059698888,0.0023097310821298,0.00274934767601447,0.0118034935179633,0.00163454311330055
NMR metabolomics,X23428.Concentration of VLDL Particles,TEF,Thyrotroph embryonic factor,37562,0.012386315851441,0.00393780792035169,0.00466821232755173,0.0201044193753303,0.00166182327851972
NMR metabolomics,X23428.Concentration of VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0117181849982292,0.00373063360424777,0.0044061431339036,0.0190302268625548,0.00168647627194277
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.016932243467438,0.0053934075994733,0.00636116457247034,0.0275033223624057,0.0016964634748008
NMR metabolomics,X23428.Concentration of VLDL Particles,EBI3_IL27,Interleukin-27,40453,-0.00887923787337344,0.00283513098433187,-0.0144360946026639,-0.00332238114408296,0.00174014790626462
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.0250540337317276,0.00801482936790627,0.00934496817063135,0.0407630992928239,0.00177611958905414
NMR metabolomics,X23428.Concentration of VLDL Particles,RCC1,Regulator of chromosome condensation,37900,0.0145471136927181,0.00465741299365181,0.00541858422516058,0.0236756431602757,0.00179134628602939
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR4,Toll-like receptor 4,37598,0.00810800474161897,0.00259648285090324,0.00301889835384862,0.0131971111293893,0.00179596819138595
NMR metabolomics,X23428.Concentration of VLDL Particles,AGR2,Anterior gradient protein 2 homolog,39839,0.0287944181573231,0.00922168241151681,0.0107199206307501,0.046868915683896,0.00179673379405693
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.017243473168925,0.00552281212636544,0.00641876140124872,0.0280681849366013,0.00179812889257558
NMR metabolomics,X23428.Concentration of VLDL Particles,CENPF,Centromere protein F,37714,0.0155073619959207,0.00497402909742962,0.00575826496495866,0.0252564590268828,0.0018267904664858
NMR metabolomics,X23428.Concentration of VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0100779867458063,0.00323602627745632,0.00373537524199192,0.0164205982496207,0.00184704639656514
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.01103012341667,0.00354558406800849,-0.0179794681899666,-0.00408077864337336,0.00186819440673402
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN8,Septin-8,37921,0.00899883161889844,0.00289972448228415,0.00331537163362151,0.0146822916041754,0.00191745715536809
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL4,Myosin light chain 4,37628,-0.0148579355330218,0.00479268339084694,-0.0242515949790819,-0.00546427608696184,0.00193844412437154
NMR metabolomics,X23428.Concentration of VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.00881776378446837,0.00285064559533006,-0.0144050291513153,-0.00323049841762145,0.00198365054014263
NMR metabolomics,X23428.Concentration of VLDL Particles,NMI,N-myc-interactor,37857,0.0199815043992753,0.00652184295282729,0.0071986922117338,0.0327643165868168,0.002189919707474
NMR metabolomics,X23428.Concentration of VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.0143556493929203,0.00469150311130896,0.00516030329475478,0.0235509954910859,0.0022176971359354
NMR metabolomics,X23428.Concentration of VLDL Particles,MYO6,Unconventional myosin-VI,37959,0.0104266969889106,0.0034126369666899,0.00373792853419837,0.0171154654436228,0.00225259107536542
NMR metabolomics,X23428.Concentration of VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0145999873050035,0.00479118482934498,-0.0239907095705197,-0.00520926503948739,0.0023131693585259
NMR metabolomics,X23428.Concentration of VLDL Particles,PTTG1,Securin,37714,0.0114753765981033,0.00377071319994669,0.00408477872620783,0.0188659744699989,0.00234464185007783
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.0074962779617691,0.00246500529899595,0.00266486757573704,0.0123276883478012,0.00236122762239283
NMR metabolomics,X23428.Concentration of VLDL Particles,SCP2,Non-specific lipid-transfer protein,39980,0.0215566815260403,0.00710231610224574,0.00763614196563868,0.035477221086442,0.00240804314927482
NMR metabolomics,X23428.Concentration of VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.014839903329865,0.00491668052358041,0.00520320950364738,0.0244765971560826,0.00254704547618079
NMR metabolomics,X23428.Concentration of VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,40341,0.0129223915832724,0.00428938813353789,0.00451519084153818,0.0213295923250067,0.00259391821576253
NMR metabolomics,X23428.Concentration of VLDL Particles,CLC,Galectin-10,40333,-0.0180034350111715,0.00597822836070116,-0.0297207625981457,-0.00628610742419719,0.00260369264530746
NMR metabolomics,X23428.Concentration of VLDL Particles,OBP2B,Odorant-binding protein 2b,40184,-0.0181503532878676,0.0060288714721335,-0.0299669413732493,-0.00633376520248594,0.00261169461495041
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN7,Septin-7,37714,0.014413391290114,0.00478821994349407,0.00502848020086565,0.0237983023793624,0.00261586219742223
NMR metabolomics,X23428.Concentration of VLDL Particles,CD109,CD109 antigen,40332,-0.00910581820008367,0.00303848297502871,-0.0150612448311399,-0.00315039156902739,0.0027322397050655
NMR metabolomics,X23428.Concentration of VLDL Particles,MERTK,Tyrosine-protein kinase Mer,40516,0.00712497922766803,0.00237779667803037,0.0024644977387285,0.0117854607166076,0.00273548617197671
NMR metabolomics,X23428.Concentration of VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.0110271078902279,0.00368383672694951,-0.0182474278750489,-0.00380678790540683,0.00276424043409476
NMR metabolomics,X23428.Concentration of VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.013561175320889,0.00453059612873717,0.00468120690856419,0.0224411437332139,0.00276544287531538
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.00743651985717749,0.00249303271912748,0.00255017572768763,0.0123228639866673,0.00285939857378565
NMR metabolomics,X23428.Concentration of VLDL Particles,NTRK3,NT-3 growth factor receptor,40471,-0.00587707317855289,0.00198324419827458,-0.00976423180717107,-0.00198991454993472,0.00304744558538358
NMR metabolomics,X23428.Concentration of VLDL Particles,NTF4,Neurotrophin-4,39980,0.0109994492172848,0.00371597986086009,0.00371612868999898,0.0182827697445705,0.0030806373270158
NMR metabolomics,X23428.Concentration of VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.0179524154953659,0.00606685170538855,0.00606138615280437,0.0298434448379275,0.00309084999785328
NMR metabolomics,X23428.Concentration of VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.0168900858515729,0.00571039403839399,-0.0280824581668251,-0.00569771353632064,0.00310415214868171
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00672807264512687,0.00227503750559043,-0.0111871461560841,-0.00226899913416963,0.00310835811432402
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,37969,0.0130049301502292,0.00441445356793793,0.00435260115707082,0.0216572591433875,0.00322473311070556
NMR metabolomics,X23428.Concentration of VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.00952403491362586,0.00324154416866085,0.00317060834305059,0.0158774614842011,0.00330696274393724
NMR metabolomics,X23428.Concentration of VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,37628,0.0155129856201409,0.00528228294219133,0.00515971105344588,0.0258662601868359,0.00332196269264586
NMR metabolomics,X23428.Concentration of VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.012657126023954,0.004316231316564,0.00419731264348859,0.0211169394044195,0.00336864042773766
NMR metabolomics,X23428.Concentration of VLDL Particles,CLMP,CXADR-like membrane protein,40489,0.00542208417820532,0.00185413878233414,0.0017879721648304,0.00905619619158024,0.00345699333148224
NMR metabolomics,X23428.Concentration of VLDL Particles,TNC,Tenascin,40403,-0.0125532618061959,0.00429342573056833,-0.0209683762381098,-0.00413814737428194,0.00346235860837012
NMR metabolomics,X23428.Concentration of VLDL Particles,EDN1,Endothelin-1,37628,0.00773270391123445,0.00264974917314412,0.00253919553187198,0.0129262122905969,0.00352565830259985
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.0138881759916115,0.004761916605081,-0.0232215325375702,-0.0045548194456527,0.00354571871227788
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.0129338768904925,0.0044413763832155,0.00422877917939011,0.0216389746015949,0.00359479224940342
NMR metabolomics,X23428.Concentration of VLDL Particles,SULT1A1,Sulfotransferase 1A1,40471,-0.0339172667927485,0.0116905042754699,-0.0568306551726694,-0.0110038784128275,0.00372163764131282
NMR metabolomics,X23428.Concentration of VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0275717151750536,0.0095130573868608,0.00892612269680642,0.0462173076533007,0.00375705587074861
NMR metabolomics,X23428.Concentration of VLDL Particles,TERF1,Telomeric repeat-binding factor 1,37598,-0.00786647060190699,0.00271429724199515,-0.0131864931962175,-0.0025464480075965,0.00375978053395667
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA4,Carboxypeptidase A4,37410,0.0115766571439105,0.00400202600268026,0.00373268617865714,0.0194206281091638,0.00382582947485439
NMR metabolomics,X23428.Concentration of VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0100643382370728,0.00348067800435608,0.00324220934853485,0.0168864671256107,0.00384035743862345
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.0137472117512163,0.00476001615264287,0.00441758009203629,0.0230768434103963,0.00388260286910351
NMR metabolomics,X23428.Concentration of VLDL Particles,NDRG1,Protein NDRG1,39961,0.0180915009366235,0.00626610244867973,0.0058099401372112,0.0303730617360357,0.00389222091223493
NMR metabolomics,X23428.Concentration of VLDL Particles,SNU13,NHP2-like protein 1,37562,0.0164245184248791,0.00569963303964433,0.00525323766717626,0.027595799182582,0.00396203299488939
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0142746304815951,0.00495387273102841,-0.0239842210344108,-0.00456503992877946,0.0039641880557337
NMR metabolomics,X23428.Concentration of VLDL Particles,ACE,Angiotensin-converting enzyme,37987,-0.00666615294707771,0.00232822178540205,-0.0112294676464657,-0.00210283824768969,0.00420036520748855
NMR metabolomics,X23428.Concentration of VLDL Particles,SHISA5,Protein shisa-5,37998,0.00647119511952483,0.00226481449773228,0.00203215870396956,0.0109102315350801,0.00427947920809465
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA2,Ephrin type-A receptor 2,39759,0.00800775722795862,0.00280613499400719,0.00250773263970453,0.0135077818162127,0.00432766464758599
NMR metabolomics,X23428.Concentration of VLDL Particles,CD248,Endosialin,37998,-0.0104010491685387,0.00364788804754619,-0.0175509097417292,-0.00325118859534819,0.00436132263377499
NMR metabolomics,X23428.Concentration of VLDL Particles,CST6,Cystatin-M,39992,0.0123742442014561,0.00434257272541215,0.0038628016596483,0.0208856867432639,0.00438429306020599
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0128398636323075,0.00451639472486328,0.00398772997157547,0.0216919972930395,0.00447677534133696
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.00998166795419343,0.0035291640281553,-0.0168988294493778,-0.00306450645900904,0.00468590998846987
NMR metabolomics,X23428.Concentration of VLDL Particles,UNC5D,Netrin receptor UNC5D,37598,0.00690788959240544,0.00244255257322047,0.00212048654889333,0.0116952926359176,0.00468895983095513
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL21,C-C motif chemokine 21,40422,0.0108868599397707,0.00386167760562617,0.00331797183274338,0.0184557480467979,0.00482020441196305
NMR metabolomics,X23428.Concentration of VLDL Particles,SATB1,DNA-binding protein SATB1,37959,0.00772419947113354,0.0027440379426714,0.00234588510349759,0.0131025138387695,0.00488626346413048
NMR metabolomics,X23428.Concentration of VLDL Particles,WNT9A,Protein Wnt-9a,40044,0.00733104107958813,0.00260975770261786,0.00221591598245714,0.0124461661767191,0.00497437625558874
NMR metabolomics,X23428.Concentration of VLDL Particles,STX3,Syntaxin-3,37942,0.00989577347035296,0.00352453221778709,0.00298769032349027,0.0168038566172157,0.00499707685450828
NMR metabolomics,X23428.Concentration of VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.0120846255923419,0.00430583722001185,0.00364518464111871,0.0205240665435652,0.00501440122084685
NMR metabolomics,X23428.Concentration of VLDL Particles,HBQ1,Hemoglobin subunit theta-1,40489,-0.0150706041910077,0.00537299144814065,-0.0256016674293634,-0.00453954095265203,0.00503956491016605
NMR metabolomics,X23428.Concentration of VLDL Particles,SOX9,Transcription factor SOX-9,37572,0.00695287953438703,0.00247988534244687,0.00209230426319117,0.0118134548055829,0.00505925005565384
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.0223110576042994,0.00797209525511439,0.0066857509042752,0.0379363643043236,0.0051379600560982
NMR metabolomics,X23428.Concentration of VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",37562,0.0147214001109025,0.00526226755230306,0.0044073557083885,0.0250354445134165,0.00515685897015361
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTN,Neuroplastin,39980,0.0214745040496729,0.00769321915511716,0.00639579450564322,0.0365532135937025,0.00525520023581059
NMR metabolomics,X23428.Concentration of VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,37562,0.0103975833358854,0.00372673021003635,0.0030931921242142,0.0177019745475567,0.00527838853677349
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0166666392699559,0.00597594922089397,-0.0283794997429081,-0.00495377879700375,0.00529529023433428
NMR metabolomics,X23428.Concentration of VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,40489,0.0155261668205817,0.00557191888181334,0.00460520581222756,0.0264471278289358,0.00533427847120784
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA4C,Semaphorin-4C,40305,0.00718215000807587,0.00257823038533913,0.00212881845281118,0.0122354815633406,0.0053477388523164
NMR metabolomics,X23428.Concentration of VLDL Particles,NGF,Beta-nerve growth factor,40228,0.00309234075746328,0.00111054696173098,0.00091566871247057,0.005269012802456,0.00536708029972924
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00990575037152296,0.00357148800736095,0.0029056338770955,0.0169058668659504,0.00555243164307344
NMR metabolomics,X23428.Concentration of VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.00794497975722942,0.00286507784762421,0.00232942717588598,0.0135605323385729,0.00555996883075701
NMR metabolomics,X23428.Concentration of VLDL Particles,SELL,L-selectin,38013,0.00584166985861318,0.00211029918692313,0.00170548345224385,0.00997785626498252,0.00564482937811715
NMR metabolomics,X23428.Concentration of VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.0301221094560604,0.0109344259515247,0.00869063459107199,0.0515535843210488,0.00587969069212113
NMR metabolomics,X23428.Concentration of VLDL Particles,GIMAP7,GTPase IMAP family member 7,37671,-0.0081156294309525,0.00295549564438939,-0.0139084008939557,-0.00232285796794931,0.0060418409896175
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA1,Apolipoprotein A-I,38013,-0.00689483499609694,0.0025111397227983,-0.0118166688527816,-0.00197300113941227,0.00604616154855327
NMR metabolomics,X23428.Concentration of VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00649437927827683,0.00237517002040573,-0.0111497125182721,-0.00183904603828159,0.00625984868768072
NMR metabolomics,X23428.Concentration of VLDL Particles,CENPJ,Centromere protein J,37714,0.0182492323522435,0.00668641996384503,0.00514384922310722,0.0313546154813797,0.00635530267977683
NMR metabolomics,X23428.Concentration of VLDL Particles,WIF1,Wnt inhibitory factor 1,40489,0.00849250036199436,0.00311254854295762,0.00239190521779742,0.0145930955061913,0.00636978752888726
NMR metabolomics,X23428.Concentration of VLDL Particles,RLN1,Prorelaxin H1,37959,-0.0205174622896299,0.00752081582388476,-0.035258261304444,-0.0057766632748158,0.00637845792570932
NMR metabolomics,X23428.Concentration of VLDL Particles,DRAXIN,Draxin,40228,0.0107566375753004,0.0039440095579334,0.00302637884175088,0.0184868963088498,0.00639186640423926
NMR metabolomics,X23428.Concentration of VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.0125141278348594,0.0045903348197875,0.00351707158807591,0.0215111840816429,0.00641529618120615
NMR metabolomics,X23428.Concentration of VLDL Particles,NOP56,Nucleolar protein 56,37562,0.0274854310920969,0.0101192543353706,0.00765169259477048,0.0473191695894233,0.00661322149643425
NMR metabolomics,X23428.Concentration of VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.00888934745386795,0.003276040503789,0.00246830806644151,0.0153103868412944,0.00666600586435025
NMR metabolomics,X23428.Concentration of VLDL Particles,JUN,Transcription factor AP-1,40044,0.0127990823445199,0.00471830455782205,0.00355120541118864,0.0220469592778511,0.00668219348584272
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF2,Trefoil factor 2,40396,0.0140318735914505,0.00517856078414114,0.00388189445453392,0.0241818527283672,0.00674346087731652
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D17,TBC1 domain family member 17,39961,0.0113309317219845,0.00418869890597507,0.00312108186627335,0.0195407815776956,0.00683543632150866
NMR metabolomics,X23428.Concentration of VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,37598,0.0159597827539338,0.00590244464339095,0.00439099125288753,0.0275285742549801,0.00686133834191352
NMR metabolomics,X23428.Concentration of VLDL Particles,CHI3L1,Chitinase-3-like protein 1,40054,0.018254676893668,0.00675734713283707,0.00501027651330737,0.0314990772740287,0.0069111171574
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH3,Cadherin-3,40471,0.00869689732524438,0.0032224148238735,0.00238096427045232,0.0150128303800364,0.00696470994889696
NMR metabolomics,X23428.Concentration of VLDL Particles,SIL1,Nucleotide exchange factor SIL1,37628,0.00784636826911145,0.00291525997906971,0.00213245871013481,0.0135602778280881,0.0071225255244397
NMR metabolomics,X23428.Concentration of VLDL Particles,TMOD4,Tropomodulin-4,37482,-0.0103019092156711,0.00382774504016788,-0.0178042894944001,-0.00279952893694203,0.00712483269386507
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.0113044198827603,0.00421064205312575,0.00305156145863379,0.0195572783068867,0.00726660514653688
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAM,Integrin alpha-M,40332,-0.00771861463909371,0.00288027363986444,-0.013363950973228,-0.00207327830495941,0.00737377478083925
NMR metabolomics,X23428.Concentration of VLDL Particles,PADI4,Protein-arginine deiminase type-4,39934,0.0169468666035648,0.00632536441202436,0.00454915235599711,0.0293445808511326,0.00738780356992589
NMR metabolomics,X23428.Concentration of VLDL Particles,GPA33,Cell surface A33 antigen,40305,-0.0332200305694787,0.0124000632744129,-0.057524154587328,-0.00891590655162934,0.00739139497850553
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH12,Protocadherin-12,37959,0.00624720890956709,0.00233310919012734,0.0016743148969175,0.0108201029222167,0.00742341699123126
NMR metabolomics,X23428.Concentration of VLDL Particles,POF1B,Protein POF1B,37598,-0.01134408140466,0.00423740985661122,-0.019649404723618,-0.00303875808570198,0.00743488166271046
NMR metabolomics,X23428.Concentration of VLDL Particles,CCND2,G1/S-specific cyclin-D2,37714,0.00892558252056102,0.00334704897057199,0.00236536653823991,0.0154857985028821,0.00766924862564304
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0100371639669012,0.00376462897626367,-0.017415836760378,-0.00265849117342441,0.00768135937229259
NMR metabolomics,X23428.Concentration of VLDL Particles,RGMA,Repulsive guidance molecule A,40471,-0.00749505565145151,0.00281286767230344,-0.0130082762891662,-0.00198183501373677,0.00771662533578848
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP4,Bone morphogenetic protein 4,40203,-0.0110173986985699,0.00413495951907742,-0.0191219193559617,-0.00291287804117821,0.00771925542432542
NMR metabolomics,X23428.Concentration of VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00980938782974242,0.00368733504013416,0.00258221115107945,0.0170365645084054,0.00781507246065525
NMR metabolomics,X23428.Concentration of VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.0128498813042759,0.00483919835885552,0.00336505252091904,0.0223347100876327,0.0079315210878593
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.0133182242485726,0.00503616916729618,0.00344733268067212,0.0231891158164732,0.00819031221788861
NMR metabolomics,X23428.Concentration of VLDL Particles,CA11,Carbonic anhydrase-related protein 11,39980,0.00792293706515686,0.00301310107289492,0.00201725896228282,0.0138286151680309,0.00855958313378725
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3GL3,Endophilin-A3,37643,0.0198704818165626,0.00755996616894497,0.00505294812543049,0.0346880155076948,0.00858914114645746
NMR metabolomics,X23428.Concentration of VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00837417744964183,0.00318650728005067,0.00212862318074252,0.0146197317185411,0.00859825594030356
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH1,Cadherin-1,39806,0.00952325481122448,0.0036492678949669,0.00237068973708935,0.0166758198853596,0.00907269872784891
NMR metabolomics,X23428.Concentration of VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,40411,0.0100735405663875,0.00386242674878408,0.00250318413877075,0.0176438969940043,0.00911349220122772
NMR metabolomics,X23428.Concentration of VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00533164581983454,0.0020509845265984,0.00131171614770167,0.0093515754919674,0.00934301543373373
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM25,Transmembrane protein 25,37959,-0.0103668903704249,0.00399215528115661,-0.0181915147214918,-0.00254226601935795,0.00941944431737487
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.00570883974371342,0.00219915810413071,-0.0100191896278096,-0.00139848985961724,0.00944236200543821
NMR metabolomics,X23428.Concentration of VLDL Particles,STX1B,Syntaxin-1B,37572,0.0101676129923218,0.00392562924446756,0.00247337967316536,0.0178618463114782,0.00960654413357034
NMR metabolomics,X23428.Concentration of VLDL Particles,SAG,S-arrestin,37541,-0.0126200554204902,0.00487479621803751,-0.0221746560078437,-0.00306545483313669,0.00964070411206807
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0130358407187763,0.00503579908481547,0.00316567451253801,0.0229060069250147,0.00964473762282536
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.0155471218928595,0.00600928884826938,-0.0273253280354675,-0.00376891575025149,0.00968702580394624
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.0101558670766092,0.00394121860777393,0.00243107860537226,0.0178806555478461,0.00997991687291724
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB2A2,Mammaglobin-A,37562,-0.007541644458659,0.00293098449780726,-0.0132863740743612,-0.00179691484295677,0.0100908141231816
NMR metabolomics,X23428.Concentration of VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0096190577809223,0.00374345032498666,-0.0169562204178961,-0.00228189514394844,0.0101915363870653
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM132A,Transmembrane protein 132A,37628,0.0147144858371936,0.00572768542056948,0.00348822241287743,0.0259407492615098,0.0102098322561889
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,40335,0.0104274227074557,0.00408067643012799,0.00242929690440484,0.0184255485105066,0.0106183397722312
NMR metabolomics,X23428.Concentration of VLDL Particles,NRXN3,Neurexin-3,37572,0.00813327019809483,0.00318412790653885,0.00189237950127868,0.014374160894911,0.0106508464447817
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.0119588847543351,0.00469945680778156,0.00274794941108325,0.021169820097587,0.0109455613695142
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.0104518614287015,0.00411755729710346,-0.0185222737310243,-0.00238144912637877,0.0111465660228161
NMR metabolomics,X23428.Concentration of VLDL Particles,TYMP,Thymidine phosphorylase,40257,0.0153081544686318,0.00605735414970598,0.0034357403352081,0.0271805686020555,0.011507220753871
NMR metabolomics,X23428.Concentration of VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.0114308672840385,0.00453327799667121,0.00254564241056293,0.0203160921575141,0.0116939867537558
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0069173727386682,0.00274559869204778,-0.0122987461750818,-0.00153599930225455,0.0117656391255241
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL4,Early placenta insulin-like peptide,37900,-0.0124269138126322,0.00493667982803813,-0.0221028062755869,-0.00275102134967744,0.0118386309025276
NMR metabolomics,X23428.Concentration of VLDL Particles,SUMF1,Formylglycine-generating enzyme,37598,0.0153833105779141,0.00613099033369614,0.00336656952386961,0.0274000516319585,0.0121156134385565
NMR metabolomics,X23428.Concentration of VLDL Particles,CA1,Carbonic anhydrase 1,40003,0.01425763332093,0.00568533185040883,0.00311438289412873,0.0254008837477314,0.0121588983740191
NMR metabolomics,X23428.Concentration of VLDL Particles,SAT1,Diamine acetyltransferase 1,37562,-0.0119727006863145,0.00477779786585066,-0.0213371845033818,-0.00260821686924722,0.0122259110503373
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A14,Protein S100-A14,37959,0.0122716055420022,0.00489818271963239,0.00267116741152273,0.0218720436724817,0.0122451009354378
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.011506899065221,0.00459532032649512,0.00250007122529055,0.0205137269051514,0.0122881780526216
NMR metabolomics,X23428.Concentration of VLDL Particles,RSPO1,R-spondin-1,40228,0.00807250059166349,0.00322446231537453,0.00175255445352941,0.0143924467297976,0.0123065509430347
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.0101961004782601,0.00407700577412347,0.00220516916097808,0.0181870317955421,0.0123984723555098
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN2B,Sodium channel subunit beta-2,37572,-0.00677782749770049,0.00271019047422068,-0.012089800827173,-0.00146585416822796,0.0124010440724289
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.00933872325884526,0.00373449872931607,-0.0166583407683048,-0.00201910574938577,0.0124082106889354
NMR metabolomics,X23428.Concentration of VLDL Particles,L1CAM,Neural cell adhesion molecule L1,40411,0.00643333828923199,0.00257353883244761,0.00138920217763468,0.0114774744008293,0.0124362210415788
NMR metabolomics,X23428.Concentration of VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.00758556773979494,0.00303451274196307,0.00163792276554732,0.0135332127140426,0.0124375614681313
NMR metabolomics,X23428.Concentration of VLDL Particles,PSME2,Proteasome activator complex subunit 2,40152,0.00842001543226376,0.00337238874450815,0.0018101334930278,0.0150298973714997,0.0125438541416338
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0658962268998036,0.0265922755807438,0.0137753667615458,0.118017087038061,0.0132216235775275
NMR metabolomics,X23428.Concentration of VLDL Particles,COL3A1,Collagen alpha-1(III) chain,37998,-0.00521456994721401,0.00210565954561012,-0.00934166265660986,-0.00108747723781817,0.013281575833757
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.0126824456291002,0.00512568235412889,0.0026361082150076,0.0227287830431929,0.0133623912990085
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,37942,0.00654661844317317,0.00265348972951619,0.00134577857332144,0.0117474583130249,0.013630777546657
NMR metabolomics,X23428.Concentration of VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.00949233135895391,0.00385383820495395,0.00193880847724416,0.0170458542406637,0.0137871023844991
NMR metabolomics,X23428.Concentration of VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.00806230816954802,0.0032812294314732,0.00163109848386056,0.0144935178552355,0.0140190882432245
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK14,Kallikrein-14,40489,0.0102428212971091,0.00417838973583548,0.00205317741487159,0.0184324651793467,0.014241552946889
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.00975124281899466,0.00399210630586512,0.00192671445949903,0.0175757711784903,0.0145937094051203
NMR metabolomics,X23428.Concentration of VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.00850094417462669,0.00348779124079128,0.0016648733426758,0.0153370150065776,0.0148065128841755
NMR metabolomics,X23428.Concentration of VLDL Particles,TCN2,Transcobalamin-2,40497,0.00661076582354058,0.00271255038904767,0.00129416706100714,0.011927364586074,0.014816235297037
NMR metabolomics,X23428.Concentration of VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0197975158728838,0.0081310882548987,0.00386058289328234,0.0357344488524852,0.0149136443549313
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE1,Ribonuclease pancreatic,37987,0.0053558178792752,0.00220105465198051,0.00104175076139341,0.00966988499715699,0.014974913248586
NMR metabolomics,X23428.Concentration of VLDL Particles,PRR4,Proline-rich protein 4,37577,-0.0152763511587197,0.00628210752259521,-0.0275892819030064,-0.00296342041443312,0.0150404423866714
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB44,Ras-related protein Rab-44,37900,0.00882820053513166,0.00363170992716032,0.00171004907789744,0.0159463519923659,0.0150757616897408
NMR metabolomics,X23428.Concentration of VLDL Particles,NRP2,Neuropilin-2,40332,-0.0064156227621797,0.00264159757956582,-0.0115931540181287,-0.0012380915062307,0.0151644895096997
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM26,Tripartite motif-containing protein 26,37482,0.0121934746629479,0.00502685921776464,0.00234083059612924,0.0220461187297666,0.0152938727622497
NMR metabolomics,X23428.Concentration of VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,40341,0.0103791896326184,0.0042792645542443,0.00199183110629953,0.0187665481589372,0.0153000200453952
NMR metabolomics,X23428.Concentration of VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.0125334737951045,0.00522094635829511,0.00230041893284612,0.022766528657363,0.0163792618533322
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN5,Contactin-5,40367,0.00808851501936253,0.00337084593680475,0.00148165698322522,0.0146953730554998,0.0164266384101681
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.00749304618285275,0.00312599266293545,-0.0136199918022062,-0.00136610056349928,0.0165432549008583
NMR metabolomics,X23428.Concentration of VLDL Particles,HMCN2,Hemicentin-2,37648,-0.012483298948633,0.00521120779381824,-0.0226972662245167,-0.00226933167274924,0.01661285960684
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.00962027505625656,0.00402444516247595,-0.0175081875747094,-0.00173236253780371,0.0168388121831177
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.0130742395973512,0.00547141812416204,0.00235026007399357,0.0237982191207088,0.0168805578221286
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0110833680868146,0.00464695749681412,0.00197533139305895,0.0201914047805703,0.0170891471471526
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.00710928186833601,0.00298589492216244,-0.0129616359157744,-0.00125692782089762,0.0172795535554918
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA6C,Semaphorin-6C,37598,0.00578228994760342,0.00243185243909116,0.00101585916698475,0.0105487207282221,0.01743376102702
NMR metabolomics,X23428.Concentration of VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.0133865229069905,0.00564404208505304,0.00232420042028652,0.0244488453936944,0.0177160921246317
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGBL1,Integrin beta-like protein 1,37998,0.00753570463938414,0.00318000610041534,0.00130289268257006,0.0137685165961982,0.0178157859644844
NMR metabolomics,X23428.Concentration of VLDL Particles,CD70,CD70 antigen,40341,0.00895815063781231,0.00378225997595989,0.00154492108493093,0.0163713801906937,0.0178739618600839
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.00688744363597632,0.00290923788086005,-0.012589549882462,-0.00118533738949062,0.0179261003610206
NMR metabolomics,X23428.Concentration of VLDL Particles,AMBN,Ameloblastin,40044,-0.00639061986279604,0.00270239044182338,-0.0116873051287699,-0.00109393459682222,0.0180518609259379
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,37482,0.00891280023367422,0.00377178691756185,0.001520097875253,0.0163055025920954,0.0181413933550964
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17RA,Interleukin-17 receptor A,40332,0.00939179473951711,0.00398964397433597,0.00157209254981861,0.0172114969292156,0.0185825596001242
NMR metabolomics,X23428.Concentration of VLDL Particles,THY1,Thy-1 membrane glycoprotein,40471,-0.0059807106995355,0.00254684903762165,-0.0109725348132739,-0.000988886585797055,0.0188725073341853
NMR metabolomics,X23428.Concentration of VLDL Particles,AZU1,Azurocidin,39809,0.0165971915263443,0.00707237749342539,0.00273533163923056,0.0304590514134581,0.0189499481991247
NMR metabolomics,X23428.Concentration of VLDL Particles,CD2,T-cell surface antigen CD2,37562,0.00819515735262628,0.00349264803528837,0.00134956720346108,0.0150407475017915,0.018970443499966
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH15,Cadherin-15,40435,0.00942476460112071,0.00402818082565352,0.0015295301828398,0.0173199990194016,0.0193110948342876
NMR metabolomics,X23428.Concentration of VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.0147335811939659,0.00629757764493586,-0.0270768333780402,-0.00239032900989162,0.019320855426128
NMR metabolomics,X23428.Concentration of VLDL Particles,SAFB2,Scaffold attachment factor B2,37959,0.00589496875107364,0.0025226638086548,0.000950547686110227,0.0108393898160371,0.0194639596901936
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.00747526792163705,0.0032095987146846,0.00118445444085524,0.0137660814024189,0.0198722834987305
NMR metabolomics,X23428.Concentration of VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,37541,0.0252975210634637,0.0109099526484093,0.00391401387258137,0.046681028254346,0.020423578998684
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.00874005284981604,0.00377065813348663,0.00134956290818224,0.0161305427914498,0.0204666878516107
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.00729002868844678,0.00314572677651784,0.00112440420647182,0.0134556531704217,0.0204924061930057
NMR metabolomics,X23428.Concentration of VLDL Particles,MB,Myoglobin,40536,-0.0103353099740972,0.00446325852912837,-0.0190832966911888,-0.00158732325700563,0.0205903252266184
NMR metabolomics,X23428.Concentration of VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.00683444855241262,0.00295318796716342,-0.0126226969680529,-0.00104620013677231,0.0206663780721626
NMR metabolomics,X23428.Concentration of VLDL Particles,THBS2,Thrombospondin-2,40332,-0.00752550200890309,0.0032553408875537,-0.0139059701485083,-0.00114503386929784,0.0208047437498204
NMR metabolomics,X23428.Concentration of VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0181805027418042,0.00787456347265987,-0.0336146471482175,-0.00274635833539085,0.0209699217510845
NMR metabolomics,X23428.Concentration of VLDL Particles,CST7,Cystatin-F,40376,0.0190938662283019,0.00836418061011901,0.00270007223246865,0.0354876602241352,0.0224544628444459
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,40341,0.0083181810481416,0.00365182581073843,0.00116060245909427,0.0154757596371889,0.0227508650632863
NMR metabolomics,X23428.Concentration of VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.015355380038592,0.00674989735690338,-0.0285851788581226,-0.00212558121906137,0.022924856834157
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGN,Secretagogin,40044,-0.00907935700499327,0.00399416636795498,-0.016907923086185,-0.00125079092380151,0.0230304169175731
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,37598,0.0042473484011443,0.00186885559919605,0.000584391426720037,0.00791030537556856,0.0230603256043728
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN1,Calsyntenin-1,39961,0.0108296350855882,0.00479026431139138,0.00144071703526111,0.0202185531359153,0.0237879589913731
NMR metabolomics,X23428.Concentration of VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.0186710981363439,0.00828405510505666,0.00243435013043281,0.0349078461422549,0.0242215411843737
NMR metabolomics,X23428.Concentration of VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00484933382588092,0.0021536378648259,-0.00907046404093969,-0.000628203610822153,0.0243576047376407
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L15,Bcl-2-like protein 15,37598,0.0115905349641664,0.0051535046147995,0.00148966591915939,0.0216914040091734,0.0245252395689619
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP6,Guanylate-binding protein 6,37562,-0.00966090800276657,0.00434233288112631,-0.0181718804497741,-0.00114993555575901,0.026110294336328
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.00982646493096405,0.0044230964193944,0.00115719594895102,0.0184957339129771,0.0263251173814235
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC51B,Organic solute transporter subunit beta,37562,-0.0161680262748362,0.00727897298503253,-0.0304348133255,-0.00190123922417247,0.0263547006035315
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.00584520764036148,0.00265178450601784,0.000647710008566509,0.0110427052721564,0.0275237219714849
NMR metabolomics,X23428.Concentration of VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.0190091344211432,0.00865230841737583,0.00205060992308655,0.0359676589191998,0.0280373379474633
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,40516,0.011699775348005,0.00532570280623989,0.00126139784777482,0.0221381528482352,0.0280453233699078
NMR metabolomics,X23428.Concentration of VLDL Particles,FMR1,Synaptic functional regulator FMR1,39980,0.00702110830316636,0.00319759798628191,0.00075381625005382,0.0132884003562789,0.0281249724938295
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.00971130942157786,0.00443444133755707,-0.0184028144431897,-0.001019804399966,0.0285437088253244
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL14,C-X-C motif chemokine 14,40044,0.0122380069019527,0.00559358313282958,0.00127458396160677,0.0232014298422987,0.0286942017073484
NMR metabolomics,X23428.Concentration of VLDL Particles,VASN,Vasorin,40116,0.00545362671051771,0.00249603829246207,0.00056139165729205,0.0103458617637434,0.0289099868630782
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.00874399925508742,0.00401609267791325,0.000872457606377455,0.0166155409037974,0.0294802057053402
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00898046932623221,0.00412598261132972,0.000893543408025966,0.0170673952444385,0.0295303782018181
NMR metabolomics,X23428.Concentration of VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,37978,-0.00480246675833126,0.00221314523326589,-0.00914023141553241,-0.000464702101130111,0.0300261925764328
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,40296,0.00944655455738203,0.00435984549858988,0.00090125738014586,0.0179918517346182,0.0302712387501585
NMR metabolomics,X23428.Concentration of VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0122224272639905,0.00564734568637957,0.00115362971868649,0.0232912248092944,0.0304609487142881
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRAL,GDNF family receptor alpha-like,37477,-0.0121736644860654,0.00564782338568649,-0.023243398322011,-0.0011039306501199,0.0311440192653641
NMR metabolomics,X23428.Concentration of VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.00644623039752804,0.00300041041229094,0.00056542598943779,0.0123270348056183,0.0316963214081937
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0112206300279948,0.0052245982913679,0.000980417376913659,0.0214608426790758,0.0317595468140506
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.00724462447436104,0.00337340793960838,0.000632744912728607,0.0138565040359935,0.031766279644247
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSPN,Claspin,39925,0.0066549625308333,0.00311072954623274,0.000557932620217126,0.0127519924414495,0.0324223285442378
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.0133353012271063,0.00623640726686798,0.00111194298404508,0.0255586594701676,0.0325104797278542
NMR metabolomics,X23428.Concentration of VLDL Particles,DPEP2,Dipeptidase 2,40305,0.00553836981819935,0.00261105774169199,0.000420696644483055,0.0106560429919156,0.0339270844420932
NMR metabolomics,X23428.Concentration of VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.00527343220451392,0.00248718035966215,0.0003985586995761,0.0101483057094517,0.0340036300191146
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,37671,0.0103395545906988,0.00487660468724915,0.000781409403690503,0.0198976997777072,0.0340046921268919
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00727498737412869,0.00343857274757135,0.000535384788888853,0.0140145899593685,0.0343889432501782
NMR metabolomics,X23428.Concentration of VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00634860503537423,0.00301479032623272,0.000439615995958106,0.0122575940747904,0.0352384423882816
NMR metabolomics,X23428.Concentration of VLDL Particles,PKLR,Pyruvate kinase PKLR,40374,-0.0126979513796755,0.00604495959800807,-0.0245460721917713,-0.000849830567579641,0.0356930980436953
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00543388055311047,0.00259199281312867,0.000353574639378283,0.0105141864668427,0.0360644416337833
NMR metabolomics,X23428.Concentration of VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.00582110474512093,0.00278000162639644,0.00037230155738391,0.011269907932858,0.0362860918625034
NMR metabolomics,X23428.Concentration of VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,39961,0.0106416172435344,0.00509855741369006,0.000648444712701876,0.0206347897743669,0.0368879708879388
NMR metabolomics,X23428.Concentration of VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,37959,0.00581492797834735,0.00282233032122679,0.000283160548742838,0.0113466954079519,0.0393862432891909
NMR metabolomics,X23428.Concentration of VLDL Particles,OMD,Osteomodulin,40422,-0.00828322143968614,0.0040272493573046,-0.0161766301800032,-0.00038981269936912,0.0397222732134104
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0114887808275541,0.00560773559780185,-0.0224799425992458,-0.000497619055862522,0.0405076430815021
NMR metabolomics,X23428.Concentration of VLDL Particles,TK1,"Thymidine kinase, cytosolic",37714,0.00834696721899012,0.00407768893427918,0.000354696907802933,0.0163392375301773,0.0406792436987133
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN8,Tetraspanin-8,37901,0.0193405161031016,0.00946681930959864,0.000785550256288219,0.0378954819499149,0.04107393675319
NMR metabolomics,X23428.Concentration of VLDL Particles,CA14,Carbonic anhydrase 14,40489,0.00637866886238133,0.00313822279545547,0.000227752183288598,0.0125295855414741,0.0421120604700001
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH7B,Myosin-7B,37482,-0.00848381160909549,0.00417788021334823,-0.016672456827258,-0.000295166390932961,0.042310797227709
NMR metabolomics,X23428.Concentration of VLDL Particles,UNG,Uracil-DNA glycosylase,37900,0.00625523632097671,0.00309064021752706,0.00019758149462367,0.0123128911473298,0.0429971919439122
NMR metabolomics,X23428.Concentration of VLDL Particles,CD33,Myeloid cell surface antigen CD33,40411,0.0145996913371954,0.00721852560284291,0.000451381155623298,0.0287480015187675,0.0431381761633623
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00652916885044204,0.00323165374117148,0.000195127517745941,0.0128632101831381,0.0433642567651523
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,37900,0.00711568801178252,0.00352249270702684,0.000211602306009907,0.0140197737175551,0.0433957342553847
NMR metabolomics,X23428.Concentration of VLDL Particles,SCG3,Secretogranin-3,40379,-0.00612264876602287,0.00303128021753682,-0.012063957992395,-0.000181339539650699,0.0434184873517339
NMR metabolomics,X23428.Concentration of VLDL Particles,SSB,Lupus La protein,39961,0.0111200643073429,0.00550562786697734,0.000329033688067351,0.0219110949266185,0.0434251235169284
NMR metabolomics,X23428.Concentration of VLDL Particles,TNN,Tenascin-N,37998,0.00804043473244642,0.0039881489916555,0.000223662708801637,0.0158572067560912,0.0438111219350889
NMR metabolomics,X23428.Concentration of VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.00474439798044579,0.00235884532556512,-0.00936773481855344,-0.00012106114233815,0.0443112048737698
NMR metabolomics,X23428.Concentration of VLDL Particles,MKI67,Proliferation marker protein Ki-67,37598,0.0069179046757128,0.00344815798581917,0.000159515023507232,0.0136762943279184,0.0448488607653701
NMR metabolomics,X23428.Concentration of VLDL Particles,PXDNL,Peroxidasin-like protein,37900,0.0106996598311486,0.00534376505559752,0.000225880322177414,0.0211734393401197,0.0452757560486021
NMR metabolomics,X23428.Concentration of VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.0118693758436978,0.00595426582077019,-0.0235397368524073,-0.000199014834988196,0.0462357678096125
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH17,Protocadherin-17,40359,-0.00631054515522517,0.00316811177469525,-0.0125200442336279,-0.000101046076822484,0.0463996761087612
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.00982270393897009,0.00497791977741867,-0.0195794267027107,-6.59811752294938e-05,0.0484838850189026
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA1,Alpha-1-antitrypsin,37779,-0.00145496191110225,0.000740119615833418,-0.00290559635813575,-4.32746406874799e-06,0.0493370180911543
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTP1,Glutathione S-transferase P,39871,-0.0125029723672531,0.00636293146811185,-0.0249743180447523,-3.16266897538737e-05,0.0494355833112538
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH23,Cadherin-23,37942,-0.00472805626877678,0.00240822018579033,-0.00944816783292582,-7.94470462773915e-06,0.0496319544484024
NMR metabolomics,X23428.Concentration of VLDL Particles,CHP1,Calcineurin B homologous protein 1,37541,0.0130257934351698,0.00666685164149558,-4.12357821615323e-05,0.0260928226525011,0.0507443917443335
NMR metabolomics,X23428.Concentration of VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.0068170864184868,0.00349347816068628,-0.0136643036134319,3.01307764583114e-05,0.0510337045178633
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.0106880415502454,0.00548048367356752,-0.0214297895504377,5.3706449946964e-05,0.0511735191081061
NMR metabolomics,X23428.Concentration of VLDL Particles,F3,Tissue factor,40393,-0.00496806287779352,0.00255342932876035,-0.0099727843621638,3.66586065767716e-05,0.051715144880369
NMR metabolomics,X23428.Concentration of VLDL Particles,CFD,Complement factor D,38013,0.00335433055432832,0.00173457078286586,-4.54281800887626e-05,0.0067540892887454,0.0531572595944887
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA4,Apolipoprotein A-IV,38013,0.00647060528882816,0.00335279135830254,-0.000100865773444812,0.0130420763511011,0.0536380927261458
NMR metabolomics,X23428.Concentration of VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.014690115894645,0.00764226684939854,-0.000288727130176155,0.0296689589194661,0.0545997483576729
NMR metabolomics,X23428.Concentration of VLDL Particles,GH2,Growth hormone variant,39980,0.0292882565355291,0.015371173200197,-0.000839242936857051,0.0594157560079153,0.0567463511474528
NMR metabolomics,X23428.Concentration of VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.00491339531363188,0.00257907367281018,-0.00996837971233983,0.000141589085076064,0.0567851339070151
NMR metabolomics,X23428.Concentration of VLDL Particles,CLIC5,Chloride intracellular channel protein 5,37572,-0.00560707971907125,0.00294811893614165,-0.0113853928339089,0.000171233395766372,0.057203789024871
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB5,Integrin beta-5,40411,0.00639975652234667,0.0033689457134327,-0.000203377075981427,0.0130028901206748,0.0574994619862849
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1B,Protein phosphatase 1B,37598,0.0109614433867417,0.00579593310000997,-0.000398585489277816,0.0223214722627613,0.0586155933485004
NMR metabolomics,X23428.Concentration of VLDL Particles,OSTN,Osteocrin,37572,-0.00742601993230753,0.00393353312383588,-0.0151357448550259,0.0002837049904108,0.0590647434964408
NMR metabolomics,X23428.Concentration of VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.00727167650237322,0.00385346384136796,-0.000281112626707986,0.0148244656314544,0.0591756490091076
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF12,Fibroblast growth factor 12,37598,0.00830698981854628,0.00440580409429665,-0.000328386206275162,0.0169423658433677,0.0593891047658423
NMR metabolomics,X23428.Concentration of VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,37598,-0.0208875227804159,0.0110833040488361,-0.0426107987161346,0.0008357531553028,0.0595067820821172
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,37541,0.0186108127820386,0.00987831915248769,-0.000750692756837312,0.0379723183209144,0.0595863052400968
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCL2,Phosducin-like protein 2,37482,0.00924583149540426,0.00493158559051338,-0.000420076262001953,0.0189117392528105,0.0608399476864221
NMR metabolomics,X23428.Concentration of VLDL Particles,CD160,CD160 antigen,40516,0.00775750901527592,0.00415330712267886,-0.00038297294517464,0.0158979909757265,0.0618094241180277
NMR metabolomics,X23428.Concentration of VLDL Particles,REG1A,Lithostathine-1-alpha,40274,-0.00827626350416363,0.00443410903029297,-0.0169671172035379,0.000414590195210592,0.0619899597084095
NMR metabolomics,X23428.Concentration of VLDL Particles,PRND,Prion-like protein doppel,37942,-0.00912544584928424,0.00489153745600406,-0.0187128592630522,0.000461967564483726,0.0621249481862244
NMR metabolomics,X23428.Concentration of VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00985658862294743,0.00528879297500975,-0.000509445608071684,0.0202226228539666,0.0623898029425333
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0100875551429281,0.00541652984470059,-0.0207039536385413,0.000528843352685061,0.062570466253388
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRDL2,Chordin-like protein 2,40359,0.00961046376789614,0.0051756389944584,-0.000533788661242327,0.0197547161970346,0.0633488118087589
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH4,Myosin-4,37562,-0.00808211276275962,0.00435255428523812,-0.0166131191618263,0.000448893636307101,0.0633525462446679
NMR metabolomics,X23428.Concentration of VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.00703998891380657,0.00382756493714065,-0.000462038362989105,0.0145420161906022,0.0658916996576753
NMR metabolomics,X23428.Concentration of VLDL Particles,IL22,Interleukin-22,37900,-0.0109309574268035,0.00594904965127072,-0.0225910947432941,0.000729179889687121,0.0661686123039833
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.00537444772564836,0.00293524518401509,-0.0111275282863179,0.000378632835021205,0.0671225081271211
NMR metabolomics,X23428.Concentration of VLDL Particles,APOF,Apolipoprotein F,37987,0.00402148724145993,0.00219880429915162,-0.000288169184877255,0.00833114366779711,0.0674301725285359
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNL1,Thioredoxin-like protein 1,37525,0.0158804439055606,0.00870462327977286,-0.0011806177227942,0.0329415055339154,0.0681191362422494
NMR metabolomics,X23428.Concentration of VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00757008062586388,0.00415545529191957,-0.0157147729980262,0.000574611746298474,0.0685198279968154
NMR metabolomics,X23428.Concentration of VLDL Particles,FBN2,Fibrillin-2,37572,0.0101234653776901,0.00556897916401748,-0.000791733783784131,0.0210386645391644,0.0691126968570532
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.00802027987077686,0.00442826549848833,-0.016699680247814,0.000659120506260269,0.0701394491105385
NMR metabolomics,X23428.Concentration of VLDL Particles,MET,Hepatocyte growth factor receptor,40375,0.00330531147774403,0.00182548719358324,-0.000272643421679117,0.00688326637716717,0.070214473105422
NMR metabolomics,X23428.Concentration of VLDL Particles,LTO1,Protein LTO1 homolog,40044,0.00678443962545716,0.00374773353516597,-0.000561118103468135,0.0141299973543824,0.0702719271123237
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH6,Cadherin-6,40359,-0.00623381687889767,0.00344709915756163,-0.0129901312277185,0.000522497469923117,0.0705594097755721
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR158,Probable G-protein coupled receptor 158,37959,0.00607362707778658,0.00336195274760798,-0.000515800307525049,0.0126630544630982,0.0708504784304623
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00933059412314558,0.00517795071916952,-0.000818189286426671,0.0194793775327178,0.0715706252729653
NMR metabolomics,X23428.Concentration of VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,40403,0.00449744934514478,0.00250010827572416,-0.00040276287527458,0.00939766156556415,0.072053107282943
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00477352082023147,0.00266094976080064,-0.000441940710937792,0.00998898235140072,0.0728459175188225
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.00523346468024687,0.00291845969597201,-0.00048671632385826,0.010953645684352,0.0729557939207638
NMR metabolomics,X23428.Concentration of VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0117809076260302,0.0065817482006377,-0.0246811340992801,0.00111931884721973,0.0734872813287905
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.00986603494145921,0.00552310859115811,-0.000959257897210689,0.0206913277801291,0.0740706735081111
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR101,Probable G-protein coupled receptor 101,37541,-0.0105315994593811,0.0058967988546326,-0.022089325214461,0.00102612629569883,0.0741246870794698
NMR metabolomics,X23428.Concentration of VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.00339192453658801,0.00190820424175125,-0.00034815577724445,0.00713200485042047,0.0754971524477268
NMR metabolomics,X23428.Concentration of VLDL Particles,MBL2,Mannose-binding protein C,37810,-0.0172474166449892,0.00971125640076608,-0.0362814791904907,0.00178664590051231,0.0757518522485927
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.00476891257007532,0.00269506653071616,-0.000513417830128354,0.010051242970279,0.0768341691981532
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.0111043863379909,0.00629512266334011,-0.00123405408215571,0.0234428267581375,0.0777601990477026
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP152,Centrosomal protein of 152 kDa,37482,0.00669591893355391,0.00379738283705022,-0.000746951427064526,0.0141387892941724,0.0778736164870533
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN3B,Sodium channel subunit beta-3,37541,0.00738749022310031,0.00419233489957921,-0.000829486180074937,0.0156044666262756,0.0780686140431589
NMR metabolomics,X23428.Concentration of VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.00973898746967837,0.00553734854229317,-0.020592190612573,0.00111421567321625,0.078633602309047
NMR metabolomics,X23428.Concentration of VLDL Particles,SELENOP,Selenoprotein P,38013,0.00362002317555406,0.00205870761137806,-0.000415043742746939,0.00765509009385506,0.0787027118764772
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B4,Protein ATP1B4,37482,-0.00674529062053877,0.00386625167906883,-0.0143231439115137,0.000832562670436133,0.0810678282102664
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,37900,0.00914802417622023,0.0052461458142386,-0.00113442161968742,0.0194304699721279,0.0812236334649423
NMR metabolomics,X23428.Concentration of VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,37901,0.00777160633998266,0.00446614321576536,-0.000982034362917454,0.0165252470428828,0.0818615614746594
NMR metabolomics,X23428.Concentration of VLDL Particles,TTN,Titin,37562,-0.0104361194383,0.00600436657951948,-0.0222046779341582,0.00133243905755819,0.0822187315325223
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.00768667493516859,0.00443019436932656,-0.000996506028711478,0.0163698558990486,0.0827491683681585
NMR metabolomics,X23428.Concentration of VLDL Particles,DCC,Netrin receptor DCC,37572,0.00369831470181532,0.00213421352463888,-0.000484743806476884,0.00788137321010753,0.0831422657939146
NMR metabolomics,X23428.Concentration of VLDL Particles,ARG1,Arginase-1,40227,0.00831915095746749,0.00481113806484796,-0.00111067964963451,0.0177489815645695,0.0838028733134619
NMR metabolomics,X23428.Concentration of VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00515690417166571,0.00298460744384146,-0.000692926418263547,0.011006734761595,0.084041544157347
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20,Interleukin-20,40044,0.00800493060392953,0.00464529596594052,-0.00109984948931388,0.0171097106971729,0.0848660959094805
NMR metabolomics,X23428.Concentration of VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,37541,0.0142878035772317,0.0083155094259936,-0.00201059489771571,0.0305862020521792,0.0857817017463499
NMR metabolomics,X23428.Concentration of VLDL Particles,NRTN,Neurturin,40044,0.00773913587095291,0.00450726418898486,-0.00109510193945742,0.0165733736813632,0.0859924132788238
NMR metabolomics,X23428.Concentration of VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,37714,0.00846979812632431,0.0049565901513316,-0.00124511857028563,0.0181847148229343,0.0875122652026073
NMR metabolomics,X23428.Concentration of VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.00413775486887961,0.00242894580601128,-0.000622978910902493,0.00889848864866171,0.0884940245416394
NMR metabolomics,X23428.Concentration of VLDL Particles,FZD8,Frizzled-8,37541,0.00698392455540612,0.00409977847856926,-0.00105164126258962,0.0150194903734019,0.0885004693551265
NMR metabolomics,X23428.Concentration of VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.0104933593644895,0.00617008644185898,-0.00160001006155413,0.0225867287905331,0.0890226303442012
NMR metabolomics,X23428.Concentration of VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.0137620898206507,0.00811263119881495,-0.00213866732902664,0.029662846970328,0.0898380406636392
NMR metabolomics,X23428.Concentration of VLDL Particles,IL33,Interleukin-33,40044,0.00596636132877998,0.00352174634860914,-0.000936261514493947,0.0128689841720539,0.0902570378465513
NMR metabolomics,X23428.Concentration of VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00453759886700122,0.0026838510473781,-0.00979794691986229,0.000722749185859843,0.0909163393510662
NMR metabolomics,X23428.Concentration of VLDL Particles,LCN15,Lipocalin-15,37959,-0.00982759505876339,0.0058149658548837,-0.0212249281343354,0.00156973801680866,0.0910410698070886
NMR metabolomics,X23428.Concentration of VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0174897884550292,0.0103797196772259,-0.0028544621123336,0.037834039022392,0.0920124012981499
NMR metabolomics,X23428.Concentration of VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.00971388875632692,0.00577133546544127,-0.0210257062685918,0.00159792875593796,0.0923736261556654
NMR metabolomics,X23428.Concentration of VLDL Particles,PADI2,Protein-arginine deiminase type-2,40044,0.00855622700780834,0.00510514366476289,-0.00144985457512692,0.0185623085907436,0.0937580029527569
NMR metabolomics,X23428.Concentration of VLDL Particles,SPARCL1,SPARC-like protein 1,40346,-0.00419937657390772,0.00250798946864884,-0.00911503593245945,0.000716282784644006,0.0940717650259688
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.00960998299385189,0.00575746929499781,-0.00167465682434382,0.0208946228120476,0.0951148669560216
NMR metabolomics,X23428.Concentration of VLDL Particles,BSND,Barttin,37482,-0.00523276156321785,0.00313599569221716,-0.0113793131199635,0.000913789993527776,0.0952182286940025
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.00655410318595481,0.00392834195499255,-0.00114544704583059,0.0142536534177402,0.0952536322522129
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0129622380413258,0.00777588523501891,-0.0282029731019629,0.00227849701931121,0.0955418500080395
NMR metabolomics,X23428.Concentration of VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.0103899381354583,0.00623909447134907,-0.00183868702838588,0.0226185632993025,0.0958775741545672
NMR metabolomics,X23428.Concentration of VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00447242630150102,0.00268895814862248,-0.000797931669799044,0.00974278427280109,0.0962850000055496
NMR metabolomics,X23428.Concentration of VLDL Particles,HIP1,Huntingtin-interacting protein 1,37562,0.00516576091729536,0.00311375340375697,-0.000937195754068304,0.011268717588659,0.0971368637675378
NMR metabolomics,X23428.Concentration of VLDL Particles,ENOPH1,Enolase-phosphatase E1,37900,0.00865322167052617,0.00522889628538886,-0.001595415048836,0.0189018583898883,0.0979711766931648
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP1,"Fatty acid-binding protein, liver",40357,0.0139518836840062,0.00844347856603454,-0.00259733430542151,0.0305011016734339,0.0984756765946685
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP164,Centrosomal protein of 164 kDa,40044,0.00959516708678896,0.00582397303350304,-0.001819820058877,0.0210101542324549,0.0994694182715581
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00504999339056639,0.00306643661719769,-0.0110602091602739,0.000960222379141081,0.0996106865411374
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF9,Fibroblast growth factor 9,37457,0.00610600461806668,0.00371243410105077,-0.00117036621999284,0.0133823754561262,0.100046733241001
NMR metabolomics,X23428.Concentration of VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0133957694479397,0.00814870546995752,-0.002575693273177,0.0293672321690565,0.100218178905653
NMR metabolomics,X23428.Concentration of VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.0075212096622776,0.0045800065651078,-0.0164980225298889,0.00145560320533369,0.10057607369541
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00965105038310623,0.00588446066531886,-0.00188249252091873,0.0211845932871312,0.101009984681462
NMR metabolomics,X23428.Concentration of VLDL Particles,BTLA,B- and T-lymphocyte attenuator,37482,0.0132937875607899,0.00812455900733684,-0.00263034809359035,0.0292179232151701,0.101811996654877
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.00822339604117694,0.00502852691459454,-0.0180793087937822,0.00163251671142836,0.101999969978118
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH4,Cadherin-4,37541,0.00738082165375613,0.0045229854938577,-0.00148422991420496,0.0162458732217172,0.10273571516949
NMR metabolomics,X23428.Concentration of VLDL Particles,EPN1,Epsin-1,37714,0.0065679290727744,0.00403568818322119,-0.00134201976633913,0.0144778779118879,0.10366277316372
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNW1,Interferon omega-1,37562,-0.00545513905510737,0.00336678906594482,-0.0120540456243592,0.00114376751414447,0.105196317239547
NMR metabolomics,X23428.Concentration of VLDL Particles,GAD1,Glutamate decarboxylase 1,37482,-0.00382692703767581,0.002364084702789,-0.00846053305514225,0.00080667897979064,0.105519355282102
NMR metabolomics,X23428.Concentration of VLDL Particles,VIM,Vimentin,40042,0.0174317055159393,0.0107750837261241,-0.00368745858726385,0.0385508696191425,0.10573043717948
NMR metabolomics,X23428.Concentration of VLDL Particles,PI16,Peptidase inhibitor 16,37987,-0.00362592859501436,0.00224547310596668,-0.00802705588270906,0.000775198692680343,0.106383243520667
NMR metabolomics,X23428.Concentration of VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.00924164029530239,0.00572879163029499,-0.0019867913000758,0.0204700718906806,0.10672272515319
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFD,Vascular endothelial growth factor D,40483,-0.00488214208342479,0.00302693978831971,-0.0108149440685314,0.00105065990168185,0.106786572108883
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,40380,0.00695143056652695,0.00432157463230703,-0.00151885571279482,0.0154217168458487,0.107736533436359
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY2A,Pancreatic alpha-amylase,39695,0.00688497730585464,0.00429073975404892,-0.00152487261208125,0.0152948272237905,0.108599688798118
NMR metabolomics,X23428.Concentration of VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.00461661463847345,0.0028773635248852,-0.0102562471472484,0.00102301787030155,0.108632525115383
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK15,Kallikrein-15,37880,0.00747500123010796,0.00467121229327312,-0.00168057486470735,0.0166305773249233,0.109571702738624
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,39980,0.00672889416344448,0.00426114793975182,-0.0016229557984691,0.0150807441253581,0.11432727714429
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.00701332028647434,0.00445249849463677,-0.0157402173359624,0.00171357676301374,0.115247529466939
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6,Seizure protein 6 homolog,37572,-0.00449527189323164,0.00285620336075032,-0.0100934304803023,0.00110288669383899,0.115543310135962
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTN3,Myeloblastin,39897,-0.00671458074465589,0.00427594473840781,-0.0150954324319352,0.00166627094262341,0.116362299146632
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.019642917797921,0.0125538800923178,-0.0442485227788639,0.00496268718302188,0.11767921367602
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB116,Beta-defensin 116,37541,-0.0112968927720682,0.00722435276150854,-0.025456624184625,0.00286283864048853,0.117906607622676
NMR metabolomics,X23428.Concentration of VLDL Particles,SOX2,Transcription factor SOX-2,37937,0.00331457947744301,0.00212604012223593,-0.000852459162139423,0.00748161811702544,0.119010615261613
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRING1,SREBP regulating gene protein,37482,0.00819614316033348,0.00526695493513396,-0.00212708851252908,0.018519374833196,0.119698012596526
NMR metabolomics,X23428.Concentration of VLDL Particles,DENND2B,DENN domain-containing protein 2B,37562,-0.0074462380200271,0.00480123529189578,-0.0168566591921428,0.00196418315208863,0.120949678663277
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARB1,Scavenger receptor class B member 1,39961,0.00836262687621559,0.00540373330828972,-0.00222869040803226,0.0189539441604634,0.121747541669958
NMR metabolomics,X23428.Concentration of VLDL Particles,MSMB,Beta-microseminoprotein,40236,0.0097262070560421,0.00629221228776272,-0.00260652902797283,0.022058943140057,0.122184240249968
NMR metabolomics,X23428.Concentration of VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00362799766589045,0.00234706135514094,-0.000972242590185804,0.0082282379219667,0.12218625529728
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP290,Centrosomal protein of 290 kDa,37714,0.00751657242733578,0.00486285657872789,-0.00201462646697088,0.0170477713216424,0.122198164392929
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM3,Paralemmin-3,37562,0.0102341450309002,0.0066318902311002,-0.00276435982205619,0.0232326498838566,0.122813268697732
NMR metabolomics,X23428.Concentration of VLDL Particles,COL1A1,Collagen alpha-1(I) chain,40536,-0.00363177261666999,0.00236020949358448,-0.00825778322409558,0.00099423799075559,0.123884985455429
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP29,Dual specificity phosphatase 29,37572,-0.00935380759745764,0.00609249525706657,-0.0212950983013081,0.00258748310639284,0.12473428236128
NMR metabolomics,X23428.Concentration of VLDL Particles,ZPR1,Zinc finger protein ZPR1,37541,0.0136052191873784,0.00887732379315057,-0.00379433544719671,0.0310047738219535,0.12540325488608
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,40411,0.00377429898341306,0.00247156557377739,-0.00106996954119063,0.00861856750801675,0.126758862131668
NMR metabolomics,X23428.Concentration of VLDL Particles,CHIT1,Chitotriosidase-1,40398,0.0207217206520981,0.0135720368942426,-0.00587947166061733,0.0473229129648136,0.126831781492211
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00795592750346268,0.00521877996420659,-0.00227288122638223,0.0181847362333076,0.127412921961056
NMR metabolomics,X23428.Concentration of VLDL Particles,PLIN3,Perilipin-3,40359,0.00586289871122946,0.00385652407268569,-0.0016958884712345,0.0134216858936934,0.128466858903291
NMR metabolomics,X23428.Concentration of VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.0207534754005774,0.0136861760618697,-0.00607142968068724,0.0475783804818421,0.129442600688648
NMR metabolomics,X23428.Concentration of VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.00515866501537659,0.00340217724373447,-0.00150960238234297,0.0118269324130962,0.12946841594619
NMR metabolomics,X23428.Concentration of VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.0086971454728362,0.00578105041403912,-0.00263371333868048,0.0200280042843529,0.132492731553249
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.00550188682773276,0.00366362054549249,-0.00167880944143252,0.012682583096898,0.133182619490656
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF20B,Kinesin-like protein KIF20B,37541,0.0107021190934403,0.00713485739743021,-0.00328220140552291,0.0246864395924035,0.133644584782142
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00405907832850247,0.00271223236604901,-0.00125689710895358,0.00937505376595852,0.13452176438258
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_A,,37959,0.00443927142935713,0.0029800832272349,-0.00140169169602329,0.0102802345547375,0.13634047972888
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN1,Contactin-1,40536,-0.00372910456381582,0.00250836812502894,-0.00864550608887254,0.00118729696124091,0.137122758187819
NMR metabolomics,X23428.Concentration of VLDL Particles,HDAC8,Histone deacetylase 8,37598,0.00849468567047461,0.00571707200093977,-0.00271077545136734,0.0197001467923166,0.137343973519366
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.00956268397112688,0.00649072683549774,-0.0222845085687024,0.00315914062644868,0.140697806146245
NMR metabolomics,X23428.Concentration of VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00437046830885524,0.00297586127813453,-0.0102031564139989,0.00146221979628845,0.141954654151377
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3D,Protein FAM3D,37901,0.010991595919544,0.00749662880486184,-0.00370179653798517,0.0256849883770732,0.142615780078807
NMR metabolomics,X23428.Concentration of VLDL Particles,GKN1,Gastrokine-1,39602,0.00373037233114563,0.00254687878682205,-0.00126151009102558,0.00872225475331684,0.14302793214328
NMR metabolomics,X23428.Concentration of VLDL Particles,LAYN,Layilin,40192,-0.0045705215699798,0.0031292493549482,-0.0107038503056783,0.00156280716571867,0.144150474546124
NMR metabolomics,X23428.Concentration of VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,37628,0.00500183169646424,0.00342628030056785,-0.00171367769264874,0.0117173410855772,0.144357038009376
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.00975638928847567,0.00668493310602644,-0.00334607959933615,0.0228588581762875,0.14446187546889
NMR metabolomics,X23428.Concentration of VLDL Particles,CADPS,Calcium-dependent secretion activator 1,37572,-0.00598972452387344,0.00411687335542332,-0.0140587963005031,0.00207934725275627,0.145715122773246
NMR metabolomics,X23428.Concentration of VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00351315109500621,0.00242222964996875,-0.00123441901893254,0.00826072120894497,0.146976921440957
NMR metabolomics,X23428.Concentration of VLDL Particles,LPO,Lactoperoxidase,39831,-0.00781929705705885,0.00539646650413476,-0.018396371405163,0.00275777729104527,0.147367437161011
NMR metabolomics,X23428.Concentration of VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,37541,0.00814443305618098,0.00563813579377049,-0.00290631309960918,0.0191951792119711,0.148615042826576
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.00565415968308086,0.00391774131903907,-0.0133329326683974,0.00202461330223573,0.14897844400161
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK4,Kallikrein-4,40489,-0.00798230050131716,0.00553243098130974,-0.0188258652246842,0.00286126422204993,0.149090794070207
NMR metabolomics,X23428.Concentration of VLDL Particles,RGS8,Regulator of G-protein signaling 8,40044,0.0087174896652623,0.00605340455138475,-0.0031471832554518,0.0205821625859764,0.149860038645256
NMR metabolomics,X23428.Concentration of VLDL Particles,YY1,Transcriptional repressor protein YY1,37598,0.00368418842979675,0.00256643534287323,-0.00134602484223478,0.00871440170182828,0.151160638881048
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF75D,Zinc finger protein 75D,37714,0.0077693392117827,0.00542921220045052,-0.00287191670110031,0.0184105951246657,0.152446569329174
NMR metabolomics,X23428.Concentration of VLDL Particles,CDK1,Cyclin-dependent kinase 1,37482,0.00478022759550083,0.00334511261457624,-0.00177619312906861,0.0113366483200703,0.15302290669213
NMR metabolomics,X23428.Concentration of VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.00902185685635039,0.00631655487391927,-0.00335859069653137,0.0214023044092322,0.15322923921083
NMR metabolomics,X23428.Concentration of VLDL Particles,FRMD7,FERM domain-containing protein 7,37572,0.0043432583891818,0.00304203878281384,-0.00161913762513333,0.0103056544034969,0.153388811646741
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00900301152964842,0.00633821064317184,-0.00341988133096838,0.0214259043902652,0.155504803997897
NMR metabolomics,X23428.Concentration of VLDL Particles,CCNE1,G1/S-specific cyclin-E1,37598,0.0121037226559769,0.00856067811625303,-0.00467520645187905,0.0288826517638328,0.157422497479981
NMR metabolomics,X23428.Concentration of VLDL Particles,GUCA2A,Guanylin,40276,-0.0042991381774632,0.00304527107405919,-0.0102678694826192,0.00166959312769282,0.158045498060487
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.00342349705107002,0.00242733409634587,-0.00133407777776788,0.00818107187990792,0.158443095284644
NMR metabolomics,X23428.Concentration of VLDL Particles,SHPK,Sedoheptulokinase,37714,-0.00551535271575301,0.0039114144176703,-0.0131817249743868,0.00215101954288078,0.158543629591293
NMR metabolomics,X23428.Concentration of VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.00657886002627218,0.00466764760255047,-0.0157274493272711,0.00256972927472674,0.158723075581225
NMR metabolomics,X23428.Concentration of VLDL Particles,LY6D,Lymphocyte antigen 6D,40268,0.00476728093917071,0.00339847432173698,-0.00189372873143377,0.0114282906097752,0.160704791272246
NMR metabolomics,X23428.Concentration of VLDL Particles,OPTC,Opticin,40305,0.00574675340238779,0.00410289483710133,-0.00229492047833081,0.0137884272831064,0.161335872919006
NMR metabolomics,X23428.Concentration of VLDL Particles,NRN1,Neuritin,37959,-0.00466626375461579,0.00333905772749446,-0.0112108169005049,0.00187828939127336,0.162292467160443
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,37990,-0.00492458782195298,0.00353430527179606,-0.0118518261546733,0.00200265051076731,0.163531416276387
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00458203750280554,0.0032955352751758,-0.00187721163653903,0.0110412866421501,0.164437914418872
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.00552827056190753,0.00398184813762179,-0.00227615178783118,0.0133326929116462,0.165047909315182
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.021889729890624,0.0158105075134416,-0.0528783246169695,0.00909886483572141,0.166226786026707
NMR metabolomics,X23428.Concentration of VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00616723364006077,0.00448340101133831,-0.0149546996222839,0.00262023234216232,0.168978183199465
NMR metabolomics,X23428.Concentration of VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.00984910254696543,0.00716848750603333,-0.0042011329648599,0.0238993380587908,0.169482447201327
NMR metabolomics,X23428.Concentration of VLDL Particles,OSM,Oncostatin-M,40268,0.0090220837976964,0.00659760884410411,-0.00390922953674766,0.0219533971321405,0.171495014808256
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.00530697578841485,0.00388764689354958,-0.00231281212294233,0.012926763699772,0.172244938474877
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD3,Extracellular superoxide dismutase,37987,-0.00733890923130995,0.00539033078313478,-0.0179039575662541,0.00322613910363422,0.173379927263525
NMR metabolomics,X23428.Concentration of VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.00407135269731751,0.00301994139415895,-0.00999043782986905,0.00184773243523404,0.177627294133922
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,40341,0.00559801835902744,0.00415344103394679,-0.00254272606750828,0.0137387627855632,0.177741117892248
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00719484705393547,0.00535328609247504,-0.00329759368731561,0.0176872877951865,0.178969735844742
NMR metabolomics,X23428.Concentration of VLDL Particles,CA8,Carbonic anhydrase-related protein,37598,-0.00341224992036444,0.00254235049802144,-0.00839525689648647,0.0015707570557576,0.179566182648275
NMR metabolomics,X23428.Concentration of VLDL Particles,LIFR,Leukemia inhibitory factor receptor,40341,-0.00298031335506315,0.00222773507710565,-0.00734667410619023,0.00138604739606394,0.180973562932765
NMR metabolomics,X23428.Concentration of VLDL Particles,TAP1,Antigen peptide transporter 1,37714,-0.00752326127282538,0.00562720873063705,-0.018552590384874,0.00350606783922323,0.181263946347248
NMR metabolomics,X23428.Concentration of VLDL Particles,MSLNL,Mesothelin-like protein,37572,-0.00459382578965575,0.00343679729005728,-0.011329948478168,0.00214229689885652,0.181357171466039
NMR metabolomics,X23428.Concentration of VLDL Particles,RTKN2,Rhotekin-2,37562,-0.00642667683948756,0.00481965362354755,-0.0158731979416408,0.00301984426266564,0.182413484842499
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.00622724216498215,0.00468301891108143,-0.00295147490073745,0.0154059592307017,0.183620344667898
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00603587323246494,0.00455003897806055,-0.00288220316453373,0.0149539496294636,0.18467934472377
NMR metabolomics,X23428.Concentration of VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",37942,0.00732282573571988,0.00552727183672099,-0.00351062706425326,0.018156278535693,0.185242169343567
NMR metabolomics,X23428.Concentration of VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.00318641591396213,0.00240658279237181,-0.00153048635908662,0.00790331818701088,0.185508261436774
NMR metabolomics,X23428.Concentration of VLDL Particles,DCN,Decorin,40042,-0.0027453811316342,0.00207431894178631,-0.00681104625753538,0.00132028399426698,0.185685358038115
NMR metabolomics,X23428.Concentration of VLDL Particles,AMPD3,AMP deaminase 3,37942,0.0087200037488364,0.00660363613785151,-0.00422312308135257,0.0216631305790254,0.18669547827885
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.0025095112931542,0.00190115729540665,-0.00623577959215124,0.00121675700584284,0.186857267847823
NMR metabolomics,X23428.Concentration of VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00604827385414824,0.00458498096651981,-0.00293828884023059,0.0150348365485271,0.187143369323883
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB118,Beta-defensin 118,37541,0.00701855908649335,0.00532173139509111,-0.00341203444788522,0.0174491526208719,0.187242737941277
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR1,Cadherin-related family member 1,39961,0.0052823340077983,0.00400601511034351,-0.00256945560847498,0.0131341236240716,0.187322137552804
NMR metabolomics,X23428.Concentration of VLDL Particles,SHH,Sonic hedgehog protein,37598,-0.00523502747734386,0.00397154327711241,-0.0130192523004842,0.00254919734579646,0.187481655868115
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00227890857549234,0.00173148693526443,-0.00111480581762594,0.00567262296861062,0.188143613383877
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.00591680194969715,0.00449730408332044,-0.0147315179530052,0.00289791405361091,0.188316184540031
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00389380411073936,0.0029716941291256,-0.00193071638234681,0.00971832460382553,0.190118086504074
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN4,Prefoldin subunit 4,37482,0.00651181869749877,0.00497015387757122,-0.00322968290254082,0.0162533202975384,0.190156515205193
NMR metabolomics,X23428.Concentration of VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00304157997440455,0.00233560178722975,-0.00761935947737485,0.00153619952856575,0.1928477308377
NMR metabolomics,X23428.Concentration of VLDL Particles,IL19,Interleukin-19,39924,0.00803359852040962,0.00617271993576059,-0.00406493255368114,0.0201321295945004,0.193117631202396
NMR metabolomics,X23428.Concentration of VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",37562,0.00747888853171291,0.00574895800450301,-0.00378906915711299,0.0187468462205388,0.193311437881446
NMR metabolomics,X23428.Concentration of VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,37572,0.00427565755578879,0.00329249835473663,-0.00217763921949501,0.0107289543310726,0.194102060395296
NMR metabolomics,X23428.Concentration of VLDL Particles,TFRC,Transferrin receptor protein 1,40391,-0.00466159421826751,0.00359406945455562,-0.0117059703491965,0.00238278191266151,0.194641715026747
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN4,Contactin-4,40332,-0.00286500451269428,0.00221065419846105,-0.00719788674167793,0.00146787771628937,0.194994839061321
NMR metabolomics,X23428.Concentration of VLDL Particles,IL5,Interleukin-5,40044,0.0171999640795007,0.0132831791414887,-0.00883506703781718,0.0432349951968185,0.195384930622546
NMR metabolomics,X23428.Concentration of VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.00460768356412144,0.00356221973738543,-0.0115896342493969,0.002374267121154,0.195865598686702
NMR metabolomics,X23428.Concentration of VLDL Particles,RLN2,Prorelaxin H2,37643,0.0166245952165368,0.0128536200664757,-0.00856850011375547,0.0418176905468292,0.195902847764659
NMR metabolomics,X23428.Concentration of VLDL Particles,RALB,Ras-related protein Ral-B,37598,0.0034923775498488,0.0027054806571144,-0.00181036453809543,0.00879511963779304,0.196777390830333
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00452576852500799,0.00350636065945434,-0.00234669836752251,0.0113982354175385,0.196819720281321
NMR metabolomics,X23428.Concentration of VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.00887390336841903,0.00690145983422315,-0.00465295790665834,0.0224007646434964,0.198535297472533
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53BP1,TP53-binding protein 1,37598,0.0104402986367617,0.00812471698925778,-0.00548414666218359,0.0263647439357069,0.198813319143036
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTN4,Alpha-actinin-4,40044,0.0038002664065255,0.00295822103060734,-0.00199784681346489,0.00959837962651589,0.198935149436781
NMR metabolomics,X23428.Concentration of VLDL Particles,PAPPA,Pappalysin-1,40044,0.00548496352680623,0.00428127878317893,-0.00290634288822447,0.0138762699418369,0.200159774668619
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A3,Protein S100-A3,37900,0.00535609071687409,0.0041893739289605,-0.0028550821838885,0.0135672636176367,0.201097254761214
NMR metabolomics,X23428.Concentration of VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,40305,-0.00522597092445949,0.00408815404814656,-0.0132387528588267,0.00278681100990776,0.201155175089348
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,37998,0.00246227877669397,0.00192961905868055,-0.0013197745783199,0.00624433213170785,0.20196185263476
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL6,Fc receptor-like protein 6,40341,0.00783720087618366,0.00614369539167302,-0.00420444209149546,0.0198788438438628,0.202098158645368
NMR metabolomics,X23428.Concentration of VLDL Particles,EPO,Erythropoietin,40341,-0.00905619645979521,0.00712172954272181,-0.0230147863635299,0.00490239344393953,0.203523648421224
NMR metabolomics,X23428.Concentration of VLDL Particles,C9orf40,Uncharacterized protein C9orf40,37901,-0.00951836170439378,0.00750931848988219,-0.0242366259445629,0.00519990253577531,0.204984208986966
NMR metabolomics,X23428.Concentration of VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00634584167431447,0.00500930741269579,-0.00347240085456928,0.0161640842031982,0.205245708644544
NMR metabolomics,X23428.Concentration of VLDL Particles,MTR,Methionine synthase,37562,0.0075757015374468,0.00598681898504594,-0.00415846367324323,0.0193098667481368,0.205751613714951
NMR metabolomics,X23428.Concentration of VLDL Particles,IL24,Interleukin-24,40044,0.00568226939624826,0.00449190036824874,-0.00312185532551928,0.0144863941180158,0.205889001978495
NMR metabolomics,X23428.Concentration of VLDL Particles,GUK1,Guanylate kinase,37562,-0.00464420223965786,0.00367365647313963,-0.0118445689270115,0.00255616444769581,0.206184074187017
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS4,Galectin-4,40357,-0.00605692014532461,0.00479779314816471,-0.0154605947157274,0.00334675442507821,0.206809450703522
NMR metabolomics,X23428.Concentration of VLDL Particles,GLI2,Zinc finger protein GLI2,37598,-0.00388211859945579,0.00307651029492334,-0.00991207877750553,0.00214784157859395,0.20702233689
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC12A2,Solute carrier family 12 member 2,37562,-0.00329811198567214,0.00261557995830754,-0.00842464870395491,0.00182842473261064,0.20734979182396
NMR metabolomics,X23428.Concentration of VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,37541,0.00498093450264619,0.00396749527358909,-0.00279535623358843,0.0127572252388808,0.209343112465946
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.00523969349228093,0.00417863815659046,-0.00295043729463638,0.0134298242791982,0.209892091672208
NMR metabolomics,X23428.Concentration of VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00415796714964667,0.00331661121371536,-0.00234259082923544,0.0106585251285288,0.209980853436736
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP350,Centrosome-associated protein 350,37482,0.00429284858709463,0.00342756088927538,-0.00242517075588511,0.0110108679300744,0.210428420299146
NMR metabolomics,X23428.Concentration of VLDL Particles,TAGLN3,Transgelin-3,37482,-0.00697730428204495,0.00557884087232058,-0.0179118323917933,0.00395722382770339,0.211076352082786
NMR metabolomics,X23428.Concentration of VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.00641828370582393,0.00514432604382757,-0.00366459534007811,0.016501162751726,0.21218338651479
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR1,TGF-beta receptor type-1,37598,0.00245485004948533,0.00196815267034309,-0.00140272918438712,0.00631242928335779,0.212314723692639
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,0.00309052007946349,0.00249641654354622,-0.00180245634588709,0.00798349650481408,0.215740888910207
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN3,Neuronal-specific septin-3,37959,-0.00828429357138407,0.00671936086161538,-0.0214542408601502,0.00488565371738207,0.217634890098313
NMR metabolomics,X23428.Concentration of VLDL Particles,DUOX2,Dual oxidase 2,40042,0.00809907415958727,0.00660019913350056,-0.00483731614207382,0.0210354644612484,0.219805257143749
NMR metabolomics,X23428.Concentration of VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00969765645773983,0.00791999771223642,-0.00582553905824356,0.0252208519737232,0.220803775986537
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00335686596173819,0.0027605761120876,-0.00876759514142989,0.00205386321795351,0.224006204356813
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTA2,"Actin, aortic smooth muscle",40042,-0.00482766678394469,0.00397358741930741,-0.0126158981257872,0.00296056455789783,0.224407713766008
NMR metabolomics,X23428.Concentration of VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00406608400937705,0.00336771047378424,-0.00253462851924006,0.0106667965379942,0.227310144448628
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD4,Sushi domain-containing protein 4,37900,0.00491134468392503,0.00406837060338516,-0.00306266169870988,0.0128853510665599,0.227375635083762
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA4,Ephrin type-A receptor 4,37671,0.00309014590372496,0.00256937737994264,-0.00194583376096262,0.00812612556841254,0.229120645174977
NMR metabolomics,X23428.Concentration of VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.00451590970716558,0.00376950944521902,-0.0119041482197949,0.0028723288054637,0.230934847751414
NMR metabolomics,X23428.Concentration of VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.0053663743458218,0.0044800982595488,-0.0141473669345374,0.00341461824289385,0.231006734823007
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,37572,0.0110743798275981,0.00928074770819149,-0.00711588568045726,0.0292646453356534,0.232787671124809
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00549184069102085,0.00461150553919633,-0.0145303915478457,0.00354671016580396,0.233714645189504
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB5,Serpin B5,40042,-0.00528729665252142,0.0044426436654086,-0.0139948782367223,0.00342028493167943,0.23401579858799
NMR metabolomics,X23428.Concentration of VLDL Particles,TEX101,Testis-expressed protein 101,37572,0.0042730245928945,0.00359085345979567,-0.00276504818830501,0.011311097374094,0.234077887640654
NMR metabolomics,X23428.Concentration of VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00395595369357029,0.00332955490441542,-0.0104818813062245,0.00256997391908393,0.234802713528361
NMR metabolomics,X23428.Concentration of VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.0043047262973104,0.00363426612697775,-0.00281843531156599,0.0114278879061868,0.23624280606482
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX2,Peroxiredoxin-2,37763,-0.006768403407671,0.00572253967249331,-0.0179845811657579,0.00444777435041589,0.236924544781965
NMR metabolomics,X23428.Concentration of VLDL Particles,GSN,Gelsolin,37928,0.00204873807036418,0.00173396626804731,-0.00134983581500856,0.00544731195573691,0.237411969720277
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP9,Matrix metalloproteinase-9,40312,-0.00653258823977232,0.00555914367638791,-0.0174285098454926,0.00436333336594798,0.239969581161515
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPN3,Calpain-3,37900,0.00397908868699063,0.00338675726905871,-0.00265895556036445,0.0106171329343457,0.240056996375453
NMR metabolomics,X23428.Concentration of VLDL Particles,CD200,OX-2 membrane glycoprotein,40341,0.00277676729662301,0.00236607949455206,-0.00186074851269902,0.00741428310594505,0.240583643898378
NMR metabolomics,X23428.Concentration of VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.00703969706332698,0.00602295570369749,-0.0188446902425741,0.00476529611592011,0.242501011003394
NMR metabolomics,X23428.Concentration of VLDL Particles,LY96,Lymphocyte antigen 96,40228,-0.00368380334830416,0.00316029539340452,-0.00987798231937701,0.00251037562276869,0.243772963464738
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR2,Toll-like receptor 2,37714,0.00243735767565362,0.0020975336770496,-0.00167380833136361,0.00654852368267084,0.245251817142674
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH22,Cadherin-22,37714,-0.00311127099920686,0.00269046647038289,-0.00838458528115732,0.0021620432827436,0.247536045511479
NMR metabolomics,X23428.Concentration of VLDL Particles,PCNA,Proliferating cell nuclear antigen,37482,0.0066072155193121,0.00571816221828854,-0.00460038242853344,0.0178148134671577,0.247915575190813
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,0.00406622183513668,0.00352308385056917,-0.00283902251197889,0.0109714661822523,0.248449682940576
NMR metabolomics,X23428.Concentration of VLDL Particles,MN1,Transcriptional activator MN1,37572,-0.00629077805636536,0.00545392712079751,-0.0169804752131285,0.00439891910039776,0.248750816511448
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMA1,Proteasome subunit alpha type-1,39980,-0.00485568472706938,0.00424046122953836,-0.0131669887369646,0.0034556192828258,0.252191970117572
NMR metabolomics,X23428.Concentration of VLDL Particles,BEX3,Protein BEX3,37482,-0.00499964305716738,0.00436824268536268,-0.0135613987204782,0.00356211260614347,0.252419399972699
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00552568816126933,0.00482898304671738,-0.0149904949328354,0.00393911861029672,0.252530191346875
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.00418007516427165,0.00366183208730823,-0.0113572660553958,0.00299711572685249,0.253668602852481
NMR metabolomics,X23428.Concentration of VLDL Particles,CDAN1,Codanin-1,37942,0.0024084570964145,0.0021159195140812,-0.00173874515118464,0.00655565934401365,0.255034009915801
NMR metabolomics,X23428.Concentration of VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00463354283817847,0.00408233107947424,-0.012634911753948,0.00336782607759104,0.256386234679122
NMR metabolomics,X23428.Concentration of VLDL Particles,JCHAIN,Immunoglobulin J chain,40044,-0.00635074896118249,0.00562280377853876,-0.0173714443671185,0.00466994644475347,0.258719934887677
NMR metabolomics,X23428.Concentration of VLDL Particles,PROK1,Prokineticin-1,40341,-0.00707686371124857,0.00626626149539038,-0.0193587362422137,0.00520500881971658,0.258763141421454
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.00787052701122372,0.00698994694383512,-0.0215708230211406,0.00582976899869312,0.26019220105849
NMR metabolomics,X23428.Concentration of VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.00666265155750631,0.00592682519852391,-0.00495392583160056,0.0182792289466132,0.260968674236164
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC44A4,Choline transporter-like protein 4,37572,-0.00713620729236159,0.00640485105718802,-0.0196897153644501,0.00541730077972693,0.265219012714132
NMR metabolomics,X23428.Concentration of VLDL Particles,COPE,Coatomer subunit epsilon,39961,0.00486000762270713,0.00440558522562256,-0.00377493941951309,0.0134949546649274,0.269980499323648
NMR metabolomics,X23428.Concentration of VLDL Particles,NLGN2,Neuroligin-2,37541,-0.00485294309562067,0.00441124482149502,-0.0134989829457509,0.00379309675450956,0.271295684157622
NMR metabolomics,X23428.Concentration of VLDL Particles,PSCA,Prostate stem cell antigen,37901,0.0259953956852949,0.0237026184709072,-0.0204617365176833,0.0724525278882731,0.2727786519087
NMR metabolomics,X23428.Concentration of VLDL Particles,MATN3,Matrilin-3,40203,-0.00311122943658496,0.00284691911062057,-0.00869119089340128,0.00246873202023136,0.27448040628555
NMR metabolomics,X23428.Concentration of VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.00796888022401865,0.00729277400118878,-0.00632495681831136,0.0222627172663487,0.274538445295204
NMR metabolomics,X23428.Concentration of VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.00568307008389414,0.00522388662140376,-0.00455574769405722,0.0159218878618455,0.276655415431616
NMR metabolomics,X23428.Concentration of VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.0050221342904441,0.00462601347146118,-0.0040448521136198,0.014089120694508,0.277663256915565
NMR metabolomics,X23428.Concentration of VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00572792286945652,0.00529702807264603,-0.0046542521529297,0.0161100978918427,0.279563014117298
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,0.00259065416435177,0.00240426425136175,-0.00212170376831726,0.00730301209702081,0.281262309060019
NMR metabolomics,X23428.Concentration of VLDL Particles,TSLP,Thymic stromal lymphopoietin,40042,0.00595233064920847,0.00554545611762152,-0.0049167633413297,0.0168214246397466,0.283121395638388
NMR metabolomics,X23428.Concentration of VLDL Particles,ABO,Histo-blood group ABO system transferase,37987,0.0140955512147132,0.0131518334900342,-0.0116820424257539,0.0398731448551803,0.283848929160691
NMR metabolomics,X23428.Concentration of VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00374661366246405,0.00350030152190604,-0.0106072046453999,0.00311397732047179,0.284473026892369
NMR metabolomics,X23428.Concentration of VLDL Particles,DCLRE1C,Protein artemis,37482,-0.00310223824352114,0.0029040718250062,-0.00879421902053329,0.00258974253349101,0.285433211416094
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00319904409905851,0.00299554266192889,-0.00267221951832212,0.00907030771643914,0.285566482714762
NMR metabolomics,X23428.Concentration of VLDL Particles,CD27,CD27 antigen,40411,-0.00394296981398662,0.00369986357977722,-0.01119470243035,0.00330876280237673,0.286572320571603
NMR metabolomics,X23428.Concentration of VLDL Particles,PODXL2,Podocalyxin-like protein 2,40411,0.00263683360581259,0.0024821023704172,-0.00222808704020511,0.00750175425183029,0.288097989971582
NMR metabolomics,X23428.Concentration of VLDL Particles,CDSN,Corneodesmosin,40456,0.00415371073909999,0.00392509339557991,-0.00353947231623663,0.0118468937944366,0.289959700216292
NMR metabolomics,X23428.Concentration of VLDL Particles,VCAN,Versican core protein,40471,-0.00289299369369128,0.00273386995600165,-0.00825137880745451,0.00246539142007196,0.289978142781557
NMR metabolomics,X23428.Concentration of VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00793097355596931,0.00752835829383355,-0.0226865558118831,0.00682460869994444,0.292140455517281
NMR metabolomics,X23428.Concentration of VLDL Particles,NLGN1,Neuroligin-1,37572,-0.00670013534839973,0.00637159408054174,-0.0191884597462616,0.00578818904946208,0.293019259127547
NMR metabolomics,X23428.Concentration of VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.00875136983740379,0.00836193733108911,-0.00763802733153087,0.0251407670063385,0.295316075326287
NMR metabolomics,X23428.Concentration of VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,37714,0.00739032550353922,0.00709137827715845,-0.00650877591969133,0.0212894269267698,0.297358154414364
NMR metabolomics,X23428.Concentration of VLDL Particles,RELB,Transcription factor RelB,37598,0.00488317245171079,0.0047122584970229,-0.00435285420245409,0.0141191991058757,0.300095225243287
NMR metabolomics,X23428.Concentration of VLDL Particles,ANK2,Ankyrin-2,37562,0.00703692741766128,0.00679265547294632,-0.0062766773093135,0.0203505321446361,0.300239358626189
NMR metabolomics,X23428.Concentration of VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,37482,0.00317405264777523,0.00307193359623966,-0.0028469372008545,0.00919504249640496,0.301509559399094
NMR metabolomics,X23428.Concentration of VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.00397031845957582,0.00388511712960244,-0.00364451111444495,0.0115851480335966,0.306832248243379
NMR metabolomics,X23428.Concentration of VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.00687623903986181,0.00673123583720062,-0.020069461280775,0.00631698320105141,0.307016430616649
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1A,Interleukin-1 alpha,40044,0.00499548682703288,0.00490529399893254,-0.0046188894108749,0.0146098630649407,0.308509957739978
NMR metabolomics,X23428.Concentration of VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.00534650267587739,0.0052727283460661,-0.00498804488241216,0.0156810502341669,0.310605465174719
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD2,Bromodomain-containing protein 2,37541,0.00319696098568971,0.00315477066511988,-0.00298638951794525,0.00938031148932468,0.310900524695303
NMR metabolomics,X23428.Concentration of VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.00396440167848169,0.00392063213657518,-0.00372003730920566,0.011648840666169,0.311956638402584
NMR metabolomics,X23428.Concentration of VLDL Particles,EVI2B,Protein EVI2B,37482,0.00389531491438982,0.00385357466487462,-0.00365769142876444,0.0114483212575441,0.312115822058812
NMR metabolomics,X23428.Concentration of VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.0027219776383357,0.00269345082411565,-0.00800114125360237,0.00255718597693097,0.312227499472725
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,40042,0.00303635576690486,0.00300730107714842,-0.00285795434430604,0.00893066587811576,0.312673219433357
NMR metabolomics,X23428.Concentration of VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.00343876184074521,0.00341889607004389,-0.00326227445654081,0.0101397981380312,0.314524737337225
NMR metabolomics,X23428.Concentration of VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,37959,0.0030826292826773,0.00308372877130391,-0.00296147910907836,0.00912673767443296,0.31750099336241
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00386678028275919,0.00390042052202724,-0.00377804394041419,0.0115116045059326,0.32152063853748
NMR metabolomics,X23428.Concentration of VLDL Particles,KLHL41,Kelch-like protein 41,37959,0.00428037889755863,0.00432873349586185,-0.00420393875433059,0.0127646965494479,0.322764335591755
NMR metabolomics,X23428.Concentration of VLDL Particles,FBLN2,Fibulin-2,37998,-0.00277661002312235,0.0028106149091264,-0.00828541524501009,0.00273219519876538,0.323218651214198
NMR metabolomics,X23428.Concentration of VLDL Particles,SPESP1,Sperm equatorial segment protein 1,37990,0.00248490739622949,0.00251589632972079,-0.00244624941002327,0.00741606420248224,0.323325698722187
NMR metabolomics,X23428.Concentration of VLDL Particles,NEB,Nebulin,37562,0.00328335148382115,0.00333151917892129,-0.00324642610686459,0.00981312907450688,0.324376186549214
NMR metabolomics,X23428.Concentration of VLDL Particles,IL21R,Interleukin-21 receptor,37598,0.00503613958246058,0.00511944157405049,-0.00499796590267837,0.0150702450675995,0.325267222962566
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP1,Methionine aminopeptidase 1,39961,0.00275412389948637,0.00280002040022939,-0.00273391608496324,0.00824216388393598,0.325323382216791
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.00200768435658485,0.00204459714558912,-0.00199972604876984,0.00601509476193953,0.326144434294872
NMR metabolomics,X23428.Concentration of VLDL Particles,TNXB,Tenascin-X,40332,-0.00227460893220169,0.00231705046165115,-0.00681602783703795,0.00226680997263457,0.326271023350785
NMR metabolomics,X23428.Concentration of VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.00856252296418074,0.00872580844602606,-0.0256651075183918,0.00854006159003035,0.326469418628578
NMR metabolomics,X23428.Concentration of VLDL Particles,DCUN1D2,DCN1-like protein 2,37482,0.00721924120404333,0.0073974010354256,-0.00727966482539086,0.0217181472334775,0.329124265295722
NMR metabolomics,X23428.Concentration of VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00287695702673047,0.00297145264649734,-0.00294709016040432,0.00870100421386526,0.332962959954456
NMR metabolomics,X23428.Concentration of VLDL Particles,NENF,Neudesin,37900,0.00951540095595081,0.00987454435019313,-0.00983870597042772,0.0288695078823293,0.335249103317109
NMR metabolomics,X23428.Concentration of VLDL Particles,TP73,Tumor protein p73,37572,0.00306634042162074,0.00319646122533986,-0.0031987235800454,0.00933140442328687,0.337429225190775
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00678549857240627,0.00709588579500754,-0.020693434730621,0.0071224375858085,0.338959020881359
NMR metabolomics,X23428.Concentration of VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.00506818124732014,0.00530575385324617,-0.00533109630504235,0.0154674587996826,0.339479277538224
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY2B,Alpha-amylase 2B,39311,0.00418261424380782,0.00438868022656493,-0.00441919900025944,0.0127844274878751,0.34058225462908
NMR metabolomics,X23428.Concentration of VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.0024434898332611,0.00257508827191323,-0.00260368317968883,0.00749066284621104,0.34269117496024
NMR metabolomics,X23428.Concentration of VLDL Particles,ADA2,Adenosine deaminase 2,40258,0.00361325969243754,0.00380998471313623,-0.00385431034530947,0.0110808297301846,0.342957697173068
NMR metabolomics,X23428.Concentration of VLDL Particles,ENG,Endoglin,40536,-0.00146885193073729,0.00154885294914143,-0.00450460371105449,0.00156689984957992,0.342966460839573
NMR metabolomics,X23428.Concentration of VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00555951119334252,0.00586835234953715,-0.0170614817984353,0.00594245941175029,0.343466953455575
NMR metabolomics,X23428.Concentration of VLDL Particles,DPEP1,Dipeptidase 1,40192,-0.00434905537559193,0.00462773684296459,-0.0134194195878025,0.00472130883661867,0.347344747381715
NMR metabolomics,X23428.Concentration of VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00580508267011855,0.00620317978537462,-0.0063531497092157,0.0179633150494528,0.349381005805049
NMR metabolomics,X23428.Concentration of VLDL Particles,IL25,Interleukin-25,37429,0.00296979823499716,0.00319281980029408,-0.00328812857357924,0.00922772504357356,0.352311230878811
NMR metabolomics,X23428.Concentration of VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.00249645827216708,0.00269215771272115,-0.00278017084476638,0.00777308738910055,0.353783377804254
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.00419428598275819,0.0045324539838966,-0.0130778957911955,0.00468932382567915,0.354777305108611
NMR metabolomics,X23428.Concentration of VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00693348483308159,0.00752519424664525,-0.0216828655565063,0.0078158958903431,0.356874281111623
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP13,Collagenase 3,39961,-0.00276284499943083,0.00300449267548241,-0.00865165064337636,0.0031259606445147,0.357811173225446
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.00352665221935165,0.00384531281863647,-0.00401016090517583,0.0110634653438791,0.359091282317024
NMR metabolomics,X23428.Concentration of VLDL Particles,HMBS,Porphobilinogen deaminase,40489,0.00378191138948227,0.00413393740575761,-0.00432060592580264,0.0118844287047672,0.360286835091195
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.0039847485313571,0.00436386165796326,-0.0045684203182509,0.0125379173809651,0.361193491694252
NMR metabolomics,X23428.Concentration of VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.00530827534158595,0.00581357242431512,-0.00608632661007169,0.0167028772932436,0.36121560051412
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.00243590728600406,0.00268018218161991,-0.00281724978997097,0.00768906436197909,0.363438257317341
NMR metabolomics,X23428.Concentration of VLDL Particles,RAP1A,Ras-related protein Rap-1A,37598,0.00577714260799755,0.00637173428391612,-0.00671145658847805,0.0182657418044732,0.364591119681251
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A16,Protein S100-A16,39934,-0.00513418229950342,0.00566569711620964,-0.0162389486472743,0.00597058404826747,0.364850870699122
NMR metabolomics,X23428.Concentration of VLDL Particles,DCUN1D1,DCN1-like protein 1,37541,-0.00617993364648223,0.00682944485282121,-0.0195656455580118,0.00720577826504735,0.36553742726154
NMR metabolomics,X23428.Concentration of VLDL Particles,CGN,Cingulin,37572,0.00345389673619758,0.00383685865910171,-0.00406634623564176,0.0109741397080369,0.368036370912348
NMR metabolomics,X23428.Concentration of VLDL Particles,RYR1,Ryanodine receptor 1,37562,-0.00284071386708109,0.00316144535010376,-0.00903714675328446,0.00335571901912228,0.368909384281665
NMR metabolomics,X23428.Concentration of VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.0047109757261784,0.00526331767946739,-0.0150270783779345,0.00560512692557769,0.370772502605614
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM171A2,Protein FAM171A2,37959,0.0130953336352681,0.0146620997595437,-0.0156423818934374,0.0418330491639737,0.371797172518243
NMR metabolomics,X23428.Concentration of VLDL Particles,CD177,CD177 antigen,40316,-0.010290701881031,0.0116217698706364,-0.0330693708274783,0.0124879670654163,0.375917851949815
NMR metabolomics,X23428.Concentration of VLDL Particles,ACHE,Acetylcholinesterase,37671,-0.00257628240962217,0.00291161661613125,-0.00828305097723942,0.00313048615799508,0.376265035490636
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00368731717869742,0.00419252195562916,-0.0119046602117306,0.00453002585433573,0.379147139554327
NMR metabolomics,X23428.Concentration of VLDL Particles,PRG3,Proteoglycan 3,37998,0.00400997520755691,0.00456502413582997,-0.00493747209866984,0.0129574225137836,0.379735371412456
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00330452616795489,0.00376692762812817,-0.0106877043190861,0.00407865198317633,0.380368537792197
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSG1,Tryptase gamma,37598,0.00217843662277748,0.00249479334379924,-0.00271135833106903,0.00706823157662399,0.382573721332208
NMR metabolomics,X23428.Concentration of VLDL Particles,EXOSC10,Exosome component 10,37562,0.00500728814886061,0.00574754634257995,-0.00625790268259609,0.0162724789803173,0.383658464685312
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD5,Sushi domain-containing protein 5,37604,-0.00271582037097127,0.00312040854890899,-0.00883182112683288,0.00340018038489034,0.384129810718253
NMR metabolomics,X23428.Concentration of VLDL Particles,LEG1,Protein LEG1 homolog,37231,-0.00551665681632122,0.00635515887381605,-0.0179727682090007,0.00693945457635824,0.385377994374297
NMR metabolomics,X23428.Concentration of VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.00161907075557548,0.00186687544351727,-0.00527814662486934,0.00204000511371837,0.385814082759769
NMR metabolomics,X23428.Concentration of VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.00455819829282125,0.00526164970462326,-0.0148710317138828,0.00575463512824034,0.386338299435501
NMR metabolomics,X23428.Concentration of VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.0099431573380292,0.0115253919132267,-0.0126466108118951,0.0325329254879535,0.388306130024957
NMR metabolomics,X23428.Concentration of VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.00942583640641902,0.0109316848997647,-0.0120002659971199,0.0308519388099579,0.388566180043518
NMR metabolomics,X23428.Concentration of VLDL Particles,DDI2,Protein DDI1 homolog 2,37671,0.00612614964750679,0.00712755009613825,-0.00784384854092419,0.0200961478359378,0.39007873249318
NMR metabolomics,X23428.Concentration of VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.00346765078755613,0.00403764666192726,-0.0113814382449336,0.00444613666982131,0.390450192761027
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYBB2,Beta-crystallin B2,37942,-0.00536740834095409,0.0062645371622909,-0.0176459011790442,0.00691108449713607,0.391574801148711
NMR metabolomics,X23428.Concentration of VLDL Particles,CORO6,Coronin-6,37541,-0.0028417914890978,0.00332762631547528,-0.00936393906742934,0.00368035608923374,0.393120848817046
NMR metabolomics,X23428.Concentration of VLDL Particles,CTNNA1,Catenin alpha-1,37541,-0.00281523115307374,0.0033133027802842,-0.00930930460243077,0.0036788422962833,0.395521239136641
NMR metabolomics,X23428.Concentration of VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00214996094415168,0.00253055682060646,-0.00710985231254035,0.00280993042423699,0.395562555585879
NMR metabolomics,X23428.Concentration of VLDL Particles,KDM3A,Lysine-specific demethylase 3A,37598,-0.00715781981989505,0.00846595357770102,-0.0237510888321891,0.00943544919239896,0.397856608936084
NMR metabolomics,X23428.Concentration of VLDL Particles,LPA,Apolipoprotein(a),37735,0.0134719431662895,0.0160077952248727,-0.017903335474461,0.04484722180704,0.400034640766251
NMR metabolomics,X23428.Concentration of VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.00277501399114655,0.00330194583710297,-0.00924682783186836,0.00369679984957526,0.400686829487524
NMR metabolomics,X23428.Concentration of VLDL Particles,CD209,CD209 antigen,40382,0.00296152887768742,0.00352766631031513,-0.00395269709053024,0.00987575484590508,0.401192958641395
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.00477853632152893,0.00572852718692171,-0.0160064496078955,0.00644937696483762,0.404203264746119
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD6,Programmed cell death protein 6,40359,-0.00528952470954798,0.00634556430354014,-0.0177268307444867,0.0071477813253907,0.404531173952242
NMR metabolomics,X23428.Concentration of VLDL Particles,EDNRB,Endothelin receptor type B,37598,0.0035825928173906,0.00433154759333256,-0.00490724046554122,0.0120724261003224,0.408199347695772
NMR metabolomics,X23428.Concentration of VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00385745861680213,0.00469918765683976,-0.0130678664242081,0.00535294919060381,0.411730949157709
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.00270327585753725,0.00329366981125263,-0.0037523169725179,0.0091588686875924,0.411804065958204
NMR metabolomics,X23428.Concentration of VLDL Particles,MAG,Myelin-associated glycoprotein,37572,0.00347527358129234,0.00426110845307248,-0.00487649898672971,0.0118270461493144,0.414755365610457
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.00206160288508251,0.00252949398545678,-0.00289620532641277,0.00701941109657779,0.415069690259691
NMR metabolomics,X23428.Concentration of VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00367258107086989,0.00451732266292995,-0.00518137134847281,0.0125265334902126,0.416233131618557
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMA1,Laminin subunit alpha-1,37562,-0.00415647646245291,0.00513561618770939,-0.0142222841903633,0.00590933126545749,0.418332404845442
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF20,Fibroblast growth factor 20,37598,0.00329670718479371,0.00408650119161968,-0.00471283515078085,0.0113062495203683,0.419836075340114
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.00281195639663064,0.00348804099351232,-0.00402460395065352,0.00964851674391479,0.420159059851648
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC39A14,Zinc transporter ZIP14,39961,0.00245145289494313,0.00304433095566415,-0.00351543577815861,0.00841834156804486,0.420686751428618
NMR metabolomics,X23428.Concentration of VLDL Particles,PALLD,Palladin,37598,0.00305163440728685,0.00379479767825289,-0.00438616904208881,0.0104894378566625,0.421317610570345
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,40228,-0.00263956248016812,0.00328445900683362,-0.00907710213356202,0.00379797717322578,0.421610015496667
NMR metabolomics,X23428.Concentration of VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00311003238110128,0.00388560015139865,-0.0107258086778426,0.00450574391564007,0.423493903080779
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXDC2,Plexin domain-containing protein 2,37942,0.00194582048010727,0.00243411190814279,-0.0028250388598526,0.00671667982006714,0.424074628486322
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,37598,0.00357200974287056,0.00447217962163498,-0.005193462315534,0.0123374818012751,0.424468456826363
NMR metabolomics,X23428.Concentration of VLDL Particles,ALMS1,Alstrom syndrome protein 1,37714,0.00328388338740518,0.00411307874511363,-0.00477775095301753,0.0113455177278279,0.424652514060573
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10,Interleukin-10,40044,0.00624905108059038,0.00783185600453164,-0.00910138668829163,0.0215994888494724,0.424939698657537
NMR metabolomics,X23428.Concentration of VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.0045148277548379,0.00575854231153547,-0.00677191517577163,0.0158015706854474,0.433040807041686
NMR metabolomics,X23428.Concentration of VLDL Particles,PYDC1,Pyrin domain-containing protein 1,37628,-0.00304191435765953,0.00389175400803013,-0.0106697522133986,0.00458592349807951,0.434445691709198
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00400841565367337,0.00513469116155554,-0.0140724103303222,0.00605557902297549,0.435020380394755
NMR metabolomics,X23428.Concentration of VLDL Particles,TJP3,Tight junction protein ZO-3,37541,-0.00311101845263861,0.00401369982177688,-0.0109778701033213,0.00475583319804406,0.438294614976251
NMR metabolomics,X23428.Concentration of VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00250326938843588,0.00324667593107387,-0.0038602154364689,0.00886675421334067,0.440703648083865
NMR metabolomics,X23428.Concentration of VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.0057622172494939,0.0075083661910599,-0.00895418048498351,0.0204786149839713,0.442834120865613
NMR metabolomics,X23428.Concentration of VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00206384191862193,0.00269128102825165,-0.00733875273399516,0.0032110688967513,0.443176771942371
NMR metabolomics,X23428.Concentration of VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00261024008230313,0.00341696796642234,-0.00408701713188467,0.00930749729649092,0.444935213088666
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,37572,0.00342773469820124,0.00453672606942583,-0.00546424839787339,0.0123197177942759,0.449931111294154
NMR metabolomics,X23428.Concentration of VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00230828084864947,0.00307108112758029,-0.00832759985870683,0.00371103816140789,0.452291966963411
NMR metabolomics,X23428.Concentration of VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00501011391159883,0.00666981253007121,-0.00806271864734075,0.0180829464705384,0.452568292788136
NMR metabolomics,X23428.Concentration of VLDL Particles,SPP1,Osteopontin,40497,-0.00324758596062523,0.00432686731904533,-0.0117282459059541,0.00523307398470362,0.45292677928472
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFL4,Insulin growth factor-like family member 4,37598,-0.00539352705739877,0.00719477883948371,-0.0194952935827868,0.0087082394679893,0.453482200363301
NMR metabolomics,X23428.Concentration of VLDL Particles,RASA1,Ras GTPase-activating protein 1,39961,0.00222351735621082,0.00296942781510167,-0.00359656116138845,0.0080435958738101,0.453987124551504
NMR metabolomics,X23428.Concentration of VLDL Particles,UPK3A,Uroplakin-3a,37541,0.00341813244715021,0.00457268904602461,-0.00554433808305802,0.0123806029773584,0.454768978573667
NMR metabolomics,X23428.Concentration of VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00496650273096117,0.00664759008978998,-0.00806277384502719,0.0179957793069495,0.455008582839483
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.00203792169576234,0.00273859426502105,-0.00332972306367891,0.00740556645520359,0.456799804483925
NMR metabolomics,X23428.Concentration of VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.00302372036202802,0.00410347528003455,-0.00501909118683968,0.0110665319108957,0.461215551004259
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL6B,Myosin light chain 6B,37572,-0.00621172089263489,0.00845777695398832,-0.022788963722452,0.0103655219371822,0.462694376059536
NMR metabolomics,X23428.Concentration of VLDL Particles,HCG22,Protein PBMUCL2,37562,0.00358409866684909,0.00488679107393146,-0.00599401183805657,0.0131622091717548,0.463311880940174
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA10,Annexin A10,39961,0.00551586019832091,0.0075228775102433,-0.00922897972175596,0.0202607001183978,0.463440533103664
NMR metabolomics,X23428.Concentration of VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00165975654421621,0.00227678263199517,-0.00612225050292675,0.00280273741449433,0.466019100357772
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA10,Ephrin type-A receptor 10,39961,0.00434098598461754,0.00595732743039686,-0.0073353757789603,0.0160173477481954,0.466208367241685
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00329135768301033,0.00452873405196141,-0.0121676764248547,0.00558496105883403,0.467378616062969
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF830,Zinc finger protein 830,37900,-0.00534204075933917,0.00736949213192031,-0.019786245337903,0.00910216381922464,0.468534658419156
NMR metabolomics,X23428.Concentration of VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.00239556004343923,0.00331070815263939,-0.00888454802261244,0.00409342793573397,0.469336934595172
NMR metabolomics,X23428.Concentration of VLDL Particles,MAMDC2,MAM domain-containing protein 2,37990,-0.00223953392423204,0.00309643249391806,-0.00830854161231144,0.00382947376384736,0.469531039735587
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS5,Transmembrane protease serine 5,40159,0.0024832068445027,0.00344123103208778,-0.00426160597838936,0.00922801966739475,0.470548583437971
NMR metabolomics,X23428.Concentration of VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00331461138781348,0.00461430140206496,-0.00572941936023384,0.0123586421358608,0.472563895975065
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00274982939541141,0.00384018163112029,-0.00477692660158436,0.0102765853924072,0.47396209801001
NMR metabolomics,X23428.Concentration of VLDL Particles,H2AP,Huntingtin-interacting protein M,37482,-0.00339555903202309,0.00476574070947824,-0.0127364108226004,0.00594529275855426,0.476172024849662
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_DRA,,40288,-0.00232572353111627,0.00328092580589445,-0.00875633811066939,0.00410489104843684,0.478420571742321
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR1,Toll-like receptor 1,37598,0.00169124678815418,0.00239193583939526,-0.00299694745706053,0.0063794410333689,0.479540521274262
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSB,Cathepsin B,40353,-0.00346345630300045,0.00490500994081773,-0.0130772757870032,0.0061503631810023,0.480132647764226
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.00185068455709151,0.00263153906582983,-0.00330713201193496,0.00700850112611798,0.48189719023128
NMR metabolomics,X23428.Concentration of VLDL Particles,HK2,Hexokinase-2,40042,-0.00177019265638487,0.00251863317143644,-0.00670671367240029,0.00316632835963055,0.482166822423258
NMR metabolomics,X23428.Concentration of VLDL Particles,STC2,Stanniocalcin-2,40309,-0.00172431950216851,0.00246935542419568,-0.00656425613359204,0.00311561712925501,0.485007787343377
NMR metabolomics,X23428.Concentration of VLDL Particles,AMIGO1,Amphoterin-induced protein 1,37572,0.00316550572141503,0.00456601800067527,-0.0057838895599085,0.0121149010027386,0.488149317253394
NMR metabolomics,X23428.Concentration of VLDL Particles,PITHD1,PITH domain-containing protein 1,37457,-0.00517143096362031,0.00750773397811543,-0.0198865895607266,0.00954372763348594,0.490952721746009
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN7,Tetraspanin-7,37541,0.0057512224065812,0.00836716481514009,-0.0106484206310934,0.0221508654442558,0.491870485754768
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB6B,Ras-related protein Rab-6B,39961,0.00305124705472881,0.00444644005776052,-0.00566377545848181,0.0117662695679394,0.492583092323696
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.00755689241146169,0.0110330021599562,-0.0140677918220526,0.0291815766449759,0.493394986250093
NMR metabolomics,X23428.Concentration of VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.00302866888154494,0.00443570314949659,-0.00566530929146837,0.0117226470545582,0.494749425866467
NMR metabolomics,X23428.Concentration of VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00604894255166372,0.00889161824405757,-0.0113786292066891,0.0234765143100166,0.496328341876908
NMR metabolomics,X23428.Concentration of VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00346271152914447,0.00510460289122438,-0.00654231013765532,0.0134677331959443,0.497561333550219
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAX,Integrin alpha-X,37714,0.003407808805361,0.00504147726823265,-0.00647348664037501,0.013289104251097,0.499081376079135
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC1A4,Neutral amino acid transporter A,37572,-0.00324269444262823,0.00480235635423913,-0.0126553128969369,0.00616992401168046,0.499541633334404
NMR metabolomics,X23428.Concentration of VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.00285440368044091,0.00422921669178361,-0.0111436683963368,0.00543486103545496,0.4997335368164
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAM1,Neural cell adhesion molecule 1,40403,0.00168920608604832,0.00251058288180389,-0.0032315363622873,0.00660994853438394,0.501062508775467
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00287497347555581,0.00429660434867053,-0.01129631799895,0.00554637104783842,0.503426397563571
NMR metabolomics,X23428.Concentration of VLDL Particles,CHGB,Secretogranin-1,40406,0.00244290242585755,0.00366764620065664,-0.00474568412742946,0.00963148897914456,0.505377153277499
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP15,Matrix metalloproteinase-15,37990,0.00302961152928768,0.00454885348700277,-0.00588614130523775,0.0119453643638131,0.505411894946142
NMR metabolomics,X23428.Concentration of VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.00327606541045251,0.00494727992043579,-0.00642060323360164,0.0129727340545067,0.507857718870557
NMR metabolomics,X23428.Concentration of VLDL Particles,TNPO1,Transportin-1,37714,0.00212705301209942,0.0032382108023199,-0.00421984016044759,0.00847394618464643,0.511281967843588
NMR metabolomics,X23428.Concentration of VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.0015321776152088,0.00233662378312501,-0.00304760499971622,0.00611196023013382,0.512013606978945
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",40293,0.00343037469543454,0.005256248739253,-0.00687187283350134,0.0137326222243704,0.514005650144553
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,-0.00215014009630551,0.0033009366914978,-0.00861997601164119,0.00431969581903017,0.514815344869391
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,0.0033495592064027,0.00518748538396666,-0.00681791214617196,0.0135170305589774,0.518482978936289
NMR metabolomics,X23428.Concentration of VLDL Particles,ESR1,Estrogen receptor,37598,0.00343480940902515,0.00532116496394816,-0.00699467392031324,0.0138642927383635,0.518614797721715
NMR metabolomics,X23428.Concentration of VLDL Particles,IL9,Interleukin-9,37714,0.003367056498737,0.00524720383684636,-0.00691746302148186,0.0136515760189559,0.521088263123813
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,40044,0.00226613871213971,0.00353568163750733,-0.00466379729737466,0.00919607472165409,0.521574959277981
NMR metabolomics,X23428.Concentration of VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.0030561700084907,0.00477116456397715,-0.0124076525538859,0.00629531253690451,0.521826206227067
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.0100758389364288,0.0159324267286944,-0.0211517174518122,0.0413033953246698,0.527127693929957
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA5,Annexin A5,39896,0.00175444298480151,0.00278639218869524,-0.00370688570504116,0.00721577167464419,0.528934996964938
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLN1,Cerebellin-1,37541,0.00564315787512013,0.00896423472081486,-0.011926742177677,0.0232130579279173,0.529020190083431
NMR metabolomics,X23428.Concentration of VLDL Particles,CD82,CD82 antigen,37714,0.00238544450568731,0.00382187907225601,-0.00510543847593447,0.00987632748730909,0.532536605885594
NMR metabolomics,X23428.Concentration of VLDL Particles,GAL,Galanin peptides,40422,0.00354151321156663,0.00567446536447232,-0.00758043890279912,0.0146634653259324,0.53256164268816
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G1B,Phospholipase A2,40514,-0.00237425554903249,0.00380894891461513,-0.00983979542167814,0.00509128432361317,0.533072498240999
NMR metabolomics,X23428.Concentration of VLDL Particles,RETN,Resistin,40283,0.00234807959489792,0.00376719429437347,-0.00503562122207408,0.00973178041186992,0.533098576212966
NMR metabolomics,X23428.Concentration of VLDL Particles,BTNL10,Butyrophilin-like protein 10,37482,0.0023774623006342,0.00382790051140058,-0.00512522270171094,0.00988014730297935,0.534552721378186
NMR metabolomics,X23428.Concentration of VLDL Particles,DKKL1,Dickkopf-like protein 1,40305,-0.00495943800887415,0.00800725902517137,-0.02065366569821,0.0107347896804617,0.535683022150541
NMR metabolomics,X23428.Concentration of VLDL Particles,DLGAP5,Disks large-associated protein 5,37959,-0.0030254701685441,0.00489978546035132,-0.0126290496708327,0.00657810933374448,0.536935220690635
NMR metabolomics,X23428.Concentration of VLDL Particles,DLL1,Delta-like protein 1,40411,-0.00164323719835243,0.0026628406398358,-0.0068624048524306,0.00357593045572573,0.537178008476371
NMR metabolomics,X23428.Concentration of VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00286344182388674,0.0046498244739397,-0.0119770977928085,0.00625021414503507,0.538025865903884
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00317837631909909,0.00516277606914848,-0.00694066477643194,0.0132974174146301,0.538147391150307
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.00182461124709755,0.00299379053880827,-0.00404321820896666,0.00769244070316176,0.542226362402253
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPEP,Glutamyl aminopeptidase,37562,0.00257528681127687,0.00424316672152126,-0.00574131996290479,0.0108918935854585,0.543910751068272
NMR metabolomics,X23428.Concentration of VLDL Particles,BOC,Brother of CDO,40042,-0.00130198008528038,0.00214771066432414,-0.0055114929873557,0.00290753281679494,0.544379068526825
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXDC1,Plexin domain-containing protein 1,39980,-0.00186492429010352,0.00309108408963758,-0.00792344910579317,0.00419360052558613,0.546302181696884
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF1,Trefoil factor 1,40261,-0.00425852655349876,0.00706947434457127,-0.0181146962688585,0.00959764316186093,0.546928297140648
NMR metabolomics,X23428.Concentration of VLDL Particles,AKAP12,A-kinase anchor protein 12,37671,-0.0011886134141289,0.00198801567486569,-0.00508512413686566,0.00270789730860786,0.54992400410161
NMR metabolomics,X23428.Concentration of VLDL Particles,ESPL1,Separin,37482,-0.00312642484978275,0.00524245391874156,-0.0134016345305162,0.00714878483095071,0.550940653298682
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR3,Folate receptor gamma,40355,0.00997588463162074,0.0167622527137008,-0.0228781306872328,0.0428298999504743,0.551758458521055
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",40310,-0.0036719846101658,0.00618497538282538,-0.0157945363605035,0.00845056714017194,0.552725066313976
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRR1B,Cornifin-B,37714,0.00460352875313239,0.00777841372176289,-0.0106421621415229,0.0198492196477877,0.553971923736069
NMR metabolomics,X23428.Concentration of VLDL Particles,PGM2,Phosphoglucomutase-2,37572,0.00324252679907944,0.0054837130902455,-0.00750555085780174,0.0139906044559606,0.554328730986541
NMR metabolomics,X23428.Concentration of VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.00382524278156058,0.00648118224198267,-0.0165283599758466,0.00887787441272546,0.555061690781607
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOC,Myocilin,40332,0.00245834174974956,0.00416976786321457,-0.00571440326215099,0.0106310867616501,0.555491906559135
NMR metabolomics,X23428.Concentration of VLDL Particles,TCP11,T-complex protein 11 homolog,37714,-0.00325277548635895,0.00554750742957255,-0.0141258900483212,0.00762033907560324,0.557650982023111
NMR metabolomics,X23428.Concentration of VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00218100611962973,0.00373028606432345,-0.0094923668057037,0.00513035456644424,0.558776012168105
NMR metabolomics,X23428.Concentration of VLDL Particles,IKZF2,Zinc finger protein Helios,39980,0.00497073781043638,0.00853250077559696,-0.0117529637097337,0.0216944393306064,0.560194513419569
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00308678508243598,0.00530572698585597,-0.0134860099747137,0.00731243980984172,0.560722438118062
NMR metabolomics,X23428.Concentration of VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.00187585388067886,0.00322594912973805,-0.00819871417496544,0.00444700641360772,0.560919113541875
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.00212475439298115,0.00368103530840577,-0.00509007481149417,0.00933958359745646,0.563803028233958
NMR metabolomics,X23428.Concentration of VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,0.0022024400646719,0.0038159150402837,-0.00527675341428416,0.00968163354362795,0.563831333350804
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6L2,Seizure 6-like protein 2,40305,0.00123106690492507,0.00216206008604588,-0.00300657086372485,0.00546870467357499,0.569095956279596
NMR metabolomics,X23428.Concentration of VLDL Particles,RRP15,RRP15-like protein,37541,-0.00473600448258469,0.00832599214312113,-0.0210549490831021,0.0115829401179327,0.569486948787818
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF5,Fibroblast growth factor 5,40044,0.00166805955666355,0.00293622114072293,-0.00408693387915339,0.00742305299248048,0.569977022854311
NMR metabolomics,X23428.Concentration of VLDL Particles,TPT1,Translationally-controlled tumor protein,40044,0.00342464765787645,0.00605682419068238,-0.00844672775586102,0.0152960230716139,0.571796470585577
NMR metabolomics,X23428.Concentration of VLDL Particles,MLLT1,Protein ENL,37482,0.00368940393775103,0.00655222793633506,-0.00915296281746569,0.0165317706929678,0.573392651314079
NMR metabolomics,X23428.Concentration of VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00150375697435683,0.00268722085564269,-0.0067707098514165,0.00376319590270285,0.575764838784497
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",37541,0.00313348352681742,0.00561791096893675,-0.00787762197229861,0.0141445890259334,0.577013259942629
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.00323353641050631,0.00581079640672737,-0.0146226973676919,0.00815562454667933,0.577897075434597
NMR metabolomics,X23428.Concentration of VLDL Particles,UBQLN3,Ubiquilin-3,37562,-0.00229183726965121,0.00412861739480422,-0.0103839273634675,0.00580025282416506,0.57882881673221
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00337740303258355,0.00613843909270967,-0.0086539375891274,0.0154087436542945,0.582187789034258
NMR metabolomics,X23428.Concentration of VLDL Particles,CRX,Cone-rod homeobox protein,40042,0.00527078686931901,0.00978360850759615,-0.0139050858055695,0.0244466595442075,0.59007638637946
NMR metabolomics,X23428.Concentration of VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,0.00167559402360822,0.00311774925393097,-0.00443519451409648,0.00778638256131292,0.59097325143851
NMR metabolomics,X23428.Concentration of VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00206980707684262,0.00386331136185337,-0.00964189734607523,0.00550228319238999,0.592133622785683
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00154192579516128,0.00295535292236738,-0.00733441752300134,0.00425056593267877,0.6018586559359
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA3,GDNF family receptor alpha-3,40194,0.00135347085626034,0.00260041115304752,-0.0037433350037128,0.00645027671623347,0.602734010054316
NMR metabolomics,X23428.Concentration of VLDL Particles,BLVRB,Flavin reductase,40332,0.00312472915525659,0.00603289942878626,-0.00869975372516448,0.0149492120356777,0.604501654977994
NMR metabolomics,X23428.Concentration of VLDL Particles,NPHS2,Podocin,37598,-0.00495303063455307,0.00958878964914766,-0.0237470583468825,0.0138409970777763,0.605483287143605
NMR metabolomics,X23428.Concentration of VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.00223291219184297,0.00434160715571155,-0.00627663783335167,0.0107424622170376,0.607047125959799
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,0.00549827041963999,0.0108354155072832,-0.0157391439746352,0.0267356848139152,0.611856592417692
NMR metabolomics,X23428.Concentration of VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00212621490536681,0.00419426651477168,-0.0103469772743193,0.00609454746358568,0.612209864744804
NMR metabolomics,X23428.Concentration of VLDL Particles,IL36A,Interleukin-36 alpha,37598,-0.00270352842170186,0.00540406891428569,-0.0132955034937018,0.0078884466502981,0.616888807063626
NMR metabolomics,X23428.Concentration of VLDL Particles,PGR,Progesterone receptor,37598,0.00469390932176409,0.00946476950706628,-0.0138570389120858,0.023244857555614,0.619948647555597
NMR metabolomics,X23428.Concentration of VLDL Particles,HMMR,Hyaluronan mediated motility receptor,37460,-0.00219860462437416,0.00445499650245182,-0.0109303977691797,0.00653318852043141,0.621657547273877
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.00257089997057564,0.00521464139919218,-0.0127915971129923,0.00764979717184103,0.62200975998203
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,37541,0.0035354445590363,0.00717647787771002,-0.0105304520812753,0.0176013411993479,0.62227283061131
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00387286214384564,0.00787186297847928,-0.019301713581665,0.0115559892939738,0.622736113132453
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.00349215444526218,0.00714957769162609,-0.0175053267208493,0.0105210178303249,0.62524468672597
NMR metabolomics,X23428.Concentration of VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,40044,-0.00139131277403604,0.00290044258512403,-0.00707618024087914,0.00429355469280706,0.631454697824429
NMR metabolomics,X23428.Concentration of VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,37541,0.00352622520384093,0.00738964722440629,-0.0109574833559954,0.0180099337636773,0.633238706146151
NMR metabolomics,X23428.Concentration of VLDL Particles,FZD10,Frizzled-10,37572,0.00265499087596487,0.00556845686096482,-0.00825918457152619,0.0135691663234559,0.633518798687043
NMR metabolomics,X23428.Concentration of VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.00175652524952279,0.00370836120803948,-0.00902491321728018,0.0055118627182346,0.635745829316648
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF174,Zinc finger protein 174,37598,-0.00167795095279569,0.00354850575264031,-0.00863302222797071,0.00527712032237932,0.636320005400104
NMR metabolomics,X23428.Concentration of VLDL Particles,TEX33,Testis-expressed protein 33,37714,-0.00167419293412501,0.00360376647358409,-0.00873757522234983,0.00538918935409981,0.642248806785555
NMR metabolomics,X23428.Concentration of VLDL Particles,GAGE2A,G antigen 2A,37482,0.00263981542217,0.00569589044321607,-0.0085241298465335,0.0138037606908735,0.643042668019365
NMR metabolomics,X23428.Concentration of VLDL Particles,CA3,Carbonic anhydrase 3,40500,-0.00256740823315084,0.00554572674924616,-0.0134370326616733,0.00830221619537163,0.643404670372185
NMR metabolomics,X23428.Concentration of VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,37901,0.00211873334930621,0.00461133143405697,-0.00691947626144545,0.0111569429600579,0.645909582525076
NMR metabolomics,X23428.Concentration of VLDL Particles,GJA8,Gap junction alpha-8 protein,37482,0.00260893121778495,0.005696210688104,-0.00855564173089889,0.0137735041664688,0.646951663487336
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00265711014613728,0.00582481665989177,-0.00875953050725059,0.0140737507995252,0.648274903458427
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.00136169389024975,0.00300217854811376,-0.00724596384455271,0.00452257606405321,0.650145484624302
NMR metabolomics,X23428.Concentration of VLDL Particles,TUBB3,Tubulin beta-3 chain,37541,-0.00114615591463543,0.00253941282289137,-0.00612340504750252,0.00383109321823166,0.651747079414786
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00250426905027966,0.00556257196495466,-0.0134069101015908,0.00839837200103148,0.652573790412004
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM3,Intercellular adhesion molecule 3,40536,-0.00103038752465715,0.00229341708614209,-0.00552548501349565,0.00346470996418135,0.653235392387363
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPT,Microtubule-associated protein tau,39961,0.00216951363111564,0.00484317579553489,-0.00732311092813275,0.011662138190364,0.654193596959266
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMG4,Proteasome assembly chaperone 4,37598,-0.00228682446613593,0.00515148642519518,-0.0123837378595185,0.00781008892724661,0.657111013122055
NMR metabolomics,X23428.Concentration of VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00257612134644223,0.00582321481855715,-0.0139896223908142,0.00883737969792979,0.658215552523801
NMR metabolomics,X23428.Concentration of VLDL Particles,SHD,SH2 domain-containing adapter protein D,37531,0.0034762208874877,0.00803378600498603,-0.0122699996822849,0.0192224414572603,0.665239712143616
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,40203,0.00132176044586464,0.0030585979000724,-0.00467309143827726,0.00731661233000654,0.665641314920297
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0025376558597772,0.00594289010571676,-0.00911040874742765,0.0141857204669821,0.669379992335448
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,37901,-0.00200709644502249,0.0047183244024174,-0.0112550122737606,0.00724081938371561,0.670564078019614
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,37598,0.00171836337189484,0.00404705077076525,-0.00621385613880505,0.00965058288259474,0.671137833233669
NMR metabolomics,X23428.Concentration of VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.00219027027227011,0.00516299855971923,-0.00792920690477959,0.0123097474493198,0.671409127968092
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17F,Interleukin-17F,40044,0.00305752943174544,0.00724414935375776,-0.0111410033016198,0.0172560621651106,0.672980618949427
NMR metabolomics,X23428.Concentration of VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.0026730652532634,0.00645675895061191,-0.0153283127964627,0.00998218228993594,0.678884616992505
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF7,Fibroblast growth factor 7,37482,0.00306209418723563,0.00741147861988355,-0.0114644039077361,0.0175885922822074,0.679499385641022
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.00154530605803084,0.00375892667117415,-0.00582219021747049,0.00891280233353216,0.681003647618627
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP4,Caspase-4,37714,-0.00628862567941545,0.0155911492573756,-0.0368472782238715,0.0242700268650406,0.686700303348423
NMR metabolomics,X23428.Concentration of VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00311289581351098,0.00774811012253992,-0.0182991916536892,0.0120734000266673,0.687865703212449
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.00240217523683633,0.00598026912181985,-0.0141235027156032,0.00931915224193058,0.687922528008668
NMR metabolomics,X23428.Concentration of VLDL Particles,TNNI3,"Troponin I, cardiac muscle",40042,0.00309175450157704,0.00770896344372103,-0.0120178138481162,0.0182013228512703,0.688381673252739
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,37562,-0.00258033427707103,0.00655401179139183,-0.015426197388199,0.010265528834057,0.693806709491485
NMR metabolomics,X23428.Concentration of VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00134665954269271,0.00346165782889171,-0.00813150888732046,0.00543818980193504,0.697266512711787
NMR metabolomics,X23428.Concentration of VLDL Particles,SCIN,Adseverin,37541,0.0025782460945321,0.00670630258338569,-0.0105661069689038,0.015722599157968,0.700650302242391
NMR metabolomics,X23428.Concentration of VLDL Particles,COMMD9,COMM domain-containing protein 9,37900,0.00136996051353562,0.0035794158120239,-0.00564569447803123,0.00838561550510246,0.701923800483763
NMR metabolomics,X23428.Concentration of VLDL Particles,KEL,Kell blood group glycoprotein,39961,0.00124119737588468,0.00324561977331857,-0.00512021737981972,0.00760261213158907,0.702153393054
NMR metabolomics,X23428.Concentration of VLDL Particles,TG,Thyroglobulin,37900,-0.00409568134907616,0.0107108845193537,-0.0250890150070094,0.0168976523088571,0.70218187337404
NMR metabolomics,X23428.Concentration of VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00211012370273115,0.0055447681092367,-0.0129778691968351,0.00875762179137279,0.703535067083999
NMR metabolomics,X23428.Concentration of VLDL Particles,HSP90B1,Endoplasmin,39878,-0.00242707586947766,0.00639684115795989,-0.014964884539079,0.0101107328001237,0.704382802563762
NMR metabolomics,X23428.Concentration of VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.0016319505761058,0.00431319135906768,-0.00682190448766685,0.0100858056398785,0.705166213290942
NMR metabolomics,X23428.Concentration of VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,37942,-0.000959844652002269,0.0025753124051472,-0.00600745696609078,0.00408776766208624,0.709370158402854
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.00103882789951941,0.00281767776801923,-0.00656147632483711,0.00448382052579829,0.712369575084638
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA11,Integrin alpha-11,40341,-0.00114098900109006,0.00309831087132269,-0.00721367830888253,0.0049317003067024,0.712683068493836
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.00128067046093095,0.00350316575618617,-0.00558553442119395,0.00814687534305585,0.714687945896271
NMR metabolomics,X23428.Concentration of VLDL Particles,FOS,Proto-oncogene c-Fos,37457,-0.00116766605018349,0.00321136793853075,-0.00746194720970376,0.00512661510933678,0.716159691048332
NMR metabolomics,X23428.Concentration of VLDL Particles,HEBP1,Heme-binding protein 1,40042,0.0018033091930651,0.00496024283876584,-0.00791876677091595,0.0115253851570461,0.716197055369721
NMR metabolomics,X23428.Concentration of VLDL Particles,ERVV_1,,37562,-0.00159817949455355,0.00442270781585498,-0.0102666868136293,0.00707032782452221,0.717837893227959
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.0017870388016483,0.00496448813633644,-0.0115174355488677,0.00794335794557113,0.718879517012659
NMR metabolomics,X23428.Concentration of VLDL Particles,TXK,Tyrosine-protein kinase TXK,37714,0.00247618825342966,0.00692551656080427,-0.0110978242057467,0.016050200712606,0.720689054677181
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP7,Retinoid-binding protein 7,37901,0.00190072094201772,0.00532373683527763,-0.00853380325512645,0.0123352451391619,0.721076751455875
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,40042,0.0016147068797297,0.00453297639093479,-0.00726992684650249,0.0104993406059619,0.721685586436283
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.002122828337959,0.0060356844030305,-0.0139527697678988,0.00970711309198079,0.725059203855045
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP2BP,LRP2-binding protein,37572,0.00277687746148626,0.00794145382541448,-0.0127883720363261,0.0183421269592986,0.726592993989535
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,0.00157044791855716,0.00450135185533702,-0.00725220171790339,0.0103930975550177,0.727182287574263
NMR metabolomics,X23428.Concentration of VLDL Particles,MUCL3,Mucin-like protein 3,37482,-0.00143773825537129,0.00412217542466154,-0.00951720208770791,0.00664172557696533,0.727259038216764
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP8,Neutrophil collagenase,40442,0.00230179103397573,0.00665796731268084,-0.0107478248988787,0.0153514069668302,0.729557861248131
NMR metabolomics,X23428.Concentration of VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.00129559895161123,0.00377716335876167,-0.00610764123156165,0.00869883913478411,0.731597598181385
NMR metabolomics,X23428.Concentration of VLDL Particles,CPE,Carboxypeptidase E,40360,-0.00118477489260935,0.00347799730635498,-0.00800164961306511,0.00563209982784641,0.733372640581272
NMR metabolomics,X23428.Concentration of VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.00106984233120767,0.00315359724110182,-0.0051112082613519,0.00725089292376725,0.73443057543112
NMR metabolomics,X23428.Concentration of VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.00206422007571732,0.00608529118114807,-0.0098629506393329,0.0139913907907675,0.734453456246682
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM2,Intercellular adhesion molecule 2,40536,0.000960461189289753,0.00283164482930665,-0.00458956267615127,0.00651048505473078,0.734472206259581
NMR metabolomics,X23428.Concentration of VLDL Particles,CASQ2,Calsequestrin-2,37562,-0.0015481793574998,0.0045879308888353,-0.010540523899617,0.00744416518461738,0.735786044590106
NMR metabolomics,X23428.Concentration of VLDL Particles,PRR5,Proline-rich protein 5,37598,0.00148438421098719,0.00440946238741324,-0.00715816206834277,0.0101269304903171,0.736396614329466
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.00141210694031981,0.00419548926129109,-0.00963526589245035,0.00681105201181074,0.736439891136321
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTF,Ciliary neurotrophic factor,37541,0.00103434569992946,0.00309340038949389,-0.00502871906347856,0.00709741046333749,0.73810441183345
NMR metabolomics,X23428.Concentration of VLDL Particles,TNR,Tenascin-R,40228,0.00129207912097252,0.00386490789110782,-0.0062831403455988,0.00886729858754384,0.738149744853938
NMR metabolomics,X23428.Concentration of VLDL Particles,STEAP4,Metalloreductase STEAP4,37541,0.00228663335902125,0.00688032407414553,-0.011198801826304,0.0157720685443465,0.739634957837852
NMR metabolomics,X23428.Concentration of VLDL Particles,REST,RE1-silencing transcription factor,37482,-0.00108643989486907,0.00327883740462666,-0.00751296120793733,0.00534008141819919,0.740386119640136
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN6,Prefoldin subunit 6,37572,0.00199918522044954,0.00604564901922727,-0.00985028685723591,0.013848657298135,0.740890241495929
NMR metabolomics,X23428.Concentration of VLDL Particles,DHODH,Dihydroorotate dehydrogenase,37562,0.00145716836139088,0.00442278104160566,-0.00721148248015621,0.010125819202938,0.741806636356524
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF3,Fibroblast growth factor 3,37598,0.00091587769229958,0.00278527156391626,-0.00454325457297628,0.00637500995757544,0.742290280670245
NMR metabolomics,X23428.Concentration of VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,40332,-0.00102596514072923,0.00312979947612178,-0.00716037211392791,0.00510844183246945,0.743063132503868
NMR metabolomics,X23428.Concentration of VLDL Particles,RUVBL1,RuvB-like 1,39980,0.00316790364697858,0.00978475710907561,-0.0160102202868096,0.0223460275807668,0.746124822797471
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2,Interleukin-2,40044,-0.000917895705820349,0.0028530524078872,-0.00650987842527927,0.00467408701363857,0.74766603466746
NMR metabolomics,X23428.Concentration of VLDL Particles,IL36G,Interleukin-36 gamma,37551,0.00202401357373261,0.0063041554415684,-0.0103321310917415,0.0143801582392067,0.748169872730915
NMR metabolomics,X23428.Concentration of VLDL Particles,CBX2,Chromobox protein homolog 2,37562,-0.00116854363374715,0.00376250153270299,-0.00854304663784501,0.00620595937035072,0.756127718465895
NMR metabolomics,X23428.Concentration of VLDL Particles,NCLN,Nicalin,40044,-0.00149173390339465,0.0048639735365091,-0.0110251220349525,0.00804165422816318,0.759083146395514
NMR metabolomics,X23428.Concentration of VLDL Particles,TBR1,T-box brain protein 1,37572,0.00136001671192688,0.00445967681946426,-0.00738094985422307,0.0101009832780768,0.760402535983579
NMR metabolomics,X23428.Concentration of VLDL Particles,DAND5,DAN domain family member 5,37598,-0.00151745273051287,0.00497668365225256,-0.0112717526889279,0.00823684722790215,0.760437671731594
NMR metabolomics,X23428.Concentration of VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,-0.00135254214300567,0.00444958511735084,-0.0100737289730133,0.00736864468700199,0.76115527058466
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP1,Retinol-binding protein 1,37572,0.00191430971614303,0.00629832995018569,-0.0104304169862209,0.014259036418507,0.761178989992357
NMR metabolomics,X23428.Concentration of VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.0026714354633609,0.0088415605764659,-0.0200008941932341,0.0146580232665122,0.762546137690219
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,0.00216757745139701,0.00725318084162427,-0.0120486569981866,0.0163838119009806,0.765062981514915
NMR metabolomics,X23428.Concentration of VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,37987,0.00069750595300071,0.00235982103457121,-0.00392774327475887,0.00532275518076029,0.767558603192426
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.000850164042934265,0.00289006776968695,-0.00651469687152068,0.00481436878565215,0.768634569811431
NMR metabolomics,X23428.Concentration of VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.00134447720110149,0.0046147041176353,-0.00770034286946369,0.0103892972716667,0.770790998417289
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00160173183351404,0.00551058968937845,-0.00919902395766772,0.0124024876246958,0.771312663554151
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSD1,Tryptase delta,37959,-0.000976725649526241,0.00348271175710841,-0.00780284069345872,0.00584938939440624,0.779136766130207
NMR metabolomics,X23428.Concentration of VLDL Particles,GDF15,Growth/differentiation factor 15,40536,-0.00107992224063778,0.00390774002783501,-0.00873909269519439,0.00657924821391884,0.782279213505119
NMR metabolomics,X23428.Concentration of VLDL Particles,FH,"Fumarate hydratase, mitochondrial",37541,0.00215598924123313,0.00781543567538383,-0.0131622646825192,0.0174742431649854,0.782657676862671
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,0.000844779591784231,0.00309432750550897,-0.00522010231901334,0.0069096615025818,0.784850521427848
NMR metabolomics,X23428.Concentration of VLDL Particles,REG1B,Lithostathine-1-beta,40536,-0.00137964954907222,0.00507780763772044,-0.0113321525190043,0.00857285342085984,0.785854793161392
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.00129231071032881,0.00477580082648934,-0.0106528803302479,0.00806825890959029,0.786706336798071
NMR metabolomics,X23428.Concentration of VLDL Particles,HBZ,Hemoglobin subunit zeta,37990,0.00258263974690535,0.00957249775160451,-0.0161794558462395,0.0213447353400502,0.787319854194652
NMR metabolomics,X23428.Concentration of VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,0.000492912836553798,0.00184749667919511,-0.00312818065466862,0.00411400632777622,0.789627049410173
NMR metabolomics,X23428.Concentration of VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00163884888913995,0.00614756379305012,-0.0104103761452383,0.0136880739235182,0.789792824192649
NMR metabolomics,X23428.Concentration of VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.00121912810137781,0.00461675722924668,-0.00782971606794568,0.0102679722707013,0.791733259422727
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK1,Kallikrein-1,40209,0.00299993564062232,0.0116057075321846,-0.0197472511224595,0.0257471224037041,0.796033717550548
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS1,"Nitric oxide synthase, brain",39961,-0.00114632908519538,0.00454513441305094,-0.0100547925347752,0.00776213436438446,0.800881966167223
NMR metabolomics,X23428.Concentration of VLDL Particles,HDAC9,Histone deacetylase 9,37541,-0.00144496076413392,0.00579230192060093,-0.0127978725285117,0.00990795100024389,0.803007140063684
NMR metabolomics,X23428.Concentration of VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,37688,0.00117565409251211,0.00479004607167104,-0.00821283620796313,0.0105641443929873,0.806121960272715
NMR metabolomics,X23428.Concentration of VLDL Particles,IGLON5,IgLON family member 5,37482,0.00209241817885379,0.00861536868025482,-0.0147937044344457,0.0189785407921532,0.808109606637697
NMR metabolomics,X23428.Concentration of VLDL Particles,SHC1,SHC-transforming protein 1,37482,0.00257012459556039,0.0106813543270982,-0.018365329885552,0.0235055790766728,0.809855093884928
NMR metabolomics,X23428.Concentration of VLDL Particles,EPGN,Epigen,37900,0.00108008448949362,0.00451373879895725,-0.00776684355646258,0.00992701253544983,0.810885751504406
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,0.000613648059811066,0.00260543923639293,-0.00449301284351909,0.00572030896314122,0.813804371235248
NMR metabolomics,X23428.Concentration of VLDL Particles,OTOA,Otoancorin,37541,-0.00117354305077815,0.00500559855297738,-0.0109845162146138,0.00863743011305751,0.814642341378091
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNL1,Interferon lambda-1,39961,-0.000955233387552053,0.00413114373659975,-0.00905227511128756,0.00714180833618345,0.81714123959023
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13,Interleukin-13,40044,0.000997332883716508,0.0043683950988023,-0.007564721509936,0.00955938727736902,0.819410985563247
NMR metabolomics,X23428.Concentration of VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,0.000694414710771688,0.00315737302897271,-0.00549403642601483,0.00688286584755821,0.825925747424205
NMR metabolomics,X23428.Concentration of VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,37900,0.000855629690121995,0.00389412446327261,-0.00677685425789232,0.00848811363813631,0.82609002974785
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM25,RNA-binding protein 25,37482,0.000930763818172994,0.00423739067295977,-0.00737452190082816,0.00923604953717415,0.826143336582926
NMR metabolomics,X23428.Concentration of VLDL Particles,APOH,Beta-2-glycoprotein 1,40332,-0.00070076853359003,0.00322671837612308,-0.00702513655079127,0.00562359948361121,0.828073315019528
NMR metabolomics,X23428.Concentration of VLDL Particles,S100G,Protein S100-G,37959,0.000862895593358996,0.00405362194341521,-0.00708220341573482,0.00880799460245281,0.831431365293424
NMR metabolomics,X23428.Concentration of VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.00108145698982221,0.00508655766678026,-0.00888819603706709,0.0110511100167115,0.831633836045717
NMR metabolomics,X23428.Concentration of VLDL Particles,DBH,Dopamine beta-hydroxylase,37967,0.00195531859885148,0.00962332457182409,-0.0169063975619237,0.0208170347596267,0.838993219614955
NMR metabolomics,X23428.Concentration of VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,37482,0.000909837974929001,0.00451083754134107,-0.00793140360609949,0.00975107955595749,0.840154057170853
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.00258374443210798,0.0129429954005796,-0.0227845265530281,0.0279520154172441,0.841777051097511
NMR metabolomics,X23428.Concentration of VLDL Particles,TPBGL,Trophoblast glycoprotein-like,37572,0.000756562055313861,0.00381757928324247,-0.00672589333984137,0.0082390174504691,0.842908495355797
NMR metabolomics,X23428.Concentration of VLDL Particles,CLNS1A,Methylosome subunit pICln,37572,-0.000599792676277544,0.00307133424963198,-0.00661960780555622,0.00542002245300113,0.845171036530582
NMR metabolomics,X23428.Concentration of VLDL Particles,PRC1,Protein regulator of cytokinesis 1,37900,-0.000806291267571939,0.00425624853092151,-0.00914853838817811,0.00753595585303423,0.849753128621887
NMR metabolomics,X23428.Concentration of VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.000749936092054858,0.00396358626949431,-0.00701869299615399,0.0085185651802637,0.849933866782309
NMR metabolomics,X23428.Concentration of VLDL Particles,GAD2,Glutamate decarboxylase 2,37598,-0.000809362362859824,0.00433040522519134,-0.00929695660423484,0.00767823187851519,0.851740180436547
NMR metabolomics,X23428.Concentration of VLDL Particles,DNLZ,DNL-type zinc finger protein,37541,-0.00161381754780793,0.00868901619789794,-0.0186442892956879,0.015416654200072,0.852658786105737
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",39530,-0.000477251130646888,0.0026047661842457,-0.00558259285176847,0.00462809059047469,0.854626097543045
NMR metabolomics,X23428.Concentration of VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.000995870647975494,0.00548714517346927,-0.00975893389202427,0.0117506751879753,0.8559845472546
NMR metabolomics,X23428.Concentration of VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,37572,-0.000708225033442694,0.00392363597729247,-0.00839855154893593,0.00698210148205054,0.856761093775013
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.000600860869895892,0.00336456895167635,-0.00719541601518155,0.00599369427538976,0.858266409627548
NMR metabolomics,X23428.Concentration of VLDL Particles,HRAS,GTPase Hras,37697,-0.0016017712339292,0.00898422679195525,-0.0192108557461615,0.0160073132783031,0.858500280160404
NMR metabolomics,X23428.Concentration of VLDL Particles,CLINT1,Clathrin interactor 1,37482,0.000743859235039903,0.00420031797606962,-0.00748876399805655,0.00897648246813635,0.859435788238869
NMR metabolomics,X23428.Concentration of VLDL Particles,TET2,Methylcytosine dioxygenase TET2,37697,-0.00159919021184431,0.00919219694740214,-0.0196158962287525,0.0164175158050639,0.861889670954635
NMR metabolomics,X23428.Concentration of VLDL Particles,LMOD2,Leiomodin-2,37541,0.00100778952836474,0.00593797975618061,-0.0106306507937493,0.0126462298504787,0.86523354964053
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC123,Cell division cycle protein 123 homolog,37482,0.000981875203427181,0.005863166710711,-0.0105099315495664,0.0124736819564207,0.867006784696187
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.000587178309882461,0.00354649232908504,-0.00753830327488914,0.00636394665512422,0.868501110033417
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNL2,Interferon lambda-2,37541,0.000968164464266939,0.00591443759470128,-0.0106241332213476,0.0125604621498815,0.869973701096578
NMR metabolomics,X23428.Concentration of VLDL Particles,ARG2,"Arginase-2, mitochondrial",37900,-0.000646289375762175,0.00405543633909,-0.00859494460037857,0.00730236584885422,0.873384722882556
NMR metabolomics,X23428.Concentration of VLDL Particles,MAGEA3,Melanoma-associated antigen 3,37714,-0.00120766176011582,0.00771645792704627,-0.0163319192971265,0.0139165957768949,0.875637614718312
NMR metabolomics,X23428.Concentration of VLDL Particles,AOC3,Membrane primary amine oxidase,40403,0.0004234689103922,0.00276244720443997,-0.00499092761031014,0.00583786543109454,0.878167706435063
NMR metabolomics,X23428.Concentration of VLDL Particles,EPB41L5,Band 4.1-like protein 5,37572,0.000841302364988251,0.00582261201943326,-0.0105710171931009,0.0122536219230774,0.885116700076392
NMR metabolomics,X23428.Concentration of VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.000483360508272393,0.00343921065985548,-0.00625749238504434,0.00722421340158913,0.888232007458249
NMR metabolomics,X23428.Concentration of VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,39980,-0.000631205028679791,0.00453632411703559,-0.00952240029806955,0.00825999024070997,0.889337685600011
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,37541,0.000887232898130303,0.00648588883044784,-0.0118251092095475,0.0135995750058081,0.891195459534749
NMR metabolomics,X23428.Concentration of VLDL Particles,PCARE,Photoreceptor cilium actin regulator,37541,0.00104916605184829,0.00786798387914091,-0.0143720823512679,0.0164704144549645,0.893921611303967
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS2,"Nitric oxide synthase, inducible",37562,-0.00047436331249048,0.00359420380684523,-0.00751900277390713,0.00657027614892618,0.895002071672149
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17A,Interleukin-17A,40028,-0.000494143694896706,0.00388431657066388,-0.00810740417339791,0.0071191167836045,0.898771801889924
NMR metabolomics,X23428.Concentration of VLDL Particles,PMCH,Pro-MCH,37562,-0.000982151835243839,0.00777377437030143,-0.0162187496010346,0.014254445930547,0.899463389802997
NMR metabolomics,X23428.Concentration of VLDL Particles,CPLX2,Complexin-2,37482,-0.000356926051415555,0.00283416503204787,-0.00591188951422938,0.00519803741139827,0.899783790200428
NMR metabolomics,X23428.Concentration of VLDL Particles,KHDC3L,KH domain-containing protein 3,37482,-0.000779861912856286,0.00623898222596731,-0.0130082670757522,0.0114485432500397,0.900526857373421
NMR metabolomics,X23428.Concentration of VLDL Particles,SKIV2L,Helicase SKI2W,37562,0.000461727971424683,0.00371317630455759,-0.0068160975855082,0.00773955352835756,0.901041239799232
NMR metabolomics,X23428.Concentration of VLDL Particles,OGN,Mimecan,40332,-0.000457814739404062,0.00370363103141129,-0.00771693156097019,0.00680130208216206,0.901623734400922
NMR metabolomics,X23428.Concentration of VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,37541,0.000442766638553421,0.00366991350365982,-0.00675026382861983,0.00763579710572668,0.903971934200845
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.000827619282182683,0.00738715277817858,-0.0136512001630473,0.0153064387274127,0.910797145883329
NMR metabolomics,X23428.Concentration of VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,37714,0.000746950702388835,0.00681697153763965,-0.0126143135113849,0.0141082149161625,0.912750301351685
NMR metabolomics,X23428.Concentration of VLDL Particles,OMP,Olfactory marker protein,37541,-0.000504319294088866,0.00462616261592751,-0.00957159802130678,0.00856295943312905,0.913192576708547
NMR metabolomics,X23428.Concentration of VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.00253001286881023,0.0239443595345509,-0.04946095755653,0.0444009318189096,0.915852008635636
NMR metabolomics,X23428.Concentration of VLDL Particles,COL5A1,Collagen alpha-1(V) chain,37671,0.000371234828585189,0.00362375011887609,-0.00673131540441195,0.00747378506158233,0.918405075872681
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL3,Insulin-like 3,37942,0.000538381782689899,0.00543850301018774,-0.0101210841172781,0.0111978476826579,0.921144123034068
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN15,Tetraspanin-15,37562,0.00044011101122732,0.00467078817827279,-0.00871463381818734,0.00959485584064198,0.924930846391523
NMR metabolomics,X23428.Concentration of VLDL Particles,IL31,Interleukin-31,37598,0.000481535027930585,0.00532026209702371,-0.00994617868223589,0.0109092487380971,0.927883609601935
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN4,Nectin-4,40411,0.000240705864122678,0.00277995063355028,-0.00520799737763587,0.00568940910588123,0.93100137806446
NMR metabolomics,X23428.Concentration of VLDL Particles,EVPL,Envoplakin,37714,0.000264179233810977,0.0031494217567464,-0.00590868740941196,0.00643704587703392,0.933151658964632
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.000309345815136255,0.00375068937195467,-0.00766069698416741,0.0070420053538949,0.934268618986416
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNIP4,Kv channel-interacting protein 4,39961,0.000381287426153458,0.00467937217418336,-0.00879028203524593,0.00955285688755285,0.935059210948103
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK12,Kallikrein-12,39980,0.000774438399507145,0.0130408742921756,-0.0247856752131571,0.0263345520121714,0.952645853115386
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,0.000291421012669023,0.00501917417752575,-0.00954616037528145,0.0101290024006195,0.953700486967401
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC25A,M-phase inducer phosphatase 1,37482,0.000211336050168622,0.00374625246373464,-0.00713131877875126,0.00755399087908851,0.955013940231772
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF6,Fibroblast growth factor 6,37598,-0.000209631254635898,0.00393208655558086,-0.00791652090357438,0.00749725839430258,0.957483347895835
NMR metabolomics,X23428.Concentration of VLDL Particles,CD58,Lymphocyte function-associated antigen 3,40335,-8.35650970867983e-05,0.00160743795225573,-0.00323414348350802,0.00306701328933442,0.95854009218246
NMR metabolomics,X23428.Concentration of VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.000202246332451622,0.00401381699947851,-0.00766483498652626,0.0080693276514295,0.959814198263161
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP112,Centrosomal protein of 112 kDa,37562,0.000198206628691368,0.0043179636063048,-0.00826500203966604,0.00866141529704878,0.963388419965904
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP1,DNA topoisomerase 1,37901,-0.000444381069338794,0.00973364937834363,-0.0195223338508923,0.0186335717122147,0.963586620844952
NMR metabolomics,X23428.Concentration of VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,37572,0.000285348260030495,0.00713741974424453,-0.0137039944386888,0.0142746909587498,0.968110325311631
NMR metabolomics,X23428.Concentration of VLDL Particles,ISM2,Isthmin-2,37998,0.000161606150947602,0.00406435083534993,-0.00780452148633825,0.00812773378823345,0.96828356904859
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPE4,NXPE family member 4,37562,0.00012967836406893,0.00332746537764725,-0.00639215377611967,0.00665151050425754,0.968913213965624
NMR metabolomics,X23428.Concentration of VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.000249154284472816,0.00640805000968373,-0.0128089323034529,0.0123106237345073,0.968985496670586
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNB2,Ephrin-B2,37572,-0.000201367665681297,0.0052933702471383,-0.0105763733500724,0.0101736380187098,0.969655184359806
NMR metabolomics,X23428.Concentration of VLDL Particles,IL15,Interleukin-15,40341,-8.37090689077824e-05,0.00298272233487136,-0.00592984484525565,0.00576242670744008,0.977610937818752
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.000208053963045502,0.00857286295957393,-0.0165947574377194,0.0170108653638104,0.980638487522879
NMR metabolomics,X23428.Concentration of VLDL Particles,MORN4,MORN repeat-containing protein 4,37482,-0.000166170782581509,0.00721562492211001,-0.0143087956299171,0.0139764540647541,0.981627254692233
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.000141555965616954,0.00775215445802458,-0.0150526667721112,0.0153357787033451,0.985431499547552
NMR metabolomics,X23428.Concentration of VLDL Particles,IL4,Interleukin-4,40044,0.000126834645549555,0.00818150398391931,-0.0159089131629323,0.0161625824540314,0.987631402557751
NMR metabolomics,X23428.Concentration of VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,37482,-8.8241093858811e-05,0.00580708579613498,-0.0114701292542834,0.0112936470665657,0.987876510091525
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,37714,8.99404680252623e-05,0.00613428256116434,-0.0119332533518569,0.0121131342879074,0.988302106050562
NMR metabolomics,X23428.Concentration of VLDL Particles,CYTH3,Cytohesin-3,37482,-9.68351707705356e-05,0.0067468839868002,-0.0133207277848989,0.0131270574433579,0.988548913435736
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,37901,0.00014149177911434,0.0117392327917633,-0.0228674044927418,0.0231503880509704,0.990383590136877
NMR metabolomics,X23428.Concentration of VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,-3.51135441474788e-05,0.00461181886520923,-0.00907427851995758,0.00900405143166262,0.993925227820708
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK3,Prostate-specific antigen,37998,-3.87950479910745e-05,0.00521441189696569,-0.0102590423660438,0.0101814522700617,0.994063930201585
NMR metabolomics,X23428.Concentration of VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,37541,-3.89408792122542e-05,0.00553943036076692,-0.0108962243863154,0.0108183426278909,0.994391214451625
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-2.83307919886017e-05,0.00674284819907994,-0.0132443132621853,0.0131876516782081,0.996647677272645
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA2,Protein disulfide-isomerase A2,37482,-1.08146456522931e-05,0.00380335030833505,-0.00746538124998899,0.0074437519586844,0.997731299798046
NMR metabolomics,X23428.Concentration of VLDL Particles,CD99,CD99 antigen,40332,3.64419521378007e-06,0.0017663207846319,-0.00345834454266475,0.00346563293309231,0.99835386681451
NMR metabolomics,X23428.Concentration of VLDL Particles,IL3,Interleukin-3,37482,7.83955397018123e-06,0.00550617190500647,-0.0107842573798425,0.0107999364877829,0.998864013499874
NMR metabolomics,X23428.Concentration of VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,8.67019942512237e-07,0.00512970174094458,-0.0100533483923089,0.0100550824321939,0.999865144473123
